> top > projects > pmc-enju-pas > docs > PMC:3342329 > annotations

PMC:3342329 JSONTXT 30 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T260 0-10 NN denotes Deficiency
T261 11-13 IN denotes of
T262 14-17 NN denotes C-C
T263 18-27 NNP denotes Chemokine
T264 28-36 NNP denotes Receptor
T265 37-38 CD denotes 5
T266 39-49 VB denotes Suppresses
T267 50-55 NN denotes Tumor
T268 56-84 NN denotes Development via Inactivation
T269 85-87 IN denotes of
T270 88-91 NF- denotes NF-
T271 91-92 NN denotes κ
T272 92-95 CC denotes B a
T273 95-107 NN denotes nd Upregulat
T274 107-109 IN denotes io
T275 109-115 NN denotes n of I
T276 115-117 IN denotes L-
T277 117-125 NNP denotes 1Ra in M
T278 125-130 NNP denotes elano
T279 195-197 TO denotes To
T280 198-206 VB denotes evaluate
T281 207-210 DT denotes the
T282 211-220 NN denotes relevance
T283 221-223 IN denotes of
T284 224-227 NN denotes C-C
T285 228-237 NN denotes chemokine
T286 238-246 NN denotes receptor
T287 247-251 NN denotes type
T288 252-253 CD denotes 5
T289 254-255 -LRB- denotes (
T290 255-259 NN denotes CCR5
T291 259-260 -RRB- denotes )
T292 261-271 NN denotes expression
T293 272-275 CC denotes and
T294 276-281 NN denotes tumor
T295 282-293 NN denotes development
T296 293-294 -COMMA- denotes ,
T297 295-297 PRP denotes we
T298 298-306 VB denotes compared
T299 307-315 NN denotes melanoma
T300 316-322 NN denotes growth
T301 323-325 IN denotes in
T302 326-330 NN denotes CCR5
T303 331-339 NN denotes knockout
T304 340-341 -LRB- denotes (
T305 341-348 NN denotes CCR5−/−
T306 348-349 -RRB- denotes )
T307 350-354 NN denotes mice
T308 355-358 CC denotes and
T309 359-363 JJ denotes wild
T310 364-368 NN denotes type
T311 369-370 -LRB- denotes (
T312 370-377 NN denotes CCR5+/+
T313 377-378 -RRB- denotes )
T314 379-383 NN denotes mice
T315 385-392 NN denotes CCR5−/−
T316 393-397 NN denotes mice
T317 398-404 VB denotes showed
T318 405-412 VB denotes reduced
T319 413-418 NN denotes tumor
T320 419-425 NN denotes volume
T321 425-426 -COMMA- denotes ,
T322 427-432 NN denotes tumor
T323 433-439 NN denotes weight
T324 439-440 -COMMA- denotes ,
T325 441-444 CC denotes and
T326 445-454 VB denotes increased
T327 455-463 NN denotes survival
T328 464-468 NN denotes rate
T329 469-473 WRB denotes when
T330 474-482 VB denotes compared
T331 483-485 TO denotes to
T332 486-493 JJ denotes CCR5+/+
T333 494-498 NN denotes mice
T334 500-502 PRP denotes We
T335 503-515 VB denotes investigated
T336 516-519 DT denotes the
T337 520-530 NN denotes activation
T338 531-533 IN denotes of
T339 534-539 NN denotes NF-κB
T340 540-545 IN denotes since
T341 546-548 PRP denotes it
T342 549-551 VB denotes is
T343 552-554 DT denotes an
T344 555-565 VB denotes implicated
T345 566-579 NN denotes transcription
T346 580-586 NN denotes factor
T347 587-589 IN denotes in
T348 590-593 DT denotes the
T349 594-604 NN denotes regulation
T350 605-607 IN denotes of
T351 608-613 NN denotes genes
T352 614-623 VB denotes involving
T353 624-628 NN denotes cell
T354 629-635 NN denotes growth
T355 635-636 -COMMA- denotes ,
T356 637-646 NN denotes apoptosis
T357 646-647 -COMMA- denotes ,
T358 648-651 CC denotes and
T359 652-657 NN denotes tumor
T360 658-664 NN denotes growth
T361 666-677 JJ denotes Significant
T362 678-688 NN denotes inhibition
T363 689-691 IN denotes of
T364 692-695 NN denotes DNA
T365 696-703 NN denotes binding
T366 704-712 NN denotes activity
T367 713-715 IN denotes of
T368 716-721 NN denotes NF-κB
T369 721-722 -COMMA- denotes ,
T370 723-726 CC denotes and
T371 727-740 NN denotes translocation
T372 741-743 IN denotes of
T373 744-747 NN denotes p50
T374 748-751 CC denotes and
T375 752-755 NN denotes p65
T376 756-760 IN denotes into
T377 761-764 DT denotes the
T378 765-772 NN denotes nucleus
T379 773-780 IN denotes through
T380 781-784 DT denotes the
T381 785-795 NN denotes inhibition
T382 796-798 IN denotes of
T383 799-814 NN denotes phosphorylation
T384 815-817 IN denotes of
T385 818-821 NN denotes IκB
T386 822-825 VB denotes was
T387 826-831 VB denotes found
T388 832-834 IN denotes in
T389 835-838 DT denotes the
T390 839-847 NN denotes melanoma
T391 848-855 NN denotes tissues
T392 856-858 IN denotes of
T393 859-866 NN denotes CCR5−/−
T394 867-871 NN denotes mice
T395 872-880 VB denotes compared
T396 881-883 TO denotes to
T397 884-892 NN denotes melanoma
T398 893-900 NN denotes tissues
T399 901-903 IN denotes of
T400 904-911 JJ denotes CCR5+/+
T401 912-916 NN denotes mice
T402 918-923 NN denotes NF-κB
T403 924-930 NN denotes target
T404 931-940 JJ denotes apoptotic
T405 941-948 NN denotes protein
T406 949-959 NN denotes expression
T407 959-960 -COMMA- denotes ,
T408 961-965 JJ denotes such
T409 966-968 IN denotes as
T410 969-976 VB denotes cleaved
T411 977-986 NN denotes caspase-3
T412 986-987 -COMMA- denotes ,
T413 988-995 VB denotes cleaved
T414 996-1000 NN denotes PARP
T415 1000-1001 -COMMA- denotes ,
T416 1002-1005 CC denotes and
T417 1006-1009 NN denotes Bax
T418 1009-1010 -COMMA- denotes ,
T419 1011-1014 VB denotes was
T420 1015-1023 VB denotes elevated
T421 1023-1024 -COMMA- denotes ,
T422 1025-1032 IN denotes whereas
T423 1033-1036 DT denotes the
T424 1037-1045 NN denotes survival
T425 1046-1053 NN denotes protein
T426 1054-1064 NN denotes expression
T427 1065-1071 NN denotes levels
T428 1071-1072 -COMMA- denotes ,
T429 1073-1077 JJ denotes such
T430 1078-1080 IN denotes as
T431 1081-1086 NN denotes Bcl-2
T432 1086-1087 -COMMA- denotes ,
T433 1088-1094 NN denotes C-IAP1
T434 1094-1095 -COMMA- denotes ,
T435 1096-1099 VB denotes was
T436 1100-1109 VB denotes decreased
T437 1110-1112 IN denotes in
T438 1113-1116 DT denotes the
T439 1117-1125 NN denotes melanoma
T440 1126-1133 NN denotes tissues
T441 1134-1136 IN denotes of
T442 1137-1144 NN denotes CCR5−/−
T443 1145-1149 NN denotes mice
T444 1151-1164 RB denotes Interestingly
T445 1164-1165 -COMMA- denotes ,
T446 1166-1168 PRP denotes we
T447 1169-1174 VB denotes found
T448 1175-1179 IN denotes that
T449 1180-1183 DT denotes the
T450 1184-1189 NN denotes level
T451 1190-1192 IN denotes of
T452 1193-1199 NN denotes IL-1Ra
T453 1199-1200 -COMMA- denotes ,
T454 1201-1202 DT denotes a
T455 1203-1208 NN denotes tumor
T456 1209-1215 NN denotes growth
T457 1216-1227 JJ denotes suppressive
T458 1228-1236 NN denotes cytokine
T459 1236-1237 -COMMA- denotes ,
T460 1238-1241 VB denotes was
T461 1242-1255 RB denotes significantly
T462 1256-1264 VB denotes elevated
T463 1265-1267 IN denotes in
T464 1268-1273 NN denotes tumor
T465 1274-1280 NN denotes tissue
T466 1281-1284 CC denotes and
T467 1285-1291 NN denotes spleen
T468 1292-1294 IN denotes of
T469 1295-1302 NN denotes CCR5−/−
T470 1303-1307 NN denotes mice
T471 1308-1316 VB denotes compared
T472 1317-1319 TO denotes to
T473 1320-1323 DT denotes the
T474 1324-1329 NN denotes level
T475 1330-1332 IN denotes in
T476 1333-1340 JJ denotes CCR5+/+
T477 1341-1345 NN denotes mice
T478 1347-1355 RB denotes Moreover
T479 1355-1356 -COMMA- denotes ,
T480 1357-1369 NN denotes infiltration
T481 1370-1372 IN denotes of
T482 1373-1377 JJ denotes CD8+
T483 1378-1387 JJ denotes cytotoxic
T484 1388-1389 NN denotes T
T485 1390-1394 NN denotes cell
T486 1395-1398 CC denotes and
T487 1399-1404 JJ denotes CD57+
T488 1405-1412 JJ denotes natural
T489 1413-1419 NN denotes killer
T490 1420-1425 NN denotes cells
T491 1426-1429 VB denotes was
T492 1430-1443 RB denotes significantly
T493 1444-1453 VB denotes increased
T494 1454-1456 IN denotes in
T495 1457-1465 NN denotes melanoma
T496 1466-1471 NN denotes tumor
T497 1472-1475 CC denotes and
T498 1476-1482 NN denotes spleen
T499 1483-1489 NN denotes tissue
T500 1490-1492 IN denotes of
T501 1493-1500 NN denotes CCR5−/−
T502 1501-1505 NN denotes mice
T503 1506-1514 VB denotes compared
T504 1515-1517 TO denotes to
T505 1518-1522 DT denotes that
T506 1523-1525 IN denotes of
T507 1526-1533 JJ denotes CCR5+/+
T508 1534-1538 NN denotes mice
T509 1540-1549 RB denotes Therefore
T510 1549-1550 -COMMA- denotes ,
T511 1551-1556 DT denotes these
T512 1557-1564 NN denotes results
T513 1565-1571 VB denotes showed
T514 1572-1576 IN denotes that
T515 1577-1581 NN denotes CCR5
T516 1582-1592 NN denotes deficiency
T517 1593-1599 VB denotes caused
T518 1600-1609 JJ denotes apoptotic
T519 1610-1614 NN denotes cell
T520 1615-1620 NN denotes death
T521 1621-1623 IN denotes of
T522 1624-1632 NN denotes melanoma
T523 1633-1640 IN denotes through
T524 1641-1651 NN denotes inhibition
T525 1652-1654 IN denotes of
T526 1655-1660 NN denotes NF-κB
T527 1661-1664 CC denotes and
T528 1665-1677 NN denotes upregulation
T529 1678-1680 IN denotes of
T530 1681-1687 NN denotes IL-1Ra
T1768 1703-1713 NN denotes Chemokines
T1769 1714-1717 VB denotes are
T1770 1718-1723 JJ denotes small
T1771 1724-1731 JJ denotes soluble
T1772 1732-1741 NN denotes molecules
T1773 1742-1746 WDT denotes that
T1774 1747-1750 VB denotes are
T1775 1751-1755 RB denotes best
T1776 1756-1761 VB denotes known
T1777 1762-1765 IN denotes for
T1778 1766-1771 PRP-DOLLAR- denotes their
T1779 1772-1778 JJ denotes potent
T1780 1779-1786 NN denotes ability
T1781 1787-1789 TO denotes to
T1782 1790-1796 VB denotes induce
T1783 1797-1803 NN denotes cancer
T1784 1804-1808 NN denotes cell
T1785 1809-1815 NN denotes growth
T1786 1816-1818 IN denotes by
T1787 1819-1831 NN denotes inflammation
T1788 1833-1837 JJ denotes Many
T1789 1838-1843 NN denotes types
T1790 1844-1846 IN denotes of
T1791 1847-1853 NN denotes cancer
T1792 1854-1859 NN denotes cells
T1793 1860-1867 VB denotes express
T1794 1868-1878 NN denotes chemokines
T1795 1879-1882 CC denotes and
T1796 1883-1892 NN denotes chemokine
T1797 1893-1902 NN denotes receptors
T1798 1903-1904 -LRB- denotes [
T1799 1904-1905 CD denotes 1
T1800 1905-1906 -RRB- denotes ]
T1801 1908-1911 DT denotes The
T1802 1912-1923 VB denotes accumulated
T1803 1924-1932 NN denotes evidence
T1804 1933-1942 VB denotes indicates
T1805 1943-1947 IN denotes that
T1806 1948-1951 DT denotes the
T1807 1952-1961 NN denotes chemokine
T1808 1962-1963 -LRB- denotes (
T1809 1963-1966 NN denotes C-C
T1810 1967-1972 NN denotes motif
T1811 1972-1973 -RRB- denotes )
T1812 1974-1980 NN denotes ligand
T1813 1981-1982 CD denotes 5
T1814 1983-1984 -LRB- denotes (
T1815 1984-1988 NN denotes CCL5
T1816 1988-1989 -RRB- denotes )
T1817 1990-1993 CC denotes and
T1818 1994-1997 NN denotes C-C
T1819 1998-2007 NN denotes chemokine
T1820 2008-2016 NN denotes receptor
T1821 2017-2018 -LRB- denotes (
T1822 2018-2022 NN denotes CCR5
T1823 2022-2023 -RRB- denotes )
T1824 2023-2024 -COMMA- denotes ,
T1825 2025-2030 WDT denotes which
T1826 2031-2034 VB denotes are
T1827 2035-2041 JJ denotes potent
T1828 2042-2053 JJ denotes chemotactic
T1829 2054-2061 NN denotes factors
T1830 2062-2065 IN denotes for
T1831 2066-2078 JJ denotes inflammatory
T1832 2079-2084 NN denotes cells
T1833 2084-2085 -COMMA- denotes ,
T1834 2086-2089 MD denotes may
T1835 2090-2092 VB denotes be
T1836 2093-2106 RB denotes significantly
T1837 2107-2115 VB denotes involved
T1838 2116-2118 IN denotes in
T1839 2119-2122 DT denotes the
T1840 2123-2136 NN denotes proliferation
T1841 2137-2140 CC denotes and
T1842 2141-2151 NN denotes metastasis
T1843 2152-2154 IN denotes of
T1844 2155-2162 JJ denotes several
T1845 2163-2170 NN denotes cancers
T1846 2172-2184 JJ denotes Intermediate
T1847 2185-2188 CC denotes and
T1848 2189-2195 JJ denotes strong
T1849 2196-2200 NN denotes CCR5
T1850 2201-2211 NN denotes expression
T1851 2212-2214 VB denotes is
T1852 2215-2228 RB denotes significantly
T1853 2229-2239 VB denotes associated
T1854 2240-2244 IN denotes with
T1855 2245-2258 JJ denotes nonmetastatic
T1856 2259-2270 NN denotes development
T1857 2271-2273 IN denotes of
T1858 2274-2284 JJ denotes colorectal
T1859 2285-2291 NN denotes cancer
T1860 2292-2293 -LRB- denotes [
T1861 2293-2294 CD denotes 2
T1862 2294-2295 -RRB- denotes ]
T1863 2295-2296 -COMMA- denotes ,
T1864 2297-2305 NN denotes melanoma
T1865 2306-2307 -LRB- denotes [
T1866 2307-2308 CD denotes 3
T1867 2308-2309 -RRB- denotes ]
T1868 2309-2310 -COMMA- denotes ,
T1869 2311-2319 NN denotes hepatoma
T1870 2320-2321 -LRB- denotes [
T1871 2321-2322 CD denotes 4
T1872 2322-2323 -RRB- denotes ]
T1873 2323-2324 -COMMA- denotes ,
T1874 2325-2337 NN denotes glioblastoma
T1875 2337-2338 -COMMA- denotes ,
T1876 2339-2346 NN denotes Hodgkin
T1877 2347-2355 NN denotes lymphoma
T1878 2356-2357 -LRB- denotes [
T1879 2357-2358 CD denotes 5
T1880 2358-2359 -RRB- denotes ]
T1881 2359-2360 -COMMA- denotes ,
T1882 2361-2363 RB denotes as
T1883 2364-2368 RB denotes well
T1884 2369-2371 IN denotes as
T1885 2372-2376 JJ denotes oral
T1886 2377-2380 CC denotes and
T1887 2381-2389 NN denotes prostate
T1888 2390-2396 NN denotes cancer
T1889 2397-2402 NN denotes cells
T1890 2403-2404 -LRB- denotes [
T1891 2404-2405 CD denotes 6
T1892 2405-2406 -RRB- denotes ]
T1893 2408-2413 JJ denotes Local
T1894 2414-2424 NN denotes production
T1895 2425-2427 IN denotes of
T1896 2428-2431 DT denotes the
T1897 2432-2436 NN denotes CCL5
T1898 2437-2439 VB denotes is
T1899 2440-2444 RB denotes also
T1900 2445-2454 JJ denotes important
T1901 2455-2457 IN denotes in
T1902 2458-2461 DT denotes the
T1903 2462-2473 NN denotes progression
T1904 2474-2476 IN denotes of
T1905 2477-2483 NN denotes breast
T1906 2484-2490 NN denotes cancer
T1907 2491-2492 -LRB- denotes [
T1908 2492-2493 CD denotes 7
T1909 2493-2494 -RRB- denotes ]
T1910 2494-2495 -COMMA- denotes ,
T1911 2496-2499 CC denotes and
T1912 2500-2504 RB denotes also
T1913 2505-2515 VB denotes correlates
T1914 2516-2520 IN denotes with
T1915 2521-2525 JJ denotes poor
T1916 2526-2535 NN denotes prognosis
T1917 2536-2537 -LRB- denotes [
T1918 2537-2538 CD denotes 8
T1919 2538-2539 -RRB- denotes ]
T1920 2541-2550 RB denotes Meanwhile
T1921 2550-2551 -COMMA- denotes ,
T1922 2552-2556 NN denotes CCR5
T1923 2557-2567 NN denotes disruption
T1924 2568-2571 VB denotes has
T1925 2572-2576 VB denotes been
T1926 2577-2589 VB denotes demonstrated
T1927 2590-2592 TO denotes to
T1928 2593-2600 VB denotes inhibit
T1929 2601-2613 JJ denotes experimental
T1930 2614-2619 NN denotes tumor
T1931 2620-2626 NN denotes growth
T1932 2627-2630 CC denotes and
T1933 2631-2641 NN denotes metastasis
T1934 2642-2644 IN denotes of
T1935 2645-2655 JJ denotes pancreatic
T1936 2656-2662 NN denotes cancer
T1937 2663-2664 -LRB- denotes [
T1938 2664-2665 CD denotes 9
T1939 2665-2666 -RRB- denotes ]
T1940 2668-2670 IN denotes In
T1941 2671-2679 NN denotes addition
T1942 2679-2680 -COMMA- denotes ,
T1943 2681-2685 NN denotes host
T1944 2686-2693 NN denotes absence
T1945 2694-2696 IN denotes of
T1946 2697-2701 NN denotes CCR5
T1947 2702-2713 VB denotes potentiates
T1948 2714-2717 DT denotes the
T1949 2718-2723 NN denotes delay
T1950 2724-2726 IN denotes of
T1951 2727-2732 NN denotes tumor
T1952 2733-2739 NN denotes growth
T1953 2740-2741 -LRB- denotes [
T1954 2741-2743 CD denotes 10
T1955 2743-2744 -RRB- denotes ]
T1956 2744-2745 -COMMA- denotes ,
T1957 2746-2749 CC denotes and
T1958 2750-2754 NN denotes CCR5
T1959 2755-2765 NN denotes inhibitors
T1960 2766-2775 VB denotes prevented
T1961 2776-2782 NN denotes cancer
T1962 2783-2787 NN denotes cell
T1963 2788-2794 NN denotes growth
T1964 2794-2795 -COMMA- denotes ,
T1965 2796-2800 JJ denotes such
T1966 2801-2803 IN denotes as
T1967 2804-2812 NN denotes prostate
T1968 2813-2819 NN denotes cancer
T1969 2820-2821 -LRB- denotes [
T1970 2821-2823 CD denotes 11
T1971 2823-2824 -RRB- denotes ]
T1972 2824-2825 -COMMA- denotes ,
T1973 2826-2832 NN denotes breast
T1974 2833-2839 NN denotes cancer
T1975 2839-2840 -COMMA- denotes ,
T1976 2841-2849 NN denotes hepatoma
T1977 2850-2855 NN denotes cells
T1978 2856-2857 -LRB- denotes [
T1979 2857-2858 CD denotes 4
T1980 2858-2859 -RRB- denotes ]
T1981 2859-2860 -COMMA- denotes ,
T1982 2861-2864 CC denotes and
T1983 2865-2869 NN denotes lung
T1984 2870-2876 NN denotes cancer
T1985 2877-2878 -LRB- denotes [
T1986 2878-2880 CD denotes 12
T1987 2880-2881 -RRB- denotes ]
T1988 2883-2888 DT denotes These
T1989 2889-2893 NN denotes data
T1990 2894-2901 VB denotes suggest
T1991 2902-2906 IN denotes that
T1992 2907-2910 DT denotes the
T1993 2911-2921 NN denotes deficiency
T1994 2922-2924 IN denotes of
T1995 2925-2937 JJ denotes inflammatory
T1996 2938-2947 NN denotes chemokine
T1997 2948-2956 NN denotes receptor
T1998 2957-2961 NN denotes CCR5
T1999 2962-2965 MD denotes may
T2000 2966-2974 VB denotes function
T2001 2975-2977 IN denotes as
T2002 2978-2979 DT denotes a
T2003 2980-2991 JJ denotes suppressive
T2004 2992-3000 NN denotes receptor
T2005 3001-3003 IN denotes in
T2006 3004-3010 NN denotes cancer
T2007 3011-3022 NN denotes progression
T2008 3024-3031 RB denotes However
T2009 3031-3032 -COMMA- denotes ,
T2010 3033-3037 JJ denotes more
T2011 3038-3045 NN denotes studies
T2012 3046-3049 VB denotes are
T2013 3050-3058 VB denotes required
T2014 3059-3061 TO denotes to
T2015 3062-3070 VB denotes describe
T2016 3071-3074 WRB denotes how
T2017 3075-3079 NN denotes CCR5
T2018 3080-3090 NN denotes deficiency
T2019 3091-3095 VB denotes acts
T2020 3096-3098 IN denotes in
T2021 3099-3102 DT denotes the
T2022 3103-3113 NN denotes inhibition
T2023 3114-3116 IN denotes of
T2024 3117-3122 NN denotes tumor
T2025 3123-3134 NN denotes development
T2026 3136-3149 NN denotes Interleukin-1
T2027 3150-3158 NN denotes receptor
T2028 3159-3169 NN denotes antagonist
T2029 3170-3171 -LRB- denotes (
T2030 3171-3177 NN denotes IL-1Ra
T2031 3177-3178 -RRB- denotes )
T2032 3178-3179 -COMMA- denotes ,
T2033 3180-3181 DT denotes a
T2034 3182-3188 NN denotes member
T2035 3189-3191 IN denotes of
T2036 3192-3195 DT denotes the
T2037 3196-3200 NN denotes IL-1
T2038 3201-3207 NN denotes family
T2039 3207-3208 -COMMA- denotes ,
T2040 3209-3211 VB denotes is
T2041 3212-3213 DT denotes a
T2042 3214-3223 RB denotes naturally
T2043 3224-3233 VB denotes occurring
T2044 3234-3242 NN denotes cytokine
T2045 3243-3247 WDT denotes that
T2046 3248-3261 RB denotes competitively
T2047 3262-3268 VB denotes blocks
T2048 3269-3272 DT denotes the
T2049 3273-3277 NN denotes IL-1
T2050 3278-3286 NN denotes receptor
T2051 3287-3288 -LRB- denotes [
T2052 3288-3290 CD denotes 13
T2053 3290-3291 -RRB- denotes ]
T2054 3293-3300 IN denotes Because
T2055 3301-3307 NN denotes IL-1Ra
T2056 3308-3311 VB denotes has
T2057 3312-3316 VB denotes been
T2058 3317-3322 VB denotes shown
T2059 3323-3325 TO denotes to
T2060 3326-3333 VB denotes inhibit
T2061 3334-3339 NN denotes tumor
T2062 3340-3351 NN denotes progression
T2063 3352-3354 IN denotes by
T2064 3355-3364 VB denotes promoting
T2065 3365-3374 JJ denotes antitumor
T2066 3375-3381 JJ denotes immune
T2067 3382-3391 NN denotes responses
T2068 3392-3395 CC denotes and
T2069 3396-3398 IN denotes by
T2070 3399-3408 VB denotes enhancing
T2071 3409-3412 DT denotes the
T2072 3413-3421 NN denotes activity
T2073 3422-3424 IN denotes of
T2074 3425-3437 NN denotes chemotherapy
T2075 3437-3438 -COMMA- denotes ,
T2076 3439-3447 JJ denotes numerous
T2077 3448-3455 NN denotes studies
T2078 3456-3460 VB denotes have
T2079 3461-3469 VB denotes examined
T2080 3470-3473 DT denotes the
T2081 3474-3481 NN denotes ability
T2082 3482-3484 IN denotes of
T2083 3485-3491 NN denotes IL-1Ra
T2084 3492-3494 TO denotes to
T2085 3495-3500 VB denotes block
T2086 3501-3506 NN denotes tumor
T2087 3507-3518 NN denotes progression
T2088 3520-3526 NN denotes IL-1Ra
T2089 3527-3537 NN denotes expression
T2090 3538-3541 VB denotes was
T2091 3542-3549 VB denotes reduced
T2092 3550-3552 IN denotes in
T2093 3553-3561 NN denotes prostate
T2094 3562-3563 -LRB- denotes [
T2095 3563-3565 CD denotes 14
T2096 3565-3566 -RRB- denotes ]
T2097 3566-3567 -COMMA- denotes ,
T2098 3568-3574 NN denotes breast
T2099 3575-3576 -LRB- denotes [
T2100 3576-3578 CD denotes 15
T2101 3578-3579 -RRB- denotes ]
T2102 3579-3580 -COMMA- denotes ,
T2103 3581-3584 CC denotes and
T2104 3585-3589 NN denotes skin
T2105 3590-3596 NN denotes cancer
T2106 3597-3598 -LRB- denotes [
T2107 3598-3600 CD denotes 16
T2108 3600-3601 -RRB- denotes ]
T2109 3603-3605 PRP denotes It
T2110 3606-3609 VB denotes was
T2111 3610-3614 RB denotes also
T2112 3615-3623 VB denotes reported
T2113 3624-3628 IN denotes that
T2114 3629-3639 JJ denotes endogenous
T2115 3640-3646 NN denotes IL-1Ra
T2116 3647-3656 JJ denotes deficient
T2117 3657-3661 NN denotes mice
T2118 3662-3671 VB denotes developed
T2119 3672-3682 JJ denotes aggressive
T2120 3683-3689 NN denotes tumors
T2121 3690-3699 VB denotes following
T2122 3700-3708 NN denotes exposure
T2123 3709-3711 TO denotes to
T2124 3712-3723 NN denotes carcinogens
T2125 3724-3725 -LRB- denotes [
T2126 3725-3727 CD denotes 17
T2127 3727-3728 -RRB- denotes ]
T2128 3730-3739 RB denotes Meanwhile
T2129 3739-3740 -COMMA- denotes ,
T2130 3741-3754 NN denotes proliferation
T2131 3755-3757 IN denotes of
T2132 3758-3761 DT denotes the
T2133 3762-3770 NN denotes melanoma
T2134 3771-3776 NN denotes cells
T2135 3777-3781 WDT denotes that
T2136 3782-3786 VB denotes were
T2137 3787-3797 VB denotes transduced
T2138 3798-3802 IN denotes with
T2139 3803-3809 NN denotes IL-1Ra
T2140 3810-3814 NN denotes gene
T2141 3815-3818 VB denotes was
T2142 3819-3826 VB denotes reduced
T2143 3827-3830 CC denotes and
T2144 3831-3840 VB denotes inhibited
T2145 3841-3849 NN denotes melanoma
T2146 3850-3861 NN denotes development
T2147 3862-3863 -LRB- denotes [
T2148 3863-3865 CD denotes 18
T2149 3865-3866 -RRB- denotes ]
T2150 3868-3873 NN denotes IL-1R
T2151 3874-3882 NN denotes blockade
T2152 3883-3887 RB denotes also
T2153 3888-3895 VB denotes reduced
T2154 3896-3903 JJ denotes hepatic
T2155 3904-3909 NN denotes tumor
T2156 3910-3916 NN denotes growth
T2157 3917-3918 -LRB- denotes [
T2158 3918-3920 CD denotes 19
T2159 3920-3921 -RRB- denotes ]
T2160 3923-3931 RB denotes Moreover
T2161 3931-3932 -COMMA- denotes ,
T2162 3933-3935 PRP denotes it
T2163 3936-3939 VB denotes has
T2164 3940-3944 RB denotes also
T2165 3945-3949 VB denotes been
T2166 3950-3958 VB denotes reported
T2167 3959-3963 IN denotes that
T2168 3964-3970 NN denotes IL-1Ra
T2169 3971-3978 VB denotes reduces
T2170 3979-3991 NN denotes fibrosarcoma
T2171 3992-4003 NN denotes development
T2172 4004-4005 -LRB- denotes [
T2173 4005-4007 CD denotes 20
T2174 4007-4008 -RRB- denotes ]
T2175 4008-4009 -COMMA- denotes ,
T2176 4010-4013 NN denotes B16
T2177 4014-4022 NN denotes melanoma
T2178 4023-4029 NN denotes growth
T2179 4030-4033 CC denotes and
T2180 4034-4044 NN denotes metastasis
T2181 4045-4046 -LRB- denotes [
T2182 4046-4048 CD denotes 21
T2183 4048-4049 -RRB- denotes ]
T2184 4049-4050 -COMMA- denotes ,
T2185 4051-4056 NN denotes colon
T2186 4057-4071 NN denotes adenocarcinoma
T2187 4072-4078 NN denotes growth
T2188 4079-4080 -LRB- denotes [
T2189 4080-4082 CD denotes 22
T2190 4082-4083 -RRB- denotes ]
T2191 4083-4084 -COMMA- denotes ,
T2192 4085-4088 CC denotes and
T2193 4089-4093 NN denotes skin
T2194 4094-4100 NN denotes cancer
T2195 4101-4112 NN denotes development
T2196 4113-4114 -LRB- denotes [
T2197 4114-4116 CD denotes 23
T2198 4116-4117 -RRB- denotes ]
T2199 4119-4123 NN denotes IL-1
T2200 4124-4132 NN denotes knockout
T2201 4133-4137 NN denotes mice
T2202 4138-4146 VB denotes injected
T2203 4147-4151 IN denotes with
T2204 4152-4160 NN denotes melanoma
T2205 4161-4167 VB denotes failed
T2206 4168-4170 TO denotes to
T2207 4171-4178 VB denotes develop
T2208 4179-4184 JJ denotes solid
T2209 4185-4191 NN denotes tumors
T2210 4192-4193 -LRB- denotes [
T2211 4193-4195 CD denotes 24
T2212 4195-4196 -RRB- denotes ]
T2213 4198-4200 PRP denotes It
T2214 4201-4204 VB denotes was
T2215 4205-4209 RB denotes also
T2216 4210-4215 VB denotes found
T2217 4216-4220 IN denotes that
T2218 4221-4227 NN denotes IL-1Ra
T2219 4227-4228 -COMMA- denotes ,
T2220 4229-4237 VB denotes combined
T2221 4238-4242 IN denotes with
T2222 4243-4255 NN denotes temozolomide
T2223 4256-4259 CC denotes and
T2224 4260-4269 NN denotes docetaxel
T2225 4270-4282 NN denotes chemotherapy
T2226 4282-4283 -COMMA- denotes ,
T2227 4284-4296 VB denotes demonstrated
T2228 4297-4301 RB denotes more
T2229 4302-4313 JJ denotes significant
T2230 4314-4323 JJ denotes antitumor
T2231 4324-4332 NN denotes activity
T2232 4333-4340 IN denotes against
T2233 4341-4344 NN denotes B16
T2234 4345-4353 NN denotes melanoma
T2235 4354-4359 NN denotes cells
T2236 4360-4362 FW denotes in
T2237 4363-4367 FW denotes vivo
T2238 4368-4369 -LRB- denotes [
T2239 4369-4371 CD denotes 25
T2240 4371-4372 -RRB- denotes ]
T2241 4374-4379 DT denotes These
T2242 4380-4384 NN denotes data
T2243 4385-4393 VB denotes indicate
T2244 4394-4398 IN denotes that
T2245 4399-4405 NN denotes IL-1Ra
T2246 4406-4408 VB denotes is
T2247 4409-4418 JJ denotes important
T2248 4419-4421 IN denotes as
T2249 4422-4423 DT denotes a
T2250 4424-4429 NN denotes tumor
T2251 4430-4436 NN denotes growth
T2252 4437-4448 VB denotes suppressing
T2253 4449-4457 NN denotes cytokine
T2254 4459-4464 NN denotes NF-κB
T2255 4465-4470 VB denotes plays
T2256 4471-4472 DT denotes a
T2257 4473-4480 JJ denotes crucial
T2258 4481-4485 NN denotes role
T2259 4486-4488 IN denotes in
T2260 4489-4492 DT denotes the
T2261 4493-4504 NN denotes suppression
T2262 4505-4507 IN denotes of
T2263 4508-4517 NN denotes apoptosis
T2264 4517-4518 -COMMA- denotes ,
T2265 4519-4521 RB denotes as
T2266 4522-4526 RB denotes well
T2267 4527-4529 IN denotes as
T2268 4530-4533 DT denotes the
T2269 4534-4543 NN denotes induction
T2270 4544-4546 IN denotes of
T2271 4547-4551 NN denotes cell
T2272 4552-4565 NN denotes proliferation
T2273 4566-4569 CC denotes and
T2274 4570-4582 NN denotes inflammation
T2275 4582-4583 -COMMA- denotes ,
T2276 4584-4587 CC denotes and
T2277 4588-4590 VB denotes is
T2278 4591-4598 RB denotes closely
T2279 4599-4609 VB denotes associated
T2280 4610-4614 IN denotes with
T2281 4615-4621 NN denotes cancer
T2282 4622-4633 NN denotes development
T2283 4634-4635 -LRB- denotes [
T2284 4635-4637 CD denotes 26
T2285 4637-4638 -RRB- denotes ]
T2286 4640-4652 JJ denotes Constitutive
T2287 4653-4663 NN denotes activation
T2288 4664-4666 IN denotes of
T2289 4667-4672 NN denotes NF-κB
T2290 4673-4676 VB denotes has
T2291 4677-4681 VB denotes been
T2292 4682-4691 VB denotes described
T2293 4692-4694 IN denotes in
T2294 4695-4696 DT denotes a
T2295 4697-4702 JJ denotes great
T2296 4703-4709 NN denotes number
T2297 4710-4712 IN denotes of
T2298 4713-4720 NN denotes cancers
T2299 4721-4730 VB denotes including
T2300 4731-4736 NN denotes colon
T2301 4737-4744 NN denotes cancers
T2302 4744-4745 -COMMA- denotes ,
T2303 4746-4754 NN denotes prostate
T2304 4755-4762 NN denotes cancers
T2305 4763-4766 CC denotes and
T2306 4767-4775 NN denotes melanoma
T2307 4776-4777 -LRB- denotes [
T2308 4777-4779 CD denotes 27
T2309 4779-4780 -RRB- denotes ]
T2310 4780-4781 -COMMA- denotes ,
T2311 4782-4785 CC denotes and
T2312 4786-4789 VB denotes was
T2313 4790-4795 VB denotes found
T2314 4796-4798 TO denotes to
T2315 4799-4810 VB denotes up-regulate
T2316 4811-4825 JJ denotes anti-apoptotic
T2317 4826-4831 NN denotes genes
T2318 4832-4838 CC denotes and/or
T2319 4839-4843 RB denotes down
T2320 4844-4852 VB denotes regulate
T2321 4853-4862 JJ denotes apoptotic
T2322 4863-4867 NN denotes gene
T2323 4868-4878 NN denotes expression
T2324 4879-4880 -LRB- denotes [
T2325 4880-4882 CD denotes 28
T2326 4882-4883 -RRB- denotes ]
T2327 4885-4893 IN denotes Although
T2328 4894-4899 NN denotes NF-κB
T2329 4900-4908 VB denotes promotes
T2330 4909-4914 NN denotes tumor
T2331 4915-4921 NN denotes growth
T2332 4921-4922 -COMMA- denotes ,
T2333 4923-4925 PRP denotes it
T2334 4926-4928 VB denotes is
T2335 4929-4937 VB denotes required
T2336 4938-4941 IN denotes for
T2337 4942-4945 DT denotes the
T2338 4946-4952 JJ denotes immune
T2339 4953-4959 NN denotes system
T2340 4960-4962 TO denotes to
T2341 4963-4971 VB denotes function
T2342 4972-4980 RB denotes normally
T2343 4981-4982 -LRB- denotes [
T2344 4982-4984 CD denotes 29
T2345 4984-4985 -RRB- denotes ]
T2346 4987-4994 NN denotes Studies
T2347 4995-4997 IN denotes on
T2348 4998-5013 JJ denotes c-Rel-deficient
T2349 5014-5018 NN denotes mice
T2350 5019-5031 VB denotes demonstrated
T2351 5032-5036 IN denotes that
T2352 5037-5042 NN denotes c-Rel
T2353 5043-5045 VB denotes is
T2354 5046-5055 JJ denotes essential
T2355 5056-5059 IN denotes for
T2356 5060-5064 NN denotes IL-2
T2357 5064-5065 -COMMA- denotes ,
T2358 5066-5070 NN denotes IL-3
T2359 5070-5071 -COMMA- denotes ,
T2360 5072-5078 NN denotes GM-CSF
T2361 5078-5079 -COMMA- denotes ,
T2362 5080-5083 CC denotes and
T2363 5084-5088 NN denotes IFNγ
T2364 5089-5099 NN denotes expression
T2365 5100-5102 IN denotes in
T2366 5103-5104 NN denotes T
T2367 5105-5116 NN denotes lymphocytes
T2368 5117-5118 -LRB- denotes [
T2369 5118-5120 CD denotes 30
T2370 5120-5121 -RRB- denotes ]
T2371 5123-5138 JJ denotes C-Rel-deficient
T2372 5139-5143 NN denotes mice
T2373 5144-5148 RB denotes also
T2374 5149-5153 VB denotes have
T2375 5154-5155 DT denotes a
T2376 5156-5171 JJ denotes tissue-specific
T2377 5172-5182 NN denotes deficiency
T2378 5183-5185 IN denotes of
T2379 5186-5193 JJ denotes various
T2380 5194-5203 NN denotes cytokines
T2381 5204-5207 CC denotes and
T2382 5208-5214 NN denotes growth
T2383 5215-5222 NN denotes factors
T2384 5223-5225 IN denotes in
T2385 5226-5227 NN denotes T
T2386 5228-5233 NN denotes cells
T2387 5234-5237 CC denotes and
T2388 5238-5249 NN denotes macrophages
T2389 5250-5259 VB denotes affecting
T2390 5260-5264 CC denotes both
T2391 5265-5271 JJ denotes innate
T2392 5272-5275 CC denotes and
T2393 5276-5283 JJ denotes humoral
T2394 5284-5290 JJ denotes immune
T2395 5291-5300 NN denotes responses
T2396 5301-5303 IN denotes in
T2397 5304-5307 DT denotes the
T2398 5308-5312 NN denotes host
T2399 5313-5314 -LRB- denotes [
T2400 5314-5316 CD denotes 31
T2401 5316-5317 -RRB- denotes ]
T2402 5319-5328 RB denotes Therefore
T2403 5328-5329 -COMMA- denotes ,
T2404 5330-5335 NN denotes NF-κB
T2405 5336-5339 MD denotes can
T2406 5340-5342 VB denotes be
T2407 5343-5352 RB denotes specially
T2408 5353-5361 VB denotes targeted
T2409 5362-5364 TO denotes to
T2410 5365-5372 VB denotes prevent
T2411 5373-5379 NN denotes cancer
T2412 5380-5384 NN denotes cell
T2413 5385-5391 NN denotes growth
T2414 5392-5394 IN denotes by
T2415 5395-5396 -LRB- denotes (
T2416 5396-5397 LS denotes 1
T2417 5397-5398 -RRB- denotes )
T2418 5399-5407 RB denotes directly
T2419 5408-5417 VB denotes affecting
T2420 5418-5427 JJ denotes apoptotic
T2421 5428-5434 NN denotes cancer
T2422 5435-5439 NN denotes cell
T2423 5440-5445 NN denotes death
T2424 5445-5446 -COMMA- denotes ,
T2425 5447-5448 -LRB- denotes (
T2426 5448-5449 CD denotes 2
T2427 5449-5450 -RRB- denotes )
T2428 5451-5462 VB denotes stimulating
T2429 5463-5468 NN denotes tumor
T2430 5469-5476 NN denotes killing
T2431 5477-5488 NN denotes lymphocytes
T2432 5489-5501 NN denotes infiltration
T2433 5502-5504 CC denotes or
T2434 5505-5506 -LRB- denotes (
T2435 5506-5507 CD denotes 3
T2436 5507-5508 -RRB- denotes )
T2437 5509-5519 VB denotes increasing
T2438 5520-5523 DT denotes the
T2439 5524-5534 NN denotes production
T2440 5535-5537 IN denotes of
T2441 5538-5543 NN denotes tumor
T2442 5544-5551 NN denotes killing
T2443 5552-5563 NN denotes lymphokines
T2444 5565-5575 NN denotes Activation
T2445 5576-5578 IN denotes of
T2446 5579-5584 NN denotes NF-κB
T2447 5585-5587 VB denotes is
T2448 5588-5597 JJ denotes important
T2449 5598-5600 IN denotes in
T2450 5601-5604 DT denotes the
T2451 5605-5615 NN denotes regulation
T2452 5616-5618 IN denotes of
T2453 5619-5631 JJ denotes CCR-mediated
T2454 5632-5637 NN denotes tumor
T2455 5638-5644 NN denotes growth
T2456 5645-5648 CC denotes and
T2457 5649-5659 NN denotes metastasis
T2458 5661-5663 PRP denotes It
T2459 5664-5667 VB denotes was
T2460 5668-5676 VB denotes reported
T2461 5677-5681 IN denotes that
T2462 5682-5692 NN denotes inhibition
T2463 5693-5695 IN denotes of
T2464 5696-5701 NN denotes NF-κB
T2465 5702-5704 IN denotes by
T2466 5705-5736 NN denotes dehydroxymethyl-epoxyquinomicin
T2467 5737-5738 -LRB- denotes (
T2468 5738-5743 NN denotes DHMEQ
T2469 5743-5744 -RRB- denotes )
T2470 5745-5752 VB denotes induces
T2471 5753-5757 NN denotes cell
T2472 5758-5763 NN denotes death
T2473 5764-5766 IN denotes of
T2474 5767-5774 JJ denotes primary
T2475 5775-5783 NN denotes effusion
T2476 5784-5792 NN denotes lymphoma
T2477 5793-5795 IN denotes by
T2478 5796-5806 NN denotes inhibition
T2479 5807-5809 IN denotes of
T2480 5810-5814 NN denotes CCR5
T2481 5815-5825 NN denotes expression
T2482 5826-5827 -LRB- denotes [
T2483 5827-5829 CD denotes 32
T2484 5829-5830 -RRB- denotes ]
T2485 5832-5842 NN denotes Activation
T2486 5843-5845 IN denotes of
T2487 5846-5851 NN denotes NF-κB
T2488 5852-5856 RB denotes also
T2489 5857-5866 VB denotes increases
T2490 5867-5880 JJ denotes CCL5-mediated
T2491 5881-5885 JJ denotes oral
T2492 5886-5892 NN denotes cancer
T2493 5893-5901 NN denotes motility
T2494 5902-5903 -LRB- denotes (
T2495 5903-5904 CD denotes 5
T2496 5904-5905 -RRB- denotes )
T2497 5906-5909 CC denotes and
T2498 5910-5914 NN denotes lung
T2499 5915-5925 NN denotes metastasis
T2500 5926-5927 -LRB- denotes [
T2501 5927-5929 CD denotes 33
T2502 5929-5930 -RRB- denotes ]
T2503 5932-5936 RB denotes Thus
T2504 5936-5937 -COMMA- denotes ,
T2505 5938-5940 PRP denotes it
T2506 5941-5943 VB denotes is
T2507 5944-5952 JJ denotes possible
T2508 5953-5957 IN denotes that
T2509 5958-5968 NN denotes inhibition
T2510 5969-5971 IN denotes of
T2511 5972-5977 NN denotes NF-κB
T2512 5978-5983 MD denotes could
T2513 5984-5986 VB denotes be
T2514 5987-5995 VB denotes involved
T2515 5996-5998 IN denotes in
T2516 5999-6003 NN denotes CCR5
T2517 6004-6012 VB denotes mediated
T2518 6013-6018 NN denotes tumor
T2519 6019-6030 NN denotes development
T2520 6032-6037 NN denotes NF-κB
T2521 6038-6051 NN denotes transcription
T2522 6052-6058 NN denotes factor
T2523 6059-6066 NN denotes binding
T2524 6067-6072 NN denotes sites
T2525 6073-6076 VB denotes are
T2526 6077-6084 JJ denotes present
T2527 6085-6087 IN denotes in
T2528 6088-6091 DT denotes the
T2529 6092-6100 NN denotes promoter
T2530 6101-6107 NN denotes region
T2531 6108-6110 IN denotes of
T2532 6111-6126 JJ denotes proinflammatory
T2533 6127-6135 NN denotes cytokine
T2534 6136-6141 NN denotes genes
T2535 6141-6142 -COMMA- denotes ,
T2536 6143-6147 JJ denotes such
T2537 6148-6150 IN denotes as
T2538 6151-6160 NN denotes IL-1alpha
T2539 6160-6161 -COMMA- denotes ,
T2540 6162-6166 NN denotes IL-6
T2541 6166-6167 -COMMA- denotes ,
T2542 6168-6174 NN denotes GM-CSF
T2543 6174-6175 -COMMA- denotes ,
T2544 6176-6179 CC denotes and
T2545 6180-6182 NNP denotes KC
T2546 6183-6184 -LRB- denotes [
T2547 6184-6186 CD denotes 34
T2548 6186-6187 -RRB- denotes ]
T2549 6189-6191 IN denotes On
T2550 6192-6195 DT denotes the
T2551 6196-6201 JJ denotes other
T2552 6202-6206 NN denotes hand
T2553 6206-6207 -COMMA- denotes ,
T2554 6208-6211 DT denotes the
T2555 6212-6218 NN denotes IL-1Ra
T2556 6219-6221 VB denotes is
T2557 6222-6223 DT denotes a
T2558 6224-6232 JJ denotes negative
T2559 6233-6242 NN denotes regulator
T2560 6243-6245 IN denotes of
T2561 6246-6249 DT denotes the
T2562 6250-6262 JJ denotes inflammatory
T2563 6263-6271 NN denotes response
T2564 6273-6280 JJ denotes Several
T2565 6281-6288 NN denotes studies
T2566 6289-6293 VB denotes have
T2567 6294-6306 VB denotes demonstrated
T2568 6307-6310 DT denotes the
T2569 6311-6318 NN denotes ability
T2570 6319-6321 IN denotes of
T2571 6322-6328 NN denotes IL-1Ra
T2572 6329-6331 TO denotes to
T2573 6332-6340 VB denotes abrogate
T2574 6341-6344 DT denotes the
T2575 6345-6360 JJ denotes proinflammatory
T2576 6361-6368 NN denotes effects
T2577 6369-6371 IN denotes of
T2578 6372-6376 NN denotes IL-1
T2579 6378-6383 NNP denotes Smith
T2580 6384-6386 FW denotes et
T2581 6387-6390 FW denotes al.
T2582 6391-6400 VB denotes suggested
T2583 6401-6405 IN denotes that
T2584 6406-6409 DT denotes the
T2585 6410-6420 NN denotes regulation
T2586 6421-6423 IN denotes of
T2587 6424-6430 NN denotes IL-1Ra
T2588 6431-6435 NN denotes gene
T2589 6436-6446 NN denotes expression
T2590 6447-6449 VB denotes is
T2591 6450-6451 DT denotes a
T2592 6452-6459 JJ denotes complex
T2593 6460-6465 NN denotes event
T2594 6466-6475 VB denotes involving
T2595 6476-6479 DT denotes the
T2596 6480-6492 NN denotes interactions
T2597 6493-6495 IN denotes of
T2598 6496-6501 CD denotes three
T2599 6502-6511 JJ denotes different
T2600 6512-6525 NN denotes transcription
T2601 6526-6533 NN denotes factors
T2602 6533-6534 -COLON- denotes ;
T2603 6535-6556 JJ denotes NF-κB/PU.1/GA-binding
T2604 6557-6564 NN denotes protein
T2605 6565-6572 NN denotes binding
T2606 6573-6577 NN denotes site
T2607 6578-6579 -LRB- denotes [
T2608 6579-6581 CD denotes 35
T2609 6581-6582 -RRB- denotes ]
T2610 6584-6591 JJ denotes Nuclear
T2611 6592-6605 NN denotes translocation
T2612 6606-6608 IN denotes of
T2613 6609-6614 NN denotes NF-κB
T2614 6615-6616 -LRB- denotes (
T2615 6616-6619 NN denotes p65
T2616 6619-6620 -RRB- denotes )
T2617 6621-6624 VB denotes was
T2618 6625-6638 RB denotes significantly
T2619 6639-6647 VB denotes enhanced
T2620 6648-6651 CC denotes and
T2621 6652-6661 VB denotes prolonged
T2622 6662-6664 IN denotes in
T2623 6665-6681 JJ denotes IL-1Ra-deficient
T2624 6682-6686 NN denotes mice
T2625 6686-6687 -COMMA- denotes ,
T2626 6688-6696 VB denotes compared
T2627 6697-6699 TO denotes to
T2628 6700-6704 DT denotes that
T2629 6705-6707 IN denotes in
T2630 6708-6712 JJ denotes wild
T2631 6713-6717 NN denotes type
T2632 6718-6722 NN denotes mice
T2633 6723-6724 -LRB- denotes [
T2634 6724-6726 CD denotes 36
T2635 6726-6727 -RRB- denotes ]
T2636 6729-6742 JJ denotes Intracellular
T2637 6743-6749 NN denotes IL-1Ra
T2638 6750-6751 -LRB- denotes (
T2639 6751-6759 NN denotes icIL-1Ra
T2640 6759-6760 -RRB- denotes )
T2641 6761-6764 VB denotes was
T2642 6765-6770 VB denotes found
T2643 6771-6773 TO denotes to
T2644 6774-6781 VB denotes inhibit
T2645 6782-6786 NN denotes IL-1
T2646 6787-6789 IN denotes by
T2647 6790-6798 VB denotes blocking
T2648 6799-6804 NN denotes NF-κB
T2649 6805-6811 NN denotes signal
T2650 6812-6824 NN denotes transduction
T2651 6825-6833 NN denotes pathways
T2652 6834-6836 IN denotes in
T2653 6837-6849 JJ denotes inflammatory
T2654 6850-6859 NN denotes responses
T2655 6860-6861 -LRB- denotes [
T2656 6861-6863 CD denotes 37
T2657 6863-6864 -RRB- denotes ]
T2658 6866-6873 IN denotes Because
T2659 6874-6878 NN denotes IL-1
T2660 6879-6882 VB denotes has
T2661 6883-6887 VB denotes been
T2662 6888-6893 VB denotes shown
T2663 6894-6896 TO denotes to
T2664 6897-6899 VB denotes be
T2665 6900-6902 DT denotes an
T2666 6903-6910 NN denotes inducer
T2667 6911-6913 IN denotes of
T2668 6914-6919 NN denotes NF-κB
T2669 6920-6930 NN denotes activation
T2670 6931-6932 -LRB- denotes [
T2671 6932-6934 CD denotes 38
T2672 6934-6935 -RRB- denotes ]
T2673 6935-6936 -COMMA- denotes ,
T2674 6937-6939 PRP denotes we
T2675 6940-6952 VB denotes hypothesized
T2676 6953-6957 IN denotes that
T2677 6958-6961 DT denotes the
T2678 6962-6972 NN denotes expression
T2679 6973-6975 IN denotes of
T2680 6976-6982 NN denotes IL-1Ra
T2681 6983-6988 MD denotes could
T2682 6989-6993 VB denotes play
T2683 6994-6996 DT denotes an
T2684 6997-7006 JJ denotes important
T2685 7007-7011 NN denotes role
T2686 7012-7014 IN denotes in
T2687 7015-7018 DT denotes the
T2688 7019-7028 JJ denotes autocrine
T2689 7029-7039 NN denotes activation
T2690 7040-7042 IN denotes of
T2691 7043-7056 NN denotes transcription
T2692 7057-7064 NN denotes factors
T2693 7065-7070 NN denotes NF-κB
T2694 7071-7073 CC denotes or
T2695 7074-7078 NN denotes vice
T2696 7079-7084 NN denotes versa
T2697 7086-7090 RB denotes Thus
T2698 7090-7091 -COMMA- denotes ,
T2699 7092-7095 DT denotes the
T2700 7096-7099 NN denotes aim
T2701 7100-7102 IN denotes of
T2702 7103-7107 DT denotes this
T2703 7108-7113 NN denotes study
T2704 7114-7117 VB denotes was
T2705 7118-7120 TO denotes to
T2706 7121-7129 VB denotes evaluate
T2707 7130-7133 DT denotes the
T2708 7134-7139 NN denotes roles
T2709 7140-7142 IN denotes of
T2710 7143-7148 NN denotes NF-κB
T2711 7149-7152 CC denotes and
T2712 7153-7159 NN denotes IL-1Ra
T2713 7160-7162 IN denotes in
T2714 7163-7166 DT denotes the
T2715 7167-7176 NN denotes chemokine
T2716 7177-7185 NN denotes receptor
T2717 7186-7199 JJ denotes CCR5-mediated
T2718 7200-7211 NN denotes suppression
T2719 7212-7214 IN denotes of
T2720 7215-7220 NN denotes tumor
T2721 7221-7232 NN denotes development
T4601 7244-7254 NN denotes Inhibition
T4602 7255-7257 IN denotes of
T4603 7258-7263 NN denotes Tumor
T4604 7264-7275 NN denotes Development
T4605 7276-7278 IN denotes in
T4606 7279-7286 NN denotes CCR5−/−
T4607 7287-7291 NN denotes Mice
T4608 7292-7295 DT denotes The
T4609 7296-7302 NN denotes effect
T4610 7303-7305 IN denotes of
T4611 7306-7310 NN denotes CCR5
T4612 7311-7313 IN denotes in
T4613 7314-7319 NN denotes tumor
T4614 7320-7331 NN denotes development
T4615 7332-7335 VB denotes was
T4616 7336-7348 VB denotes investigated
T4617 7349-7354 VB denotes using
T4618 7355-7362 NN denotes CCR5+/+
T4619 7363-7366 CC denotes and
T4620 7367-7374 NN denotes CCR5−/−
T4621 7375-7379 NN denotes mice
T4622 7381-7387 NN denotes B16-F0
T4623 7388-7396 NN denotes melanoma
T4624 7397-7402 NN denotes cells
T4625 7403-7407 VB denotes were
T4626 7408-7418 VB denotes inoculated
T4627 7419-7433 RB denotes subcutaneously
T4628 7434-7438 IN denotes into
T4629 7439-7446 NN denotes CCR5+/+
T4630 7447-7450 CC denotes and
T4631 7451-7458 NN denotes CCR5−/−
T4632 7459-7463 NN denotes mice
T4633 7464-7465 -LRB- denotes (
T4634 7465-7471 NN denotes n = 20
T4635 7471-7472 -RRB- denotes )
T4636 7474-7479 NN denotes Tumor
T4637 7480-7486 NN denotes growth
T4638 7487-7490 VB denotes was
T4639 7491-7500 VB denotes monitored
T4640 7501-7504 IN denotes for
T4641 7505-7507 CD denotes 31
T4642 7508-7512 NN denotes days
T4643 7514-7519 NN denotes Tumor
T4644 7520-7526 NN denotes growth
T4645 7527-7529 IN denotes in
T4646 7530-7533 DT denotes the
T4647 7534-7541 NN denotes CCR5−/−
T4648 7542-7546 NN denotes mice
T4649 7547-7550 VB denotes was
T4650 7551-7564 RB denotes significantly
T4651 7565-7570 JJ denotes lower
T4652 7571-7575 IN denotes than
T4653 7576-7580 DT denotes that
T4654 7581-7583 IN denotes in
T4655 7584-7587 DT denotes the
T4656 7588-7595 JJ denotes CCR5+/+
T4657 7596-7600 NN denotes mice
T4658 7602-7605 DT denotes The
T4659 7606-7611 NN denotes tumor
T4660 7612-7618 NN denotes growth
T4661 7619-7621 IN denotes in
T4662 7622-7625 DT denotes the
T4663 7626-7633 NN denotes CCR5−/−
T4664 7634-7638 NN denotes mice
T4665 7639-7642 VB denotes was
T4666 7643-7650 VB denotes reduced
T4667 7651-7653 TO denotes to
T4668 7654-7658 CD denotes 19.1
T4669 7658-7659 NN denotes %
T4670 7659-7660 -COMMA- denotes ,
T4671 7661-7668 IN denotes whereas
T4672 7669-7672 DT denotes the
T4673 7673-7678 NN denotes tumor
T4674 7679-7685 NN denotes growth
T4675 7686-7688 IN denotes in
T4676 7689-7692 DT denotes the
T4677 7693-7700 JJ denotes CCR5+/+
T4678 7701-7705 NN denotes mice
T4679 7706-7709 VB denotes was
T4680 7710-7714 RB denotes only
T4681 7715-7722 VB denotes reduced
T4682 7723-7725 TO denotes to
T4683 7726-7730 CD denotes 24.3
T4684 7730-7731 NN denotes %
T4685 7731-7732 -COMMA- denotes ,
T4686 7733-7735 IN denotes in
T4687 7736-7740 CC denotes both
T4688 7741-7746 NN denotes tumor
T4689 7747-7753 NN denotes weight
T4690 7754-7755 -LRB- denotes (
T4691 7755-7761 NN denotes Figure
T4692 7762-7764 NN denotes 1A
T4693 7765-7768 CC denotes and
T4694 7769-7771 NN denotes 1B
T4695 7771-7772 -RRB- denotes )
T4696 7773-7776 CC denotes and
T4697 7777-7782 NN denotes tumor
T4698 7783-7789 NN denotes volume
T4699 7789-7790 -COMMA- denotes ,
T4700 7791-7803 RB denotes respectively
T4701 7804-7805 -LRB- denotes (
T4702 7805-7811 NN denotes Figure
T4703 7812-7814 NN denotes 1A
T4704 7815-7818 CC denotes and
T4705 7819-7821 NN denotes 1C
T4706 7821-7822 -RRB- denotes )
T4707 7824-7829 DT denotes These
T4708 7830-7837 NN denotes results
T4709 7838-7848 VB denotes correlated
T4710 7849-7853 IN denotes with
T4711 7854-7858 NN denotes mice
T4712 7859-7867 NN denotes survival
T4713 7868-7873 NN denotes rates
T4714 7875-7880 EX denotes There
T4715 7881-7884 VB denotes was
T4716 7885-7886 DT denotes a
T4717 7887-7898 JJ denotes significant
T4718 7899-7909 NN denotes difference
T4719 7910-7912 IN denotes in
T4720 7913-7921 NN denotes survival
T4721 7922-7927 NN denotes rates
T4722 7928-7935 IN denotes between
T4723 7936-7943 NN denotes CCR5−/−
T4724 7944-7948 NN denotes mice
T4725 7949-7950 -LRB- denotes (
T4726 7950-7952 CD denotes 75
T4727 7952-7953 NN denotes %
T4728 7954-7956 IN denotes of
T4729 7957-7965 VB denotes starting
T4730 7966-7970 NN denotes time
T4731 7970-7971 -RRB- denotes )
T4732 7972-7975 CC denotes and
T4733 7976-7983 JJ denotes CCR5+/+
T4734 7984-7988 NN denotes mice
T4735 7989-7990 -LRB- denotes (
T4736 7990-7992 CD denotes 15
T4737 7992-7993 NN denotes %
T4738 7993-7994 -RRB- denotes )
T4739 7995-7997 IN denotes at
T4740 7998-8001 DT denotes the
T4741 8002-8005 NN denotes end
T4742 8006-8008 IN denotes of
T4743 8009-8012 DT denotes the
T4744 8013-8023 NN denotes experiment
T4745 8024-8025 -LRB- denotes (
T4746 8025-8031 NN denotes Figure
T4747 8032-8034 NN denotes 1D
T4748 8034-8035 -RRB- denotes )
T4749 8037-8042 EX denotes There
T4750 8043-8046 VB denotes was
T4751 8047-8048 DT denotes a
T4752 8049-8060 JJ denotes significant
T4753 8061-8071 NN denotes difference
T4754 8072-8074 IN denotes in
T4755 8075-8083 NN denotes survival
T4756 8084-8089 NN denotes rates
T4757 8090-8097 IN denotes between
T4758 8098-8105 NN denotes CCR5−/−
T4759 8106-8110 NN denotes mice
T4760 8111-8114 CC denotes and
T4761 8115-8122 JJ denotes CCR5+/+
T4762 8123-8127 NN denotes mice
T4763 8129-8131 IN denotes At
T4764 8132-8135 DT denotes the
T4765 8136-8139 NN denotes end
T4766 8140-8142 IN denotes of
T4767 8143-8146 DT denotes the
T4768 8147-8157 NN denotes experiment
T4769 8157-8158 -COMMA- denotes ,
T4770 8159-8161 CD denotes 75
T4771 8161-8162 NN denotes %
T4772 8163-8165 IN denotes of
T4773 8166-8169 DT denotes the
T4774 8170-8177 NN denotes CCR5−/−
T4775 8178-8182 NN denotes mice
T4776 8183-8191 VB denotes survived
T4777 8192-8197 IN denotes while
T4778 8198-8202 RB denotes only
T4779 8203-8205 CD denotes 15
T4780 8205-8206 NN denotes %
T4781 8207-8209 IN denotes of
T4782 8210-8213 DT denotes the
T4783 8214-8221 JJ denotes CCR5+/+
T4784 8222-8226 NN denotes mice
T4785 8227-8235 VB denotes survived
T4786 8237-8249 JJ denotes Subcutaneous
T4787 8250-8256 NN denotes tumors
T4788 8257-8261 VB denotes were
T4789 8262-8271 VB denotes harvested
T4790 8272-8276 IN denotes from
T4791 8277-8280 DT denotes the
T4792 8281-8291 VB denotes sacrificed
T4793 8292-8296 NN denotes mice
T4794 8297-8299 CD denotes 31
T4795 8300-8304 NN denotes days
T4796 8305-8310 IN denotes after
T4797 8311-8322 NN denotes inoculation
T4798 8324-8327 DT denotes The
T4799 8328-8347 JJ denotes immunohistochemical
T4800 8348-8356 NN denotes analysis
T4801 8357-8359 IN denotes of
T4802 8360-8365 NN denotes tumor
T4803 8366-8374 NN denotes sections
T4804 8374-8375 -COMMA- denotes ,
T4805 8376-8383 VB denotes stained
T4806 8384-8388 IN denotes with
T4807 8389-8390 NN denotes H
T4808 8390-8391 CC denotes &
T4809 8391-8392 NN denotes E
T4810 8393-8396 CC denotes and
T4811 8397-8400 IN denotes for
T4812 8401-8414 NN denotes proliferation
T4813 8415-8422 NN denotes antigen
T4814 8423-8427 NN denotes PCNA
T4815 8427-8428 -COMMA- denotes ,
T4816 8429-8437 VB denotes revealed
T4817 8438-8445 JJ denotes greater
T4818 8446-8456 NN denotes inhibition
T4819 8457-8459 IN denotes of
T4820 8460-8465 NN denotes tumor
T4821 8466-8470 NN denotes cell
T4822 8471-8477 NN denotes growth
T4823 8478-8480 IN denotes in
T4824 8481-8488 NN denotes CCR5−/−
T4825 8489-8493 NN denotes mice
T4826 8495-8498 DT denotes The
T4827 8499-8509 JJ denotes histologic
T4828 8510-8518 NN denotes findings
T4829 8519-8524 IN denotes after
T4830 8525-8526 NN denotes H
T4831 8526-8527 CC denotes &
T4832 8527-8528 NN denotes E
T4833 8529-8537 NN denotes staining
T4834 8538-8547 VB denotes indicated
T4835 8548-8552 IN denotes that
T4836 8553-8556 DT denotes the
T4837 8557-8562 NN denotes tumor
T4838 8563-8570 NN denotes tissues
T4839 8571-8573 IN denotes of
T4840 8574-8577 DT denotes the
T4841 8578-8585 NN denotes CCR5−/−
T4842 8586-8590 NN denotes mice
T4843 8590-8591 -COMMA- denotes ,
T4844 8592-8595 CC denotes but
T4845 8596-8599 RB denotes not
T4846 8600-8605 DT denotes those
T4847 8606-8608 IN denotes of
T4848 8609-8612 DT denotes the
T4849 8613-8620 JJ denotes CCR5+/+
T4850 8621-8625 NN denotes mice
T4851 8625-8626 -COMMA- denotes ,
T4852 8627-8636 VB denotes contained
T4853 8637-8642 JJ denotes large
T4854 8643-8648 NN denotes areas
T4855 8649-8651 IN denotes of
T4856 8652-8660 NN denotes necrosis
T4857 8662-8666 NN denotes PCNA
T4858 8667-8675 JJ denotes reactive
T4859 8676-8681 NN denotes cells
T4860 8682-8686 VB denotes were
T4861 8687-8700 RB denotes significantly
T4862 8701-8708 VB denotes reduced
T4863 8709-8711 IN denotes in
T4864 8712-8715 DT denotes the
T4865 8716-8723 NN denotes CCR5−/−
T4866 8724-8728 NN denotes mice
T4867 8729-8730 -LRB- denotes (
T4868 8730-8736 NN denotes Figure
T4869 8737-8739 NN denotes 1E
T4870 8739-8740 -RRB- denotes )
T17257 8786-8796 NN denotes Inhibition
T17258 8797-8799 IN denotes of
T17259 8800-8805 NN denotes tumor
T17260 8806-8817 NN denotes development
T17261 8818-8820 IN denotes in
T17262 8821-8828 NN denotes CCR5−/−
T17263 8829-8833 NN denotes mice
T17264 8835-8838 NN denotes A–C
T17265 8838-8839 -COMMA- denotes ,
T17266 8840-8845 NN denotes Tumor
T17267 8846-8852 NN denotes images
T17268 8852-8853 -COMMA- denotes ,
T17269 8854-8861 NN denotes volumes
T17270 8861-8862 -COMMA- denotes ,
T17271 8863-8866 CC denotes and
T17272 8867-8874 NN denotes weights
T17273 8876-8879 NN denotes B16
T17274 8880-8888 NN denotes melanoma
T17275 8889-8894 NN denotes cells
T17276 8895-8896 -LRB- denotes (
T17277 8896-8901 CD denotes 5×105
T17278 8902-8913 NN denotes cells/mouse
T17279 8913-8914 -RRB- denotes )
T17280 8915-8919 VB denotes were
T17281 8920-8930 VB denotes inoculated
T17282 8931-8935 RB denotes s.c.
T17283 8936-8940 IN denotes into
T17284 8941-8948 JJ denotes CCR5+/+
T17285 8949-8953 NN denotes mice
T17286 8954-8957 CC denotes and
T17287 8958-8965 NN denotes CCR5−/−
T17288 8966-8970 NN denotes mice
T17289 8971-8972 -LRB- denotes (
T17290 8972-8978 NN denotes n = 20
T17291 8978-8979 -RRB- denotes )
T17292 8981-8986 NN denotes Tumor
T17293 8987-8994 NN denotes volumes
T17294 8995-8999 VB denotes were
T17295 9000-9008 VB denotes measured
T17296 9009-9014 DT denotes every
T17297 9015-9018 NN denotes day
T17298 9019-9022 CC denotes and
T17299 9023-9028 NN denotes tumor
T17300 9029-9036 NN denotes weights
T17301 9037-9041 VB denotes were
T17302 9042-9050 VB denotes measured
T17303 9051-9053 IN denotes at
T17304 9054-9059 NN denotes study
T17305 9060-9071 NN denotes termination
T17306 9072-9073 -LRB- denotes (
T17307 9073-9076 NN denotes Day
T17308 9077-9079 CD denotes 31
T17309 9079-9080 -RRB- denotes )
T17310 9082-9085 DT denotes The
T17311 9086-9093 NN denotes CCR5−/−
T17312 9094-9098 NN denotes mice
T17313 9099-9102 VB denotes had
T17314 9103-9104 DT denotes a
T17315 9105-9116 JJ denotes significant
T17316 9117-9126 NN denotes reduction
T17317 9127-9129 IN denotes in
T17318 9130-9135 NN denotes tumor
T17319 9136-9142 NN denotes growth
T17320 9143-9146 CC denotes and
T17321 9147-9153 NN denotes volume
T17322 9154-9156 IN denotes as
T17323 9157-9165 VB denotes compared
T17324 9166-9168 TO denotes to
T17325 9169-9176 JJ denotes CCR5+/+
T17326 9177-9181 NN denotes mice
T17327 9183-9186 DT denotes The
T17328 9187-9194 NN denotes results
T17329 9195-9198 VB denotes are
T17330 9199-9208 VB denotes expressed
T17331 9209-9211 IN denotes as
T17332 9212-9216 JJ denotes mean
T17333 9217-9218 SYM denotes ±
T17334 9219-9222 NNP denotes SD.
T17335 9223-9224 SYM denotes *
T17336 9225-9234 VB denotes indicates
T17337 9235-9246 JJ denotes significant
T17338 9247-9257 NN denotes difference
T17339 9258-9262 IN denotes from
T17340 9263-9270 JJ denotes CCR5+/+
T17341 9271-9275 NN denotes mice
T17342 9276-9277 -LRB- denotes (
T17343 9277-9278 NN denotes P
T17344 9278-9279 SYM denotes <
T17345 9279-9283 CD denotes 0.05
T17346 9283-9284 -RRB- denotes )
T17347 9286-9287 NN denotes D
T17348 9287-9288 -COMMA- denotes ,
T17349 9289-9292 DT denotes The
T17350 9293-9300 NN denotes CCR5−/−
T17351 9301-9305 NN denotes mice
T17352 9306-9318 VB denotes demonstrated
T17353 9319-9332 RB denotes significantly
T17354 9333-9339 JJ denotes higher
T17355 9340-9348 NN denotes survival
T17356 9349-9354 NN denotes rates
T17357 9355-9363 VB denotes compared
T17358 9364-9366 TO denotes to
T17359 9367-9374 JJ denotes CCR5+/+
T17360 9375-9379 NN denotes mice
T17361 9380-9381 -LRB- denotes (
T17362 9381-9383 IN denotes by
T17363 9384-9392 NNP denotes Log-rank
T17364 9393-9397 NNP denotes Test
T17365 9397-9398 -RRB- denotes )
T17366 9400-9402 FW denotes E.
T17367 9403-9408 NN denotes Tumor
T17368 9409-9417 NN denotes sections
T17369 9418-9422 VB denotes were
T17370 9423-9431 VB denotes analyzed
T17371 9432-9434 IN denotes by
T17372 9435-9436 NN denotes H
T17373 9436-9437 CC denotes &
T17374 9437-9438 NN denotes E
T17375 9439-9444 NN denotes stain
T17376 9445-9448 CC denotes and
T17377 9449-9459 NN denotes expression
T17378 9460-9462 IN denotes of
T17379 9463-9476 VB denotes proliferating
T17380 9477-9481 NN denotes cell
T17381 9482-9489 JJ denotes nuclear
T17382 9490-9497 NN denotes antigen
T17383 9498-9499 -LRB- denotes (
T17384 9499-9503 NN denotes PCNA
T17385 9503-9504 -RRB- denotes )
T17386 9505-9507 IN denotes by
T17387 9508-9528 NN denotes immunohistochemistry
T17388 9530-9534 NN denotes Data
T17389 9535-9538 VB denotes are
T17390 9539-9544 NN denotes means
T17391 9545-9546 VB denotes ±
T17392 9547-9551 NNP denotes S.D.
T17393 9552-9554 IN denotes of
T17394 9555-9559 CD denotes four
T17395 9560-9572 JJ denotes experimental
T17396 9573-9581 NN denotes animals.
T17397 9582-9583 SYM denotes *
T17398 9584-9593 VB denotes indicates
T17399 9594-9605 JJ denotes significant
T17400 9606-9616 NN denotes difference
T17401 9617-9621 IN denotes from
T17402 9622-9629 JJ denotes CCR5+/+
T17403 9630-9634 NN denotes mice
T17404 9635-9636 -LRB- denotes (
T17405 9636-9637 NN denotes P
T17406 9637-9638 SYM denotes <
T17407 9638-9642 CD denotes 0.05
T17408 9642-9643 -RRB- denotes )
T17409 9645-9650 NN denotes Scale
T17410 9651-9654 NN denotes bar
T17411 9655-9664 VB denotes indicates
T17412 9665-9667 CD denotes 50
T17413 9668-9669 NN denotes m
T17786 9672-9680 NN denotes Decrease
T5481 9672-9680 NN denotes Decrease
T17787 9681-9683 IN denotes of
T5482 9681-9683 IN denotes of
T17788 9684-9689 NN denotes NF-κB
T5483 9684-9689 NN denotes NF-κB
T17789 9690-9698 NN denotes Activity
T5484 9690-9698 NN denotes Activity
T17790 9699-9701 IN denotes in
T5485 9699-9701 IN denotes in
T17791 9702-9707 NN denotes Tumor
T5486 9702-9707 NN denotes Tumor
T17792 9708-9714 NN denotes Tissue
T5487 9708-9714 NN denotes Tissue
T17793 9715-9717 IN denotes of
T5488 9715-9717 IN denotes of
T17794 9718-9725 NN denotes CCR5−/−
T5489 9718-9725 NN denotes CCR5−/−
T17795 9726-9730 NN denotes Mice
T5490 9726-9730 NN denotes Mice
T5491 9731-9734 DT denotes The
T5492 9735-9745 NN denotes activation
T5493 9746-9748 IN denotes of
T5494 9749-9754 NN denotes NF-κB
T5495 9755-9760 VB denotes plays
T5496 9761-9762 DT denotes a
T5497 9763-9771 JJ denotes critical
T5498 9772-9776 NN denotes role
T5499 9777-9779 IN denotes in
T5500 9780-9786 NN denotes cancer
T5501 9787-9791 NN denotes cell
T5502 9792-9800 NN denotes survival
T5503 9800-9801 -COMMA- denotes ,
T5504 9802-9812 RB denotes especially
T5505 9813-9821 NN denotes melanoma
T5506 9822-9828 NN denotes cancer
T5507 9829-9834 NN denotes cells
T5508 9835-9838 CC denotes and
T5509 9839-9841 IN denotes in
T5510 9842-9846 NN denotes CCR5
T5511 9847-9857 NN denotes expression
T5512 9859-9861 TO denotes To
T5513 9862-9870 VB denotes evaluate
T5514 9871-9878 IN denotes whether
T5515 9879-9882 DT denotes the
T5516 9883-9888 NN denotes tumor
T5517 9889-9899 NN denotes inhibition
T5518 9900-9903 VB denotes was
T5519 9904-9911 VB denotes related
T5520 9912-9916 IN denotes with
T5521 9917-9920 DT denotes the
T5522 9921-9933 NN denotes inactivation
T5523 9934-9936 IN denotes of
T5524 9937-9942 NN denotes NF-κB
T5525 9943-9945 IN denotes in
T5526 9946-9954 NN denotes melanoma
T5527 9954-9955 -COMMA- denotes ,
T5528 9956-9959 DT denotes the
T5529 9960-9963 NN denotes DNA
T5530 9964-9971 NN denotes binding
T5531 9972-9980 NN denotes activity
T5532 9981-9983 IN denotes of
T5533 9984-9989 NN denotes NF-κB
T5534 9990-9993 VB denotes was
T5535 9994-10004 VB denotes determined
T5536 10005-10007 IN denotes by
T5537 10008-10023 NN denotes electromobility
T5538 10024-10029 NN denotes shift
T5539 10030-10035 NN denotes assay
T5540 10036-10037 -LRB- denotes (
T5541 10037-10041 NN denotes EMSA
T5542 10041-10042 -RRB- denotes )
T5543 10043-10045 IN denotes in
T5544 10046-10054 NN denotes melanoma
T5545 10055-10061 NN denotes tissue
T5546 10063-10066 DT denotes The
T5547 10067-10081 RB denotes constitutively
T5548 10082-10091 VB denotes activated
T5549 10092-10095 NN denotes DNA
T5550 10096-10103 NN denotes binding
T5551 10104-10112 NN denotes activity
T5552 10113-10116 VB denotes was
T5553 10117-10124 VB denotes reduced
T5554 10125-10127 IN denotes in
T5555 10128-10131 DT denotes the
T5556 10132-10139 NN denotes CCR5−/−
T5557 10140-10144 NN denotes mice
T5558 10145-10150 NN denotes tumor
T5559 10151-10157 NN denotes tissue
T5560 10158-10159 -LRB- denotes (
T5561 10159-10165 NN denotes Figure
T5562 10166-10168 NN denotes 2A
T5563 10168-10169 -RRB- denotes )
T5564 10171-10179 RB denotes Moreover
T5565 10179-10180 -COMMA- denotes ,
T5566 10181-10184 DT denotes the
T5567 10185-10198 NN denotes translocation
T5568 10199-10201 IN denotes of
T5569 10202-10205 NN denotes p50
T5570 10206-10209 CC denotes and
T5571 10210-10215 NN denotes p-p65
T5572 10216-10220 IN denotes into
T5573 10221-10224 DT denotes the
T5574 10225-10232 NN denotes nucleus
T5575 10233-10240 IN denotes through
T5576 10241-10244 DT denotes the
T5577 10245-10255 NN denotes inhibition
T5578 10256-10258 IN denotes of
T5579 10259-10274 NN denotes phosphorylation
T5580 10275-10277 IN denotes of
T5581 10278-10281 NN denotes IκB
T5582 10282-10285 VB denotes was
T5583 10286-10290 RB denotes also
T5584 10291-10300 VB denotes prevented
T5585 10301-10303 IN denotes in
T5586 10304-10307 DT denotes the
T5587 10308-10313 NN denotes tumor
T5588 10314-10321 NN denotes tissues
T5589 10322-10324 IN denotes of
T5590 10325-10332 NN denotes CCR5−/−
T5591 10333-10337 NN denotes mice
T5592 10338-10339 -LRB- denotes (
T5593 10339-10345 NN denotes Figure
T5594 10346-10348 NN denotes 2B
T5595 10348-10349 -RRB- denotes )
T5596 10351-10369 NN denotes Immunofluorescence
T5597 10370-10378 NN denotes analysis
T5598 10379-10383 RB denotes also
T5599 10384-10393 VB denotes confirmed
T5600 10394-10398 IN denotes that
T5601 10399-10402 DT denotes the
T5602 10403-10412 NN denotes intensity
T5603 10413-10415 IN denotes of
T5604 10416-10423 JJ denotes nuclear
T5605 10424-10432 NN denotes staining
T5606 10433-10436 IN denotes for
T5607 10437-10440 NN denotes p50
T5608 10441-10444 VB denotes had
T5609 10445-10454 VB denotes decreased
T5610 10455-10457 IN denotes in
T5611 10458-10461 DT denotes the
T5612 10462-10467 NN denotes tumor
T5613 10468-10475 NN denotes tissues
T5614 10476-10478 IN denotes of
T5615 10479-10486 NN denotes CCR5−/−
T5616 10487-10491 NN denotes mice
T5617 10492-10493 -LRB- denotes (
T5618 10493-10499 NN denotes Figure
T5619 10500-10502 NN denotes 2C
T5620 10502-10503 -RRB- denotes )
T17796 10609-10610 DT denotes A
T17797 10610-10611 -COMMA- denotes ,
T17798 10612-10615 DT denotes The
T17799 10616-10619 NN denotes DNA
T17800 10620-10627 NN denotes binding
T17801 10628-10636 NN denotes activity
T17802 10637-10639 IN denotes of
T17803 10640-10645 NN denotes NF-κB
T17804 10646-10649 VB denotes was
T17805 10650-10660 VB denotes determined
T17806 10661-10663 IN denotes in
T17807 10664-10667 DT denotes the
T17808 10668-10675 JJ denotes nuclear
T17809 10676-10684 NN denotes extracts
T17810 10685-10687 IN denotes of
T17811 10688-10691 DT denotes the
T17812 10692-10699 NN denotes CCR5−/−
T17813 10700-10704 NN denotes mice
T17814 10705-10708 CC denotes and
T17815 10709-10716 JJ denotes CCR5+/+
T17816 10717-10721 NN denotes mice
T17817 10722-10727 NN denotes tumor
T17818 10728-10735 NN denotes tissues
T17819 10736-10738 IN denotes by
T17820 10739-10743 NN denotes EMSA
T17821 10744-10753 VB denotes described
T17822 10754-10756 IN denotes in
T17823 10757-10765 NN denotes material
T17824 10766-10769 CC denotes and
T17825 10770-10777 NN denotes methods
T17826 10779-10780 NN denotes B
T17827 10780-10781 -COMMA- denotes ,
T17828 10782-10792 NN denotes Expression
T17829 10793-10795 IN denotes of
T17830 10796-10799 NN denotes p50
T17831 10800-10803 CC denotes and
T17832 10804-10807 NN denotes p65
T17833 10808-10823 NN denotes phosphorylation
T17834 10824-10826 IN denotes in
T17835 10827-10834 JJ denotes nuclear
T17836 10835-10843 NN denotes extracts
T17837 10844-10845 -LRB- denotes (
T17838 10845-10847 NN denotes NE
T17839 10847-10848 -RRB- denotes )
T17840 10848-10849 -COMMA- denotes ,
T17841 10850-10853 CC denotes and
T17842 10854-10857 NN denotes IκB
T17843 10858-10861 CC denotes and
T17844 10862-10865 NN denotes IκB
T17845 10866-10881 NN denotes phosphorylation
T17846 10882-10884 IN denotes in
T17847 10885-10888 DT denotes the
T17848 10889-10896 NN denotes cytosol
T17849 10897-10898 -LRB- denotes (
T17850 10898-10900 NN denotes CE
T17851 10900-10901 -RRB- denotes )
T17852 10902-10912 VB denotes determined
T17853 10913-10915 IN denotes by
T17854 10916-10923 JJ denotes Western
T17855 10924-10932 NN denotes blotting
T17856 10934-10935 NN denotes C
T17857 10935-10936 -COMMA- denotes ,
T17858 10937-10956 NN denotes Immunolfluorescence
T17859 10957-10965 NN denotes analysis
T17860 10966-10968 IN denotes of
T17861 10969-10972 NN denotes p50
T17862 10973-10982 VB denotes confirmed
T17863 10983-10987 IN denotes that
T17864 10988-10991 DT denotes the
T17865 10992-11003 NN denotes intensities
T17866 11004-11006 IN denotes of
T17867 11007-11014 JJ denotes nuclear
T17868 11015-11023 NN denotes staining
T17869 11024-11027 IN denotes for
T17870 11028-11031 NN denotes p50
T17871 11032-11036 VB denotes were
T17872 11037-11046 VB denotes decreased
T17873 11047-11049 IN denotes in
T17874 11050-11053 DT denotes the
T17875 11054-11059 NN denotes tumor
T17876 11060-11067 NN denotes tissues
T17877 11068-11070 IN denotes of
T17878 11071-11078 NN denotes CCR5−/−
T17879 11079-11083 NN denotes mice
T17880 11085-11089 NN denotes Data
T17881 11090-11093 VB denotes are
T17882 11094-11099 NN denotes means
T17883 11100-11101 VB denotes ±
T17884 11102-11106 NNP denotes S.D.
T17885 11107-11109 IN denotes of
T17886 11110-11114 CD denotes four
T17887 11115-11127 JJ denotes experimental
T17888 11128-11136 NN denotes animals.
T17889 11137-11138 SYM denotes *
T17890 11139-11148 VB denotes indicates
T17891 11149-11160 JJ denotes significant
T17892 11161-11171 NN denotes difference
T17893 11172-11176 IN denotes from
T17894 11177-11184 JJ denotes CCR5+/+
T17895 11185-11189 NN denotes mice
T17896 11190-11191 -LRB- denotes (
T17897 11191-11192 NN denotes p
T17898 11192-11193 SYM denotes <
T17899 11193-11197 CD denotes 0.05
T17900 11197-11198 -RRB- denotes )
T17901 11200-11205 NN denotes Scale
T17902 11206-11209 NN denotes bar
T17903 11210-11219 VB denotes indicates
T17904 11220-11222 CD denotes 50
T17905 11223-11225 NN denotes µm
T18249 11228-11237 NN denotes Induction
T6030 11228-11237 NN denotes Induction
T18250 11238-11240 IN denotes of
T6031 11238-11240 IN denotes of
T18251 11241-11250 JJ denotes Apoptotic
T6032 11241-11250 NNP denotes Apoptotic
T18252 11251-11255 NN denotes Cell
T6033 11251-11255 NNP denotes Cell
T18253 11256-11261 NN denotes Death
T6034 11256-11261 NNP denotes Death
T6035 11262-11265 CC denotes and
T6036 11266-11276 NN denotes Inhibition
T6037 11277-11279 IN denotes of
T6038 11280-11283 DT denotes the
T6039 11284-11294 NN denotes Expression
T6040 11295-11297 IN denotes of
T6041 11298-11312 JJ denotes Anti-apoptotic
T6042 11313-11321 NN denotes Proteins
T6043 11322-11324 IN denotes in
T6044 11325-11332 NN denotes CCR5−/−
T6045 11333-11337 NN denotes Mice
T6046 11338-11340 TO denotes To
T6047 11341-11344 VB denotes see
T6048 11345-11352 IN denotes whether
T6049 11353-11363 NN denotes inhibition
T6050 11364-11366 IN denotes of
T6051 11367-11372 NN denotes NF-κB
T6052 11373-11381 NN denotes activity
T6053 11382-11389 VB denotes results
T6054 11390-11392 IN denotes in
T6055 11393-11396 DT denotes the
T6056 11397-11406 NN denotes induction
T6057 11407-11409 IN denotes of
T6058 11410-11419 JJ denotes apoptotic
T6059 11420-11424 NN denotes cell
T6060 11425-11430 NN denotes death
T6061 11431-11434 CC denotes and
T6062 11435-11445 NN denotes expression
T6063 11446-11448 IN denotes of
T6064 11449-11454 NN denotes NF-κB
T6065 11455-11461 NN denotes target
T6066 11462-11471 JJ denotes apoptotic
T6067 11472-11476 NN denotes cell
T6068 11477-11482 NN denotes death
T6069 11483-11493 JJ denotes regulatory
T6070 11494-11501 NN denotes protein
T6071 11501-11502 -COMMA- denotes ,
T6072 11503-11506 DT denotes the
T6073 11507-11513 NN denotes levels
T6074 11514-11516 IN denotes of
T6075 11517-11526 JJ denotes apoptotic
T6076 11527-11531 NN denotes cell
T6077 11532-11537 NN denotes death
T6078 11538-11541 CC denotes and
T6079 11542-11552 NN denotes expression
T6080 11553-11555 IN denotes of
T6081 11556-11565 JJ denotes apoptotic
T6082 11566-11570 NN denotes cell
T6083 11571-11576 NN denotes death
T6084 11577-11587 JJ denotes regulatory
T6085 11588-11596 NN denotes proteins
T6086 11597-11601 VB denotes were
T6087 11602-11610 VB denotes assessed
T6088 11612-11621 JJ denotes Apoptotic
T6089 11622-11626 NN denotes cell
T6090 11627-11632 NN denotes death
T6091 11633-11635 IN denotes in
T6092 11636-11639 DT denotes the
T6093 11640-11645 NN denotes tumor
T6094 11646-11654 NN denotes sections
T6095 11655-11659 VB denotes were
T6096 11660-11669 VB denotes evaluated
T6097 11670-11672 IN denotes in
T6098 11673-11676 DT denotes the
T6099 11677-11684 NN denotes CCR5+/+
T6100 11685-11688 CC denotes and
T6101 11689-11696 NN denotes CCR5−/−
T6102 11697-11701 NN denotes mice
T6103 11702-11706 WDT denotes that
T6104 11707-11711 VB denotes were
T6105 11712-11722 VB denotes inoculated
T6106 11723-11727 IN denotes with
T6107 11728-11736 NN denotes melanoma
T6108 11737-11742 NN denotes cells
T6109 11744-11749 NN denotes TUNEL
T6110 11750-11758 NN denotes staining
T6111 11759-11767 VB denotes revealed
T6112 11768-11769 DT denotes a
T6113 11770-11776 JJ denotes higher
T6114 11777-11786 NN denotes frequency
T6115 11787-11789 IN denotes of
T6116 11790-11799 JJ denotes apoptotic
T6117 11800-11804 NN denotes cell
T6118 11805-11810 NN denotes death
T6119 11811-11813 IN denotes in
T6120 11814-11817 DT denotes the
T6121 11818-11823 NN denotes tumor
T6122 11824-11831 NN denotes tissues
T6123 11832-11834 IN denotes of
T6124 11835-11838 DT denotes the
T6125 11839-11846 NN denotes CCR5−/−
T6126 11847-11851 NN denotes mice
T6127 11852-11856 IN denotes than
T6128 11857-11861 DT denotes that
T6129 11862-11864 IN denotes of
T6130 11865-11868 DT denotes the
T6131 11869-11876 JJ denotes CCR5+/+
T6132 11877-11881 NN denotes mice
T6133 11882-11883 -LRB- denotes (
T6134 11883-11889 NN denotes Figure
T6135 11890-11892 NN denotes 3A
T6136 11892-11893 -RRB- denotes )
T6137 11895-11914 JJ denotes Immunohistochemical
T6138 11915-11918 CC denotes and
T6139 11919-11937 NN denotes immunofluorescence
T6140 11938-11944 VB denotes showed
T6141 11945-11949 IN denotes that
T6142 11950-11954 JJ denotes high
T6143 11955-11961 NN denotes levels
T6144 11962-11964 IN denotes of
T6145 11965-11972 VB denotes cleaved
T6146 11973-11982 NN denotes caspase-3
T6147 11983-11986 CC denotes and
T6148 11987-11990 NN denotes Bax
T6149 11991-11995 VB denotes were
T6150 11996-12001 VB denotes found
T6151 12002-12006 RB denotes more
T6152 12007-12017 RB denotes frequently
T6153 12018-12020 IN denotes in
T6154 12021-12024 DT denotes the
T6155 12025-12032 NN denotes CCR5−/−
T6156 12033-12037 NN denotes mice
T6157 12038-12042 IN denotes than
T6158 12043-12045 IN denotes in
T6159 12046-12049 DT denotes the
T6160 12050-12057 JJ denotes CCR5+/+
T6161 12058-12062 NN denotes mice
T6162 12063-12064 -LRB- denotes (
T6163 12064-12070 NN denotes Figure
T6164 12071-12073 NN denotes 3B
T6165 12074-12077 CC denotes and
T6166 12078-12080 NN denotes 3C
T6167 12080-12081 -RRB- denotes )
T6168 12083-12093 JJ denotes Consistent
T6169 12094-12098 IN denotes with
T6170 12099-12102 DT denotes the
T6171 12103-12122 JJ denotes immunohistochemical
T6172 12123-12127 NN denotes data
T6173 12127-12128 -COMMA- denotes ,
T6174 12129-12136 JJ denotes Western
T6175 12137-12141 NN denotes blot
T6176 12142-12150 NN denotes analysis
T6177 12151-12153 IN denotes of
T6178 12154-12159 NN denotes tumor
T6179 12160-12168 NN denotes proteins
T6180 12169-12175 VB denotes showed
T6181 12176-12183 JJ denotes greater
T6182 12184-12193 VB denotes increased
T6183 12194-12200 NN denotes levels
T6184 12201-12203 IN denotes of
T6185 12204-12211 VB denotes cleaved
T6186 12212-12221 NN denotes caspase-3
T6187 12221-12222 -COMMA- denotes ,
T6188 12223-12230 VB denotes cleaved
T6189 12231-12240 NN denotes caspase-9
T6190 12240-12241 -COMMA- denotes ,
T6191 12242-12249 VB denotes cleaved
T6192 12250-12254 NN denotes PARP
T6193 12255-12258 CC denotes and
T6194 12259-12262 NN denotes Bax
T6195 12262-12263 -COMMA- denotes ,
T6196 12264-12271 IN denotes whereas
T6197 12272-12275 DT denotes the
T6198 12276-12282 NN denotes levels
T6199 12283-12285 IN denotes of
T6200 12286-12291 NN denotes Bcl-2
T6201 12292-12295 CC denotes and
T6202 12296-12302 NN denotes C-IAP1
T6203 12303-12307 VB denotes were
T6204 12308-12321 RB denotes significantly
T6205 12322-12331 VB denotes decreased
T6206 12332-12334 IN denotes in
T6207 12335-12342 NN denotes CCR5−/−
T6208 12343-12347 NN denotes mice
T6209 12348-12355 NN denotes tissues
T6210 12356-12357 -LRB- denotes (
T6211 12357-12363 NN denotes Figure
T6212 12364-12366 NN denotes 3D
T6213 12366-12367 -RRB- denotes )
T18254 12447-12449 IN denotes in
T18255 12450-12455 NN denotes tumor
T18256 12456-12463 NN denotes tissues
T18257 12464-12466 IN denotes of
T18258 12467-12471 NN denotes CCR5
T18259 12472-12475 NN denotes −/−
T18260 12476-12480 NN denotes mice
T18261 12482-12483 DT denotes A
T18262 12483-12484 -COMMA- denotes ,
T18263 12485-12494 JJ denotes Apoptotic
T18264 12495-12500 NN denotes cells
T18265 12501-12503 IN denotes in
T18266 12504-12509 NN denotes tumor
T18267 12510-12518 NN denotes sections
T18268 12519-12523 VB denotes were
T18269 12524-12532 VB denotes examined
T18270 12533-12535 IN denotes by
T18271 12536-12548 NN denotes fluorescence
T18272 12549-12559 NN denotes microscopy
T18273 12560-12565 IN denotes after
T18274 12566-12570 NN denotes DAPI
T18275 12571-12574 CC denotes and
T18276 12575-12580 NN denotes TUNEL
T18277 12581-12589 NN denotes staining
T18278 12590-12592 IN denotes as
T18279 12593-12602 VB denotes described
T18280 12603-12605 IN denotes in
T18281 12606-12614 NN denotes material
T18282 12615-12618 CC denotes and
T18283 12619-12626 NN denotes methods
T18284 12628-12631 DT denotes The
T18285 12632-12641 JJ denotes apoptotic
T18286 12642-12647 NN denotes index
T18287 12648-12651 VB denotes was
T18288 12652-12662 VB denotes determined
T18289 12663-12665 IN denotes as
T18290 12666-12669 DT denotes the
T18291 12670-12676 NN denotes number
T18292 12677-12679 IN denotes of
T18293 12680-12692 JJ denotes DAPI-stained
T18294 12692-12693 -COMMA- denotes ,
T18295 12694-12708 JJ denotes TUNEL-positive
T18296 12709-12714 NN denotes cells
T18297 12715-12719 WDT denotes that
T18298 12720-12724 VB denotes were
T18299 12725-12732 VB denotes counted
T18300 12734-12740 NN denotes Values
T18301 12741-12744 VB denotes are
T18302 12745-12748 DT denotes the
T18303 12749-12753 JJ denotes mean
T18304 12754-12755 NN denotes ±
T18305 12756-12760 NNP denotes S.D.
T18306 12761-12763 IN denotes of
T18307 12764-12768 CD denotes four
T18308 12769-12781 JJ denotes experimental
T18309 12782-12790 NN denotes animals.
T18310 12791-12792 SYM denotes *
T18311 12793-12802 VB denotes indicates
T18312 12803-12816 RB denotes statistically
T18313 12817-12828 JJ denotes significant
T18314 12829-12840 NN denotes differences
T18315 12841-12845 IN denotes from
T18316 12846-12853 JJ denotes CCR5+/+
T18317 12854-12858 NN denotes mice
T18318 12860-12865 NN denotes Scale
T18319 12866-12869 NN denotes bar
T18320 12870-12879 VB denotes indicates
T18321 12880-12882 CD denotes 50
T18322 12883-12885 NN denotes µm
T18323 12887-12888 NN denotes B
T18324 12889-12892 CC denotes and
T18325 12893-12894 NN denotes C
T18326 12894-12895 -COMMA- denotes ,
T18327 12896-12905 JJ denotes Apoptotic
T18328 12906-12913 NN denotes protein
T18329 12914-12915 -LRB- denotes (
T18330 12915-12922 VB denotes cleaved
T18331 12923-12932 NN denotes caspase-3
T18332 12933-12936 CC denotes and
T18333 12937-12940 NN denotes Bax
T18334 12940-12941 -RRB- denotes )
T18335 12942-12944 IN denotes in
T18336 12945-12950 NN denotes tumor
T18337 12951-12959 NN denotes sections
T18338 12960-12964 VB denotes were
T18339 12965-12973 VB denotes detected
T18340 12974-12976 IN denotes by
T18341 12977-12995 NN denotes immunofluorescence
T18342 12996-13001 NN denotes assay
T18343 13003-13006 DT denotes The
T18344 13007-13015 JJ denotes reactive
T18345 13016-13020 NN denotes cell
T18346 13021-13027 NN denotes number
T18347 13028-13031 VB denotes was
T18348 13032-13042 VB denotes determined
T18349 13043-13045 IN denotes as
T18350 13046-13049 DT denotes the
T18351 13050-13056 NN denotes number
T18352 13057-13059 IN denotes of
T18353 13060-13072 JJ denotes DAPI-stained
T18354 13072-13073 -COMMA- denotes ,
T18355 13074-13082 JJ denotes Specific
T18356 13083-13091 NN denotes antibody
T18357 13092-13093 -LRB- denotes (
T18358 13093-13100 VB denotes cleaved
T18359 13101-13110 NN denotes caspase-3
T18360 13111-13114 CC denotes and
T18361 13115-13118 NN denotes Bax
T18362 13118-13119 -RRB- denotes )
T18363 13119-13128 JJ denotes -positive
T18364 13129-13134 NN denotes cells
T18365 13135-13139 WDT denotes that
T18366 13140-13144 VB denotes were
T18367 13145-13152 VB denotes counted
T18368 13154-13160 NN denotes Values
T18369 13161-13164 VB denotes are
T18370 13165-13168 DT denotes the
T18371 13169-13173 JJ denotes mean
T18372 13174-13175 NN denotes ±
T18373 13176-13180 NNP denotes S.D.
T18374 13181-13183 IN denotes of
T18375 13184-13188 CD denotes four
T18376 13189-13201 JJ denotes experimental
T18377 13202-13210 NN denotes animals.
T18378 13211-13212 SYM denotes *
T18379 13213-13222 VB denotes indicates
T18380 13223-13236 RB denotes statistically
T18381 13237-13248 JJ denotes significant
T18382 13249-13260 NN denotes differences
T18383 13261-13265 IN denotes from
T18384 13266-13273 JJ denotes CCR5+/+
T18385 13274-13278 NN denotes mice
T18386 13280-13285 NN denotes Scale
T18387 13286-13289 NN denotes bar
T18388 13290-13299 VB denotes indicates
T18389 13300-13302 CD denotes 50
T18390 13303-13305 NN denotes µm
T18391 13307-13308 NN denotes D
T18392 13308-13309 -COMMA- denotes ,
T18393 13310-13313 DT denotes The
T18394 13314-13324 NN denotes expression
T18395 13325-13327 IN denotes of
T18396 13328-13337 JJ denotes apoptotic
T18397 13338-13346 NN denotes proteins
T18398 13347-13350 VB denotes was
T18399 13351-13359 VB denotes detected
T18400 13360-13362 IN denotes by
T18401 13363-13370 JJ denotes Western
T18402 13371-13379 NN denotes blotting
T18403 13380-13385 VB denotes using
T18404 13386-13394 JJ denotes specific
T18405 13395-13405 NN denotes antibodies
T18406 13405-13406 -COLON- denotes ;
T18407 13407-13414 VB denotes cleaved
T18408 13415-13424 NN denotes caspase-3
T18409 13424-13425 -COMMA- denotes ,
T18410 13426-13433 VB denotes cleaved
T18411 13434-13443 NN denotes caspase-9
T18412 13443-13444 -COMMA- denotes ,
T18413 13445-13452 VB denotes cleaved
T18414 13453-13457 NN denotes PARP
T18415 13457-13458 -COMMA- denotes ,
T18416 13459-13462 NN denotes Bax
T18417 13462-13463 -COMMA- denotes ,
T18418 13464-13469 NN denotes Bcl-2
T18419 13470-13473 CC denotes and
T18420 13474-13480 NN denotes c-IAP1
T18421 13481-13483 IN denotes in
T18422 13484-13487 DT denotes the
T18423 13488-13493 NN denotes tumor
T18424 13494-13501 NN denotes tissues
T18425 13503-13506 DT denotes The
T18426 13507-13514 JJ denotes β-actin
T18427 13515-13522 NN denotes protein
T18428 13523-13526 VB denotes was
T18429 13527-13531 VB denotes used
T18430 13532-13534 IN denotes as
T18431 13535-13537 DT denotes an
T18432 13538-13546 JJ denotes internal
T18433 13547-13554 NN denotes control
T18434 13556-13560 DT denotes Each
T18435 13561-13565 NN denotes band
T18436 13566-13568 VB denotes is
T18437 13569-13583 JJ denotes representative
T18438 13584-13586 IN denotes of
T18439 13587-13592 CD denotes three
T18440 13593-13604 JJ denotes independent
T18441 13605-13617 JJ denotes experimental
T18442 13618-13625 NN denotes results
T18443 13627-13631 NN denotes Data
T18444 13632-13635 VB denotes are
T18445 13636-13641 NN denotes means
T18446 13642-13643 VB denotes ±
T18447 13644-13648 NNP denotes S.D.
T18448 13649-13651 IN denotes of
T18449 13652-13657 CD denotes three
T18450 13658-13670 JJ denotes experimental
T18451 13671-13679 NN denotes animals.
T18452 13680-13681 SYM denotes *
T18453 13682-13691 VB denotes indicates
T18454 13692-13703 JJ denotes significant
T18455 13704-13714 NN denotes difference
T18456 13715-13719 IN denotes from
T18457 13720-13727 JJ denotes CCR5+/+
T18458 13728-13732 NN denotes mice
T18459 13733-13734 -LRB- denotes (
T18460 13734-13735 NN denotes p
T18461 13735-13736 SYM denotes <
T18462 13736-13740 CD denotes 0.05
T18463 13740-13741 -RRB- denotes )
T18934 13744-13756 NN denotes Upregulation
T6715 13744-13756 NN denotes Upregulation
T18935 13757-13759 IN denotes of
T6716 13757-13759 IN denotes of
T18936 13760-13766 NN denotes IL-1Ra
T6717 13760-13766 NN denotes IL-1Ra
T18937 13767-13769 IN denotes in
T6718 13767-13769 IN denotes in
T18938 13770-13773 DT denotes the
T6719 13770-13773 DT denotes the
T18939 13774-13779 NN denotes Tumor
T6720 13774-13779 NN denotes Tumor
T18940 13780-13783 CC denotes and
T6721 13780-13783 CC denotes and
T18941 13784-13790 NN denotes Spleen
T6722 13784-13790 NN denotes Spleen
T18942 13791-13793 IN denotes of
T6723 13791-13793 IN denotes of
T18943 13794-13801 NN denotes CCR5−/−
T6724 13794-13801 NN denotes CCR5−/−
T18944 13802-13806 NN denotes Mice
T6725 13802-13806 NN denotes Mice
T6726 13807-13809 TO denotes To
T6727 13810-13821 VB denotes investigate
T6728 13822-13825 DT denotes the
T6729 13826-13836 NN denotes difference
T6730 13837-13839 IN denotes in
T6731 13840-13843 DT denotes the
T6732 13844-13852 NN denotes cytokine
T6733 13853-13859 NN denotes levels
T6734 13860-13867 IN denotes between
T6735 13868-13871 DT denotes the
T6736 13872-13877 NN denotes tumor
T6737 13878-13881 CC denotes and
T6738 13882-13888 NN denotes spleen
T6739 13889-13896 NN denotes tissues
T6740 13897-13899 IN denotes of
T6741 13900-13903 DT denotes the
T6742 13904-13911 NN denotes CCR5+/+
T6743 13912-13915 CC denotes and
T6744 13916-13923 NN denotes CCR5−/−
T6745 13924-13928 NN denotes mice
T6746 13928-13929 -COMMA- denotes ,
T6747 13930-13932 PRP denotes we
T6748 13933-13942 VB denotes conducted
T6749 13943-13944 DT denotes a
T6750 13945-13953 NN denotes cytokine
T6751 13954-13959 NN denotes array
T6752 13960-13965 NN denotes assay
T6753 13966-13971 VB denotes using
T6754 13972-13973 DT denotes a
T6755 13974-13979 NNP denotes Mouse
T6756 13980-13988 NNP denotes Proteome
T6757 13989-13994 NNP denotes Array
T6758 13995-13996 -LRB- denotes (
T6759 13996-14002 NN denotes Figure
T6760 14003-14005 NN denotes 4A
T6761 14005-14006 -RRB- denotes )
T6762 14008-14013 IN denotes Among
T6763 14014-14016 CD denotes 40
T6764 14017-14023 VB denotes tested
T6765 14024-14033 NN denotes cytokines
T6766 14033-14034 -COMMA- denotes ,
T6767 14035-14038 DT denotes the
T6768 14039-14045 NN denotes levels
T6769 14046-14048 IN denotes of
T6770 14049-14055 NN denotes IL-1Ra
T6771 14055-14056 -COMMA- denotes ,
T6772 14057-14060 NN denotes MIG
T6773 14060-14061 -COMMA- denotes ,
T6774 14062-14068 NN denotes MIP-1α
T6775 14069-14078 VB denotes increased
T6776 14079-14084 RB denotes about
T6777 14085-14088 CD denotes 686
T6778 14088-14089 -COMMA- denotes ,
T6779 14090-14091 CD denotes 9
T6780 14092-14095 CC denotes and
T6781 14096-14103 RB denotes 25-fold
T6782 14104-14116 RB denotes respectively
T6783 14116-14117 -COMMA- denotes ,
T6784 14118-14120 IN denotes in
T6785 14121-14128 NN denotes CCR5−/−
T6786 14129-14133 NN denotes mice
T6787 14134-14142 VB denotes compared
T6788 14143-14145 TO denotes to
T6789 14146-14153 JJ denotes CCR5+/+
T6790 14154-14158 NN denotes mice
T6791 14160-14165 VB denotes Using
T6792 14166-14170 DT denotes this
T6793 14171-14180 NN denotes technique
T6794 14180-14181 -COMMA- denotes ,
T6795 14182-14184 DT denotes no
T6796 14185-14190 JJ denotes other
T6797 14191-14200 NN denotes cytokines
T6798 14201-14205 VB denotes were
T6799 14206-14211 VB denotes found
T6800 14212-14214 TO denotes to
T6801 14215-14217 VB denotes be
T6802 14218-14227 JJ denotes different
T6803 14228-14235 IN denotes between
T6804 14236-14239 DT denotes the
T6805 14240-14247 NN denotes CCR5−/−
T6806 14248-14252 NN denotes mice
T6807 14253-14256 CC denotes and
T6808 14257-14260 DT denotes the
T6809 14261-14268 JJ denotes CCR5+/+
T6810 14269-14273 NN denotes mice
T6811 14274-14275 -LRB- denotes (
T6812 14275-14281 NN denotes Figure
T6813 14282-14284 NN denotes 4B
T6814 14284-14285 -RRB- denotes )
T6815 14287-14294 JJ denotes Similar
T6816 14295-14302 JJ denotes altered
T6817 14303-14311 NN denotes cytokine
T6818 14312-14318 NN denotes levels
T6819 14319-14323 VB denotes were
T6820 14324-14329 VB denotes found
T6821 14330-14332 IN denotes in
T6822 14333-14336 DT denotes the
T6823 14337-14344 NN denotes spleens
T6824 14345-14347 IN denotes of
T6825 14348-14355 NN denotes CCR5−/−
T6826 14356-14360 NN denotes mice
T6827 14361-14362 -LRB- denotes (
T6828 14362-14368 NN denotes Figure
T6829 14369-14371 NN denotes 4C
T6830 14371-14372 -RRB- denotes )
T6831 14374-14379 IN denotes Since
T6832 14380-14383 DT denotes the
T6833 14384-14390 NN denotes IL-1Ra
T6834 14391-14396 NN denotes level
T6835 14397-14400 VB denotes was
T6836 14401-14404 DT denotes the
T6837 14405-14409 RB denotes most
T6838 14410-14423 RB denotes significantly
T6839 14424-14432 VB denotes elevated
T6840 14432-14433 -COMMA- denotes ,
T6841 14434-14437 DT denotes the
T6842 14438-14448 NN denotes expression
T6843 14449-14451 IN denotes of
T6844 14452-14458 NN denotes IL-1Ra
T6845 14459-14461 IN denotes in
T6846 14462-14467 NN denotes tumor
T6847 14468-14471 CC denotes and
T6848 14472-14478 NN denotes spleen
T6849 14479-14486 NN denotes tissues
T6850 14487-14490 VB denotes was
T6851 14491-14499 VB denotes analyzed
T6852 14500-14502 IN denotes by
T6853 14503-14521 NN denotes immunofluorescence
T6854 14522-14525 CC denotes and
T6855 14526-14533 JJ denotes western
T6856 14534-14542 NN denotes blotting
T6857 14544-14547 DT denotes The
T6858 14548-14558 NN denotes expression
T6859 14559-14561 IN denotes of
T6860 14562-14568 NN denotes IL-1Ra
T6861 14569-14572 VB denotes was
T6862 14573-14584 VB denotes upregulated
T6863 14585-14587 IN denotes in
T6864 14588-14593 NN denotes tumor
T6865 14594-14597 CC denotes and
T6866 14598-14604 NN denotes spleen
T6867 14605-14612 NN denotes tissues
T6868 14613-14615 IN denotes of
T6869 14616-14619 DT denotes the
T6870 14620-14627 NN denotes CCR5−/−
T6871 14628-14632 NN denotes mice
T6872 14633-14634 -LRB- denotes (
T6873 14634-14640 NN denotes Figure
T6874 14641-14645 NN denotes 4D-G
T6875 14645-14646 -RRB- denotes )
T18945 14756-14757 DT denotes A
T18946 14757-14758 -COMMA- denotes ,
T18947 14759-14765 NNP denotes Figure
T18948 14766-14768 NN denotes 4A
T18949 14769-14778 VB denotes indicates
T18950 14779-14784 NN denotes mouse
T18951 14785-14793 NN denotes cytokine
T18952 14794-14799 NN denotes array
T18953 14800-14805 NN denotes panel
T18954 14806-14817 VB denotes coordinates
T18955 14819-14833 NN denotes Nitrocellulose
T18956 14834-14843 NN denotes membranes
T18957 14844-14851 VB denotes contain
T18958 14852-14854 CD denotes 40
T18959 14855-14864 JJ denotes different
T18960 14865-14878 JJ denotes anti-cytokine
T18961 14879-14889 NN denotes antibodies
T18962 14890-14897 VB denotes printed
T18963 14898-14900 IN denotes in
T18964 14901-14910 NN denotes duplicate
T18965 14912-14913 NN denotes B
T18966 14913-14914 -COMMA- denotes ,
T18967 14915-14920 NN denotes Mouse
T18968 14921-14929 NN denotes cytokine
T18969 14930-14935 NN denotes array
T18970 14936-14941 NN denotes panel
T18971 14942-14950 VB denotes indicate
T18972 14951-14954 DT denotes the
T18973 14955-14963 NN denotes cytokine
T18974 14964-14974 NN denotes expression
T18975 14975-14985 NN denotes difference
T18976 14986-14988 IN denotes in
T18977 14989-14994 NN denotes tumor
T18978 14995-15002 NN denotes tissues
T18979 15003-15005 IN denotes of
T18980 15006-15013 JJ denotes CCR5+/+
T18981 15014-15018 NN denotes mice
T18982 15019-15022 CC denotes and
T18983 15023-15030 NN denotes CCR5−/−
T18984 15031-15035 NN denotes mice
T18985 15035-15036 -COMMA- denotes ,
T18986 15037-15047 RB denotes especially
T18987 15048-15054 NN denotes IL-1Ra
T18988 15056-15070 JJ denotes Representative
T18989 15071-15075 NN denotes blot
T18990 15076-15080 IN denotes from
T18991 15081-15086 CD denotes three
T18992 15087-15098 JJ denotes independent
T18993 15099-15110 NN denotes experiments
T18994 15111-15113 VB denotes is
T18995 15114-15119 VB denotes shown
T18996 15121-15129 JJ denotes Positive
T18997 15130-15138 NN denotes controls
T18998 15139-15143 VB denotes show
T18999 15144-15147 DT denotes the
T19000 15148-15162 NN denotes manufacturer’s
T19001 15163-15171 JJ denotes internal
T19002 15172-15180 JJ denotes positive
T19003 15181-15188 NN denotes control
T19004 15189-15196 NN denotes samples
T19005 15197-15199 IN denotes on
T19006 15200-15203 DT denotes the
T19007 15204-15212 NN denotes membrane
T19008 15214-15215 NN denotes C
T19009 15215-15216 -COMMA- denotes ,
T19010 15217-15224 NN denotes Protein
T19011 15225-15238 NN denotes immune-arrays
T19012 15239-15243 VB denotes were
T19013 15244-15253 VB denotes performed
T19014 15254-15259 VB denotes using
T19015 15260-15265 NN denotes Mouse
T19016 15266-15274 NN denotes cytokine
T19017 15275-15280 NN denotes array
T19018 15281-15283 IN denotes in
T19019 15284-15290 NN denotes spleen
T19020 15291-15298 NN denotes tissues
T19021 15300-15305 EX denotes There
T19022 15306-15310 VB denotes were
T19023 15311-15322 NN denotes differences
T19024 15323-15325 IN denotes in
T19025 15326-15335 NN denotes cytokines
T19026 15336-15343 IN denotes between
T19027 15344-15351 JJ denotes CCR5+/+
T19028 15352-15356 NN denotes mice
T19029 15357-15360 CC denotes and
T19030 15361-15368 NN denotes CCR5−/−
T19031 15369-15373 NN denotes mice
T19032 15373-15374 -COMMA- denotes ,
T19033 15375-15385 RB denotes especially
T19034 15386-15392 NN denotes IL-1Ra
T19035 15394-15408 JJ denotes Representative
T19036 15409-15413 NN denotes blot
T19037 15414-15418 IN denotes from
T19038 15419-15424 CD denotes three
T19039 15425-15436 JJ denotes independent
T19040 15437-15448 NN denotes experiments
T19041 15449-15451 VB denotes is
T19042 15452-15457 VB denotes shown
T19043 15459-15467 JJ denotes Positive
T19044 15468-15476 NN denotes controls
T19045 15477-15481 VB denotes show
T19046 15482-15485 DT denotes the
T19047 15486-15500 NN denotes manufacturer’s
T19048 15501-15509 JJ denotes internal
T19049 15510-15518 JJ denotes positive
T19050 15519-15526 NN denotes control
T19051 15527-15534 NN denotes samples
T19052 15535-15537 IN denotes on
T19053 15538-15541 DT denotes the
T19054 15542-15550 NN denotes membrane
T19055 15552-15553 NN denotes D
T19056 15554-15557 CC denotes and
T19057 15558-15559 NN denotes E
T19058 15559-15560 -COMMA- denotes ,
T19059 15561-15580 NN denotes Immunolfluorescence
T19060 15581-15589 NN denotes analysis
T19061 15590-15593 VB denotes was
T19062 15594-15598 VB denotes used
T19063 15599-15601 TO denotes to
T19064 15602-15611 VB denotes determine
T19065 15612-15615 DT denotes the
T19066 15616-15626 NN denotes expression
T19067 15627-15633 NN denotes levels
T19068 15634-15636 IN denotes of
T19069 15637-15643 NN denotes IL-1Ra
T19070 15644-15646 IN denotes in
T19071 15647-15652 NN denotes tumor
T19072 15653-15656 CC denotes and
T19073 15657-15663 NN denotes spleen
T19074 15664-15671 NN denotes tissues
T19075 15673-15676 DT denotes The
T19076 15677-15685 JJ denotes reactive
T19077 15686-15690 NN denotes cell
T19078 15691-15697 NN denotes number
T19079 15698-15701 VB denotes was
T19080 15702-15712 VB denotes determined
T19081 15713-15715 IN denotes as
T19082 15716-15719 DT denotes the
T19083 15720-15726 NN denotes number
T19084 15727-15729 IN denotes of
T19085 15730-15742 JJ denotes DAPI-stained
T19086 15742-15743 -COMMA- denotes ,
T19087 15744-15750 NN denotes IL-1Ra
T19088 15751-15768 JJ denotes antibody-positive
T19089 15769-15774 NN denotes cells
T19090 15775-15779 WDT denotes that
T19091 15780-15784 VB denotes were
T19092 15785-15792 VB denotes counted
T19093 15794-15800 NN denotes Values
T19094 15801-15804 VB denotes are
T19095 15805-15808 DT denotes the
T19096 15809-15813 JJ denotes mean
T19097 15814-15815 NN denotes ±
T19098 15816-15820 NNP denotes S.D.
T19099 15821-15823 IN denotes of
T19100 15824-15828 CD denotes four
T19101 15829-15841 JJ denotes experimental
T19102 15842-15850 NN denotes animals.
T19103 15851-15852 SYM denotes *
T19104 15853-15862 VB denotes indicates
T19105 15863-15876 RB denotes statistically
T19106 15877-15888 JJ denotes significant
T19107 15889-15900 NN denotes differences
T19108 15901-15905 IN denotes from
T19109 15906-15913 JJ denotes CCR5+/+
T19110 15914-15918 NN denotes mice
T19111 15920-15925 NN denotes Scale
T19112 15926-15929 NN denotes bar
T19113 15930-15939 VB denotes indicates
T19114 15940-15942 CD denotes 50
T19115 15943-15945 NN denotes µm
T19116 15947-15948 NN denotes F
T19117 15949-15952 CC denotes and
T19118 15953-15954 NN denotes G
T19119 15954-15955 -COMMA- denotes ,
T19120 15956-15966 NN denotes Expression
T19121 15967-15969 IN denotes of
T19122 15970-15976 NN denotes IL-1Ra
T19123 15977-15980 VB denotes was
T19124 15981-15989 VB denotes analyzed
T19125 15990-15992 IN denotes by
T19126 15993-16000 JJ denotes western
T19127 16001-16009 NN denotes blotting
T19128 16010-16012 IN denotes in
T19129 16013-16018 NN denotes tumor
T19130 16019-16022 CC denotes and
T19131 16023-16029 NN denotes spleen
T19132 16030-16037 NN denotes tissues
T19133 16039-16043 DT denotes Each
T19134 16044-16048 NN denotes band
T19135 16049-16051 VB denotes is
T19136 16052-16066 JJ denotes representative
T19137 16067-16069 IN denotes of
T19138 16070-16075 CD denotes three
T19139 16076-16087 JJ denotes independent
T19140 16088-16100 JJ denotes experimental
T19141 16101-16108 NN denotes results
T19142 16110-16114 NN denotes Data
T19143 16115-16118 VB denotes are
T19144 16119-16124 NN denotes means
T19145 16125-16126 VB denotes ±
T19146 16127-16131 NNP denotes S.D.
T19147 16132-16134 IN denotes of
T19148 16135-16140 CD denotes three
T19149 16141-16153 JJ denotes experimental
T19150 16154-16162 NN denotes animals.
T19151 16163-16164 SYM denotes *
T19152 16165-16174 VB denotes indicates
T19153 16175-16186 JJ denotes significant
T19154 16187-16197 NN denotes difference
T19155 16198-16202 IN denotes from
T19156 16203-16210 JJ denotes CCR5+/+
T19157 16211-16215 NN denotes mice
T19158 16216-16217 -LRB- denotes (
T19159 16217-16218 NN denotes p
T19160 16218-16219 SYM denotes <
T19161 16219-16223 CD denotes 0.05
T19162 16223-16224 -RRB- denotes )
T7434 16227-16236 NN denotes Induction
T7435 16237-16239 IN denotes of
T7436 16240-16243 NN denotes CD8
T7437 16244-16245 NN denotes T
T7438 16246-16251 NN denotes cells
T7439 16252-16255 CC denotes and
T7440 16256-16258 NN denotes NK
T7441 16259-16263 NNP denotes Cell
T7442 16264-16276 NNP denotes Infiltration
T7443 16277-16281 IN denotes into
T7444 16282-16287 NN denotes Tumor
T7445 16288-16291 CC denotes and
T7446 16292-16298 NN denotes Spleen
T7447 16299-16301 IN denotes of
T7448 16302-16309 NN denotes CCR5−/−
T7449 16310-16314 NN denotes Mice
T7450 16315-16317 TO denotes To
T7451 16318-16329 VB denotes investigate
T7452 16330-16337 IN denotes whether
T7453 16338-16341 DT denotes the
T7454 16342-16352 NN denotes inhibition
T7455 16353-16355 IN denotes of
T7456 16356-16361 NN denotes tumor
T7457 16362-16368 NN denotes growth
T7458 16369-16371 IN denotes in
T7459 16372-16379 NN denotes CCR5−/−
T7460 16380-16384 NN denotes mice
T7461 16385-16387 VB denotes is
T7462 16388-16395 JJ denotes related
T7463 16396-16398 TO denotes to
T7464 16399-16413 JJ denotes tumor-specific
T7465 16414-16420 JJ denotes immune
T7466 16421-16430 NN denotes responses
T7467 16430-16431 -COMMA- denotes ,
T7468 16432-16434 PRP denotes we
T7469 16435-16443 VB denotes analyzed
T7470 16444-16447 DT denotes the
T7471 16448-16460 NN denotes distribution
T7472 16461-16469 NN denotes patterns
T7473 16470-16472 IN denotes of
T7474 16473-16477 JJ denotes CD8+
T7475 16478-16487 JJ denotes cytotoxic
T7476 16488-16489 NN denotes T
T7477 16490-16494 NN denotes cell
T7478 16495-16498 CC denotes and
T7479 16499-16504 JJ denotes CD57+
T7480 16505-16512 JJ denotes Natural
T7481 16513-16519 NN denotes Killer
T7482 16520-16525 NN denotes cells
T7483 16526-16528 IN denotes in
T7484 16529-16534 NN denotes tumor
T7485 16535-16538 CC denotes and
T7486 16539-16545 NN denotes spleen
T7487 16546-16553 NN denotes tissues
T7488 16555-16557 IN denotes By
T7489 16558-16566 VB denotes staining
T7490 16567-16570 DT denotes the
T7491 16571-16576 NN denotes tumor
T7492 16577-16585 NN denotes sections
T7493 16586-16590 IN denotes from
T7494 16591-16598 NN denotes CCR5−/−
T7495 16599-16603 NN denotes mice
T7496 16603-16604 -COMMA- denotes ,
T7497 16605-16607 PRP denotes we
T7498 16608-16613 VB denotes found
T7499 16614-16618 IN denotes that
T7500 16619-16624 EX denotes there
T7501 16625-16628 VB denotes was
T7502 16629-16630 DT denotes a
T7503 16631-16642 JJ denotes significant
T7504 16643-16649 NN denotes influx
T7505 16650-16652 IN denotes of
T7506 16653-16657 JJ denotes CD8+
T7507 16658-16663 NN denotes cells
T7508 16664-16668 IN denotes into
T7509 16669-16672 DT denotes the
T7510 16673-16678 NN denotes tumor
T7511 16678-16679 -COMMA- denotes ,
T7512 16680-16682 RB denotes as
T7513 16683-16687 RB denotes well
T7514 16688-16690 IN denotes as
T7515 16691-16693 DT denotes an
T7516 16694-16702 NN denotes increase
T7517 16703-16705 IN denotes in
T7518 16706-16709 DT denotes the
T7519 16710-16716 NN denotes number
T7520 16717-16719 IN denotes of
T7521 16720-16732 VB denotes infiltrating
T7522 16733-16735 NN denotes NK
T7523 16736-16741 NN denotes cells
T7524 16742-16743 -LRB- denotes (
T7525 16743-16749 NN denotes Figure
T7526 16750-16752 NN denotes 5A
T7527 16752-16753 -RRB- denotes )
T7528 16755-16759 JJ denotes CD8+
T7529 16760-16761 NN denotes T
T7530 16762-16767 NN denotes cells
T7531 16768-16771 CC denotes and
T7532 16772-16777 JJ denotes CD57+
T7533 16778-16780 NN denotes NK
T7534 16781-16786 NN denotes cells
T7535 16787-16791 VB denotes were
T7536 16792-16798 VB denotes spread
T7537 16799-16808 RB denotes diffusely
T7538 16809-16819 IN denotes throughout
T7539 16820-16823 DT denotes the
T7540 16824-16830 JJ denotes entire
T7541 16831-16839 NN denotes sections
T7542 16841-16843 TO denotes To
T7543 16844-16851 RB denotes further
T7544 16852-16863 VB denotes investigate
T7545 16864-16867 DT denotes the
T7546 16868-16879 NN denotes differences
T7547 16880-16882 IN denotes in
T7548 16883-16886 DT denotes the
T7549 16887-16894 NN denotes numbers
T7550 16895-16897 IN denotes of
T7551 16898-16902 JJ denotes CD8+
T7552 16903-16904 NN denotes T
T7553 16905-16910 NN denotes cells
T7554 16911-16914 CC denotes and
T7555 16915-16920 JJ denotes CD57+
T7556 16921-16923 NN denotes NK
T7557 16924-16929 NN denotes cells
T7558 16930-16937 IN denotes between
T7559 16938-16945 JJ denotes CCR5+/+
T7560 16946-16950 NN denotes mice
T7561 16951-16954 CC denotes and
T7562 16955-16962 NN denotes CCR5−/−
T7563 16963-16967 NN denotes mice
T7564 16968-16970 IN denotes in
T7565 16971-16987 JJ denotes immunity-related
T7566 16988-16993 NN denotes organ
T7567 16993-16994 -COMMA- denotes ,
T7568 16995-16997 PRP denotes we
T7569 16998-17002 RB denotes also
T7570 17003-17011 VB denotes analyzed
T7571 17012-17015 DT denotes the
T7572 17016-17019 NN denotes CD8
T7573 17020-17023 CC denotes and
T7574 17024-17028 NN denotes CD57
T7575 17029-17037 JJ denotes reactive
T7576 17038-17042 NN denotes cell
T7577 17043-17049 NN denotes number
T7578 17050-17052 IN denotes in
T7579 17053-17059 NN denotes spleen
T7580 17060-17067 NN denotes tissues
T7581 17069-17072 DT denotes The
T7582 17073-17079 NN denotes number
T7583 17080-17082 IN denotes of
T7584 17083-17087 JJ denotes CD8+
T7585 17088-17089 NN denotes T
T7586 17090-17095 NN denotes cells
T7587 17096-17099 CC denotes and
T7588 17100-17105 JJ denotes CD57+
T7589 17106-17108 NN denotes NK
T7590 17109-17114 NN denotes cells
T7591 17115-17119 VB denotes were
T7592 17120-17126 JJ denotes higher
T7593 17127-17129 IN denotes in
T7594 17130-17133 DT denotes the
T7595 17134-17140 NN denotes spleen
T7596 17141-17143 IN denotes of
T7597 17144-17147 DT denotes the
T7598 17148-17155 NN denotes CCR5−/−
T7599 17156-17160 NN denotes mice
T7600 17161-17165 IN denotes than
T7601 17166-17168 IN denotes in
T7602 17169-17172 DT denotes the
T7603 17173-17179 NN denotes spleen
T7604 17180-17182 IN denotes of
T7605 17183-17186 DT denotes the
T7606 17187-17194 JJ denotes CCR5+/+
T7607 17195-17199 NN denotes mice
T7608 17200-17201 -LRB- denotes (
T7609 17201-17207 NN denotes Figure
T7610 17208-17210 NN denotes 5B
T7611 17210-17211 -RRB- denotes )
T7612 17213-17218 DT denotes These
T7613 17219-17223 NN denotes data
T7614 17224-17231 VB denotes suggest
T7615 17232-17236 IN denotes that
T7616 17237-17239 IN denotes by
T7617 17240-17249 VB denotes promoting
T7618 17250-17253 DT denotes the
T7619 17254-17266 NN denotes infiltration
T7620 17267-17269 IN denotes of
T7621 17270-17273 NN denotes CD8
T7622 17274-17275 NN denotes T
T7623 17276-17281 NN denotes cells
T7624 17282-17285 CC denotes and
T7625 17286-17288 NN denotes NK
T7626 17289-17294 NN denotes cells
T7627 17294-17295 -COMMA- denotes ,
T7628 17296-17301 WDT denotes which
T7629 17302-17305 VB denotes are
T7630 17306-17312 JJ denotes potent
T7631 17313-17322 JJ denotes cytotoxic
T7632 17323-17332 NN denotes effectors
T7633 17333-17336 IN denotes for
T7634 17337-17343 NN denotes tumors
T7635 17343-17344 -COMMA- denotes ,
T7636 17345-17350 MD denotes could
T7637 17351-17355 VB denotes play
T7638 17356-17357 DT denotes a
T7639 17358-17362 NN denotes role
T7640 17363-17365 IN denotes in
T7641 17366-17368 DT denotes an
T7642 17369-17379 JJ denotes anti-tumor
T7643 17380-17386 NN denotes effect
T7644 17387-17389 IN denotes in
T7645 17390-17397 NN denotes CCR5−/−
T7646 17398-17402 NN denotes mice
T19603 17448-17457 NN denotes Induction
T19604 17458-17460 IN denotes of
T19605 17461-17464 DT denotes the
T19606 17465-17477 NN denotes infiltration
T19607 17478-17480 IN denotes of
T19608 17481-17485 JJ denotes CD8+
T19609 17486-17487 NN denotes T
T19610 17488-17493 NN denotes cells
T19611 17494-17497 CC denotes and
T19612 17498-17500 NN denotes NK
T19613 17501-17506 NN denotes cells
T19614 17507-17511 IN denotes into
T19615 17512-17517 NN denotes tumor
T19616 17517-17518 -COMMA- denotes ,
T19617 17519-17522 CC denotes and
T19618 17523-17531 NN denotes increase
T19619 17532-17534 IN denotes in
T19620 17535-17541 NN denotes spleen
T19621 17542-17544 IN denotes of
T19622 17545-17552 NN denotes CCR5−/−
T19623 17553-17557 NN denotes mice
T19624 17559-17560 DT denotes A
T19625 17561-17564 CC denotes and
T19626 17565-17566 NN denotes B
T19627 17566-17567 -COMMA- denotes ,
T19628 17568-17587 NN denotes Immunolfluorescence
T19629 17588-17596 NN denotes analysis
T19630 17597-17600 VB denotes was
T19631 17601-17605 VB denotes used
T19632 17606-17608 TO denotes to
T19633 17609-17618 VB denotes determine
T19634 17619-17622 DT denotes the
T19635 17623-17633 NN denotes expression
T19636 17634-17640 NN denotes levels
T19637 17641-17643 IN denotes of
T19638 17644-17647 NN denotes CD8
T19639 17648-17649 -LRB- denotes (
T19640 17649-17653 JJ denotes CD8+
T19641 17654-17663 JJ denotes cytotoxic
T19642 17664-17670 NN denotes T-cell
T19643 17671-17678 NN denotes surface
T19644 17679-17685 NN denotes marker
T19645 17685-17686 -RRB- denotes )
T19646 17687-17690 CC denotes and
T19647 17691-17695 NN denotes CD57
T19648 17696-17697 -LRB- denotes (
T19649 17697-17699 NN denotes NK
T19650 17700-17704 NN denotes cell
T19651 17705-17711 NN denotes marker
T19652 17711-17712 -RRB- denotes )
T19653 17713-17715 IN denotes in
T19654 17716-17721 NN denotes tumor
T19655 17722-17725 CC denotes and
T19656 17726-17732 NN denotes spleen
T19657 17733-17741 NN denotes sections
T19658 17743-17746 DT denotes The
T19659 17747-17753 NN denotes images
T19660 17754-17759 VB denotes shown
T19661 17760-17763 VB denotes are
T19662 17764-17778 JJ denotes representative
T19663 17779-17781 IN denotes of
T19664 17782-17787 CD denotes three
T19665 17788-17796 JJ denotes separate
T19666 17797-17808 NN denotes experiments
T19667 17809-17818 VB denotes performed
T19668 17819-17821 IN denotes in
T19669 17822-17832 NN denotes triplicate
T19670 17834-17839 NN denotes Scale
T19671 17840-17844 NN denotes bars
T19672 17845-17853 VB denotes indicate
T19673 17854-17856 CD denotes 50
T19674 17857-17859 NN denotes µm
T19675 17860-17861 -LRB- denotes (
T19676 17861-17862 NN denotes A
T19677 17862-17863 -RRB- denotes )
T19678 17864-17867 CC denotes and
T19679 17868-17871 CD denotes 100
T19680 17872-17874 NN denotes µm
T19681 17875-17876 -LRB- denotes (
T19682 17876-17877 NN denotes B
T19683 17877-17878 -RRB- denotes )
T19684 17880-17881 NN denotes C
T19685 17882-17885 CC denotes and
T19686 17886-17887 NN denotes D
T19687 17887-17888 -COMMA- denotes ,
T19688 17889-17897 NN denotes Analysis
T19689 17898-17900 IN denotes of
T19690 17901-17911 NN denotes lymphocyte
T19691 17912-17922 NN denotes phenotypes
T19692 17924-17927 DT denotes The
T19693 17928-17933 NN denotes tumor
T19694 17934-17937 CC denotes and
T19695 17938-17944 NN denotes spleen
T19696 17945-17952 NN denotes tissues
T19697 17953-17957 VB denotes were
T19698 17958-17967 VB denotes separated
T19699 17968-17970 IN denotes at
T19700 17971-17976 NN denotes study
T19701 17977-17988 NN denotes termination
T19702 17989-17990 -LRB- denotes (
T19703 17990-17993 NN denotes Day
T19704 17994-17996 CD denotes 31
T19705 17996-17997 -RRB- denotes )
T19706 17999-18003 NN denotes Flow
T19707 18004-18013 NN denotes cytometry
T19708 18014-18022 NN denotes analysis
T19709 18023-18026 VB denotes was
T19710 18027-18036 VB denotes performed
T19711 18037-18042 VB denotes using
T19712 18043-18051 NN denotes FACSAria
T19713 18052-18056 NN denotes flow
T19714 18057-18066 NN denotes cytometry
T19715 18066-18067 -COMMA- denotes ,
T19716 18068-18071 CC denotes and
T19717 18072-18081 VB denotes represent
T19718 18082-18086 NN denotes data
T19719 18087-18091 VB denotes were
T19720 18092-18097 VB denotes shown
T19721 18099-18103 NN denotes Data
T19722 18104-18107 VB denotes are
T19723 18108-18113 NN denotes means
T19724 18114-18115 VB denotes ±
T19725 18116-18120 NNP denotes S.D.
T19726 18121-18123 IN denotes of
T19727 18124-18128 CD denotes four
T19728 18129-18141 JJ denotes experimental
T19729 18142-18149 NN denotes animals
T7647 18151-18153 TO denotes To
T7648 18154-18161 VB denotes analyze
T7649 18162-18165 DT denotes the
T7650 18166-18170 NN denotes cell
T7651 18171-18180 NN denotes phenotype
T7652 18181-18187 NN denotes change
T7653 18188-18190 IN denotes in
T7654 18191-18198 NN denotes CCR5−/−
T7655 18199-18203 NN denotes mice
T7656 18204-18207 CC denotes and
T7657 18208-18215 JJ denotes CCR5+/+
T7658 18216-18220 NN denotes mice
T7659 18221-18223 IN denotes by
T7660 18224-18235 NN denotes inoculation
T7661 18236-18238 IN denotes of
T7662 18239-18242 DT denotes the
T7663 18243-18251 NN denotes melanoma
T7664 18252-18256 NN denotes cell
T7665 18256-18257 -COMMA- denotes ,
T7666 18258-18269 NN denotes lymphocytes
T7667 18270-18274 VB denotes were
T7668 18275-18283 VB denotes isolated
T7669 18284-18288 IN denotes from
T7670 18289-18292 DT denotes the
T7671 18293-18298 NN denotes tumor
T7672 18299-18302 CC denotes and
T7673 18303-18309 NN denotes spleen
T7674 18310-18317 NN denotes tissues
T7675 18319-18322 DT denotes The
T7676 18323-18324 NN denotes B
T7677 18324-18325 -COMMA- denotes ,
T7678 18326-18329 NN denotes CD3
T7679 18330-18331 NNP denotes T
T7680 18331-18332 -COMMA- denotes ,
T7681 18333-18336 NN denotes CD4
T7682 18337-18338 NN denotes T
T7683 18338-18339 -COMMA- denotes ,
T7684 18340-18342 NN denotes CD
T7685 18343-18344 CD denotes 8
T7686 18345-18346 NN denotes T
T7687 18347-18350 CC denotes and
T7688 18351-18353 NN denotes NK
T7689 18354-18358 NN denotes cell
T7690 18359-18366 NN denotes portion
T7691 18367-18369 IN denotes of
T7692 18370-18377 NN denotes CCR5−/−
T7693 18378-18382 NN denotes mice
T7694 18383-18388 NN denotes tumor
T7695 18389-18395 NN denotes tissue
T7696 18396-18400 VB denotes were
T7697 18401-18404 CD denotes 7.2
T7698 18404-18405 NN denotes %
T7699 18405-18406 -COMMA- denotes ,
T7700 18407-18411 CD denotes 48.2
T7701 18411-18412 NN denotes %
T7702 18412-18413 -COMMA- denotes ,
T7703 18414-18418 CD denotes 16.9
T7704 18418-18419 NN denotes %
T7705 18419-18420 -COMMA- denotes ,
T7706 18421-18425 CD denotes 32.1
T7707 18425-18426 NN denotes %
T7708 18427-18430 CC denotes and
T7709 18431-18434 CD denotes 7.8
T7710 18434-18435 NN denotes %
T7711 18435-18436 -COMMA- denotes ,
T7712 18437-18449 RB denotes respectively
T7713 18449-18450 -COMMA- denotes ,
T7714 18451-18459 VB denotes compared
T7715 18460-18462 TO denotes to
T7716 18463-18466 CD denotes 2.9
T7717 18466-18467 NN denotes %
T7718 18467-18468 -COMMA- denotes ,
T7719 18469-18473 CD denotes 11.1
T7720 18473-18474 NN denotes %
T7721 18474-18475 -COMMA- denotes ,
T7722 18476-18479 CD denotes 2.3
T7723 18479-18480 NN denotes %
T7724 18480-18481 -COMMA- denotes ,
T7725 18482-18485 CD denotes 0.6
T7726 18485-18486 NN denotes %
T7727 18487-18490 CC denotes and
T7728 18491-18494 CD denotes 3.1
T7729 18494-18495 NN denotes %
T7730 18496-18498 IN denotes of
T7731 18499-18506 JJ denotes CCR5+/+
T7732 18507-18511 NN denotes mice
T7733 18512-18513 -LRB- denotes (
T7734 18513-18519 NN denotes Figure
T7735 18520-18522 NN denotes 5C
T7736 18522-18523 -RRB- denotes )
T7737 18525-18528 DT denotes The
T7738 18529-18540 NN denotes lymphocytes
T7739 18541-18545 WDT denotes that
T7740 18546-18557 VB denotes infiltrated
T7741 18558-18561 DT denotes the
T7742 18562-18567 NN denotes tumor
T7743 18568-18574 NN denotes tissue
T7744 18575-18577 IN denotes of
T7745 18578-18581 DT denotes the
T7746 18582-18589 NN denotes CCR5−/−
T7747 18590-18594 NN denotes mice
T7748 18595-18599 RB denotes also
T7749 18600-18603 VB denotes had
T7750 18604-18610 JJ denotes higher
T7751 18611-18617 NN denotes levels
T7752 18618-18620 IN denotes of
T7753 18621-18625 NN denotes CD19
T7754 18625-18626 -COMMA- denotes ,
T7755 18627-18630 NN denotes CD3
T7756 18630-18631 -COMMA- denotes ,
T7757 18632-18635 NN denotes CD4
T7758 18635-18636 -COMMA- denotes ,
T7759 18637-18640 NN denotes CD8
T7760 18641-18644 CC denotes and
T7761 18645-18649 NN denotes CD57
T7762 18650-18654 WRB denotes when
T7763 18655-18663 VB denotes compared
T7764 18664-18666 TO denotes to
T7765 18667-18670 DT denotes the
T7766 18671-18678 NN denotes CCR5+/+
T7767 18679-18683 NN denotes mice
T7768 18685-18688 DT denotes The
T7769 18689-18690 NN denotes B
T7770 18690-18691 -COMMA- denotes ,
T7771 18692-18695 NN denotes CD3
T7772 18696-18697 NNP denotes T
T7773 18697-18698 -COMMA- denotes ,
T7774 18699-18702 NN denotes CD4
T7775 18703-18704 NN denotes T
T7776 18704-18705 -COMMA- denotes ,
T7777 18706-18708 NN denotes CD
T7778 18709-18710 CD denotes 8
T7779 18711-18712 NN denotes T
T7780 18713-18716 CC denotes and
T7781 18717-18719 NN denotes NK
T7782 18720-18724 NN denotes cell
T7783 18725-18732 NN denotes portion
T7784 18733-18735 IN denotes of
T7785 18736-18739 DT denotes the
T7786 18740-18747 NN denotes CCR5−/−
T7787 18748-18752 NN denotes mice
T7788 18753-18759 NN denotes spleen
T7789 18760-18764 VB denotes were
T7790 18765-18769 CD denotes 61.3
T7791 18769-18770 NN denotes %
T7792 18770-18771 -COMMA- denotes ,
T7793 18772-18776 CD denotes 33.4
T7794 18776-18777 NN denotes %
T7795 18777-18778 -COMMA- denotes ,
T7796 18779-18783 CD denotes 17.6
T7797 18783-18784 NN denotes %
T7798 18784-18785 -COMMA- denotes ,
T7799 18786-18789 CD denotes 9.2
T7800 18789-18790 NN denotes %
T7801 18791-18794 CC denotes and
T7802 18795-18798 CD denotes 0.6
T7803 18798-18799 NN denotes %
T7804 18799-18800 -COMMA- denotes ,
T7805 18801-18813 RB denotes respectively
T7806 18814-18822 VB denotes compared
T7807 18823-18825 TO denotes to
T7808 18826-18830 CD denotes 38.3
T7809 18830-18831 NN denotes %
T7810 18831-18832 -COMMA- denotes ,
T7811 18833-18836 CD denotes 5.9
T7812 18836-18837 NN denotes %
T7813 18837-18838 -COMMA- denotes ,
T7814 18839-18842 CD denotes 4.0
T7815 18842-18843 NN denotes %
T7816 18843-18844 -COMMA- denotes ,
T7817 18845-18848 CD denotes 1.0
T7818 18848-18849 NN denotes %
T7819 18850-18853 CC denotes and
T7820 18854-18857 CD denotes 3.9
T7821 18857-18858 NN denotes %
T7822 18859-18861 IN denotes of
T7823 18862-18865 DT denotes the
T7824 18866-18873 JJ denotes CCR5+/+
T7825 18874-18878 NN denotes mice
T7826 18879-18880 -LRB- denotes (
T7827 18880-18886 NN denotes Figure
T7828 18887-18889 NN denotes 5D
T7829 18889-18890 -RRB- denotes )
T7830 18892-18897 DT denotes These
T7831 18898-18902 NN denotes data
T7832 18903-18910 VB denotes suggest
T7833 18911-18915 IN denotes that
T7834 18916-18918 IN denotes by
T7835 18919-18928 VB denotes promoting
T7836 18929-18932 DT denotes the
T7837 18933-18945 NN denotes infiltration
T7838 18946-18948 IN denotes of
T7839 18949-18952 NN denotes CD8
T7840 18953-18954 NN denotes T
T7841 18955-18960 NN denotes cells
T7842 18961-18964 CC denotes and
T7843 18965-18967 NN denotes NK
T7844 18968-18973 NN denotes cells
T7845 18973-18974 -COMMA- denotes ,
T7846 18975-18980 WDT denotes which
T7847 18981-18984 VB denotes are
T7848 18985-18991 JJ denotes potent
T7849 18992-19001 JJ denotes cytotoxic
T7850 19002-19011 NN denotes effectors
T7851 19012-19015 IN denotes for
T7852 19016-19022 NN denotes tumors
T7853 19022-19023 -COMMA- denotes ,
T7854 19024-19029 MD denotes could
T7855 19030-19034 VB denotes play
T7856 19035-19036 DT denotes a
T7857 19037-19041 NN denotes role
T7858 19042-19044 IN denotes in
T7859 19045-19048 DT denotes the
T7860 19049-19059 NN denotes inhibition
T7861 19060-19062 IN denotes of
T7862 19063-19068 NN denotes tumor
T7863 19069-19075 NN denotes growth
T7864 19076-19078 IN denotes in
T7865 19079-19086 NN denotes CCR5−/−
T7866 19087-19091 NN denotes mice
T9412 19105-19107 IN denotes In
T9413 19108-19111 DT denotes the
T9414 19112-19119 JJ denotes present
T9415 19120-19125 NN denotes study
T9416 19125-19126 -COMMA- denotes ,
T9417 19127-19129 PRP denotes we
T9418 19130-19135 VB denotes found
T9419 19136-19140 IN denotes that
T9420 19141-19146 NN denotes tumor
T9421 19147-19153 NN denotes weight
T9422 19154-19157 CC denotes and
T9423 19158-19164 NN denotes volume
T9424 19165-19169 VB denotes were
T9425 19170-19174 RB denotes much
T9426 19175-19182 JJ denotes smaller
T9427 19183-19185 IN denotes in
T9428 19186-19189 DT denotes the
T9429 19190-19197 NN denotes CCR5−/−
T9430 19198-19202 NN denotes mice
T9431 19203-19211 VB denotes compared
T9432 19212-19214 TO denotes to
T9433 19215-19218 DT denotes the
T9434 19219-19226 JJ denotes CCR5+/+
T9435 19227-19231 NN denotes mice
T9436 19232-19242 VB denotes inoculated
T9437 19243-19247 IN denotes with
T9438 19248-19251 NN denotes B16
T9439 19252-19260 NN denotes melanoma
T9440 19261-19266 NN denotes cells
T9441 19267-19268 -LRB- denotes (
T9442 19268-19274 NN denotes Figure
T9443 19275-19277 NN denotes 1A
T9444 19278-19281 CC denotes and
T9445 19282-19284 NN denotes 1B
T9446 19284-19285 -RRB- denotes )
T9447 19287-19290 DT denotes The
T9448 19291-19296 NN denotes tumor
T9449 19297-19303 NN denotes growth
T9450 19304-19314 NN denotes inhibition
T9451 19315-19317 IN denotes in
T9452 19318-19321 DT denotes the
T9453 19322-19329 NN denotes CCR5−/−
T9454 19330-19334 NN denotes mice
T9455 19335-19338 VB denotes was
T9456 19339-19349 VB denotes associated
T9457 19350-19354 IN denotes with
T9458 19355-19358 DT denotes the
T9459 19359-19369 NN denotes inhibition
T9460 19370-19372 IN denotes of
T9461 19373-19387 RB denotes constitutively
T9462 19388-19397 VB denotes activated
T9463 19398-19403 NN denotes NF-κB
T9464 19404-19407 CC denotes and
T9465 19408-19417 NN denotes elevation
T9466 19418-19420 IN denotes of
T9467 19421-19427 NN denotes IL-1Ra
T9468 19428-19430 IN denotes in
T9469 19431-19434 DT denotes the
T9470 19435-19440 NN denotes tumor
T9471 19441-19447 NN denotes tissue
T9472 19449-19453 DT denotes This
T9473 19454-19464 JJ denotes anti-tumor
T9474 19465-19473 NN denotes activity
T9475 19474-19477 VB denotes was
T9476 19478-19482 RB denotes also
T9477 19483-19493 VB denotes associated
T9478 19494-19498 IN denotes with
T9479 19499-19508 VB denotes decreased
T9480 19509-19519 NN denotes expression
T9481 19520-19522 IN denotes of
T9482 19523-19528 NN denotes NF-κB
T9483 19529-19535 NN denotes target
T9484 19536-19550 JJ denotes anti-apoptotic
T9485 19550-19551 -COMMA- denotes ,
T9486 19552-19556 NN denotes cell
T9487 19557-19570 JJ denotes proliferative
T9488 19570-19571 -COMMA- denotes ,
T9489 19572-19575 CC denotes and
T9490 19576-19581 NN denotes tumor
T9491 19582-19591 VB denotes promoting
T9492 19592-19597 NN denotes genes
T9493 19598-19599 -LRB- denotes (
T9494 19599-19604 NN denotes Bcl-2
T9495 19605-19608 CC denotes and
T9496 19609-19615 NN denotes C-IAP1
T9497 19615-19616 -RRB- denotes )
T9498 19617-19620 CC denotes but
T9499 19621-19625 IN denotes with
T9500 19626-19635 VB denotes increased
T9501 19636-19646 NN denotes expression
T9502 19647-19649 IN denotes of
T9503 19650-19655 PRP-DOLLAR- denotes their
T9504 19656-19662 NN denotes target
T9505 19663-19672 JJ denotes apoptotic
T9506 19673-19678 NN denotes genes
T9507 19678-19679 -COLON- denotes ;
T9508 19680-19687 VB denotes cleaved
T9509 19688-19697 NN denotes caspase-3
T9510 19698-19701 CC denotes and
T9511 19702-19703 CD denotes 9
T9512 19703-19704 -COMMA- denotes ,
T9513 19705-19708 CC denotes and
T9514 19709-19712 NN denotes Bax
T9515 19713-19714 -LRB- denotes (
T9516 19714-19720 NN denotes Figure
T9517 19721-19725 NN denotes 3A-D
T9518 19725-19726 -RRB- denotes )
T9519 19728-19730 IN denotes In
T9520 19731-19734 DT denotes the
T9521 19735-19740 NN denotes tumor
T9522 19741-19744 CC denotes and
T9523 19745-19748 DT denotes the
T9524 19749-19755 NN denotes spleen
T9525 19755-19756 -COMMA- denotes ,
T9526 19757-19760 DT denotes the
T9527 19761-19767 NN denotes number
T9528 19768-19770 IN denotes of
T9529 19771-19780 JJ denotes cytotoxic
T9530 19781-19785 JJ denotes CD8+
T9531 19786-19787 NN denotes T
T9532 19788-19793 NN denotes cells
T9533 19793-19794 -COMMA- denotes ,
T9534 19795-19800 JJ denotes CD57+
T9535 19801-19808 JJ denotes natural
T9536 19809-19815 NN denotes killer
T9537 19816-19821 NN denotes cells
T9538 19821-19822 -COMMA- denotes ,
T9539 19823-19826 CC denotes and
T9540 19827-19830 DT denotes the
T9541 19831-19837 NN denotes levels
T9542 19838-19840 IN denotes of
T9543 19841-19847 NN denotes IL-1Ra
T9544 19848-19852 VB denotes were
T9545 19853-19862 VB denotes increased
T9546 19863-19864 -LRB- denotes (
T9547 19864-19870 NN denotes Figure
T9548 19871-19872 CD denotes 4
T9549 19873-19876 CC denotes and
T9550 19877-19878 CD denotes 5
T9551 19878-19879 -RRB- denotes )
T9552 19881-19886 DT denotes These
T9553 19887-19895 NN denotes findings
T9554 19896-19903 VB denotes suggest
T9555 19904-19908 IN denotes that
T9556 19909-19917 NN denotes melanoma
T9557 19918-19924 NN denotes growth
T9558 19925-19928 VB denotes was
T9559 19929-19938 VB denotes inhibited
T9560 19939-19941 IN denotes in
T9561 19942-19945 DT denotes the
T9562 19946-19953 NN denotes CCR5−/−
T9563 19954-19958 NN denotes mice
T9564 19958-19959 -COMMA- denotes ,
T9565 19960-19963 CC denotes and
T9566 19964-19968 IN denotes that
T9567 19969-19972 DT denotes the
T9568 19973-19982 NN denotes elevation
T9569 19983-19985 IN denotes of
T9570 19986-19992 NN denotes IL-1Ra
T9571 19992-19993 -COMMA- denotes ,
T9572 19994-20005 VB denotes accompanied
T9573 20006-20010 IN denotes with
T9574 20011-20020 VB denotes decreased
T9575 20021-20026 NN denotes NF-κB
T9576 20026-20027 -COMMA- denotes ,
T9577 20028-20030 VB denotes is
T9578 20031-20042 JJ denotes significant
T9579 20043-20045 IN denotes in
T9580 20046-20049 DT denotes the
T9581 20050-20060 NN denotes inhibition
T9582 20061-20063 IN denotes of
T9583 20064-20072 NN denotes melanoma
T9584 20073-20079 NN denotes growth
T9585 20080-20082 IN denotes in
T9586 20083-20090 NN denotes CCR5−/−
T9587 20091-20095 NN denotes mice
T9588 20097-20102 NN denotes NF-κB
T9589 20103-20112 VB denotes regulates
T9590 20113-20116 DT denotes the
T9591 20117-20127 NN denotes expression
T9592 20128-20130 IN denotes of
T9593 20131-20135 IN denotes over
T9594 20136-20139 CD denotes 200
T9595 20140-20145 NN denotes genes
T9596 20146-20150 WDT denotes that
T9597 20151-20158 VB denotes control
T9598 20159-20162 DT denotes the
T9599 20163-20169 JJ denotes immune
T9600 20170-20176 NN denotes system
T9601 20176-20177 -COMMA- denotes ,
T9602 20178-20184 NN denotes cancer
T9603 20185-20189 NN denotes cell
T9604 20190-20196 NN denotes growth
T9605 20197-20200 CC denotes and
T9606 20201-20213 NN denotes inflammation
T9607 20214-20215 -LRB- denotes [
T9608 20215-20217 CD denotes 39
T9609 20217-20218 -RRB- denotes ]
T9610 20220-20227 IN denotes Because
T9611 20228-20230 IN denotes of
T9612 20231-20234 PRP-DOLLAR- denotes its
T9613 20235-20244 NN denotes abilities
T9614 20245-20247 TO denotes to
T9615 20248-20254 VB denotes induce
T9616 20255-20258 DT denotes the
T9617 20259-20269 NN denotes expression
T9618 20270-20272 IN denotes of
T9619 20273-20274 DT denotes a
T9620 20275-20280 JJ denotes large
T9621 20281-20286 NN denotes array
T9622 20287-20289 IN denotes of
T9623 20290-20302 JJ denotes inflammatory
T9624 20303-20312 NN denotes mediators
T9625 20313-20316 CC denotes and
T9626 20317-20320 PRP-DOLLAR- denotes its
T9627 20321-20326 NN denotes roles
T9628 20327-20329 IN denotes as
T9629 20330-20334 NN denotes core
T9630 20335-20348 NN denotes transcription
T9631 20349-20356 NN denotes factors
T9632 20357-20359 IN denotes in
T9633 20360-20367 JJ denotes diverse
T9634 20368-20374 JJ denotes immune
T9635 20375-20384 NN denotes responses
T9636 20384-20385 -COMMA- denotes ,
T9637 20386-20391 NN denotes NF-κB
T9638 20392-20395 VB denotes has
T9639 20396-20400 VB denotes been
T9640 20401-20411 VB denotes recognized
T9641 20412-20414 IN denotes as
T9642 20415-20416 DT denotes a
T9643 20417-20422 JJ denotes major
T9644 20423-20429 NN denotes factor
T9645 20430-20441 JJ denotes responsible
T9646 20442-20445 IN denotes for
T9647 20446-20465 JJ denotes cytokine-associated
T9648 20466-20472 NN denotes cancer
T9649 20473-20484 NN denotes development
T9650 20485-20487 CC denotes or
T9651 20488-20498 JJ denotes anti-tumor
T9652 20499-20507 NN denotes immunity
T9653 20509-20511 IN denotes In
T9654 20512-20515 DT denotes the
T9655 20516-20524 NN denotes melanoma
T9656 20525-20530 NN denotes tumor
T9657 20531-20538 NN denotes tissues
T9658 20539-20541 IN denotes of
T9659 20542-20545 DT denotes the
T9660 20546-20553 NN denotes CCR5−/−
T9661 20554-20558 NN denotes mice
T9662 20558-20559 -COMMA- denotes ,
T9663 20560-20563 DT denotes the
T9664 20564-20574 NN denotes expression
T9665 20575-20577 IN denotes of
T9666 20578-20583 NN denotes NF-κB
T9667 20584-20590 NN denotes target
T9668 20591-20595 NN denotes cell
T9669 20596-20601 NN denotes death
T9670 20602-20607 NN denotes genes
T9671 20608-20609 -LRB- denotes (
T9672 20609-20612 NN denotes Bax
T9673 20612-20613 -COMMA- denotes ,
T9674 20614-20623 NN denotes caspase-3
T9675 20624-20627 CC denotes and
T9676 20628-20629 CD denotes 9
T9677 20629-20630 -RRB- denotes )
T9678 20631-20634 CC denotes and
T9679 20635-20638 DT denotes the
T9680 20639-20642 NN denotes DNA
T9681 20643-20650 NN denotes binding
T9682 20651-20659 NN denotes activity
T9683 20660-20662 IN denotes of
T9684 20663-20668 NN denotes NF-κB
T9685 20668-20669 -COMMA- denotes ,
T9686 20670-20674 VB denotes were
T9687 20675-20688 RB denotes significantly
T9688 20689-20698 VB denotes inhibited
T9689 20698-20699 -COMMA- denotes ,
T9690 20700-20703 CC denotes but
T9691 20704-20707 DT denotes the
T9692 20708-20718 NN denotes expression
T9693 20719-20721 IN denotes of
T9694 20722-20726 NN denotes cell
T9695 20727-20732 NN denotes death
T9696 20733-20743 JJ denotes inhibitory
T9697 20744-20749 NN denotes NF-κB
T9698 20750-20756 NN denotes target
T9699 20757-20762 NN denotes genes
T9700 20762-20763 -COMMA- denotes ,
T9701 20764-20768 JJ denotes such
T9702 20769-20771 IN denotes as
T9703 20772-20777 NN denotes Bcl-2
T9704 20778-20781 CC denotes and
T9705 20782-20786 NN denotes cIAP
T9706 20787-20791 VB denotes were
T9707 20792-20800 VB denotes enhanced
T9708 20802-20804 IN denotes In
T9709 20805-20813 NN denotes addition
T9710 20813-20814 -COMMA- denotes ,
T9711 20815-20822 NN denotes CCR5−/−
T9712 20823-20832 VB denotes prevented
T9713 20833-20836 DT denotes the
T9714 20837-20852 NN denotes phosphorylation
T9715 20853-20855 IN denotes of
T9716 20856-20859 NN denotes IκB
T9717 20859-20860 -COMMA- denotes ,
T9718 20861-20872 VB denotes accompanied
T9719 20873-20877 IN denotes with
T9720 20878-20881 DT denotes the
T9721 20882-20892 NN denotes inhibition
T9722 20893-20895 IN denotes of
T9723 20896-20899 DT denotes the
T9724 20900-20903 NN denotes p50
T9725 20904-20907 CC denotes and
T9726 20908-20911 NN denotes p65
T9727 20912-20925 NN denotes translocation
T9728 20926-20930 IN denotes into
T9729 20931-20934 DT denotes the
T9730 20935-20942 NN denotes nucleus
T9731 20943-20944 -LRB- denotes (
T9732 20944-20950 NN denotes Figure
T9733 20951-20955 NN denotes 2A-C
T9734 20955-20956 -RRB- denotes )
T9735 20958-20962 JJ denotes Many
T9736 20963-20969 NN denotes tumors
T9737 20969-20970 -COMMA- denotes ,
T9738 20971-20980 VB denotes including
T9739 20981-20989 NN denotes melanoma
T9740 20989-20990 -COMMA- denotes ,
T9741 20991-20995 VB denotes have
T9742 20996-21005 VB denotes increased
T9743 21006-21012 NN denotes levels
T9744 21013-21015 IN denotes of
T9745 21016-21021 NN denotes NF-κB
T9746 21022-21023 -LRB- denotes [
T9747 21023-21025 CD denotes 40
T9748 21025-21026 -RRB- denotes ]
T9749 21026-21027 -COMMA- denotes ,
T9750 21028-21033 WDT denotes which
T9751 21034-21036 VB denotes is
T9752 21037-21043 RB denotes likely
T9753 21044-21050 VB denotes acting
T9754 21051-21053 IN denotes as
T9755 21054-21055 DT denotes a
T9756 21056-21064 NN denotes survival
T9757 21065-21071 NN denotes factor
T9758 21072-21075 IN denotes for
T9759 21076-21084 NN denotes melanoma
T9760 21085-21091 NN denotes growth
T9761 21093-21097 RB denotes Thus
T9762 21097-21098 -COMMA- denotes ,
T9763 21099-21102 DT denotes the
T9764 21103-21114 NN denotes inhibitions
T9765 21115-21117 IN denotes of
T9766 21118-21123 NN denotes NF-κB
T9767 21124-21132 NN denotes activity
T9768 21133-21136 CC denotes and
T9769 21137-21140 DT denotes the
T9770 21141-21151 NN denotes expression
T9771 21152-21154 IN denotes of
T9772 21155-21161 NN denotes target
T9773 21162-21167 NN denotes genes
T9774 21168-21171 VB denotes are
T9775 21172-21180 JJ denotes critical
T9776 21181-21183 IN denotes in
T9777 21184-21187 DT denotes the
T9778 21188-21198 NN denotes inhibition
T9779 21199-21201 IN denotes of
T9780 21202-21207 NN denotes tumor
T9781 21208-21214 NN denotes growth
T9782 21215-21217 IN denotes in
T9783 21218-21225 NN denotes CCR5−/−
T9784 21226-21230 NN denotes mice
T9785 21232-21240 IN denotes Although
T9786 21241-21244 DT denotes the
T9787 21245-21254 NN denotes mechanism
T9788 21255-21257 VB denotes is
T9789 21258-21261 RB denotes not
T9790 21262-21267 JJ denotes clear
T9791 21268-21270 IN denotes as
T9792 21271-21273 TO denotes to
T9793 21274-21277 WRB denotes how
T9794 21278-21285 NN denotes CCR5−/−
T9795 21286-21299 VB denotes downregulates
T9796 21300-21305 NN denotes NF-κB
T9797 21305-21306 -COMMA- denotes ,
T9798 21307-21309 PRP denotes it
T9799 21310-21312 VB denotes is
T9800 21313-21323 JJ denotes noteworthy
T9801 21324-21328 IN denotes that
T9802 21329-21334 NN denotes NF-κB
T9803 21335-21337 VB denotes is
T9804 21338-21347 VB denotes activated
T9805 21348-21350 CC denotes or
T9806 21351-21362 VB denotes inactivated
T9807 21363-21365 IN denotes by
T9808 21366-21370 JJ denotes many
T9809 21371-21380 NN denotes cytokines
T9810 21382-21390 JJ denotes Numerous
T9811 21391-21398 NN denotes studies
T9812 21399-21405 VB denotes showed
T9813 21406-21410 IN denotes that
T9814 21411-21419 NN denotes cytokine
T9815 21420-21426 VB denotes affect
T9816 21427-21432 NN denotes tumor
T9817 21433-21439 NN denotes growth
T9818 21440-21442 IN denotes by
T9819 21443-21453 VB denotes regulating
T9820 21454-21459 NN denotes NF-κB
T9821 21461-21473 JJ denotes Inflammatory
T9822 21474-21483 NN denotes cytokines
T9823 21483-21484 -COMMA- denotes ,
T9824 21485-21494 VB denotes including
T9825 21495-21499 NN denotes IL-1
T9826 21499-21500 -COMMA- denotes ,
T9827 21501-21505 NN denotes IL-6
T9828 21506-21509 CC denotes and
T9829 21510-21514 NN denotes IL-8
T9830 21514-21515 -COMMA- denotes ,
T9831 21516-21524 VB denotes activate
T9832 21525-21530 NN denotes NF-κB
T9833 21531-21539 NN denotes pathways
T9834 21540-21542 IN denotes in
T9835 21543-21548 NN denotes tumor
T9836 21549-21554 NN denotes cells
T9837 21555-21556 -LRB- denotes [
T9838 21556-21558 CD denotes 41
T9839 21558-21559 -RRB- denotes ]
T9840 21561-21564 DT denotes The
T9841 21565-21576 NN denotes interleukin
T9842 21577-21579 CD denotes 10
T9843 21580-21581 -LRB- denotes (
T9844 21581-21586 NN denotes IL-10
T9845 21586-21587 -RRB- denotes )
T9846 21588-21590 VB denotes is
T9847 21591-21595 RB denotes well
T9848 21596-21601 VB denotes known
T9849 21602-21604 IN denotes as
T9850 21605-21607 DT denotes an
T9851 21608-21618 JJ denotes anti-tumor
T9852 21619-21625 NN denotes factor
T9853 21626-21628 RB denotes as
T9854 21629-21633 RB denotes well
T9855 21634-21636 IN denotes as
T9856 21637-21639 DT denotes an
T9857 21640-21657 JJ denotes anti-inflammatory
T9858 21658-21664 NN denotes factor
T9859 21665-21666 -LRB- denotes [
T9860 21666-21668 CD denotes 42
T9861 21668-21669 -RRB- denotes ]
T9862 21669-21670 -COMMA- denotes ,
T9863 21671-21672 -LRB- denotes [
T9864 21672-21674 CD denotes 43
T9865 21674-21675 -RRB- denotes ]
T9866 21677-21682 NN denotes IL-10
T9867 21683-21691 VB denotes inhibits
T9868 21692-21706 RB denotes constitutively
T9869 21707-21716 VB denotes activated
T9870 21717-21722 NN denotes NF-κB
T9871 21723-21727 CC denotes both
T9872 21728-21730 FW denotes in
T9873 21731-21736 FW denotes vitro
T9874 21737-21738 -LRB- denotes [
T9875 21738-21740 CD denotes 44
T9876 21740-21741 -RRB- denotes ]
T9877 21742-21745 CC denotes and
T9878 21746-21748 FW denotes in
T9879 21749-21753 FW denotes vivo
T9880 21754-21755 -LRB- denotes [
T9881 21755-21757 CD denotes 45
T9882 21757-21758 -RRB- denotes ]
T9883 21760-21770 NN denotes Inhibition
T9884 21771-21773 IN denotes of
T9885 21774-21779 NN denotes NF-κB
T9886 21780-21782 IN denotes by
T9887 21783-21786 DT denotes the
T9888 21787-21792 NN denotes IL-10
T9889 21793-21804 VB denotes contributes
T9890 21805-21807 TO denotes to
T9891 21808-21811 DT denotes the
T9892 21812-21822 JJ denotes anti-tumor
T9893 21823-21830 NN denotes effects
T9894 21831-21838 IN denotes through
T9895 21839-21842 DT denotes the
T9896 21843-21853 NN denotes activation
T9897 21854-21856 IN denotes of
T9898 21857-21866 NN denotes caspase-3
T9899 21867-21870 CC denotes and
T9900 21871-21880 NN denotes apoptosis
T9901 21881-21883 IN denotes in
T9902 21884-21899 JJ denotes Colon26-bearing
T9903 21900-21904 NN denotes mice
T9904 21905-21906 -LRB- denotes [
T9905 21906-21908 CD denotes 43
T9906 21908-21909 -RRB- denotes ]
T9907 21911-21920 RB denotes Similarly
T9908 21920-21921 -COMMA- denotes ,
T9909 21922-21929 JJ denotes several
T9910 21930-21937 NN denotes studies
T9911 21938-21942 VB denotes have
T9912 21943-21955 VB denotes demonstrated
T9913 21956-21959 DT denotes the
T9914 21960-21967 NN denotes ability
T9915 21968-21970 IN denotes of
T9916 21971-21977 NN denotes IL-1Ra
T9917 21978-21980 TO denotes to
T9918 21981-21989 VB denotes abrogate
T9919 21990-21993 DT denotes the
T9920 21994-22009 JJ denotes proinflammatory
T9921 22010-22017 NN denotes effects
T9922 22018-22020 IN denotes of
T9923 22021-22025 NN denotes IL-1
T9924 22026-22027 -LRB- denotes [
T9925 22027-22029 CD denotes 46
T9926 22029-22030 -RRB- denotes ]
T9927 22032-22034 PRP denotes It
T9928 22035-22038 VB denotes has
T9929 22039-22043 VB denotes been
T9930 22044-22052 VB denotes reported
T9931 22053-22057 IN denotes that
T9932 22058-22062 NN denotes IL-1
T9933 22063-22070 VB denotes induces
T9934 22071-22074 DT denotes the
T9935 22075-22085 NN denotes activation
T9936 22086-22088 IN denotes of
T9937 22089-22094 NN denotes NF-κB
T9938 22095-22097 IN denotes in
T9939 22098-22105 JJ denotes several
T9940 22106-22113 NN denotes cancers
T9941 22113-22114 -COMMA- denotes ,
T9942 22115-22118 CC denotes and
T9943 22119-22128 VB denotes increases
T9944 22129-22133 NN denotes cell
T9945 22134-22139 NN denotes cycle
T9946 22140-22151 NN denotes progression
T9947 22151-22152 -COMMA- denotes ,
T9948 22153-22156 CC denotes and
T9949 22157-22160 DT denotes the
T9950 22161-22172 NN denotes suppression
T9951 22173-22175 IN denotes of
T9952 22176-22185 JJ denotes apoptotic
T9953 22186-22190 NN denotes cell
T9954 22191-22196 NN denotes death
T9955 22197-22204 VB denotes leading
T9956 22205-22207 TO denotes to
T9957 22208-22213 NN denotes tumor
T9958 22214-22223 NN denotes promotion
T9959 22225-22228 DT denotes The
T9960 22229-22236 NN denotes results
T9961 22237-22239 IN denotes of
T9962 22240-22247 JJ denotes various
T9963 22248-22255 NN denotes studies
T9964 22256-22260 IN denotes over
T9965 22261-22264 DT denotes the
T9966 22265-22269 JJ denotes past
T9967 22270-22272 CD denotes 10
T9968 22273-22278 NN denotes years
T9969 22279-22287 VB denotes indicate
T9970 22288-22292 IN denotes that
T9971 22293-22296 DT denotes the
T9972 22297-22302 JJ denotes major
T9973 22303-22311 NN denotes function
T9974 22312-22314 IN denotes of
T9975 22315-22321 NN denotes IL-1Ra
T9976 22322-22324 VB denotes is
T9977 22325-22327 TO denotes to
T9978 22328-22336 VB denotes regulate
T9979 22337-22340 DT denotes the
T9980 22341-22352 JJ denotes pleiotropic
T9981 22353-22360 NN denotes effects
T9982 22361-22363 IN denotes of
T9983 22364-22368 NN denotes IL-1
T9984 22369-22371 IN denotes by
T9985 22372-22385 RB denotes competitively
T9986 22386-22394 VB denotes blocking
T9987 22395-22398 PRP-DOLLAR- denotes its
T9988 22399-22408 NN denotes functions
T9989 22409-22410 -LRB- denotes [
T9990 22410-22412 CD denotes 47
T9991 22412-22413 -RRB- denotes ]
T9992 22415-22418 DT denotes The
T9993 22419-22426 NN denotes ability
T9994 22427-22429 IN denotes of
T9995 22430-22434 NN denotes IL-1
T9996 22435-22437 TO denotes to
T9997 22438-22444 VB denotes induce
T9998 22445-22448 PRP-DOLLAR- denotes its
T9999 22449-22452 JJ denotes own
T10000 22453-22463 NN denotes antagonist
T10001 22464-22466 VB denotes is
T10002 22467-22469 IN denotes of
T10003 22470-22478 NN denotes interest
T10004 22479-22481 IN denotes in
T10005 22482-22495 VB denotes understanding
T10006 22496-22499 DT denotes the
T10007 22500-22510 NN denotes regulation
T10008 22511-22514 CC denotes and
T10009 22515-22528 NN denotes dysregulation
T10010 22529-22531 IN denotes of
T10011 22532-22536 NN denotes IL-1
T10012 22537-22546 NN denotes signaling
T10013 22547-22549 IN denotes in
T10014 22550-22556 JJ denotes normal
T10015 22557-22560 CC denotes and
T10016 22561-22569 JJ denotes diseased
T10017 22570-22576 NN denotes tissue
T10018 22578-22591 NN denotes Up-regulation
T10019 22592-22594 IN denotes of
T10020 22595-22598 DT denotes the
T10021 22599-22607 NN denotes receptor
T10022 22608-22618 NN denotes antagonist
T10023 22619-22629 VB denotes represents
T10024 22630-22631 DT denotes a
T10025 22632-22641 NN denotes mechanism
T10026 22642-22645 IN denotes for
T10027 22646-22653 VB denotes turning
T10028 22654-22657 RP denotes off
T10029 22658-22662 NN denotes IL-1
T10030 22663-22672 NN denotes signaling
T10031 22673-22676 CC denotes and
T10032 22677-22685 VB denotes creating
T10033 22686-22687 DT denotes a
T10034 22688-22697 JJ denotes temporary
T10035 22698-22703 NN denotes state
T10036 22704-22706 IN denotes of
T10037 22707-22721 NN denotes refractoriness
T10038 22723-22726 DT denotes The
T10039 22727-22735 VB denotes elevated
T10040 22736-22746 NN denotes expression
T10041 22747-22749 IN denotes of
T10042 22750-22756 NN denotes IL-1Ra
T10043 22756-22757 -COMMA- denotes ,
T10044 22758-22765 IN denotes without
T10045 22766-22769 DT denotes any
T10046 22770-22776 NN denotes change
T10047 22777-22779 IN denotes of
T10048 22780-22784 NN denotes IL-1
T10049 22785-22787 IN denotes in
T10050 22788-22794 NN denotes tumors
T10051 22794-22795 -COMMA- denotes ,
T10052 22796-22804 VB denotes suggests
T10053 22805-22809 IN denotes that
T10054 22810-22813 DT denotes the
T10055 22814-22828 JJ denotes IL-1-signaling
T10056 22829-22835 NN denotes system
T10057 22836-22839 MD denotes may
T10058 22840-22842 VB denotes be
T10059 22843-22855 VB denotes dysregulated
T10060 22856-22858 IN denotes by
T10061 22859-22865 NN denotes IL-1Ra
T10062 22866-22868 IN denotes in
T10063 22869-22875 NN denotes tumors
T10064 22877-22883 NN denotes IL-1Ra
T10065 22884-22887 VB denotes has
T10066 22888-22892 VB denotes been
T10067 22893-22898 VB denotes shown
T10068 22899-22901 TO denotes to
T10069 22902-22909 VB denotes inhibit
T10070 22910-22915 NN denotes tumor
T10071 22916-22927 NN denotes progression
T10072 22928-22930 IN denotes in
T10073 22931-22939 NN denotes prostate
T10074 22939-22940 -COMMA- denotes ,
T10075 22941-22947 NN denotes breast
T10076 22947-22948 -COMMA- denotes ,
T10077 22949-22952 CC denotes and
T10078 22953-22957 NN denotes skin
T10079 22958-22964 NN denotes cancer
T10080 22965-22966 -LRB- denotes [
T10081 22966-22968 CD denotes 14
T10082 22968-22969 -RRB- denotes ]
T10083 22969-22970 -COMMA- denotes ,
T10084 22971-22972 -LRB- denotes [
T10085 22972-22974 CD denotes 15
T10086 22974-22975 -RRB- denotes ]
T10087 22975-22976 -COMMA- denotes ,
T10088 22977-22978 -LRB- denotes [
T10089 22978-22980 CD denotes 16
T10090 22980-22981 -RRB- denotes ]
T10091 22983-22996 JJ denotes Intracellular
T10092 22997-23003 NN denotes IL-1Ra
T10093 23004-23005 -LRB- denotes (
T10094 23005-23013 NN denotes icIL-1Ra
T10095 23013-23014 -RRB- denotes )
T10096 23015-23023 VB denotes inhibits
T10097 23024-23028 NN denotes IL-6
T10098 23029-23032 CC denotes and
T10099 23033-23037 NN denotes IL-8
T10100 23038-23048 NN denotes production
T10101 23049-23051 IN denotes in
T10102 23052-23058 NN denotes Caco-2
T10103 23059-23064 NN denotes cells
T10104 23065-23067 IN denotes by
T10105 23068-23076 VB denotes blocking
T10106 23077-23082 NN denotes NF-κB
T10107 23083-23091 NN denotes pathways
T10108 23092-23093 -LRB- denotes [
T10109 23093-23095 CD denotes 37
T10110 23095-23096 -RRB- denotes ]
T10111 23098-23100 PRP denotes We
T10112 23101-23106 VB denotes found
T10113 23107-23111 IN denotes that
T10114 23112-23115 DT denotes the
T10115 23116-23122 NN denotes levels
T10116 23123-23125 IN denotes of
T10117 23126-23132 NN denotes IL-1Ra
T10118 23133-23137 VB denotes were
T10119 23138-23151 RB denotes significantly
T10120 23152-23160 VB denotes elevated
T10121 23161-23163 IN denotes in
T10122 23164-23167 DT denotes the
T10123 23168-23173 NN denotes tumor
T10124 23174-23181 NN denotes tissues
T10125 23182-23184 IN denotes of
T10126 23185-23192 NN denotes CCR5−/−
T10127 23193-23197 NN denotes mice
T10128 23198-23208 VB denotes inoculated
T10129 23209-23213 IN denotes with
T10130 23214-23217 NN denotes B16
T10131 23218-23226 NN denotes melanoma
T10132 23227-23232 NN denotes cells
T10133 23234-23239 VB denotes Taken
T10134 23240-23248 RB denotes together
T10135 23248-23249 -COMMA- denotes ,
T10136 23250-23255 DT denotes these
T10137 23256-23260 NN denotes data
T10138 23261-23269 VB denotes indicate
T10139 23270-23276 NN denotes IL-1Ra
T10140 23277-23282 MD denotes could
T10141 23283-23285 VB denotes be
T10142 23286-23296 RB denotes critically
T10143 23297-23305 VB denotes involved
T10144 23306-23308 IN denotes in
T10145 23309-23312 DT denotes the
T10146 23313-23318 NN denotes tumor
T10147 23319-23325 NN denotes growth
T10148 23326-23336 NN denotes inhibition
T10149 23337-23339 IN denotes of
T10150 23340-23347 NN denotes CCR5−/−
T10151 23348-23352 NN denotes mice
T10152 23353-23360 IN denotes through
T10153 23361-23364 DT denotes the
T10154 23365-23377 NN denotes inactivation
T10155 23378-23380 IN denotes of
T10156 23381-23386 NN denotes NF-κB
T10157 23387-23389 IN denotes in
T10158 23390-23393 DT denotes the
T10159 23394-23401 JJ denotes present
T10160 23402-23407 NN denotes study
T10161 23409-23413 NN denotes CCR5
T10162 23414-23423 VB denotes increases
T10163 23424-23429 NN denotes tumor
T10164 23430-23436 NN denotes growth
T10165 23437-23439 IN denotes in
T10166 23440-23441 DT denotes a
T10167 23442-23447 JJ denotes local
T10168 23448-23453 NN denotes model
T10169 23454-23457 CC denotes and
T10170 23458-23466 VB denotes inhibits
T10171 23467-23470 DT denotes the
T10172 23471-23479 NN denotes efficacy
T10173 23480-23482 IN denotes of
T10174 23483-23484 DT denotes a
T10175 23485-23493 NN denotes dendrite
T10176 23494-23498 NN denotes cell
T10177 23499-23506 NN denotes vaccine
T10178 23507-23509 IN denotes in
T10179 23510-23517 JJ denotes CCR5+/+
T10180 23518-23522 NN denotes mice
T10181 23523-23531 VB denotes compared
T10182 23532-23536 IN denotes with
T10183 23537-23544 NN denotes CCR5−/−
T10184 23545-23549 NN denotes mice
T10185 23550-23551 -LRB- denotes [
T10186 23551-23553 CD denotes 10
T10187 23553-23554 -RRB- denotes ]
T10188 23556-23561 NNP denotes Cheng
T10189 23562-23563 NNP denotes J
T10190 23564-23567 CC denotes and
T10191 23568-23572 NNP denotes Sung
T10192 23573-23575 NNP denotes RS
T10193 23576-23584 VB denotes examined
T10194 23585-23588 DT denotes the
T10195 23589-23595 NN denotes effect
T10196 23596-23598 IN denotes of
T10197 23599-23603 NN denotes CCR5
T10198 23604-23606 IN denotes on
T10199 23607-23610 DT denotes the
T10200 23611-23617 JJ denotes immune
T10201 23618-23626 NN denotes response
T10202 23627-23629 TO denotes to
T10203 23630-23640 NN denotes adenovirus
T10204 23641-23648 NN denotes vectors
T10205 23649-23652 CC denotes and
T10206 23653-23658 NN denotes graft
T10207 23659-23667 NN denotes function
T10208 23668-23670 IN denotes in
T10209 23671-23673 DT denotes an
T10210 23674-23679 NN denotes islet
T10211 23680-23690 NN denotes transplant
T10212 23691-23696 NN denotes model
T10213 23698-23702 PRP denotes They
T10214 23703-23708 VB denotes found
T10215 23709-23713 IN denotes that
T10216 23714-23718 NN denotes CCR5
T10217 23719-23726 NN denotes absence
T10218 23727-23731 VB denotes does
T10219 23732-23735 RB denotes not
T10220 23736-23743 VB denotes prevent
T10221 23744-23747 DT denotes the
T10222 23748-23753 JJ denotes local
T10223 23754-23760 JJ denotes immune
T10224 23761-23769 NN denotes response
T10225 23770-23772 TO denotes to
T10226 23773-23783 NN denotes adenovirus
T10227 23784-23796 NN denotes transduction
T10228 23797-23798 -LRB- denotes [
T10229 23798-23800 CD denotes 48
T10230 23800-23801 -RRB- denotes ]
T10231 23803-23815 RB denotes Additionally
T10232 23815-23816 -COMMA- denotes ,
T10233 23817-23820 NNP denotes Tan
T10234 23821-23823 NNP denotes MC
T10235 23824-23826 FW denotes et
T10236 23827-23830 FW denotes al.
T10237 23831-23840 VB denotes suggested
T10238 23841-23845 IN denotes that
T10239 23846-23856 NN denotes disruption
T10240 23857-23859 IN denotes of
T10241 23860-23869 NN denotes CCR5/CCL5
T10242 23870-23879 NN denotes signaling
T10243 23879-23880 -COMMA- denotes ,
T10244 23881-23887 CC denotes either
T10245 23888-23890 IN denotes by
T10246 23891-23899 VB denotes reducing
T10247 23900-23904 NN denotes CCL5
T10248 23905-23915 NN denotes production
T10249 23916-23918 IN denotes by
T10250 23919-23924 NN denotes tumor
T10251 23925-23930 NN denotes cells
T10252 23931-23933 CC denotes or
T10253 23934-23936 IN denotes by
T10254 23937-23945 JJ denotes systemic
T10255 23946-23960 NN denotes administration
T10256 23961-23963 IN denotes of
T10257 23964-23965 DT denotes a
T10258 23966-23970 NN denotes CCR5
T10259 23971-23980 NN denotes inhibitor
T10260 23981-23982 -LRB- denotes (
T10261 23982-23989 NN denotes TAK-779
T10262 23989-23990 -RRB- denotes )
T10263 23990-23991 -COMMA- denotes ,
T10264 23992-23999 VB denotes reduced
T10265 24000-24004 NNP denotes Treg
T10266 24005-24006 -LRB- denotes (
T10267 24006-24016 JJ denotes regulatory
T10268 24017-24018 NN denotes T
T10269 24019-24024 NN denotes cells
T10270 24024-24025 -RRB- denotes )
T10271 24026-24035 NN denotes migration
T10272 24036-24038 TO denotes to
T10273 24039-24045 NN denotes tumors
T10274 24046-24048 IN denotes so
T10275 24049-24053 IN denotes that
T10276 24054-24060 NN denotes tumors
T10277 24061-24064 VB denotes are
T10278 24065-24072 JJ denotes smaller
T10279 24073-24075 IN denotes in
T10280 24076-24083 NN denotes control
T10281 24084-24088 NN denotes mice
T10282 24089-24090 -LRB- denotes [
T10283 24090-24091 CD denotes 9
T10284 24091-24092 -RRB- denotes ]
T10285 24094-24099 DT denotes These
T10286 24100-24104 NN denotes data
T10287 24105-24112 VB denotes support
T10288 24113-24116 DT denotes the
T10289 24117-24126 JJ denotes important
T10290 24127-24134 NN denotes premise
T10291 24135-24139 IN denotes that
T10292 24140-24150 NN denotes inhibition
T10293 24151-24153 IN denotes of
T10294 24154-24159 NN denotes tumor
T10295 24160-24166 NN denotes growth
T10296 24167-24169 IN denotes in
T10297 24170-24177 NN denotes CCR5−/−
T10298 24178-24182 NN denotes mice
T10299 24183-24188 MD denotes could
T10300 24189-24191 VB denotes be
T10301 24192-24199 VB denotes related
T10302 24200-24204 IN denotes with
T10303 24205-24208 DT denotes the
T10304 24209-24219 NN denotes inhibition
T10305 24220-24222 IN denotes of
T10306 24223-24229 JJ denotes immune
T10307 24230-24236 NN denotes escape
T10308 24238-24245 JJ denotes Similar
T10309 24246-24248 TO denotes to
T10310 24249-24253 DT denotes this
T10311 24254-24261 NN denotes finding
T10312 24261-24262 -COMMA- denotes ,
T10313 24263-24265 PRP denotes we
T10314 24266-24271 VB denotes found
T10315 24272-24276 IN denotes that
T10316 24277-24280 DT denotes the
T10317 24281-24288 JJ denotes CCR5+/+
T10318 24289-24293 NN denotes mice
T10319 24294-24302 VB denotes injected
T10320 24303-24307 IN denotes with
T10321 24308-24316 NN denotes melanoma
T10322 24317-24322 NN denotes cells
T10323 24323-24333 RB denotes apparently
T10324 24334-24338 VB denotes have
T10325 24339-24340 DT denotes a
T10326 24341-24346 JJ denotes lower
T10327 24347-24353 NN denotes number
T10328 24354-24356 IN denotes of
T10329 24357-24366 JJ denotes cytotoxic
T10330 24367-24368 NN denotes T
T10331 24369-24374 NN denotes cells
T10332 24375-24376 -LRB- denotes (
T10333 24376-24388 JJ denotes CD8+positive
T10334 24389-24390 NN denotes T
T10335 24391-24402 NN denotes Lymphocytes
T10336 24403-24408 NN denotes cells
T10337 24408-24409 -RRB- denotes )
T10338 24410-24413 CC denotes and
T10339 24414-24421 JJ denotes natural
T10340 24422-24428 NN denotes killer
T10341 24429-24434 NN denotes cells
T10342 24435-24436 -LRB- denotes (
T10343 24436-24440 NN denotes CD57
T10344 24441-24449 JJ denotes positive
T10345 24450-24452 NN denotes NK
T10346 24453-24458 NN denotes cells
T10347 24458-24459 -RRB- denotes )
T10348 24459-24460 -COMMA- denotes ,
T10349 24461-24463 RB denotes as
T10350 24464-24468 RB denotes well
T10351 24469-24471 IN denotes as
T10352 24472-24480 NN denotes dendrite
T10353 24481-24486 NN denotes cells
T10354 24486-24487 -COMMA- denotes ,
T10355 24488-24490 IN denotes in
T10356 24491-24497 NN denotes spleen
T10357 24498-24505 NN denotes tissues
T10358 24506-24514 VB denotes compared
T10359 24515-24517 TO denotes to
T10360 24518-24523 DT denotes those
T10361 24524-24531 IN denotes without
T10362 24532-24540 NN denotes melanoma
T10363 24541-24546 NN denotes cells
T10364 24548-24551 CC denotes But
T10365 24552-24555 DT denotes the
T10366 24556-24567 NN denotes lymphocytes
T10367 24568-24570 IN denotes of
T10368 24571-24574 DT denotes the
T10369 24575-24582 NN denotes CCR5−/−
T10370 24583-24587 NN denotes mice
T10371 24588-24591 VB denotes did
T10372 24592-24595 RB denotes not
T10373 24596-24604 VB denotes decrease
T10374 24605-24609 WRB denotes when
T10375 24610-24618 VB denotes injected
T10376 24619-24623 IN denotes with
T10377 24624-24632 NN denotes melanoma
T10378 24633-24638 NN denotes cells
T10379 24640-24645 DT denotes These
T10380 24646-24657 NN denotes differences
T10381 24658-24660 IN denotes of
T10382 24661-24664 DT denotes the
T10383 24665-24671 JJ denotes immune
T10384 24672-24680 NN denotes response
T10385 24681-24688 IN denotes between
T10386 24689-24692 DT denotes the
T10387 24693-24700 JJ denotes CCR5+/+
T10388 24701-24705 NN denotes mice
T10389 24706-24709 CC denotes and
T10390 24710-24713 DT denotes the
T10391 24714-24721 NN denotes CCR5−/−
T10392 24722-24726 NN denotes mice
T10393 24726-24727 -COMMA- denotes ,
T10394 24728-24737 VB denotes involving
T10395 24738-24743 NN denotes tumor
T10396 24744-24750 JJ denotes immune
T10397 24751-24760 NN denotes tolerance
T10398 24760-24761 -COMMA- denotes ,
T10399 24762-24765 MD denotes may
T10400 24766-24768 VB denotes be
T10401 24769-24778 VB denotes connected
T10402 24779-24783 IN denotes with
T10403 24784-24787 DT denotes the
T10404 24788-24798 NN denotes inhibition
T10405 24799-24801 IN denotes of
T10406 24802-24808 NN denotes cancer
T10407 24809-24820 NN denotes progression
T10408 24822-24827 VB denotes Taken
T10409 24828-24836 RB denotes together
T10410 24836-24837 -COMMA- denotes ,
T10411 24838-24840 IN denotes in
T10412 24841-24844 DT denotes the
T10413 24845-24853 NN denotes cytokine
T10414 24854-24859 NN denotes array
T10415 24860-24870 NN denotes experiment
T10416 24870-24871 -COMMA- denotes ,
T10417 24872-24875 DT denotes the
T10418 24876-24881 NN denotes level
T10419 24882-24884 IN denotes of
T10420 24885-24891 NN denotes MIP-1α
T10421 24892-24893 -LRB- denotes (
T10422 24893-24898 WDT denotes which
T10423 24899-24902 VB denotes has
T10424 24903-24904 DT denotes a
T10425 24905-24911 JJ denotes potent
T10426 24912-24920 NN denotes activity
T10427 24921-24923 IN denotes of
T10428 24924-24925 NN denotes T
T10429 24926-24930 NN denotes cell
T10430 24931-24934 CC denotes and
T10431 24935-24936 NN denotes B
T10432 24937-24941 NN denotes cell
T10433 24942-24951 NN denotes migration
T10434 24951-24952 -RRB- denotes )
T10435 24953-24956 VB denotes was
T10436 24957-24966 VB denotes increased
T10437 24967-24969 IN denotes in
T10438 24970-24973 DT denotes the
T10439 24974-24981 NN denotes CCR5−/−
T10440 24982-24986 NN denotes mice
T10441 24987-24995 VB denotes compared
T10442 24996-25000 IN denotes with
T10443 25001-25006 DT denotes those
T10444 25007-25009 IN denotes in
T10445 25010-25013 DT denotes the
T10446 25014-25021 JJ denotes CCR5+/+
T10447 25022-25026 NN denotes mice
T10448 25028-25032 RB denotes Thus
T10449 25032-25033 -COMMA- denotes ,
T10450 25034-25044 RB denotes relatively
T10451 25045-25054 VB denotes increased
T10452 25055-25060 NN denotes tumor
T10453 25061-25071 VB denotes associated
T10454 25072-25081 JJ denotes cytotoxic
T10455 25082-25093 NN denotes lymphocytes
T10456 25094-25099 MD denotes could
T10457 25100-25104 VB denotes play
T10458 25105-25107 DT denotes an
T10459 25108-25117 JJ denotes important
T10460 25118-25122 NN denotes role
T10461 25123-25125 IN denotes in
T10462 25126-25136 VB denotes inhibiting
T10463 25137-25140 DT denotes the
T10464 25141-25146 NN denotes tumor
T10465 25147-25153 NN denotes growth
T10466 25154-25156 IN denotes in
T10467 25157-25164 NN denotes CCR5−/−
T10468 25165-25169 NN denotes mice
T10469 25171-25181 NN denotes Activation
T10470 25182-25184 IN denotes of
T10471 25185-25190 NN denotes NF-κB
T10472 25191-25196 MD denotes could
T10473 25197-25205 VB denotes modulate
T10474 25206-25217 JJ denotes subcellular
T10475 25218-25230 NN denotes localization
T10476 25231-25233 IN denotes of
T10477 25234-25236 NN denotes NK
T10478 25237-25242 NN denotes cells
T10479 25243-25246 CC denotes and
T10480 25247-25259 NN denotes pathogenesis
T10481 25260-25261 -LRB- denotes [
T10482 25261-25263 CD denotes 49
T10483 25263-25264 -RRB- denotes ]
T10484 25266-25276 NN denotes Inhibition
T10485 25277-25279 IN denotes of
T10486 25280-25285 NN denotes NF-κB
T10487 25286-25294 NN denotes activity
T10488 25295-25304 VB denotes prevented
T10489 25305-25307 NN denotes NK
T10490 25308-25312 NN denotes cell
T10491 25313-25322 NN denotes depletion
T10492 25322-25323 -COMMA- denotes ,
T10493 25324-25327 CC denotes and
T10494 25328-25332 RB denotes thus
T10495 25333-25342 VB denotes increased
T10496 25343-25353 JJ denotes anti-tumor
T10497 25354-25362 NN denotes activity
T10498 25363-25365 IN denotes by
T10499 25366-25376 VB denotes decreasing
T10500 25377-25381 NN denotes IL-6
T10501 25382-25392 NN denotes production
T10502 25393-25394 -LRB- denotes [
T10503 25394-25396 CD denotes 50
T10504 25396-25397 -RRB- denotes ]
T10505 25399-25403 RB denotes Thus
T10506 25403-25404 -COMMA- denotes ,
T10507 25405-25408 DT denotes the
T10508 25409-25418 VB denotes decreased
T10509 25419-25424 NN denotes NF-κB
T10510 25425-25428 CC denotes and
T10511 25429-25437 JJ denotes elevated
T10512 25438-25444 NN denotes IL-1Ra
T10513 25445-25450 MD denotes could
T10514 25451-25455 RB denotes also
T10515 25456-25458 VB denotes be
T10516 25459-25469 VB denotes associated
T10517 25470-25472 IN denotes in
T10518 25473-25476 DT denotes the
T10519 25477-25489 NN denotes infiltration
T10520 25490-25492 IN denotes of
T10521 25493-25502 JJ denotes cytotoxic
T10522 25503-25514 NN denotes lymphocytes
T10523 25515-25519 IN denotes into
T10524 25520-25525 NN denotes tumor
T10525 25525-25526 -COMMA- denotes ,
T10526 25527-25536 VB denotes resulting
T10527 25537-25539 IN denotes in
T10528 25540-25545 NN denotes tumor
T10529 25546-25552 NN denotes growth
T10530 25553-25563 NN denotes inhibition
T10531 25565-25567 IN denotes In
T10532 25568-25576 NN denotes contrast
T10533 25576-25577 -COMMA- denotes ,
T10534 25578-25583 NN denotes IL-23
T10535 25583-25584 -COMMA- denotes ,
T10536 25585-25586 DT denotes a
T10537 25587-25592 NN denotes tumor
T10538 25593-25599 NN denotes growth
T10539 25600-25609 VB denotes promoting
T10540 25610-25618 NN denotes cytokine
T10541 25618-25619 -COMMA- denotes ,
T10542 25620-25629 VB denotes increased
T10543 25630-25635 NN denotes NF-κB
T10544 25636-25639 CC denotes and
T10545 25640-25646 JJ denotes immune
T10546 25647-25651 NN denotes cell
T10547 25652-25664 NN denotes infiltration
T10548 25665-25667 IN denotes in
T10549 25668-25672 JJ denotes oral
T10550 25673-25678 NN denotes tumor
T10551 25679-25680 -LRB- denotes [
T10552 25680-25682 CD denotes 51
T10553 25682-25683 -RRB- denotes ]
T10554 25685-25690 DT denotes These
T10555 25691-25695 NN denotes data
T10556 25696-25704 VB denotes indicate
T10557 25705-25709 IN denotes that
T10558 25710-25715 NN denotes NF-κB
T10559 25716-25721 MD denotes could
T10560 25722-25724 VB denotes be
T10561 25725-25733 VB denotes involved
T10562 25734-25736 IN denotes in
T10563 25737-25740 DT denotes the
T10564 25741-25749 NN denotes cytokine
T10565 25750-25758 VB denotes mediated
T10566 25759-25769 JJ denotes anti-tumor
T10567 25770-25780 NN denotes activities
T10568 25781-25783 IN denotes of
T10569 25784-25790 JJ denotes immune
T10570 25791-25796 NN denotes cells
T10571 25798-25800 PRP denotes It
T10572 25801-25803 VB denotes is
T10573 25804-25808 RB denotes also
T10574 25809-25819 JJ denotes noteworthy
T10575 25820-25824 IN denotes that
T10576 25825-25831 NN denotes IL-1Ra
T10577 25832-25841 VB denotes inhibited
T10578 25842-25850 NN denotes melanoma
T10579 25851-25856 NN denotes tumor
T10580 25857-25863 NN denotes growth
T10581 25864-25866 IN denotes by
T10582 25867-25877 VB denotes increasing
T10583 25878-25881 DT denotes the
T10584 25882-25888 NN denotes number
T10585 25889-25891 IN denotes of
T10586 25892-25899 JJ denotes myeloid
T10587 25900-25910 NN denotes suppressor
T10588 25911-25916 NN denotes cells
T10589 25917-25919 IN denotes in
T10590 25920-25925 NN denotes tumor
T10591 25926-25927 -LRB- denotes [
T10592 25927-25929 CD denotes 25
T10593 25929-25930 -RRB- denotes ]
T10594 25932-25935 DT denotes The
T10595 25936-25962 JJ denotes 3-methylcholatrene-induced
T10596 25963-25968 NN denotes tumor
T10597 25969-25978 NN denotes incidence
T10598 25979-25982 VB denotes was
T10599 25983-25990 VB denotes reduced
T10600 25991-25993 IN denotes in
T10601 25994-25999 NN denotes IL-1α
T10602 26000-26008 NN denotes knockout
T10603 26009-26013 NN denotes mice
T10604 26013-26014 -COMMA- denotes ,
T10605 26015-26018 CC denotes but
T10606 26019-26028 VB denotes increased
T10607 26029-26031 IN denotes in
T10608 26032-26038 NN denotes IL-1Ra
T10609 26039-26043 NN denotes mice
T10610 26044-26048 IN denotes with
T10611 26049-26060 JJ denotes concomitant
T10612 26061-26071 NN denotes maturation
T10613 26072-26074 IN denotes of
T10614 26075-26077 NN denotes NK
T10615 26078-26083 NN denotes cells
T10616 26084-26087 CC denotes and
T10617 26088-26098 JJ denotes anti-tumor
T10618 26099-26107 NN denotes immunity
T10619 26108-26109 -LRB- denotes [
T10620 26109-26111 CD denotes 52
T10621 26111-26112 -RRB- denotes ]
T10622 26114-26119 DT denotes These
T10623 26120-26124 NN denotes data
T10624 26125-26133 VB denotes indicate
T10625 26134-26138 IN denotes that
T10626 26139-26142 DT denotes the
T10627 26143-26151 NN denotes decrease
T10628 26152-26154 IN denotes of
T10629 26155-26160 NN denotes NF-κB
T10630 26160-26161 -COMMA- denotes ,
T10631 26162-26165 CC denotes and
T10632 26166-26170 RB denotes thus
T10633 26171-26179 NN denotes increase
T10634 26180-26182 IN denotes of
T10635 26183-26189 NN denotes IL-1Ra
T10636 26190-26195 MD denotes could
T10637 26196-26198 VB denotes be
T10638 26199-26210 JJ denotes significant
T10639 26211-26213 IN denotes in
T10640 26214-26219 NN denotes tumor
T10641 26220-26226 NN denotes growth
T10642 26227-26237 NN denotes inhibition
T10643 26238-26240 IN denotes of
T10644 26241-26248 NN denotes CCR5−/−
T10645 26249-26253 NN denotes mice
T10646 26255-26258 PRP-DOLLAR- denotes Our
T10647 26259-26263 NN denotes data
T10648 26264-26268 RB denotes thus
T10649 26269-26273 VB denotes show
T10650 26274-26285 JJ denotes significant
T10651 26286-26294 JJ denotes clinical
T10652 26295-26307 NN denotes implications
T10653 26308-26310 IN denotes of
T10654 26311-26315 NN denotes CCR5
T10655 26315-26316 -COMMA- denotes ,
T10656 26317-26324 IN denotes because
T10657 26325-26329 NN denotes CCR5
T10658 26330-26332 VB denotes is
T10659 26333-26334 DT denotes a
T10660 26335-26336 NN denotes G
T10661 26337-26352 VB denotes protein–coupled
T10662 26353-26361 NN denotes receptor
T10663 26362-26365 CC denotes and
T10664 26366-26368 PRP denotes it
T10665 26369-26371 VB denotes is
T10666 26372-26380 JJ denotes amenable
T10667 26381-26383 TO denotes to
T10668 26384-26387 VB denotes use
T10669 26388-26390 IN denotes as
T10670 26391-26392 DT denotes a
T10671 26393-26398 JJ denotes small
T10672 26399-26407 NN denotes molecule
T10673 26408-26411 IN denotes for
T10674 26412-26415 DT denotes the
T10675 26416-26426 NN denotes inhibition
T10676 26427-26429 IN denotes of
T10677 26430-26434 NN denotes CCR5
T10678 26436-26443 JJ denotes Several
T10679 26444-26448 JJ denotes such
T10680 26449-26458 NN denotes compounds
T10681 26459-26463 VB denotes have
T10682 26464-26471 RB denotes already
T10683 26472-26476 VB denotes been
T10684 26477-26482 VB denotes shown
T10685 26483-26485 TO denotes to
T10686 26486-26488 VB denotes be
T10687 26489-26493 JJ denotes safe
T10688 26494-26496 IN denotes in
T10689 26497-26505 JJ denotes clinical
T10690 26506-26512 NN denotes trials
T10691 26513-26516 IN denotes for
T10692 26517-26520 NN denotes use
T10693 26521-26523 IN denotes in
T10694 26524-26531 JJ denotes certain
T10695 26532-26540 NN denotes diseases
T10696 26541-26545 JJ denotes such
T10697 26546-26548 IN denotes as
T10698 26549-26552 NN denotes HIV
T10699 26553-26554 -LRB- denotes [
T10700 26554-26556 CD denotes 53
T10701 26556-26557 -RRB- denotes ]
T10702 26559-26563 RB denotes Thus
T10703 26563-26564 -COMMA- denotes ,
T10704 26565-26567 PRP denotes we
T10705 26568-26575 VB denotes believe
T10706 26576-26580 NN denotes CCR5
T10707 26581-26583 VB denotes is
T10708 26584-26585 DT denotes a
T10709 26586-26592 NN denotes cancer
T10710 26593-26599 NN denotes target
T10711 26600-26604 WDT denotes that
T10712 26605-26613 VB denotes warrants
T10713 26614-26623 JJ denotes continued
T10714 26624-26637 NN denotes investigation
T10715 26639-26641 IN denotes In
T10716 26642-26649 NN denotes summary
T10717 26649-26650 -COMMA- denotes ,
T10718 26651-26655 DT denotes this
T10719 26656-26661 NN denotes study
T10720 26662-26668 VB denotes showed
T10721 26669-26673 IN denotes that
T10722 26674-26682 NN denotes melanoma
T10723 26683-26688 NN denotes cells
T10724 26689-26695 NN denotes growth
T10725 26696-26699 VB denotes was
T10726 26700-26709 VB denotes inhibited
T10727 26710-26713 IN denotes via
T10728 26714-26724 NN denotes modulation
T10729 26725-26727 IN denotes of
T10730 26728-26740 NN denotes NF-κB/IL-1Ra
T10731 26741-26749 NN denotes pathways
T10732 26750-26752 IN denotes in
T10733 26753-26760 NN denotes CCR5−/−
T10734 26761-26765 NN denotes mice
T13208 26791-26797 NNP denotes Ethics
T13209 26798-26807 NNP denotes Statement
T13210 26808-26811 DT denotes All
T13211 26812-26823 NN denotes experiments
T13212 26824-26828 VB denotes were
T13213 26829-26837 VB denotes approved
T13214 26838-26841 CC denotes and
T13215 26842-26849 VB denotes carried
T13216 26850-26853 RP denotes out
T13217 26854-26863 VB denotes according
T13218 26864-26866 TO denotes to
T13219 26867-26870 DT denotes the
T13220 26871-26876 NNP denotes Guide
T13221 26877-26880 IN denotes for
T13222 26881-26884 DT denotes the
T13223 26885-26889 NNP denotes Care
T13224 26890-26893 CC denotes and
T13225 26894-26897 NNP denotes Use
T13226 26898-26900 IN denotes of
T13227 26901-26908 NNP denotes Animals
T13228 26909-26910 -LRB- denotes [
T13229 26910-26916 NNP denotes Animal
T13230 26917-26921 NNP denotes Care
T13231 26922-26931 NNP denotes Committee
T13232 26932-26934 IN denotes of
T13233 26935-26943 NNP denotes Chungbuk
T13234 26944-26952 NNP denotes National
T13235 26953-26963 NNP denotes University
T13236 26963-26964 -COMMA- denotes ,
T13237 26965-26970 NNP denotes Korea
T13238 26971-26972 -LRB- denotes (
T13239 26972-26989 NN denotes CBNUA-045-0902-01
T13240 26989-26990 -RRB- denotes )
T13241 26990-26991 -RRB- denotes ]
T13343 26994-27001 NN denotes Animals
T13344 27002-27005 DT denotes The
T13345 27006-27010 NN denotes CCR5
T13346 27011-27015 JJ denotes wild
T13347 27016-27020 NN denotes type
T13348 27021-27022 -LRB- denotes (
T13349 27022-27029 NN denotes CCR5+/+
T13350 27029-27030 -RRB- denotes )
T13351 27031-27034 CC denotes and
T13352 27035-27039 NN denotes CCR5
T13353 27040-27048 NN denotes knockout
T13354 27049-27050 -LRB- denotes (
T13355 27050-27057 NN denotes CCR5−/−
T13356 27057-27058 -RRB- denotes )
T13357 27059-27063 NN denotes mice
T13358 27064-27068 VB denotes were
T13359 27069-27078 VB denotes purchased
T13360 27079-27083 IN denotes from
T13361 27084-27087 DT denotes The
T13362 27088-27095 NNP denotes Jackson
T13363 27096-27106 NNP denotes Laboratory
T13364 27107-27108 -LRB- denotes (
T13365 27108-27111 NNP denotes Bar
T13366 27112-27118 NNP denotes Harbor
T13367 27118-27119 -COMMA- denotes ,
T13368 27120-27125 NNP denotes Maine
T13369 27126-27131 CD denotes 04609
T13370 27132-27135 NNP denotes USA
T13371 27135-27136 -RRB- denotes )
T13372 27138-27141 DT denotes The
T13373 27142-27146 NN denotes mice
T13374 27147-27151 VB denotes were
T13375 27152-27158 VB denotes housed
T13376 27159-27162 CC denotes and
T13377 27163-27167 VB denotes bred
T13378 27168-27173 IN denotes under
T13379 27174-27182 JJ denotes specific
T13380 27183-27191 NN denotes pathogen
T13381 27192-27196 JJ denotes free
T13382 27197-27207 NN denotes conditions
T13383 27208-27210 IN denotes at
T13384 27211-27214 DT denotes the
T13385 27215-27225 NNP denotes Laboratory
T13386 27226-27232 NNP denotes Animal
T13387 27233-27241 NNP denotes Research
T13388 27242-27248 NNP denotes Center
T13389 27249-27251 IN denotes of
T13390 27252-27260 NNP denotes Chungbuk
T13391 27261-27269 NNP denotes National
T13392 27270-27280 NNP denotes University
T13393 27280-27281 -COMMA- denotes ,
T13394 27282-27288 NNP denotes Korea.
T13395 27289-27292 DT denotes The
T13396 27293-27297 NN denotes mice
T13397 27298-27299 -LRB- denotes (
T13398 27299-27309 NN denotes n = 4/cage
T13399 27309-27310 -RRB- denotes )
T13400 27311-27315 VB denotes were
T13401 27316-27326 VB denotes maintained
T13402 27327-27329 IN denotes in
T13403 27330-27331 DT denotes a
T13404 27332-27336 NN denotes room
T13405 27337-27341 IN denotes with
T13406 27342-27343 DT denotes a
T13407 27344-27352 JJ denotes constant
T13408 27353-27364 NN denotes temperature
T13409 27365-27367 IN denotes of
T13410 27368-27374 NN denotes 22±1°C
T13411 27374-27375 -COMMA- denotes ,
T13412 27376-27384 JJ denotes relative
T13413 27385-27393 NN denotes humidity
T13414 27394-27396 IN denotes of
T13415 27397-27402 CD denotes 55±10
T13416 27402-27403 NN denotes %
T13417 27403-27404 -COMMA- denotes ,
T13418 27405-27408 CC denotes and
T13419 27409-27413 JJ denotes 12-h
T13420 27414-27424 NN denotes light/dark
T13421 27425-27430 NN denotes cycle
T13422 27430-27431 -COMMA- denotes ,
T13423 27432-27435 CC denotes and
T13424 27436-27439 VB denotes fed
T13425 27440-27448 JJ denotes standard
T13426 27449-27455 NN denotes rodent
T13427 27456-27460 NN denotes chow
T13428 27461-27462 -LRB- denotes (
T13429 27462-27469 NNP denotes Samyang
T13430 27469-27470 -COMMA- denotes ,
T13431 27471-27476 NNP denotes Korea
T13432 27476-27477 -RRB- denotes )
T13433 27478-27481 CC denotes and
T13434 27482-27490 VB denotes purified
T13435 27491-27494 NN denotes tap
T13436 27495-27500 NN denotes water
T13437 27501-27503 NN denotes ad
T13438 27504-27511 NN denotes libitum
T13439 27513-27516 DT denotes The
T13440 27517-27524 JJ denotes CCR5+/+
T13441 27525-27529 NN denotes mice
T13442 27530-27531 -LRB- denotes (
T13443 27531-27537 NN denotes n = 20
T13444 27537-27538 -RRB- denotes )
T13445 27539-27542 CC denotes and
T13446 27543-27550 NN denotes CCR5−/−
T13447 27551-27555 NN denotes mice
T13448 27556-27557 -LRB- denotes (
T13449 27557-27563 NN denotes n = 20
T13450 27563-27564 -RRB- denotes )
T13451 27564-27565 -COMMA- denotes ,
T13452 27566-27570 WDT denotes that
T13453 27571-27575 VB denotes were
T13454 27576-27580 VB denotes used
T13455 27580-27581 -COMMA- denotes ,
T13456 27582-27585 VB denotes had
T13457 27586-27593 VB denotes matched
T13458 27594-27598 NN denotes ages
T13459 27599-27600 -LRB- denotes (
T13460 27600-27605 CD denotes 10–11
T13461 27606-27611 NN denotes weeks
T13462 27612-27615 JJ denotes old
T13463 27615-27616 -RRB- denotes )
T13464 27617-27620 CC denotes and
T13465 27621-27628 NN denotes weights
T13466 27629-27630 -LRB- denotes (
T13467 27630-27635 CD denotes 16–19
T13468 27636-27637 NN denotes g
T13469 27637-27638 -RRB- denotes )
T13470 27640-27647 NN denotes Control
T13471 27648-27652 NN denotes mice
T13472 27653-27654 -LRB- denotes (
T13473 27654-27664 NN denotes B6129PF2/J
T13474 27664-27665 -RRB- denotes )
T13475 27666-27670 VB denotes were
T13476 27671-27673 NN denotes F2
T13477 27674-27680 JJ denotes hybrid
T13478 27681-27685 NN denotes mice
T13479 27686-27690 IN denotes from
T13480 27691-27694 DT denotes the
T13481 27695-27708 NN denotes C57BL/6J-AW-J
T13482 27709-27712 CC denotes and
T13483 27713-27720 NN denotes 129P3/J
T13484 27721-27729 JJ denotes parental
T13485 27730-27737 NN denotes strains
T13486 27739-27743 NN denotes CCR5
T13487 27744-27748 NN denotes mice
T13488 27749-27750 -LRB- denotes (
T13489 27750-27752 NN denotes B6
T13490 27752-27753 -COMMA- denotes ,
T13491 27754-27772 NN denotes 129P2-Ccr5tm1Kuz/J
T13492 27772-27773 -RRB- denotes )
T13493 27774-27778 VB denotes have
T13494 27779-27782 DT denotes the
T13495 27783-27789 JJ denotes entire
T13496 27790-27796 VB denotes coding
T13497 27797-27803 NN denotes region
T13498 27804-27806 IN denotes of
T13499 27807-27810 DT denotes the
T13500 27811-27815 NN denotes CCR5
T13501 27816-27820 NN denotes gene
T13502 27821-27828 VB denotes deleted
T13503 27829-27833 IN denotes from
T13504 27834-27837 DT denotes the
T13505 27838-27846 JJ denotes parental
T13506 27847-27854 NN denotes strains
T13507 27854-27855 -COMMA- denotes ,
T13508 27856-27858 NN denotes B6
T13509 27858-27859 -COLON- denotes ;
T13510 27859-27875 NN denotes 129P2-Ccr5tm1kuz
T13511 27876-27879 CC denotes and
T13512 27880-27882 NN denotes B6
T13513 27882-27883 -COLON- denotes ;
T13514 27883-27901 NN denotes 129P2-Cmkbr5tm1Kuz
T13814 27904-27909 NN denotes Tumor
T13815 27910-27921 NN denotes Inoculation
T13816 27922-27925 CC denotes and
T13817 27926-27931 NN denotes Tumor
T13818 27932-27942 NN denotes Monitoring
T13819 27943-27946 NN denotes B16
T13820 27947-27955 NN denotes melanoma
T13821 27956-27961 NN denotes cells
T13822 27962-27966 VB denotes were
T13823 27967-27975 VB denotes injected
T13824 27976-27990 RB denotes subcutaneously
T13825 27991-27992 -LRB- denotes [
T13826 27992-27997 CD denotes 5×105
T13827 27998-28003 NN denotes tumor
T13828 28004-28009 NN denotes cells
T13829 28010-28012 IN denotes in
T13830 28013-28016 CD denotes 0.1
T13831 28017-28019 NN denotes ml
T13832 28020-28029 NN denotes Phosphate
T13833 28030-28038 VB denotes buffered
T13834 28039-28045 NN denotes saline
T13835 28045-28046 -LRB- denotes (
T13836 28046-28049 NN denotes PBS
T13837 28049-28050 -RRB- denotes )
T13838 28050-28057 JJ denotes /animal
T13839 28057-28058 -RRB- denotes ]
T13840 28059-28064 VB denotes using
T13841 28065-28066 DT denotes a
T13842 28067-28069 CD denotes 27
T13843 28070-28071 NN denotes G
T13844 28072-28078 NN denotes needle
T13845 28079-28083 IN denotes into
T13846 28084-28087 DT denotes the
T13847 28088-28099 JJ denotes right-lower
T13848 28100-28106 NN denotes flanks
T13849 28107-28109 IN denotes of
T13850 28110-28113 DT denotes the
T13851 28114-28121 NN denotes carrier
T13852 28122-28126 NN denotes mice
T13853 28127-28129 IN denotes as
T13854 28130-28140 RB denotes previously
T13855 28141-28150 VB denotes described
T13856 28151-28152 -LRB- denotes [
T13857 28152-28154 CD denotes 54
T13858 28154-28155 -RRB- denotes ]
T13859 28157-28160 DT denotes The
T13860 28161-28165 NN denotes body
T13861 28166-28173 NN denotes weights
T13862 28174-28177 CC denotes and
T13863 28178-28183 NN denotes tumor
T13864 28184-28191 NN denotes volumes
T13865 28192-28194 IN denotes of
T13866 28195-28198 DT denotes the
T13867 28199-28206 NN denotes animals
T13868 28207-28211 VB denotes were
T13869 28212-28221 VB denotes monitored
T13870 28222-28227 RB denotes twice
T13871 28228-28234 RB denotes weekly
T13872 28236-28239 DT denotes The
T13873 28240-28245 NN denotes tumor
T13874 28246-28253 NN denotes volumes
T13875 28254-28258 VB denotes were
T13876 28259-28267 VB denotes measured
T13877 28268-28272 IN denotes with
T13878 28273-28280 JJ denotes Vernier
T13879 28281-28289 NN denotes calipers
T13880 28290-28293 CC denotes and
T13881 28294-28304 VB denotes calculated
T13882 28305-28310 VB denotes using
T13883 28311-28314 DT denotes the
T13884 28315-28324 VB denotes following
T13885 28325-28332 NN denotes formula
T13886 28332-28333 -COLON- denotes :
T13887 28334-28335 -LRB- denotes (
T13888 28335-28339 NN denotes A×B2
T13889 28339-28340 -RRB- denotes )
T13890 28340-28342 CD denotes /2
T13891 28342-28343 -COMMA- denotes ,
T13892 28344-28349 WRB denotes where
T13893 28350-28351 NN denotes A
T13894 28352-28354 VB denotes is
T13895 28355-28358 DT denotes the
T13896 28359-28365 JJ denotes larger
T13897 28366-28369 CC denotes and
T13898 28370-28371 NN denotes B
T13899 28372-28374 VB denotes is
T13900 28375-28378 DT denotes the
T13901 28379-28386 JJ denotes smaller
T13902 28387-28389 IN denotes of
T13903 28390-28393 DT denotes the
T13904 28394-28397 CD denotes two
T13905 28398-28408 NN denotes dimensions
T13906 28410-28412 IN denotes At
T13907 28413-28416 DT denotes the
T13908 28417-28420 NN denotes end
T13909 28421-28423 IN denotes of
T13910 28424-28427 DT denotes the
T13911 28428-28438 NN denotes experiment
T13912 28438-28439 -COMMA- denotes ,
T13913 28440-28443 DT denotes the
T13914 28444-28451 NN denotes animals
T13915 28452-28456 VB denotes were
T13916 28457-28467 VB denotes sacrificed
T13917 28469-28472 DT denotes The
T13918 28473-28479 NN denotes tumors
T13919 28480-28484 VB denotes were
T13920 28485-28494 VB denotes separated
T13921 28495-28499 IN denotes from
T13922 28500-28503 DT denotes the
T13923 28504-28515 VB denotes surrounding
T13924 28516-28523 NN denotes muscles
T13925 28524-28527 CC denotes and
T13926 28528-28534 NN denotes dermis
T14102 28537-28544 NNP denotes Western
T14103 28545-28553 NNP denotes Blotting
T14104 28554-28559 NN denotes Tumor
T14105 28560-28567 NN denotes tissues
T14106 28568-28572 VB denotes were
T14107 28573-28584 VB denotes homogenized
T14108 28585-28589 IN denotes with
T14109 28590-28597 NN denotes protein
T14110 28598-28608 NN denotes extraction
T14111 28609-28617 NN denotes solution
T14112 28618-28619 -LRB- denotes (
T14113 28619-28629 NN denotes PRO-PREPTM
T14114 28629-28630 -COMMA- denotes ,
T14115 28631-28637 NNP denotes Intron
T14116 28638-28651 NNP denotes Biotechnology
T14117 28651-28652 -COMMA- denotes ,
T14118 28653-28658 NNP denotes Seoul
T14119 28658-28659 -COMMA- denotes ,
T14120 28660-28665 NNP denotes Korea
T14121 28665-28666 -RRB- denotes )
T14122 28666-28667 -COMMA- denotes ,
T14123 28668-28671 CC denotes and
T14124 28672-28677 VB denotes lysed
T14125 28678-28680 IN denotes by
T14126 28681-28683 CD denotes 60
T14127 28684-28687 NN denotes min
T14128 28688-28698 NN denotes incubation
T14129 28699-28701 IN denotes on
T14130 28702-28705 NN denotes ice
T14131 28707-28710 DT denotes The
T14132 28711-28717 NN denotes tissue
T14133 28718-28724 NN denotes lysate
T14134 28725-28736 VB denotes centrifuged
T14135 28737-28739 IN denotes at
T14136 28740-28746 CD denotes 15,000
T14137 28747-28750 NN denotes rpm
T14138 28751-28754 IN denotes for
T14139 28755-28757 CD denotes 15
T14140 28758-28761 NN denotes min
T14141 28762-28764 IN denotes at
T14142 28765-28769 NNP denotes 4°C.
T14143 28770-28775 NNP denotes Equal
T14144 28776-28783 NN denotes amounts
T14145 28784-28786 IN denotes of
T14146 28787-28795 NN denotes proteins
T14147 28796-28797 -LRB- denotes (
T14148 28797-28799 CD denotes 40
T14149 28800-28802 NN denotes µg
T14150 28802-28803 -RRB- denotes )
T14151 28804-28808 VB denotes were
T14152 28809-28818 VB denotes separated
T14153 28819-28821 IN denotes on
T14154 28822-28823 DT denotes a
T14155 28824-28830 NN denotes SDS/12
T14156 28830-28831 NN denotes %
T14157 28831-28846 NN denotes -polyacrylamide
T14158 28847-28850 NN denotes gel
T14159 28850-28851 -COMMA- denotes ,
T14160 28852-28855 CC denotes and
T14161 28856-28860 RB denotes then
T14162 28861-28872 VB denotes transferred
T14163 28873-28875 TO denotes to
T14164 28876-28877 DT denotes a
T14165 28878-28892 NN denotes polyvinylidene
T14166 28893-28903 NN denotes difluoride
T14167 28904-28905 -LRB- denotes (
T14168 28905-28909 NN denotes PVDF
T14169 28909-28910 -RRB- denotes )
T14170 28911-28919 NN denotes membrane
T14171 28920-28921 -LRB- denotes (
T14172 28921-28923 NNP denotes GE
T14173 28924-28929 NNP denotes Water
T14174 28930-28933 CC denotes and
T14175 28934-28941 NNP denotes Process
T14176 28942-28954 NN denotes technologies
T14177 28954-28955 -COMMA- denotes ,
T14178 28956-28963 NNP denotes Trevose
T14179 28963-28964 -COMMA- denotes ,
T14180 28965-28967 NNP denotes PA
T14181 28967-28968 -COMMA- denotes ,
T14182 28969-28972 NNP denotes USA
T14183 28972-28973 -RRB- denotes )
T14184 28975-28980 NN denotes Blots
T14185 28981-28985 VB denotes were
T14186 28986-28993 VB denotes blocked
T14187 28994-28997 IN denotes for
T14188 28998-28999 CD denotes 1
T14189 29000-29001 NN denotes h
T14190 29002-29004 IN denotes at
T14191 29005-29009 NN denotes room
T14192 29010-29021 NN denotes temperature
T14193 29022-29026 IN denotes with
T14194 29027-29028 CD denotes 5
T14195 29028-29029 NN denotes %
T14196 29030-29031 -LRB- denotes (
T14197 29031-29034 NN denotes w/v
T14198 29034-29035 -RRB- denotes )
T14199 29036-29043 JJ denotes non-fat
T14200 29044-29049 VB denotes dried
T14201 29050-29054 NN denotes milk
T14202 29055-29057 IN denotes in
T14203 29058-29071 JJ denotes Tris-Buffered
T14204 29072-29078 NN denotes Saline
T14205 29079-29087 CD denotes Tween-20
T14206 29088-29089 -LRB- denotes [
T14207 29089-29093 NN denotes TBST
T14208 29093-29094 -COLON- denotes :
T14209 29095-29097 CD denotes 10
T14210 29098-29100 NN denotes mM
T14211 29101-29105 NN denotes Tris
T14212 29106-29107 -LRB- denotes (
T14213 29107-29109 NN denotes pH
T14214 29110-29113 CD denotes 8.0
T14215 29113-29114 -RRB- denotes )
T14216 29115-29118 CC denotes and
T14217 29119-29122 CD denotes 150
T14218 29123-29125 NN denotes mM
T14219 29126-29130 NN denotes NaCl
T14220 29131-29139 NN denotes solution
T14221 29140-29150 VB denotes containing
T14222 29151-29155 CD denotes 0.05
T14223 29155-29156 NN denotes %
T14224 29157-29165 CD denotes Tween-20
T14225 29165-29166 -RRB- denotes ]
T14226 29168-29173 IN denotes After
T14227 29174-29175 DT denotes a
T14228 29176-29181 JJ denotes short
T14229 29182-29189 NN denotes washing
T14230 29190-29192 IN denotes in
T14231 29193-29197 NN denotes TBST
T14232 29197-29198 -COMMA- denotes ,
T14233 29199-29202 DT denotes the
T14234 29203-29212 NN denotes membranes
T14235 29213-29217 VB denotes were
T14236 29218-29231 VB denotes immunoblotted
T14237 29232-29236 IN denotes with
T14238 29237-29240 DT denotes the
T14239 29241-29250 VB denotes following
T14240 29251-29258 JJ denotes primary
T14241 29259-29269 NN denotes antibodies
T14242 29269-29270 -COLON- denotes :
T14243 29271-29276 NN denotes mouse
T14244 29277-29287 JJ denotes monoclonal
T14245 29288-29298 NN denotes antibodies
T14246 29299-29307 VB denotes directed
T14247 29308-29315 IN denotes against
T14248 29316-29319 NN denotes p65
T14249 29320-29323 CC denotes and
T14250 29324-29327 NN denotes p50
T14251 29328-29329 -LRB- denotes (
T14252 29329-29334 CD denotes 1∶500
T14253 29335-29344 NN denotes dilutions
T14254 29344-29345 -COLON- denotes ;
T14255 29346-29351 NNP denotes Santa
T14256 29352-29356 NNP denotes Cruz
T14257 29357-29370 NNP denotes Biotechnology
T14258 29370-29371 -COMMA- denotes ,
T14259 29372-29377 NNP denotes Santa
T14260 29378-29382 NNP denotes Cruz
T14261 29382-29383 -COMMA- denotes ,
T14262 29384-29386 NNP denotes CA
T14263 29386-29387 -RRB- denotes )
T14264 29387-29388 -COMMA- denotes ,
T14265 29389-29395 NN denotes rabbit
T14266 29396-29406 JJ denotes polyclonal
T14267 29407-29417 NN denotes antibodies
T14268 29418-29426 VB denotes directed
T14269 29427-29434 IN denotes against
T14270 29435-29438 NN denotes Bax
T14271 29439-29442 CC denotes and
T14272 29443-29447 NN denotes PARP
T14273 29448-29449 -LRB- denotes (
T14274 29449-29454 CD denotes 1∶500
T14275 29455-29464 NN denotes dilutions
T14276 29464-29465 -COLON- denotes ;
T14277 29466-29471 NNP denotes Santa
T14278 29472-29476 NNP denotes Cruz
T14279 29477-29490 NNP denotes Biotechnology
T14280 29490-29491 -RRB- denotes )
T14281 29491-29492 -COMMA- denotes ,
T14282 29493-29496 CC denotes and
T14283 29497-29504 IN denotes against
T14284 29505-29514 NN denotes caspase-3
T14285 29514-29515 -COMMA- denotes ,
T14286 29516-29525 NN denotes caspase-9
T14287 29525-29526 -COMMA- denotes ,
T14288 29527-29532 NN denotes Bcl-2
T14289 29533-29536 CC denotes and
T14290 29537-29544 NN denotes c-IAP-1
T14291 29545-29546 -LRB- denotes (
T14292 29546-29552 CD denotes 1∶1000
T14293 29553-29562 NN denotes dilutions
T14294 29562-29563 -COLON- denotes ;
T14295 29564-29568 NNP denotes Cell
T14296 29569-29578 NNP denotes Signaling
T14297 29579-29589 NNP denotes Technology
T14298 29589-29590 -COMMA- denotes ,
T14299 29591-29598 NNP denotes Beverly
T14300 29598-29599 -COMMA- denotes ,
T14301 29600-29602 JJ denotes MA
T14302 29602-29603 -RRB- denotes )
T14303 29605-29608 DT denotes The
T14304 29609-29614 NN denotes blots
T14305 29615-29619 VB denotes were
T14306 29620-29629 VB denotes incubated
T14307 29630-29634 IN denotes with
T14308 29635-29638 DT denotes the
T14309 29639-29649 JJ denotes respective
T14310 29650-29661 NN denotes horseradish
T14311 29662-29683 JJ denotes peroxidase-conjugated
T14312 29684-29695 JJ denotes anti-rabbit
T14313 29696-29698 CC denotes or
T14314 29699-29709 JJ denotes anti-mouse
T14315 29710-29713 NN denotes IgG
T14316 29714-29715 -LRB- denotes (
T14317 29715-29721 CD denotes 1∶4000
T14318 29722-29731 NN denotes dilutions
T14319 29731-29732 -COLON- denotes ;
T14320 29733-29738 NNP denotes Santa
T14321 29739-29743 NNP denotes Cruz
T14322 29744-29757 NNP denotes Biotechnology
T14323 29757-29758 -RRB- denotes )
T14324 29760-29774 JJ denotes Immunoreactive
T14325 29775-29783 NN denotes proteins
T14326 29784-29788 VB denotes were
T14327 29789-29797 VB denotes detected
T14328 29798-29802 IN denotes with
T14329 29803-29806 DT denotes the
T14330 29807-29810 NN denotes ECL
T14331 29811-29820 NN denotes detection
T14332 29821-29827 NN denotes system
T14693 29830-29850 NN denotes Immunohistochemistry
T14694 29851-29854 DT denotes All
T14695 29855-29864 NN denotes specimens
T14696 29865-29869 VB denotes were
T14697 29870-29875 VB denotes fixed
T14698 29876-29878 IN denotes in
T14699 29879-29887 NN denotes formalin
T14700 29888-29891 CC denotes and
T14701 29892-29900 VB denotes embedded
T14702 29901-29903 IN denotes in
T14703 29904-29912 NN denotes paraffin
T14704 29913-29916 IN denotes for
T14705 29917-29928 NN denotes examination
T14706 29930-29938 NN denotes Sections
T14707 29939-29940 -LRB- denotes (
T14708 29940-29941 CD denotes 4
T14709 29942-29944 NN denotes µm
T14710 29945-29950 JJ denotes thick
T14711 29950-29951 -RRB- denotes )
T14712 29952-29956 VB denotes were
T14713 29957-29964 VB denotes stained
T14714 29965-29969 IN denotes with
T14715 29970-29971 NN denotes H
T14716 29971-29972 CC denotes &
T14717 29972-29973 NN denotes E
T14718 29974-29977 CC denotes and
T14719 29978-29986 VB denotes analyzed
T14720 29987-29989 IN denotes by
T14721 29990-30010 NN denotes immunohistochemistry
T14722 30012-30015 DT denotes The
T14723 30016-30033 JJ denotes paraffin-embedded
T14724 30034-30042 NN denotes sections
T14725 30043-30047 VB denotes were
T14726 30048-30062 VB denotes deparaffinized
T14727 30063-30066 CC denotes and
T14728 30067-30077 VB denotes rehydrated
T14729 30077-30078 -COMMA- denotes ,
T14730 30079-30085 VB denotes washed
T14731 30086-30088 IN denotes in
T14732 30089-30098 JJ denotes distilled
T14733 30099-30104 NN denotes water
T14734 30104-30105 -COMMA- denotes ,
T14735 30106-30109 CC denotes and
T14736 30110-30114 RB denotes then
T14737 30115-30124 VB denotes subjected
T14738 30125-30127 TO denotes to
T14739 30128-30141 JJ denotes heat-mediated
T14740 30142-30149 NN denotes antigen
T14741 30150-30159 NN denotes retrieval
T14742 30161-30171 JJ denotes Endogenous
T14743 30172-30182 NN denotes peroxidase
T14744 30183-30191 NN denotes activity
T14745 30192-30195 VB denotes was
T14746 30196-30204 VB denotes quenched
T14747 30205-30207 IN denotes by
T14748 30208-30218 NN denotes incubation
T14749 30219-30221 IN denotes in
T14750 30222-30223 CD denotes 3
T14751 30223-30224 NN denotes %
T14752 30225-30233 NN denotes hydrogen
T14753 30234-30242 NN denotes peroxide
T14754 30243-30245 IN denotes in
T14755 30246-30254 NN denotes methanol
T14756 30255-30258 IN denotes for
T14757 30259-30261 CD denotes 15
T14758 30262-30265 NN denotes min
T14759 30265-30266 -COMMA- denotes ,
T14760 30267-30275 VB denotes followed
T14761 30276-30278 IN denotes by
T14762 30279-30287 VB denotes clearing
T14763 30288-30290 IN denotes in
T14764 30291-30294 NNP denotes PBS
T14765 30295-30298 IN denotes for
T14766 30299-30300 CD denotes 5
T14767 30301-30304 NN denotes min
T14768 30306-30309 DT denotes The
T14769 30310-30318 NN denotes sections
T14770 30319-30323 VB denotes were
T14771 30324-30331 VB denotes blocked
T14772 30332-30335 IN denotes for
T14773 30336-30338 CD denotes 30
T14774 30339-30342 NN denotes min
T14775 30343-30347 IN denotes with
T14776 30348-30349 CD denotes 3
T14777 30349-30350 NN denotes %
T14778 30351-30357 JJ denotes normal
T14779 30358-30363 NN denotes horse
T14780 30364-30369 NN denotes serum
T14781 30370-30377 VB denotes diluted
T14782 30378-30380 IN denotes in
T14783 30381-30384 NNP denotes PBS
T14784 30384-30385 -COMMA- denotes ,
T14785 30386-30393 VB denotes blotted
T14786 30393-30394 -COMMA- denotes ,
T14787 30395-30398 CC denotes and
T14788 30399-30408 VB denotes incubated
T14789 30409-30413 IN denotes with
T14790 30414-30421 JJ denotes primary
T14791 30422-30427 NN denotes mouse
T14792 30428-30438 JJ denotes anti-mouse
T14793 30439-30452 VB denotes proliferating
T14794 30453-30457 NN denotes cell
T14795 30458-30465 JJ denotes nuclear
T14796 30466-30473 NN denotes antigen
T14797 30474-30475 -LRB- denotes (
T14798 30475-30479 NN denotes PCNA
T14799 30479-30480 -COMMA- denotes ,
T14800 30481-30486 CD denotes 1∶200
T14801 30487-30495 NN denotes dilution
T14802 30495-30496 -RRB- denotes )
T14803 30497-30507 JJ denotes monoclonal
T14804 30508-30518 NN denotes antibodies
T14805 30519-30521 IN denotes in
T14806 30522-30530 VB denotes blocking
T14807 30531-30536 NN denotes serum
T14808 30537-30540 IN denotes for
T14809 30541-30542 CD denotes 4
T14810 30543-30544 NN denotes h
T14811 30545-30547 IN denotes at
T14812 30548-30552 NN denotes room
T14813 30553-30564 NN denotes temperature
T14814 30566-30576 RB denotes Thereafter
T14815 30576-30577 -COMMA- denotes ,
T14816 30578-30581 DT denotes the
T14817 30582-30588 NN denotes slides
T14818 30589-30593 VB denotes were
T14819 30594-30600 VB denotes washed
T14820 30601-30606 CD denotes three
T14821 30607-30612 NN denotes times
T14822 30613-30616 IN denotes for
T14823 30617-30618 CD denotes 5
T14824 30619-30622 NN denotes min
T14825 30623-30627 DT denotes each
T14826 30628-30630 IN denotes in
T14827 30631-30634 NNP denotes PBS
T14828 30635-30638 CC denotes and
T14829 30639-30648 VB denotes incubated
T14830 30649-30653 IN denotes with
T14831 30654-30666 VB denotes biotinylated
T14832 30667-30677 JJ denotes anti-mouse
T14833 30678-30681 CC denotes and
T14834 30682-30693 JJ denotes anti-rabbit
T14835 30694-30704 NN denotes antibodies
T14836 30705-30708 IN denotes for
T14837 30709-30710 CD denotes 2
T14838 30711-30712 NN denotes h
T14839 30714-30717 DT denotes The
T14840 30718-30724 NN denotes slides
T14841 30725-30729 VB denotes were
T14842 30730-30736 VB denotes washed
T14843 30737-30739 IN denotes in
T14844 30740-30743 NNP denotes PBS
T14845 30743-30744 -COMMA- denotes ,
T14846 30745-30753 VB denotes followed
T14847 30754-30756 IN denotes by
T14848 30757-30760 DT denotes the
T14849 30761-30769 NN denotes addition
T14850 30770-30772 IN denotes of
T14851 30773-30776 DT denotes the
T14852 30777-30783 NN denotes avidin
T14853 30784-30790 NN denotes biotin
T14854 30791-30801 NN denotes peroxidase
T14855 30802-30809 NN denotes complex
T14856 30810-30811 -LRB- denotes (
T14857 30811-30814 NN denotes ABC
T14858 30815-30818 NN denotes kit
T14859 30818-30819 -COLON- denotes ;
T14860 30820-30826 NNP denotes Vector
T14861 30827-30839 NNP denotes Laboratories
T14862 30839-30840 -COMMA- denotes ,
T14863 30841-30851 NNP denotes Burlingame
T14864 30851-30852 -COMMA- denotes ,
T14865 30853-30855 NNP denotes CA
T14866 30855-30856 -COMMA- denotes ,
T14867 30857-30860 NNP denotes USA
T14868 30860-30861 -RRB- denotes )
T14869 30863-30866 DT denotes The
T14870 30867-30873 NN denotes slides
T14871 30874-30878 VB denotes were
T14872 30879-30885 VB denotes washed
T14873 30886-30889 CC denotes and
T14874 30890-30893 DT denotes the
T14875 30894-30904 NN denotes peroxidase
T14876 30905-30913 NN denotes reaction
T14877 30914-30917 VB denotes was
T14878 30918-30927 VB denotes developed
T14879 30928-30932 IN denotes with
T14880 30933-30949 NN denotes diaminobenzidine
T14881 30950-30951 -LRB- denotes (
T14882 30951-30954 NN denotes DAB
T14883 30954-30955 -RRB- denotes )
T14884 30956-30959 CC denotes and
T14885 30960-30968 NN denotes peroxide
T14886 30968-30969 -COMMA- denotes ,
T14887 30970-30978 VB denotes followed
T14888 30979-30981 IN denotes by
T14889 30982-30997 VB denotes counterstaining
T14890 30998-31002 IN denotes with
T14891 31003-31014 NN denotes hematoxylin
T14892 31014-31015 -COMMA- denotes ,
T14893 31016-31024 VB denotes mounting
T14894 31025-31027 IN denotes in
T14895 31028-31038 JJ denotes aqua-mount
T14896 31038-31039 -COMMA- denotes ,
T14897 31040-31043 CC denotes and
T14898 31044-31054 NN denotes evaluation
T14899 31055-31060 IN denotes under
T14900 31061-31062 DT denotes a
T14901 31063-31068 JJ denotes light
T14902 31069-31079 NN denotes microscope
T14903 31080-31081 -LRB- denotes (
T14904 31081-31098 NN denotes magnification×200
T14905 31098-31099 -COLON- denotes ;
T14906 31100-31107 NNP denotes Olympus
T14907 31107-31108 -COMMA- denotes ,
T14908 31109-31114 NNP denotes Tokyo
T14909 31114-31115 -COMMA- denotes ,
T14910 31116-31121 NNP denotes Japan
T14911 31121-31122 -RRB- denotes )
T14912 31124-31125 DT denotes A
T14913 31126-31134 JJ denotes negative
T14914 31135-31142 NN denotes control
T14915 31143-31146 VB denotes was
T14916 31147-31155 VB denotes included
T14917 31156-31158 IN denotes in
T14918 31159-31162 DT denotes all
T14919 31163-31174 NN denotes experiments
T14920 31175-31177 IN denotes by
T14921 31178-31186 VB denotes omitting
T14922 31187-31190 DT denotes the
T14923 31191-31198 JJ denotes primary
T14924 31199-31207 NN denotes antibody
T14925 31209-31212 IN denotes For
T14926 31213-31216 DT denotes the
T14927 31217-31226 NN denotes detection
T14928 31227-31229 IN denotes of
T14929 31230-31239 JJ denotes apoptotic
T14930 31240-31244 NN denotes cell
T14931 31245-31250 NN denotes death
T14932 31251-31253 IN denotes in
T14933 31254-31257 DT denotes the
T14934 31258-31263 NN denotes tumor
T14935 31264-31271 NN denotes tissues
T14936 31271-31272 -COMMA- denotes ,
T14937 31273-31276 DT denotes the
T14938 31277-31294 JJ denotes paraffin-embedded
T14939 31295-31303 NN denotes sections
T14940 31304-31308 VB denotes were
T14941 31309-31318 VB denotes incubated
T14942 31319-31321 IN denotes in
T14943 31322-31323 DT denotes a
T14944 31324-31331 NN denotes mixture
T14945 31332-31334 IN denotes of
T14946 31335-31338 DT denotes the
T14947 31339-31347 NN denotes labeling
T14948 31348-31356 NN denotes solution
T14949 31357-31358 -LRB- denotes (
T14950 31358-31361 CD denotes 540
T14951 31362-31364 NN denotes µl
T14952 31364-31365 -RRB- denotes )
T14953 31366-31369 CC denotes and
T14954 31370-31376 NN denotes enzyme
T14955 31377-31385 NN denotes solution
T14956 31386-31387 -LRB- denotes (
T14957 31387-31389 CD denotes 60
T14958 31390-31392 NN denotes µl
T14959 31392-31393 -RRB- denotes )
T14960 31394-31397 IN denotes for
T14961 31398-31399 CD denotes 1
T14962 31400-31401 NN denotes h
T14963 31402-31404 IN denotes at
T14964 31405-31409 NN denotes 37°C
T14965 31409-31410 -COMMA- denotes ,
T14966 31411-31414 CC denotes and
T14967 31415-31419 RB denotes then
T14968 31420-31426 VB denotes washed
T14969 31427-31432 CD denotes three
T14970 31433-31438 NN denotes times
T14971 31439-31441 IN denotes in
T14972 31442-31445 CD denotes 0.1
T14973 31446-31447 NN denotes M
T14974 31448-31451 NNP denotes PBS
T14975 31452-31455 IN denotes for
T14976 31456-31457 CD denotes 5
T14977 31458-31461 NN denotes min
T14978 31462-31466 DT denotes each
T14979 31466-31467 -COMMA- denotes ,
T14980 31468-31477 VB denotes according
T14981 31478-31480 TO denotes to
T14982 31481-31484 DT denotes the
T14983 31485-31499 NN denotes manufacturer’s
T14984 31500-31512 NN denotes instructions
T14985 31514-31518 RB denotes Next
T14986 31518-31519 -COMMA- denotes ,
T14987 31520-31523 DT denotes the
T14988 31524-31532 NN denotes sections
T14989 31533-31537 VB denotes were
T14990 31538-31547 VB denotes incubated
T14991 31548-31552 IN denotes with
T14992 31553-31555 NN denotes 4′
T14993 31555-31556 -COMMA- denotes ,
T14994 31556-31582 NN denotes 6-diamidino-2-phenylindole
T14995 31583-31584 -LRB- denotes (
T14996 31584-31588 NN denotes DAPI
T14997 31588-31589 -RRB- denotes )
T14998 31590-31593 IN denotes for
T14999 31594-31596 CD denotes 15
T15000 31597-31600 NN denotes min
T15001 31601-31603 IN denotes at
T15002 31604-31609 NNP denotes 37°C.
T15003 31610-31617 NNP denotes Finally
T15004 31617-31618 -COMMA- denotes ,
T15005 31619-31622 DT denotes the
T15006 31623-31631 NN denotes sections
T15007 31632-31636 VB denotes were
T15008 31637-31643 VB denotes rinsed
T15009 31643-31644 -COMMA- denotes ,
T15010 31645-31652 VB denotes mounted
T15011 31653-31655 IN denotes on
T15012 31656-31662 NN denotes slides
T15013 31662-31663 -COMMA- denotes ,
T15014 31664-31667 CC denotes and
T15015 31668-31681 JJ denotes cover-slipped
T15016 31682-31685 IN denotes for
T15017 31686-31698 NN denotes fluorescence
T15018 31699-31709 NN denotes microscopy
T15019 31710-31711 -LRB- denotes (
T15020 31711-31714 NN denotes DAS
T15021 31715-31725 NN denotes microscope
T15022 31725-31726 -RRB- denotes )
T15449 31729-31747 NN denotes Immunofluorescence
T15450 32314-32321 RB denotes Finally
T15451 32321-32322 -COMMA- denotes ,
T15452 32323-32326 DT denotes the
T15453 32327-32335 NN denotes sections
T15454 32336-32340 VB denotes were
T15455 32341-32347 VB denotes rinsed
T15456 32347-32348 -COMMA- denotes ,
T15457 32349-32356 VB denotes mounted
T15458 32357-32359 IN denotes on
T15459 32360-32366 NN denotes slides
T15460 32366-32367 -COMMA- denotes ,
T15461 32368-32371 CC denotes and
T15462 32372-32385 JJ denotes cover-slipped
T15463 32386-32389 IN denotes for
T15464 32390-32402 NN denotes fluorescence
T15465 32403-32413 NN denotes microscopy
T15466 32414-32417 CC denotes and
T15467 32418-32429 NN denotes photography
T15468 32430-32435 VB denotes using
T15469 32436-32443 NN denotes ApoTome
T15470 32444-32454 NN denotes microscopy
T15471 32455-32456 -LRB- denotes (
T15472 32456-32460 NNP denotes Carl
T15473 32461-32466 NNP denotes Zeiss
T15474 32466-32467 -COMMA- denotes ,
T15475 32468-32477 NNP denotes Thornwood
T15476 32477-32478 -COMMA- denotes ,
T15477 32479-32481 NNP denotes NY
T15478 32481-32482 -COMMA- denotes ,
T15479 32483-32486 NNP denotes USA
T15480 32486-32487 -RRB- denotes )
T15697 32490-32493 NN denotes Gel
T15698 32494-32509 NN denotes Electromobility
T15699 32510-32515 NN denotes Shift
T15700 32516-32521 NN denotes Assay
T15701 32522-32523 DT denotes A
T15702 32524-32527 NN denotes gel
T15703 32528-32543 NN denotes electromobility
T15704 32544-32549 NN denotes shift
T15705 32550-32555 NN denotes assay
T15706 32556-32557 -LRB- denotes (
T15707 32557-32561 NN denotes EMSA
T15708 32561-32562 -RRB- denotes )
T15709 32563-32566 VB denotes was
T15710 32567-32576 VB denotes performed
T15711 32577-32586 VB denotes according
T15712 32587-32589 TO denotes to
T15713 32590-32593 DT denotes the
T15714 32594-32608 NN denotes manufacturer’s
T15715 32609-32624 NN denotes recommendations
T15716 32625-32626 -LRB- denotes (
T15717 32626-32633 NNP denotes Promega
T15718 32633-32634 -COMMA- denotes ,
T15719 32635-32642 NNP denotes Madison
T15720 32642-32643 -COMMA- denotes ,
T15721 32644-32646 NNP denotes WI
T15722 32646-32647 -RRB- denotes )
T15723 32649-32652 DT denotes The
T15724 32653-32658 NN denotes tumor
T15725 32659-32666 NN denotes tissues
T15726 32667-32671 VB denotes were
T15727 32672-32679 RB denotes briefly
T15728 32680-32691 VB denotes homogenized
T15729 32692-32694 IN denotes in
T15730 32695-32698 CD denotes 200
T15731 32699-32701 NN denotes µl
T15732 32702-32704 IN denotes of
T15733 32705-32713 NN denotes solution
T15734 32714-32715 NN denotes A
T15735 32716-32717 -LRB- denotes (
T15736 32717-32719 CD denotes 10
T15737 32720-32722 NN denotes mM
T15738 32723-32728 NN denotes HEPES
T15739 32729-32730 -LRB- denotes [
T15740 32730-32732 NN denotes pH
T15741 32733-32736 CD denotes 7.9
T15742 32736-32737 -RRB- denotes ]
T15743 32737-32738 -COMMA- denotes ,
T15744 32739-32742 CD denotes 1.5
T15745 32743-32745 NN denotes mM
T15746 32746-32751 NN denotes MgCl2
T15747 32751-32752 -COMMA- denotes ,
T15748 32753-32755 CD denotes 10
T15749 32756-32758 NN denotes mM
T15750 32759-32762 NN denotes KCl
T15751 32762-32763 -COMMA- denotes ,
T15752 32764-32767 CD denotes 0.5
T15753 32768-32770 NN denotes mM
T15754 32771-32785 NN denotes dithiothreitol
T15755 32785-32786 -COMMA- denotes ,
T15756 32787-32790 CD denotes 0.2
T15757 32791-32793 NN denotes mM
T15758 32794-32822 NN denotes phenylmethylsulfonylfluoride
T15759 32822-32823 -RRB- denotes )
T15760 32823-32824 -COMMA- denotes ,
T15761 32825-32833 VB denotes vortexed
T15762 32834-32844 RB denotes vigorously
T15763 32844-32845 -COMMA- denotes ,
T15764 32846-32855 VB denotes incubated
T15765 32856-32858 IN denotes on
T15766 32859-32862 NN denotes ice
T15767 32863-32866 IN denotes for
T15768 32867-32869 CD denotes 10
T15769 32870-32873 NN denotes min
T15770 32873-32874 -COMMA- denotes ,
T15771 32875-32878 CC denotes and
T15772 32879-32883 RB denotes then
T15773 32884-32895 VB denotes centrifuged
T15774 32896-32898 IN denotes at
T15775 32899-32904 CD denotes 15000
T15776 32905-32908 NN denotes rpm
T15777 32909-32912 IN denotes for
T15778 32913-32915 CD denotes 15
T15779 32916-32919 NN denotes min
T15780 32921-32924 DT denotes The
T15781 32925-32933 VB denotes pelleted
T15782 32934-32940 NN denotes nuclei
T15783 32941-32945 VB denotes were
T15784 32946-32957 VB denotes resuspended
T15785 32958-32960 IN denotes in
T15786 32961-32969 NN denotes solution
T15787 32970-32971 NN denotes C
T15788 32972-32973 -LRB- denotes (
T15789 32973-32981 NN denotes solution
T15790 32982-32983 NN denotes A
T15791 32984-32996 VB denotes supplemented
T15792 32997-33001 IN denotes with
T15793 33002-33005 CD denotes 420
T15794 33006-33008 NN denotes mM
T15795 33009-33013 NN denotes NaCl
T15796 33014-33017 CC denotes and
T15797 33018-33020 CD denotes 20
T15798 33020-33021 NN denotes %
T15799 33022-33030 NN denotes glycerol
T15800 33030-33031 -RRB- denotes )
T15801 33031-33032 -COMMA- denotes ,
T15802 33033-33036 CC denotes and
T15803 33037-33046 VB denotes incubated
T15804 33047-33049 IN denotes on
T15805 33050-33053 NN denotes ice
T15806 33054-33057 IN denotes for
T15807 33058-33060 CD denotes 20
T15808 33061-33064 NN denotes min
T15809 33066-33069 DT denotes The
T15810 33070-33081 JJ denotes resuspended
T15811 33082-33088 NN denotes pellet
T15812 33089-33092 VB denotes was
T15813 33093-33104 VB denotes centrifuged
T15814 33105-33107 IN denotes at
T15815 33108-33113 CD denotes 15000
T15816 33114-33117 NN denotes rpm
T15817 33118-33121 IN denotes for
T15818 33122-33124 CD denotes 15
T15819 33125-33128 NN denotes min
T15820 33128-33129 -COMMA- denotes ,
T15821 33130-33133 CC denotes and
T15822 33134-33137 DT denotes the
T15823 33138-33147 VB denotes resulting
T15824 33148-33155 JJ denotes nuclear
T15825 33156-33164 NN denotes extracts
T15826 33165-33176 NN denotes supernatant
T15827 33177-33181 VB denotes were
T15828 33182-33191 VB denotes collected
T15829 33192-33194 IN denotes in
T15830 33195-33196 DT denotes a
T15831 33197-33204 JJ denotes chilled
T15832 33205-33214 NNP denotes Eppendorf
T15833 33215-33219 NN denotes tube
T15834 33221-33230 NNP denotes Consensus
T15835 33231-33247 NN denotes oligonucleotides
T15836 33248-33252 VB denotes were
T15837 33253-33264 VB denotes end-labeled
T15838 33265-33270 VB denotes using
T15839 33271-33273 NN denotes T4
T15840 33274-33288 NN denotes polynucleotide
T15841 33289-33295 NN denotes kinase
T15842 33296-33299 CC denotes and
T15843 33300-33301 -LRB- denotes [
T15844 33301-33304 NN denotes P32
T15845 33304-33305 -RRB- denotes ]
T15846 33305-33309 NN denotes -ATP
T15847 33310-33313 IN denotes for
T15848 33314-33316 CD denotes 10
T15849 33317-33320 NN denotes min
T15850 33321-33323 IN denotes at
T15851 33324-33329 NNP denotes 37°C.
T15852 33330-33333 DT denotes The
T15853 33334-33337 NN denotes gel
T15854 33338-33343 NN denotes shift
T15855 33344-33353 NN denotes reactions
T15856 33354-33358 VB denotes were
T15857 33359-33368 VB denotes assembled
T15858 33369-33372 CC denotes and
T15859 33373-33382 VB denotes incubated
T15860 33383-33385 IN denotes at
T15861 33386-33390 NN denotes room
T15862 33391-33402 NN denotes temperature
T15863 33404-33416 RB denotes Subsequently
T15864 33416-33417 -COMMA- denotes ,
T15865 33418-33419 CD denotes 1
T15866 33420-33422 NN denotes ml
T15867 33423-33425 IN denotes of
T15868 33426-33429 NN denotes gel
T15869 33430-33437 NN denotes loading
T15870 33438-33444 NN denotes buffer
T15871 33445-33448 VB denotes was
T15872 33449-33454 VB denotes added
T15873 33455-33457 TO denotes to
T15874 33458-33462 DT denotes each
T15875 33463-33471 NN denotes reaction
T15876 33472-33475 CC denotes and
T15877 33476-33482 VB denotes loaded
T15878 33483-33487 IN denotes onto
T15879 33488-33489 DT denotes a
T15880 33490-33491 CD denotes 6
T15881 33491-33492 NN denotes %
T15882 33493-33509 JJ denotes non-denaturating
T15883 33510-33513 NN denotes gel
T15884 33515-33518 DT denotes The
T15885 33519-33522 NN denotes gel
T15886 33523-33526 VB denotes was
T15887 33527-33536 VB denotes subjected
T15888 33537-33539 TO denotes to
T15889 33540-33555 NN denotes electrophoresis
T15890 33556-33561 IN denotes until
T15891 33562-33565 DT denotes the
T15892 33566-33569 NN denotes dye
T15893 33570-33573 VB denotes was
T15894 33574-33585 NN denotes four-fifths
T15895 33586-33588 IN denotes of
T15896 33589-33592 DT denotes the
T15897 33593-33596 NN denotes way
T15898 33597-33601 IN denotes down
T15899 33602-33605 DT denotes the
T15900 33606-33609 NN denotes gel
T15901 33611-33614 DT denotes The
T15902 33615-33618 NN denotes gel
T15903 33619-33622 VB denotes was
T15904 33623-33628 VB denotes dried
T15905 33629-33632 IN denotes for
T15906 33633-33634 CD denotes 1
T15907 33635-33636 NN denotes h
T15908 33637-33639 IN denotes at
T15909 33640-33644 NN denotes 80°C
T15910 33645-33648 CC denotes and
T15911 33649-33656 VB denotes exposed
T15912 33657-33659 TO denotes to
T15913 33660-33664 VB denotes film
T15914 33665-33674 NN denotes overnight
T15915 33675-33677 IN denotes at
T15916 33678-33683 NN denotes -70°C
T16223 33686-33690 NN denotes Flow
T16224 33691-33701 JJ denotes Cytometric
T16225 33702-33710 NN denotes Analysis
T16226 33711-33722 NN denotes Lymphocytes
T16227 33723-33727 VB denotes were
T16228 33728-33736 VB denotes obtained
T16229 33737-33741 IN denotes from
T16230 33742-33747 NN denotes tumor
T16231 33748-33751 CC denotes and
T16232 33752-33758 NN denotes spleen
T16233 33759-33766 NN denotes tissues
T16234 33767-33770 IN denotes for
T16235 33771-33780 NN denotes phenotype
T16236 33781-33789 NN denotes analysis
T16237 33791-33797 NN denotes Spleen
T16238 33798-33801 CC denotes and
T16239 33802-33807 NN denotes tumor
T16240 33808-33819 NN denotes lymphocytes
T16241 33820-33824 VB denotes were
T16242 33825-33833 VB denotes isolated
T16243 33834-33838 IN denotes from
T16244 33839-33844 JJ denotes fresh
T16245 33845-33851 NN denotes spleen
T16246 33852-33855 CC denotes and
T16247 33856-33861 NN denotes tumor
T16248 33862-33870 NN denotes biopsies
T16249 33871-33879 VB denotes obtained
T16250 33880-33884 IN denotes from
T16251 33885-33890 CD denotes three
T16252 33891-33895 NN denotes mice
T16253 33896-33899 IN denotes per
T16254 33900-33905 NN denotes group
T16255 33907-33913 NN denotes Spleen
T16256 33914-33917 CC denotes and
T16257 33918-33923 NN denotes tumor
T16258 33924-33932 NN denotes biopsies
T16259 33933-33937 VB denotes were
T16260 33938-33945 RB denotes briefly
T16261 33946-33957 VB denotes homogenized
T16262 33958-33970 RB denotes mechanically
T16263 33971-33973 IN denotes in
T16264 33974-33977 NNP denotes PBS
T16265 33977-33978 -COMMA- denotes ,
T16266 33979-33987 VB denotes filtered
T16267 33988-33989 -LRB- denotes (
T16268 33989-33992 CD denotes 100
T16269 33993-33995 NN denotes µm
T16270 33996-34000 NN denotes cell
T16271 34001-34009 NN denotes strainer
T16272 34009-34010 -COLON- denotes ;
T16273 34011-34013 NN denotes BD
T16274 34014-34024 NN denotes PharMingen
T16275 34024-34025 -RRB- denotes )
T16276 34026-34029 CC denotes and
T16277 34030-34034 RB denotes then
T16278 34035-34041 VB denotes placed
T16279 34042-34044 IN denotes in
T16280 34045-34050 NN denotes lysis
T16281 34051-34057 NN denotes buffer
T16282 34058-34059 -LRB- denotes (
T16283 34059-34062 NN denotes ACK
T16284 34063-34069 NN denotes lysing
T16285 34070-34076 NN denotes buffer
T16286 34076-34077 -COMMA- denotes ,
T16287 34078-34083 NN denotes LONZA
T16288 34083-34084 -RRB- denotes )
T16289 34085-34087 TO denotes to
T16290 34088-34094 VB denotes remove
T16291 34095-34098 JJ denotes red
T16292 34099-34104 NN denotes blood
T16293 34105-34110 NN denotes cells
T16294 34112-34115 CD denotes One
T16295 34116-34123 CD denotes million
T16296 34124-34135 NN denotes splenocytes
T16297 34136-34140 VB denotes were
T16298 34141-34147 VB denotes washed
T16299 34148-34152 RB denotes once
T16300 34153-34155 IN denotes in
T16301 34156-34159 NN denotes PBS
T16302 34160-34170 VB denotes containing
T16303 34171-34172 CD denotes 1
T16304 34172-34173 NN denotes %
T16305 34174-34180 JJ denotes bovine
T16306 34181-34186 NN denotes serum
T16307 34187-34194 NN denotes albumin
T16308 34195-34196 -LRB- denotes (
T16309 34196-34199 NN denotes BSA
T16310 34199-34200 -RRB- denotes )
T16311 34201-34204 CC denotes and
T16312 34205-34217 JJ denotes re-suspended
T16313 34218-34220 IN denotes in
T16314 34221-34224 CD denotes 100
T16315 34225-34227 NN denotes µl
T16316 34228-34230 IN denotes of
T16317 34231-34238 NN denotes PBS/BSA
T16318 34239-34245 NN denotes buffer
T16319 34247-34256 RB denotes Meanwhile
T16320 34256-34257 -COMMA- denotes ,
T16321 34258-34261 CD denotes one
T16322 34262-34269 CD denotes million
T16323 34270-34275 NN denotes cells
T16324 34276-34284 VB denotes obtained
T16325 34285-34289 IN denotes from
T16326 34290-34295 NN denotes tumor
T16327 34296-34303 NN denotes tissues
T16328 34304-34308 VB denotes were
T16329 34309-34315 VB denotes placed
T16330 34316-34318 IN denotes in
T16331 34319-34323 NN denotes RPMI
T16332 34324-34330 NN denotes medium
T16333 34330-34331 -COMMA- denotes ,
T16334 34332-34341 VB denotes incubated
T16335 34342-34344 TO denotes to
T16336 34345-34351 VB denotes obtain
T16337 34352-34362 NN denotes suspension
T16338 34363-34367 NN denotes cell
T16339 34368-34371 IN denotes for
T16340 34372-34377 NN denotes 1hour
T16341 34378-34380 IN denotes at
T16342 34381-34385 NN denotes 37°C
T16343 34385-34386 -COMMA- denotes ,
T16344 34387-34398 VB denotes centrifuged
T16345 34399-34400 -LRB- denotes (
T16346 34400-34404 CD denotes 1200
T16347 34405-34408 NN denotes rpm
T16348 34408-34409 -COMMA- denotes ,
T16349 34410-34411 CD denotes 3
T16350 34412-34415 NN denotes min
T16351 34415-34416 -RRB- denotes )
T16352 34417-34420 CC denotes and
T16353 34421-34425 RB denotes then
T16354 34426-34432 VB denotes washed
T16355 34433-34435 IN denotes in
T16356 34436-34439 NNP denotes PBS
T16357 34441-34445 RB denotes Next
T16358 34445-34446 -COMMA- denotes ,
T16359 34447-34450 DT denotes the
T16360 34451-34462 NN denotes lymphocytes
T16361 34463-34467 VB denotes were
T16362 34468-34477 VB denotes incubated
T16363 34478-34482 IN denotes with
T16364 34483-34490 JJ denotes various
T16365 34491-34501 VB denotes conjugated
T16366 34502-34512 JJ denotes monoclonal
T16367 34513-34523 NN denotes antibodies
T16368 34523-34524 -COMMA- denotes ,
T16369 34525-34534 VB denotes including
T16370 34535-34542 NN denotes CD4-APC
T16371 34542-34543 -COMMA- denotes ,
T16372 34544-34552 NN denotes CD8-FITC
T16373 34553-34556 CC denotes and
T16374 34557-34564 NN denotes CD19-PE
T16375 34565-34568 IN denotes for
T16376 34569-34574 NN denotes 20min
T16377 34575-34577 IN denotes at
T16378 34578-34581 NN denotes 4°C
T16379 34581-34582 -COMMA- denotes ,
T16380 34583-34589 VB denotes washed
T16381 34590-34595 RB denotes twice
T16382 34596-34598 IN denotes in
T16383 34599-34602 NNP denotes PBS
T16384 34602-34603 -COMMA- denotes ,
T16385 34604-34607 CC denotes and
T16386 34608-34620 JJ denotes re-suspended
T16387 34621-34623 IN denotes in
T16388 34624-34627 CD denotes 400
T16389 34628-34630 NN denotes µl
T16390 34631-34633 IN denotes of
T16391 34634-34637 NNP denotes PBS
T16392 34639-34640 DT denotes A
T16393 34641-34645 NN denotes flow
T16394 34646-34656 JJ denotes cytometric
T16395 34657-34665 NN denotes analysis
T16396 34666-34669 VB denotes was
T16397 34670-34679 VB denotes performed
T16398 34680-34682 IN denotes on
T16399 34683-34684 DT denotes a
T16400 34685-34693 NN denotes FACSAria
T16401 34694-34698 NN denotes flow
T16402 34699-34708 NN denotes cytometry
T16403 34709-34710 -LRB- denotes (
T16404 34710-34712 NN denotes BD
T16405 34713-34724 NNP denotes Biosciences
T16406 34724-34725 -RRB- denotes )
T16407 34725-34726 -COMMA- denotes ,
T16408 34727-34730 CC denotes and
T16409 34731-34734 DT denotes the
T16410 34735-34739 NN denotes data
T16411 34740-34744 VB denotes were
T16412 34745-34753 VB denotes analyzed
T16413 34754-34759 VB denotes using
T16414 34760-34763 DT denotes the
T16415 34764-34770 NNP denotes WinMDI
T16416 34771-34782 JJ denotes statistical
T16417 34783-34791 NN denotes software
T16418 34792-34793 -LRB- denotes (
T16419 34793-34800 NNP denotes Scripps
T16420 34800-34801 -COMMA- denotes ,
T16421 34802-34804 NNP denotes La
T16422 34805-34810 NNP denotes Jolla
T16423 34810-34811 -COMMA- denotes ,
T16424 34812-34814 NNP denotes CA
T16425 34814-34815 -COMMA- denotes ,
T16426 34816-34819 NNP denotes USA
T16427 34819-34820 -RRB- denotes )
T16428 34822-34829 RB denotes Forward
T16429 34830-34833 CC denotes and
T16430 34834-34838 NN denotes side
T16431 34839-34846 NN denotes scatter
T16432 34847-34857 NN denotes parameters
T16433 34858-34862 VB denotes were
T16434 34863-34867 VB denotes used
T16435 34868-34870 TO denotes to
T16436 34871-34875 VB denotes gate
T16437 34876-34878 IN denotes on
T16438 34879-34890 NN denotes lymphocytes
T16734 34893-34900 NN denotes Protein
T16735 34901-34914 NN denotes Immuno-arrays
T16736 34915-34918 DT denotes The
T16737 34919-34924 NN denotes tumor
T16738 34925-34928 CC denotes and
T16739 34929-34935 NN denotes spleen
T16740 34936-34943 NN denotes tissues
T16741 34944-34948 VB denotes were
T16742 34949-34956 VB denotes excised
T16743 34957-34960 CC denotes and
T16744 34961-34972 VB denotes homogenized
T16745 34973-34975 IN denotes in
T16746 34976-34979 NNP denotes PBS
T16747 34980-34984 IN denotes with
T16748 34985-34993 NN denotes protease
T16749 34994-35003 NN denotes inhibitor
T16750 35004-35012 NN denotes cocktail
T16751 35013-35014 -LRB- denotes (
T16752 35014-35027 NNP denotes Sigma-Aldrich
T16753 35027-35028 -COMMA- denotes ,
T16754 35029-35032 NNP denotes USA
T16755 35032-35033 -RRB- denotes )
T16756 35034-35037 CC denotes and
T16757 35038-35044 NN denotes Triton
T16758 35045-35050 NN denotes X-100
T16759 35051-35052 -LRB- denotes (
T16760 35052-35057 JJ denotes final
T16761 35058-35071 NN denotes concentration
T16762 35072-35073 CD denotes 1
T16763 35073-35074 NN denotes %
T16764 35074-35075 -RRB- denotes )
T16765 35077-35080 DT denotes The
T16766 35081-35088 NN denotes samples
T16767 35089-35093 VB denotes were
T16768 35094-35100 VB denotes frozen
T16769 35101-35103 IN denotes at
T16770 35104-35109 NN denotes −70°C
T16771 35109-35110 -COMMA- denotes ,
T16772 35111-35117 VB denotes thawed
T16773 35117-35118 -COMMA- denotes ,
T16774 35119-35122 CC denotes and
T16775 35123-35134 VB denotes centrifuged
T16776 35135-35137 IN denotes at
T16777 35138-35146 NN denotes 10,000×g
T16778 35147-35150 IN denotes for
T16779 35151-35152 CD denotes 5
T16780 35153-35156 NN denotes min
T16781 35157-35159 TO denotes to
T16782 35160-35166 VB denotes remove
T16783 35167-35175 JJ denotes cellular
T16784 35176-35182 NN denotes debris
T16785 35184-35187 DT denotes The
T16786 35188-35194 NN denotes tissue
T16787 35195-35202 NN denotes lysates
T16788 35203-35207 VB denotes were
T16789 35208-35217 VB denotes performed
T16790 35218-35225 NN denotes protein
T16791 35226-35231 NN denotes assay
T16792 35232-35234 IN denotes in
T16793 35235-35238 DT denotes the
T16794 35239-35243 JJ denotes same
T16795 35244-35247 NN denotes way
T16796 35248-35250 IN denotes as
T16797 35251-35254 IN denotes for
T16798 35255-35262 JJ denotes western
T16799 35263-35271 NN denotes blotting
T16800 35273-35276 CD denotes 4.5
T16801 35277-35279 NN denotes mg
T16802 35280-35282 IN denotes of
T16803 35283-35291 NN denotes proteins
T16804 35291-35292 -COMMA- denotes ,
T16805 35293-35302 VB denotes collected
T16806 35303-35307 IN denotes from
T16807 35308-35313 CD denotes three
T16808 35314-35321 NN denotes samples
T16809 35322-35325 IN denotes per
T16810 35326-35331 NN denotes group
T16811 35331-35332 -COMMA- denotes ,
T16812 35333-35337 VB denotes were
T16813 35338-35342 VB denotes used
T16814 35343-35346 IN denotes for
T16815 35347-35352 NN denotes Mouse
T16816 35353-35361 NN denotes cytokine
T16817 35362-35367 NN denotes array
T16818 35368-35370 IN denotes as
T16819 35371-35374 DT denotes the
T16820 35375-35383 NN denotes protocol
T16821 35384-35392 VB denotes provided
T16822 35393-35395 IN denotes by
T16823 35396-35404 NN denotes supplier
T16824 35405-35406 -LRB- denotes (
T16825 35406-35414 NNP denotes Proteome
T16826 35415-35424 NNP denotes Profiler™
T16827 35424-35425 -COMMA- denotes ,
T16828 35426-35427 -SHARP- denotes #
T16829 35427-35433 NN denotes ARY006
T16830 35433-35434 -COMMA- denotes ,
T16831 35435-35436 NNP denotes R
T16832 35436-35437 CC denotes &
T16833 35437-35438 NNP denotes D
T16834 35439-35446 NNP denotes Systems
T16835 35446-35447 -COMMA- denotes ,
T16836 35448-35451 NNP denotes USA
T16837 35451-35452 -RRB- denotes )
T16985 35455-35466 JJ denotes Statistical
T16986 35467-35475 NN denotes Analysis
T16987 35476-35479 DT denotes The
T16988 35480-35484 NN denotes data
T16989 35485-35489 VB denotes were
T16990 35490-35498 VB denotes analyzed
T16991 35499-35504 VB denotes using
T16992 35505-35508 DT denotes the
T16993 35509-35517 NNP denotes GraphPad
T16994 35518-35523 NNP denotes Prism
T16995 35524-35525 CD denotes 4
T16996 35526-35529 NN denotes ver
T16997 35531-35535 CD denotes 4.03
T16998 35536-35544 NN denotes software
T16999 35545-35546 -LRB- denotes (
T17000 35546-35554 NNP denotes GraphPad
T17001 35555-35563 NNP denotes Software
T17002 35563-35564 -COMMA- denotes ,
T17003 35565-35567 NNP denotes La
T17004 35568-35573 NNP denotes Jolla
T17005 35573-35574 -COMMA- denotes ,
T17006 35575-35577 NNP denotes CA
T17007 35577-35578 -RRB- denotes )
T17008 35580-35584 NN denotes Data
T17009 35585-35588 VB denotes are
T17010 35589-35598 VB denotes presented
T17011 35599-35601 IN denotes as
T17012 35602-35606 JJ denotes mean
T17013 35607-35608 NN denotes ±
T17014 35609-35611 NN denotes SD
T17015 35613-35623 NN denotes Difference
T17016 35624-35631 IN denotes between
T17017 35632-35639 NN denotes CCR5−/−
T17018 35640-35644 NN denotes mice
T17019 35645-35648 CC denotes and
T17020 35649-35656 JJ denotes CCR5+/+
T17021 35657-35661 NN denotes mice
T17022 35662-35666 VB denotes were
T17023 35667-35675 VB denotes compared
T17024 35676-35681 VB denotes using
T17025 35682-35683 NN denotes t
T17026 35684-35688 NN denotes test
T17027 35690-35691 DT denotes A
T17028 35692-35697 NN denotes value
T17029 35698-35700 IN denotes of
T17030 35701-35702 NN denotes p
T17031 35702-35703 SYM denotes <
T17032 35703-35707 CD denotes 0.05
T17033 35708-35711 VB denotes was
T17034 35712-35722 VB denotes considered
T17035 35723-35725 TO denotes to
T17036 35726-35728 VB denotes be
T17037 35729-35742 RB denotes statistically
T17038 35743-35754 JJ denotes significant
T17039 35756-35764 NN denotes Survival
T17040 35765-35769 NN denotes data
T17041 35770-35774 VB denotes were
T17042 35775-35784 VB denotes presented
T17043 35785-35787 IN denotes by
T17044 35788-35800 NNP denotes Kaplan-Meier
T17045 35801-35809 NN denotes survival
T17046 35810-35819 NN denotes estimates
T17047 35820-35823 CC denotes and
T17048 35824-35832 VB denotes compared
T17049 35833-35836 CC denotes and
T17050 35837-35847 VB denotes calculated
T17051 35848-35850 IN denotes by
T17052 35851-35859 NNP denotes Log-rank
T17053 35860-35861 -LRB- denotes (
T17054 35861-35871 JJ denotes Mantel-Cox
T17055 35871-35872 -RRB- denotes )
T17056 35873-35877 NN denotes Test
T17057 35878-35880 IN denotes in
T17058 35881-35889 NNP denotes GraphPad
T17059 35890-35895 NNP denotes Prism
R100 T317 T329 arg1Of showed,when
R1000 T1926 T1925 arg2Of demonstrated,been
R1001 T1928 T1926 arg3Of inhibit,demonstrated
R1002 T1928 T1927 arg1Of inhibit,to
R1003 T1928 T1937 arg1Of inhibit,[
R1004 T1931 T1929 arg1Of growth,experimental
R1005 T1931 T1930 arg1Of growth,tumor
R1006 T1931 T1932 arg1Of growth,and
R1007 T1932 T1928 arg2Of and,inhibit
R1008 T1933 T1932 arg2Of metastasis,and
R1009 T1933 T1934 arg1Of metastasis,of
R101 T320 T318 arg2Of volume,reduced
R1010 T1936 T1934 arg2Of cancer,of
R1011 T1936 T1935 arg1Of cancer,pancreatic
R1012 T1938 T1937 arg2Of 9,[
R1013 T1939 T1937 arg3Of ],[
R1014 T1941 T1940 arg2Of addition,In
R1015 T1944 T1943 arg1Of absence,host
R1016 T1944 T1945 arg1Of absence,of
R1017 T1944 T1947 arg1Of absence,potentiates
R1018 T1946 T1945 arg2Of CCR5,of
R1019 T1947 T1957 arg1Of potentiates,and
R102 T320 T319 arg1Of volume,tumor
R1020 T1949 T1947 arg2Of delay,potentiates
R1021 T1949 T1948 arg1Of delay,the
R1022 T1949 T1950 arg1Of delay,of
R10220 T14695 T14694 arg1Of specimens,All
R10221 T14695 T14696 arg1Of specimens,were
R10222 T14695 T14697 arg2Of specimens,fixed
R10223 T14695 T14701 arg2Of specimens,embedded
R10224 T14697 T14698 arg1Of fixed,in
R10225 T14697 T14700 arg1Of fixed,and
R10226 T14699 T14698 arg2Of formalin,in
R10227 T14700 T14696 arg2Of and,were
R10228 T14701 T14700 arg2Of embedded,and
R10229 T14701 T14702 arg1Of embedded,in
R1023 T1952 T1950 arg2Of growth,of
R10230 T14703 T14702 arg2Of paraffin,in
R10231 T14703 T14704 arg1Of paraffin,for
R10232 T14705 T14704 arg2Of examination,for
R10233 T14706 T14707 arg1Of Sections,(
R10234 T14706 T14712 arg1Of Sections,were
R10235 T14706 T14713 arg2Of Sections,stained
R10236 T14706 T14719 arg2Of Sections,analyzed
R10237 T14709 T14707 arg2Of µm,(
R10238 T14709 T14708 arg1Of µm,4
R10239 T14709 T14710 arg1Of µm,thick
R1024 T1952 T1951 arg1Of growth,tumor
R10240 T14711 T14707 arg3Of ),(
R10241 T14713 T14714 arg1Of stained,with
R10242 T14713 T14718 arg1Of stained,and
R10243 T14717 T14714 arg2Of E,with
R10244 T14717 T14715 arg1Of E,H
R10245 T14717 T14716 arg1Of E,&
R10246 T14718 T14712 arg2Of and,were
R10247 T14719 T14718 arg2Of analyzed,and
R10248 T14721 T14719 arg1Of immunohistochemistry,analyzed
R10249 T14721 T14720 arg2Of immunohistochemistry,by
R1025 T1952 T1953 arg1Of growth,[
R10250 T14724 T14722 arg1Of sections,The
R10251 T14724 T14723 arg1Of sections,paraffin-embedded
R10252 T14724 T14725 arg1Of sections,were
R10253 T14724 T14726 arg2Of sections,deparaffinized
R10254 T14724 T14728 arg2Of sections,rehydrated
R10255 T14724 T14730 arg2Of sections,washed
R10256 T14724 T14737 arg2Of sections,subjected
R10257 T14726 T14727 arg1Of deparaffinized,and
R10258 T14727 T14729 arg1Of and,","
R10259 T14728 T14727 arg2Of rehydrated,and
R1026 T1954 T1953 arg2Of 10,[
R10260 T14729 T14735 arg1Of ",",and
R10261 T14730 T14729 arg2Of washed,","
R10262 T14730 T14731 arg1Of washed,in
R10263 T14733 T14731 arg2Of water,in
R10264 T14733 T14732 arg1Of water,distilled
R10265 T14735 T14725 arg2Of and,were
R10266 T14735 T14734 arg1Of and,","
R10267 T14737 T14735 arg2Of subjected,and
R10268 T14737 T14736 arg1Of subjected,then
R10269 T14737 T14738 arg1Of subjected,to
R1027 T1955 T1953 arg3Of ],[
R10270 T14741 T14738 arg2Of retrieval,to
R10271 T14741 T14739 arg1Of retrieval,heat-mediated
R10272 T14741 T14740 arg1Of retrieval,antigen
R10273 T14744 T14742 arg1Of activity,Endogenous
R10274 T14744 T14743 arg1Of activity,peroxidase
R10275 T14744 T14745 arg1Of activity,was
R10276 T14744 T14746 arg2Of activity,quenched
R10277 T14746 T14745 arg2Of quenched,was
R10278 T14746 T14759 arg1Of quenched,","
R10279 T14746 T14760 modOf quenched,followed
R1028 T1957 T1940 arg1Of and,In
R10280 T14748 T14746 arg1Of incubation,quenched
R10281 T14748 T14747 arg2Of incubation,by
R10282 T14748 T14749 arg1Of incubation,in
R10283 T14753 T14749 arg2Of peroxide,in
R10284 T14753 T14750 arg1Of peroxide,3
R10285 T14753 T14751 arg1Of peroxide,%
R10286 T14753 T14752 arg1Of peroxide,hydrogen
R10287 T14753 T14754 arg1Of peroxide,in
R10288 T14753 T14756 arg1Of peroxide,for
R10289 T14755 T14754 arg2Of methanol,in
R1029 T1957 T1942 arg1Of and,","
R10290 T14758 T14756 arg2Of min,for
R10291 T14758 T14757 arg1Of min,15
R10292 T14760 T14761 arg1Of followed,by
R10293 T14762 T14761 arg2Of clearing,by
R10294 T14762 T14763 arg1Of clearing,in
R10295 T14762 T14765 arg1Of clearing,for
R10296 T14764 T14763 arg2Of PBS,in
R10297 T14767 T14765 arg2Of min,for
R10298 T14767 T14766 arg1Of min,5
R10299 T14769 T14768 arg1Of sections,The
R103 T320 T321 arg1Of volume,","
R1030 T1957 T1956 arg1Of and,","
R10300 T14769 T14770 arg1Of sections,were
R10301 T14769 T14771 arg2Of sections,blocked
R10302 T14769 T14788 arg2Of sections,incubated
R10303 T14771 T14772 arg1Of blocked,for
R10304 T14771 T14787 arg1Of blocked,and
R10305 T14774 T14772 arg2Of min,for
R10306 T14774 T14773 arg1Of min,30
R10307 T14774 T14775 arg1Of min,with
R10308 T14776 T14777 arg1Of 3,%
R10309 T14780 T14775 arg2Of serum,with
R1031 T1959 T1958 arg1Of inhibitors,CCR5
R10310 T14780 T14776 arg1Of serum,3
R10311 T14780 T14778 arg1Of serum,normal
R10312 T14780 T14779 arg1Of serum,horse
R10313 T14780 T14781 arg2Of serum,diluted
R10314 T14781 T14782 arg1Of diluted,in
R10315 T14783 T14782 arg2Of PBS,in
R10316 T14783 T14784 arg1Of PBS,","
R10317 T14783 T14785 arg2Of PBS,blotted
R10318 T14787 T14770 arg2Of and,were
R10319 T14787 T14786 arg1Of and,","
R1032 T1959 T1960 arg1Of inhibitors,prevented
R10320 T14788 T14787 arg2Of incubated,and
R10321 T14788 T14789 arg1Of incubated,with
R10322 T14791 T14792 arg2Of mouse,anti-mouse
R10323 T14796 T14792 arg3Of antigen,anti-mouse
R10324 T14796 T14793 arg1Of antigen,proliferating
R10325 T14796 T14794 arg1Of antigen,cell
R10326 T14796 T14795 arg1Of antigen,nuclear
R10327 T14796 T14797 arg1Of antigen,(
R10328 T14798 T14797 arg2Of PCNA,(
R10329 T14798 T14799 arg1Of PCNA,","
R1033 T1960 T1957 arg2Of prevented,and
R10330 T14801 T14799 arg2Of dilution,","
R10331 T14801 T14800 arg1Of dilution,1∶200
R10332 T14802 T14797 arg3Of ),(
R10333 T14804 T14789 arg2Of antibodies,with
R10334 T14804 T14790 arg1Of antibodies,primary
R10335 T14804 T14791 arg1Of antibodies,mouse
R10336 T14804 T14803 arg1Of antibodies,monoclonal
R10337 T14804 T14805 arg1Of antibodies,in
R10338 T14806 T14805 arg2Of blocking,in
R10339 T14806 T14808 arg1Of blocking,for
R1034 T1963 T1960 arg2Of growth,prevented
R10340 T14806 T14811 arg1Of blocking,at
R10341 T14807 T14806 arg2Of serum,blocking
R10342 T14810 T14808 arg2Of h,for
R10343 T14810 T14809 arg1Of h,4
R10344 T14813 T14811 arg2Of temperature,at
R10345 T14813 T14812 arg1Of temperature,room
R10346 T14817 T14816 arg1Of slides,the
R10347 T14817 T14818 arg1Of slides,were
R10348 T14817 T14819 arg2Of slides,washed
R10349 T14817 T14829 arg2Of slides,incubated
R1035 T1963 T1961 arg1Of growth,cancer
R10350 T14819 T14821 arg1Of washed,times
R10351 T14819 T14822 arg1Of washed,for
R10352 T14819 T14828 arg1Of washed,and
R10353 T14821 T14820 arg1Of times,three
R10354 T14824 T14822 arg2Of min,for
R10355 T14824 T14823 arg1Of min,5
R10356 T14824 T14825 arg1Of min,each
R10357 T14824 T14826 arg1Of min,in
R10358 T14827 T14826 arg2Of PBS,in
R10359 T14828 T14814 arg1Of and,Thereafter
R1036 T1963 T1962 arg1Of growth,cell
R10360 T14828 T14815 arg1Of and,","
R10361 T14828 T14818 arg2Of and,were
R10362 T14829 T14828 arg2Of incubated,and
R10363 T14829 T14830 arg1Of incubated,with
R10364 T14832 T14833 arg1Of anti-mouse,and
R10365 T14834 T14833 arg2Of anti-rabbit,and
R10366 T14835 T14830 arg2Of antibodies,with
R10367 T14835 T14831 arg2Of antibodies,biotinylated
R10368 T14835 T14832 arg1Of antibodies,anti-mouse
R10369 T14835 T14834 arg1Of antibodies,anti-rabbit
R1037 T1963 T1964 arg1Of growth,","
R10370 T14835 T14836 arg1Of antibodies,for
R10371 T14838 T14836 arg2Of h,for
R10372 T14838 T14837 arg1Of h,2
R10373 T14840 T14839 arg1Of slides,The
R10374 T14840 T14841 arg1Of slides,were
R10375 T14840 T14842 arg2Of slides,washed
R10376 T14842 T14841 arg2Of washed,were
R10377 T14842 T14843 arg1Of washed,in
R10378 T14844 T14843 arg2Of PBS,in
R10379 T14844 T14845 arg1Of PBS,","
R1038 T1963 T1966 arg1Of growth,as
R10380 T14844 T14846 arg2Of PBS,followed
R10381 T14844 T14856 arg1Of PBS,(
R10382 T14849 T14846 arg1Of addition,followed
R10383 T14849 T14847 arg2Of addition,by
R10384 T14849 T14848 arg1Of addition,the
R10385 T14849 T14850 arg1Of addition,of
R10386 T14855 T14850 arg2Of complex,of
R10387 T14855 T14851 arg1Of complex,the
R10388 T14855 T14852 arg1Of complex,avidin
R10389 T14855 T14853 arg1Of complex,biotin
R1039 T1966 T1965 arg1Of as,such
R10390 T14855 T14854 arg1Of complex,peroxidase
R10391 T14858 T14857 arg1Of kit,ABC
R10392 T14858 T14859 arg1Of kit,;
R10393 T14859 T14856 arg2Of ;,(
R10394 T14859 T14866 arg1Of ;,","
R10395 T14859 T14867 arg1Of ;,USA
R10396 T14861 T14860 arg1Of Laboratories,Vector
R10397 T14861 T14862 arg1Of Laboratories,","
R10398 T14862 T14864 arg1Of ",",","
R10399 T14863 T14862 arg2Of Burlingame,","
R104 T321 T325 arg1Of ",",and
R1040 T1968 T1967 arg1Of cancer,prostate
R10400 T14864 T14859 arg2Of ",",;
R10401 T14865 T14864 arg2Of CA,","
R10402 T14868 T14856 arg3Of ),(
R10403 T14870 T14869 arg1Of slides,The
R10404 T14870 T14871 arg1Of slides,were
R10405 T14870 T14872 arg2Of slides,washed
R10406 T14872 T14871 arg2Of washed,were
R10407 T14872 T14873 arg1Of washed,and
R10408 T14876 T14874 arg1Of reaction,the
R10409 T14876 T14875 arg1Of reaction,peroxidase
R1041 T1968 T1969 arg1Of cancer,[
R10410 T14876 T14877 arg1Of reaction,was
R10411 T14876 T14878 arg2Of reaction,developed
R10412 T14878 T14873 arg2Of developed,and
R10413 T14878 T14877 arg2Of developed,was
R10414 T14878 T14879 arg1Of developed,with
R10415 T14878 T14886 arg1Of developed,","
R10416 T14878 T14887 modOf developed,followed
R10417 T14880 T14881 arg1Of diaminobenzidine,(
R10418 T14880 T14884 arg1Of diaminobenzidine,and
R10419 T14882 T14881 arg2Of DAB,(
R1042 T1968 T1972 arg1Of cancer,","
R10420 T14883 T14881 arg3Of ),(
R10421 T14884 T14879 arg2Of and,with
R10422 T14885 T14884 arg2Of peroxide,and
R10423 T14889 T14890 arg1Of counterstaining,with
R10424 T14889 T14892 arg1Of counterstaining,","
R10425 T14889 T14893 modOf counterstaining,mounting
R10426 T14889 T14897 arg1Of counterstaining,and
R10427 T14891 T14890 arg2Of hematoxylin,with
R10428 T14893 T14894 arg1Of mounting,in
R10429 T14895 T14894 arg2Of aqua-mount,in
R1043 T1970 T1969 arg2Of 11,[
R10430 T14897 T14887 arg1Of and,followed
R10431 T14897 T14888 arg2Of and,by
R10432 T14897 T14896 arg1Of and,","
R10433 T14897 T14899 arg1Of and,under
R10434 T14898 T14897 arg2Of evaluation,and
R10435 T14902 T14899 arg2Of microscope,under
R10436 T14902 T14900 arg1Of microscope,a
R10437 T14902 T14901 arg1Of microscope,light
R10438 T14902 T14903 arg1Of microscope,(
R10439 T14904 T14903 arg2Of magnification×200,(
R1044 T1971 T1969 arg3Of ],[
R10440 T14904 T14905 arg1Of magnification×200,;
R10441 T14906 T14905 arg2Of Olympus,;
R10442 T14906 T14907 arg1Of Olympus,","
R10443 T14908 T14907 arg2Of Tokyo,","
R10444 T14908 T14909 arg1Of Tokyo,","
R10445 T14910 T14909 arg2Of Japan,","
R10446 T14911 T14903 arg3Of ),(
R10447 T14914 T14912 arg1Of control,A
R10448 T14914 T14913 arg1Of control,negative
R10449 T14914 T14915 arg1Of control,was
R1045 T1972 T1975 arg1Of ",",","
R10450 T14914 T14916 arg2Of control,included
R10451 T14914 T14921 arg1Of control,omitting
R10452 T14916 T14915 arg2Of included,was
R10453 T14916 T14917 arg1Of included,in
R10454 T14916 T14920 arg1Of included,by
R10455 T14919 T14917 arg2Of experiments,in
R10456 T14919 T14918 arg1Of experiments,all
R10457 T14921 T14920 arg2Of omitting,by
R10458 T14924 T14921 arg2Of antibody,omitting
R10459 T14924 T14922 arg1Of antibody,the
R1046 T1974 T1972 arg2Of cancer,","
R10460 T14924 T14923 arg1Of antibody,primary
R10461 T14927 T14925 arg2Of detection,For
R10462 T14927 T14926 arg1Of detection,the
R10463 T14927 T14928 arg1Of detection,of
R10464 T14927 T14932 arg1Of detection,in
R10465 T14931 T14928 arg2Of death,of
R10466 T14931 T14929 arg1Of death,apoptotic
R10467 T14931 T14930 arg1Of death,cell
R10468 T14935 T14932 arg2Of tissues,in
R10469 T14935 T14933 arg1Of tissues,the
R1047 T1974 T1973 arg1Of cancer,breast
R10470 T14935 T14934 arg1Of tissues,tumor
R10471 T14939 T14937 arg1Of sections,the
R10472 T14939 T14938 arg1Of sections,paraffin-embedded
R10473 T14939 T14940 arg1Of sections,were
R10474 T14939 T14941 arg2Of sections,incubated
R10475 T14939 T14968 arg1Of sections,washed
R10476 T14941 T14940 arg2Of incubated,were
R10477 T14941 T14942 arg1Of incubated,in
R10478 T14941 T14966 arg1Of incubated,and
R10479 T14944 T14945 arg1Of mixture,of
R1048 T1975 T1982 arg1Of ",",and
R10480 T14944 T14953 arg1Of mixture,and
R10481 T14948 T14945 arg2Of solution,of
R10482 T14948 T14946 arg1Of solution,the
R10483 T14948 T14947 arg1Of solution,labeling
R10484 T14948 T14949 arg1Of solution,(
R10485 T14951 T14949 arg2Of µl,(
R10486 T14951 T14950 arg1Of µl,540
R10487 T14952 T14949 arg3Of ),(
R10488 T14953 T14942 arg2Of and,in
R10489 T14953 T14943 arg1Of and,a
R1049 T1977 T1975 arg2Of cells,","
R10490 T14955 T14953 arg2Of solution,and
R10491 T14955 T14954 arg1Of solution,enzyme
R10492 T14955 T14956 arg1Of solution,(
R10493 T14955 T14960 arg1Of solution,for
R10494 T14958 T14956 arg2Of µl,(
R10495 T14958 T14957 arg1Of µl,60
R10496 T14959 T14956 arg3Of ),(
R10497 T14962 T14960 arg2Of h,for
R10498 T14962 T14961 arg1Of h,1
R10499 T14962 T14963 arg1Of h,at
R105 T323 T321 arg2Of weight,","
R1050 T1977 T1976 arg1Of cells,hepatoma
R10500 T14964 T14963 arg2Of 37°C,at
R10501 T14966 T14925 arg1Of and,For
R10502 T14966 T14936 arg1Of and,","
R10503 T14966 T14965 arg1Of and,","
R10504 T14968 T14966 arg2Of washed,and
R10505 T14968 T14967 arg1Of washed,then
R10506 T14968 T14970 arg1Of washed,times
R10507 T14968 T14971 arg1Of washed,in
R10508 T14968 T14975 arg1Of washed,for
R10509 T14968 T14979 arg1Of washed,","
R1051 T1977 T1978 arg1Of cells,[
R10510 T14968 T14980 arg1Of washed,according
R10511 T14970 T14969 arg1Of times,three
R10512 T14972 T14973 arg1Of 0.1,M
R10513 T14974 T14971 arg2Of PBS,in
R10514 T14974 T14972 arg1Of PBS,0.1
R10515 T14977 T14975 arg2Of min,for
R10516 T14977 T14976 arg1Of min,5
R10517 T14978 T14968 arg2Of each,washed
R10518 T14981 T14980 arg2Of to,according
R10519 T14984 T14981 arg2Of instructions,to
R1052 T1979 T1978 arg2Of 4,[
R10520 T14984 T14982 arg1Of instructions,the
R10521 T14984 T14983 arg1Of instructions,manufacturer’s
R10522 T14988 T14987 arg1Of sections,the
R10523 T14988 T14989 arg1Of sections,were
R10524 T14988 T14990 arg2Of sections,incubated
R10525 T14988 T15010 arg2Of sections,mounted
R10526 T14988 T15015 arg1Of sections,cover-slipped
R10527 T14990 T14989 arg2Of incubated,were
R10528 T14990 T14991 arg1Of incubated,with
R10529 T14990 T14993 arg1Of incubated,","
R1053 T1980 T1978 arg3Of ],[
R10530 T14992 T14991 arg2Of 4′,with
R10531 T14993 T14985 arg1Of ",",Next
R10532 T14993 T14986 arg1Of ",",","
R10533 T14993 T15010 modOf ",",mounted
R10534 T14993 T15015 modOf ",",cover-slipped
R10535 T14994 T14995 arg1Of 6-diamidino-2-phenylindole,(
R10536 T14994 T14998 arg1Of 6-diamidino-2-phenylindole,for
R10537 T14994 T15001 arg1Of 6-diamidino-2-phenylindole,at
R10538 T14994 T15007 arg1Of 6-diamidino-2-phenylindole,were
R10539 T14994 T15008 arg2Of 6-diamidino-2-phenylindole,rinsed
R1054 T1982 T1966 arg2Of and,as
R10540 T14996 T14995 arg2Of DAPI,(
R10541 T14997 T14995 arg3Of ),(
R10542 T15000 T14998 arg2Of min,for
R10543 T15000 T14999 arg1Of min,15
R10544 T15003 T15001 arg2Of Finally,at
R10545 T15003 T15002 arg1Of Finally,37°C.
R10546 T15003 T15004 arg1Of Finally,","
R10547 T15006 T15004 arg2Of sections,","
R10548 T15006 T15005 arg1Of sections,the
R10549 T15008 T14993 arg2Of rinsed,","
R1055 T1982 T1981 arg1Of and,","
R10550 T15008 T15007 arg2Of rinsed,were
R10551 T15008 T15009 arg1Of rinsed,","
R10552 T15010 T15011 arg1Of mounted,on
R10553 T15010 T15014 arg1Of mounted,and
R10554 T15012 T15011 arg2Of slides,on
R10555 T15014 T15013 arg1Of and,","
R10556 T15015 T15014 arg2Of cover-slipped,and
R10557 T15015 T15016 arg1Of cover-slipped,for
R10558 T15018 T15016 arg2Of microscopy,for
R10559 T15018 T15017 arg1Of microscopy,fluorescence
R1056 T1984 T1982 arg2Of cancer,and
R10560 T15018 T15019 arg1Of microscopy,(
R10561 T15021 T15019 arg2Of microscope,(
R10562 T15021 T15020 arg1Of microscope,DAS
R10563 T15022 T15019 arg3Of ),(
R1057 T1984 T1983 arg1Of cancer,lung
R1058 T1984 T1985 arg1Of cancer,[
R1059 T1986 T1985 arg2Of 12,[
R106 T323 T322 arg1Of weight,tumor
R1060 T1987 T1985 arg3Of ],[
R1061 T1989 T1988 arg1Of data,These
R1062 T1989 T1990 arg1Of data,suggest
R1063 T1993 T1992 arg1Of deficiency,the
R1064 T1993 T1994 arg1Of deficiency,of
R1065 T1993 T1999 arg1Of deficiency,may
R1066 T1993 T2000 arg1Of deficiency,function
R1067 T1998 T1994 arg2Of CCR5,of
R1068 T1998 T1995 arg1Of CCR5,inflammatory
R1069 T1998 T1996 arg1Of CCR5,chemokine
R107 T325 T317 arg2Of and,showed
R1070 T1998 T1997 arg1Of CCR5,receptor
R1071 T2000 T1990 arg2Of function,suggest
R1072 T2000 T1991 arg1Of function,that
R1073 T2000 T1999 arg2Of function,may
R1074 T2000 T2001 arg1Of function,as
R1075 T2004 T2001 arg2Of receptor,as
R1076 T2004 T2002 arg1Of receptor,a
R1077 T2004 T2003 arg1Of receptor,suppressive
R1078 T2004 T2005 arg1Of receptor,in
R1079 T2007 T2005 arg2Of progression,in
R108 T325 T324 arg1Of and,","
R1080 T2007 T2006 arg1Of progression,cancer
R1081 T2011 T2010 arg1Of studies,more
R1082 T2011 T2012 arg1Of studies,are
R1083 T2011 T2013 arg2Of studies,required
R1084 T2013 T2008 arg1Of required,However
R1085 T2013 T2009 arg1Of required,","
R1086 T2013 T2012 arg2Of required,are
R1087 T2015 T2013 arg3Of describe,required
R1088 T2015 T2014 arg1Of describe,to
R1089 T2016 T2015 arg2Of how,describe
R109 T328 T325 arg2Of rate,and
R1090 T2018 T2017 arg1Of deficiency,CCR5
R1091 T2018 T2019 arg1Of deficiency,acts
R10916 T15453 T15452 arg1Of sections,the
R10917 T15453 T15454 arg1Of sections,were
R10918 T15453 T15455 arg2Of sections,rinsed
R10919 T15453 T15457 arg2Of sections,mounted
R1092 T2019 T2016 arg1Of acts,how
R10920 T15453 T15462 arg1Of sections,cover-slipped
R10921 T15455 T15456 arg1Of rinsed,","
R10922 T15456 T15461 arg1Of ",",and
R10923 T15457 T15456 arg2Of mounted,","
R10924 T15457 T15458 arg1Of mounted,on
R10925 T15459 T15458 arg2Of slides,on
R10926 T15461 T15450 arg1Of and,Finally
R10927 T15461 T15451 arg1Of and,","
R10928 T15461 T15454 arg2Of and,were
R10929 T15461 T15460 arg1Of and,","
R1093 T2019 T2020 arg1Of acts,in
R10930 T15462 T15461 arg2Of cover-slipped,and
R10931 T15462 T15463 arg1Of cover-slipped,for
R10932 T15465 T15464 arg1Of microscopy,fluorescence
R10933 T15465 T15466 arg1Of microscopy,and
R10934 T15466 T15463 arg2Of and,for
R10935 T15466 T15468 arg1Of and,using
R10936 T15467 T15466 arg2Of photography,and
R10937 T15470 T15468 arg2Of microscopy,using
R10938 T15470 T15469 arg1Of microscopy,ApoTome
R10939 T15470 T15471 arg1Of microscopy,(
R1094 T2022 T2020 arg2Of inhibition,in
R10940 T15473 T15472 arg1Of Zeiss,Carl
R10941 T15473 T15474 arg1Of Zeiss,","
R10942 T15474 T15476 arg1Of ",",","
R10943 T15475 T15474 arg2Of Thornwood,","
R10944 T15476 T15471 arg2Of ",",(
R10945 T15476 T15478 arg1Of ",",","
R10946 T15476 T15479 arg1Of ",",USA
R10947 T15477 T15476 arg2Of NY,","
R10948 T15480 T15471 arg3Of ),(
R1095 T2022 T2021 arg1Of inhibition,the
R1096 T2022 T2023 arg1Of inhibition,of
R1097 T2025 T2023 arg2Of development,of
R1098 T2025 T2024 arg1Of development,tumor
R1099 T2028 T2026 arg1Of antagonist,Interleukin-1
R110 T328 T326 arg2Of rate,increased
R1100 T2028 T2027 arg1Of antagonist,receptor
R1101 T2028 T2029 arg1Of antagonist,(
R1102 T2028 T2032 arg1Of antagonist,","
R1103 T2028 T2040 arg1Of antagonist,is
R1104 T2030 T2029 arg2Of IL-1Ra,(
R1105 T2031 T2029 arg3Of ),(
R1106 T2034 T2032 arg2Of member,","
R1107 T2034 T2033 arg1Of member,a
R1108 T2034 T2035 arg1Of member,of
R1109 T2038 T2035 arg2Of family,of
R111 T328 T327 arg1Of rate,survival
R1110 T2038 T2036 arg1Of family,the
R1111 T2038 T2037 arg1Of family,IL-1
R1112 T2040 T2039 arg1Of is,","
R11125 T15700 T15697 arg1Of Assay,Gel
R11126 T15700 T15698 arg1Of Assay,Electromobility
R11127 T15700 T15699 arg1Of Assay,Shift
R11128 T15705 T15701 arg1Of assay,A
R11129 T15705 T15702 arg1Of assay,gel
R1113 T2043 T2042 arg1Of occurring,naturally
R11130 T15705 T15703 arg1Of assay,electromobility
R11131 T15705 T15704 arg1Of assay,shift
R11132 T15705 T15706 arg1Of assay,(
R11133 T15705 T15709 arg1Of assay,was
R11134 T15705 T15710 arg2Of assay,performed
R11135 T15707 T15706 arg2Of EMSA,(
R11136 T15708 T15706 arg3Of ),(
R11137 T15710 T15709 arg2Of performed,was
R11138 T15710 T15711 arg1Of performed,according
R11139 T15710 T15716 arg1Of performed,(
R1114 T2044 T2040 arg2Of cytokine,is
R11140 T15712 T15711 arg2Of to,according
R11141 T15715 T15712 arg2Of recommendations,to
R11142 T15715 T15713 arg1Of recommendations,the
R11143 T15715 T15714 arg1Of recommendations,manufacturer’s
R11144 T15717 T15718 arg1Of Promega,","
R11145 T15718 T15716 arg2Of ",",(
R11146 T15718 T15720 arg1Of ",",","
R11147 T15719 T15718 arg2Of Madison,","
R11148 T15721 T15720 arg2Of WI,","
R11149 T15722 T15716 arg3Of ),(
R1115 T2044 T2041 arg1Of cytokine,a
R11150 T15725 T15723 arg1Of tissues,The
R11151 T15725 T15724 arg1Of tissues,tumor
R11152 T15725 T15726 arg1Of tissues,were
R11153 T15725 T15728 arg2Of tissues,homogenized
R11154 T15725 T15761 arg1Of tissues,vortexed
R11155 T15725 T15764 arg1Of tissues,incubated
R11156 T15725 T15773 arg1Of tissues,centrifuged
R11157 T15728 T15726 arg2Of homogenized,were
R11158 T15728 T15727 arg1Of homogenized,briefly
R11159 T15728 T15729 arg1Of homogenized,in
R1116 T2044 T2043 arg1Of cytokine,occurring
R11160 T15728 T15760 arg1Of homogenized,","
R11161 T15731 T15729 arg2Of µl,in
R11162 T15731 T15730 arg1Of µl,200
R11163 T15731 T15732 arg1Of µl,of
R11164 T15731 T15735 arg1Of µl,(
R11165 T15734 T15732 arg2Of A,of
R11166 T15734 T15733 arg1Of A,solution
R11167 T15736 T15737 arg1Of 10,mM
R11168 T15738 T15736 arg1Of HEPES,10
R11169 T15738 T15739 arg1Of HEPES,[
R1117 T2044 T2045 arg1Of cytokine,that
R11170 T15738 T15743 arg1Of HEPES,","
R11171 T15740 T15739 arg2Of pH,[
R11172 T15740 T15741 arg1Of pH,7.9
R11173 T15742 T15739 arg3Of ],[
R11174 T15743 T15747 arg1Of ",",","
R11175 T15744 T15745 arg1Of 1.5,mM
R11176 T15746 T15743 arg2Of MgCl2,","
R11177 T15746 T15744 arg1Of MgCl2,1.5
R11178 T15747 T15751 arg1Of ",",","
R11179 T15748 T15749 arg1Of 10,mM
R1118 T2044 T2047 arg1Of cytokine,blocks
R11180 T15750 T15747 arg2Of KCl,","
R11181 T15750 T15748 arg1Of KCl,10
R11182 T15751 T15735 arg2Of ",",(
R11183 T15751 T15755 arg1Of ",",","
R11184 T15752 T15753 arg1Of 0.5,mM
R11185 T15754 T15751 arg2Of dithiothreitol,","
R11186 T15754 T15752 arg1Of dithiothreitol,0.5
R11187 T15756 T15757 arg1Of 0.2,mM
R11188 T15758 T15755 arg2Of phenylmethylsulfonylfluoride,","
R11189 T15758 T15756 arg1Of phenylmethylsulfonylfluoride,0.2
R1119 T2047 T2046 arg1Of blocks,competitively
R11190 T15759 T15735 arg3Of ),(
R11191 T15760 T15763 arg1Of ",",","
R11192 T15761 T15760 arg2Of vortexed,","
R11193 T15761 T15762 arg1Of vortexed,vigorously
R11194 T15763 T15771 arg1Of ",",and
R11195 T15764 T15763 arg2Of incubated,","
R11196 T15764 T15765 arg1Of incubated,on
R11197 T15764 T15767 arg1Of incubated,for
R11198 T15766 T15765 arg2Of ice,on
R11199 T15769 T15767 arg2Of min,for
R112 T330 T329 arg2Of compared,when
R1120 T2047 T2051 arg1Of blocks,[
R11200 T15769 T15768 arg1Of min,10
R11201 T15771 T15770 arg1Of and,","
R11202 T15773 T15771 arg2Of centrifuged,and
R11203 T15773 T15772 arg1Of centrifuged,then
R11204 T15773 T15774 arg1Of centrifuged,at
R11205 T15773 T15777 arg1Of centrifuged,for
R11206 T15776 T15774 arg2Of rpm,at
R11207 T15776 T15775 arg1Of rpm,15000
R11208 T15779 T15777 arg2Of min,for
R11209 T15779 T15778 arg1Of min,15
R1121 T2050 T2047 arg2Of receptor,blocks
R11210 T15782 T15780 arg1Of nuclei,The
R11211 T15782 T15781 arg2Of nuclei,pelleted
R11212 T15782 T15783 arg1Of nuclei,were
R11213 T15782 T15784 arg2Of nuclei,resuspended
R11214 T15782 T15803 arg2Of nuclei,incubated
R11215 T15784 T15785 arg1Of resuspended,in
R11216 T15784 T15802 arg1Of resuspended,and
R11217 T15787 T15785 arg2Of C,in
R11218 T15787 T15786 arg1Of C,solution
R11219 T15787 T15788 arg1Of C,(
R1122 T2050 T2048 arg1Of receptor,the
R11220 T15790 T15788 arg2Of A,(
R11221 T15790 T15789 arg1Of A,solution
R11222 T15790 T15791 arg2Of A,supplemented
R11223 T15791 T15792 arg1Of supplemented,with
R11224 T15793 T15794 arg1Of 420,mM
R11225 T15795 T15793 arg1Of NaCl,420
R11226 T15795 T15796 arg1Of NaCl,and
R11227 T15796 T15792 arg2Of and,with
R11228 T15797 T15798 arg1Of 20,%
R11229 T15799 T15796 arg2Of glycerol,and
R1123 T2050 T2049 arg1Of receptor,IL-1
R11230 T15799 T15797 arg1Of glycerol,20
R11231 T15800 T15788 arg3Of ),(
R11232 T15802 T15783 arg2Of and,were
R11233 T15802 T15801 arg1Of and,","
R11234 T15803 T15802 arg2Of incubated,and
R11235 T15803 T15804 arg1Of incubated,on
R11236 T15803 T15806 arg1Of incubated,for
R11237 T15805 T15804 arg2Of ice,on
R11238 T15808 T15806 arg2Of min,for
R11239 T15808 T15807 arg1Of min,20
R1124 T2052 T2051 arg2Of 13,[
R11240 T15811 T15809 arg1Of pellet,The
R11241 T15811 T15810 arg1Of pellet,resuspended
R11242 T15811 T15812 arg1Of pellet,was
R11243 T15811 T15813 arg2Of pellet,centrifuged
R11244 T15813 T15812 arg2Of centrifuged,was
R11245 T15813 T15814 arg1Of centrifuged,at
R11246 T15813 T15817 arg1Of centrifuged,for
R11247 T15813 T15821 arg1Of centrifuged,and
R11248 T15816 T15814 arg2Of rpm,at
R11249 T15816 T15815 arg1Of rpm,15000
R1125 T2053 T2051 arg3Of ],[
R11250 T15819 T15817 arg2Of min,for
R11251 T15819 T15818 arg1Of min,15
R11252 T15821 T15820 arg1Of and,","
R11253 T15826 T15822 arg1Of supernatant,the
R11254 T15826 T15823 arg1Of supernatant,resulting
R11255 T15826 T15824 arg1Of supernatant,nuclear
R11256 T15826 T15825 arg1Of supernatant,extracts
R11257 T15826 T15827 arg1Of supernatant,were
R11258 T15826 T15828 arg2Of supernatant,collected
R11259 T15828 T15821 arg2Of collected,and
R1126 T2055 T2056 arg1Of IL-1Ra,has
R11260 T15828 T15827 arg2Of collected,were
R11261 T15828 T15829 arg1Of collected,in
R11262 T15833 T15829 arg2Of tube,in
R11263 T15833 T15830 arg1Of tube,a
R11264 T15833 T15831 arg1Of tube,chilled
R11265 T15833 T15832 arg1Of tube,Eppendorf
R11266 T15835 T15834 arg1Of oligonucleotides,Consensus
R11267 T15835 T15836 arg1Of oligonucleotides,were
R11268 T15835 T15837 arg2Of oligonucleotides,end-labeled
R11269 T15835 T15859 arg2Of oligonucleotides,incubated
R1127 T2055 T2057 arg1Of IL-1Ra,been
R11270 T15837 T15858 arg1Of end-labeled,and
R11271 T15838 T15837 arg3Of using,end-labeled
R11272 T15838 T15847 arg1Of using,for
R11273 T15841 T15839 arg1Of kinase,T4
R11274 T15841 T15840 arg1Of kinase,polynucleotide
R11275 T15841 T15842 arg1Of kinase,and
R11276 T15842 T15838 arg2Of and,using
R11277 T15844 T15843 arg2Of P32,[
R11278 T15845 T15843 arg3Of ],[
R11279 T15846 T15842 arg2Of -ATP,and
R1128 T2055 T2058 arg2Of IL-1Ra,shown
R11280 T15846 T15843 arg1Of -ATP,[
R11281 T15849 T15847 arg2Of min,for
R11282 T15849 T15848 arg1Of min,10
R11283 T15849 T15850 arg1Of min,at
R11284 T15851 T15850 arg2Of 37°C.,at
R11285 T15851 T15856 modOf 37°C.,were
R11286 T15855 T15852 arg1Of reactions,The
R11287 T15855 T15853 arg1Of reactions,gel
R11288 T15855 T15854 arg1Of reactions,shift
R11289 T15855 T15856 arg1Of reactions,were
R1129 T2055 T2060 arg1Of IL-1Ra,inhibit
R11290 T15855 T15857 arg2Of reactions,assembled
R11291 T15857 T15856 arg2Of assembled,were
R11292 T15858 T15836 arg2Of and,were
R11293 T15859 T15858 arg2Of incubated,and
R11294 T15859 T15860 arg1Of incubated,at
R11295 T15862 T15860 arg2Of temperature,at
R11296 T15862 T15861 arg1Of temperature,room
R11297 T15866 T15865 arg1Of ml,1
R11298 T15866 T15867 arg1Of ml,of
R11299 T15866 T15871 arg1Of ml,was
R113 T330 T331 arg1Of compared,to
R1130 T2055 T2064 arg1Of IL-1Ra,promoting
R11300 T15866 T15872 arg2Of ml,added
R11301 T15866 T15877 arg2Of ml,loaded
R11302 T15870 T15867 arg2Of buffer,of
R11303 T15870 T15868 arg1Of buffer,gel
R11304 T15870 T15869 arg1Of buffer,loading
R11305 T15872 T15873 arg1Of added,to
R11306 T15872 T15876 arg1Of added,and
R11307 T15875 T15873 arg2Of reaction,to
R11308 T15875 T15874 arg1Of reaction,each
R11309 T15876 T15863 arg1Of and,Subsequently
R1131 T2055 T2070 arg1Of IL-1Ra,enhancing
R11310 T15876 T15864 arg1Of and,","
R11311 T15876 T15871 arg2Of and,was
R11312 T15877 T15876 arg2Of loaded,and
R11313 T15877 T15878 arg1Of loaded,onto
R11314 T15880 T15881 arg1Of 6,%
R11315 T15883 T15878 arg2Of gel,onto
R11316 T15883 T15879 arg1Of gel,a
R11317 T15883 T15880 arg1Of gel,6
R11318 T15883 T15882 arg1Of gel,non-denaturating
R11319 T15885 T15884 arg1Of gel,The
R1132 T2058 T2054 arg2Of shown,Because
R11320 T15885 T15886 arg1Of gel,was
R11321 T15885 T15887 arg2Of gel,subjected
R11322 T15887 T15890 arg1Of subjected,until
R11323 T15887 T15886 arg2Of subjected,was
R11324 T15887 T15888 arg1Of subjected,to
R11325 T15889 T15888 arg2Of electrophoresis,to
R11326 T15892 T15891 arg1Of dye,the
R11327 T15892 T15893 arg1Of dye,was
R11328 T15893 T15890 arg2Of was,until
R11329 T15894 T15893 arg2Of four-fifths,was
R1133 T2058 T2056 arg2Of shown,has
R11330 T15894 T15895 arg1Of four-fifths,of
R11331 T15897 T15895 arg2Of way,of
R11332 T15897 T15896 arg1Of way,the
R11333 T15897 T15898 arg1Of way,down
R11334 T15900 T15898 arg2Of gel,down
R11335 T15900 T15899 arg1Of gel,the
R11336 T15902 T15901 arg1Of gel,The
R11337 T15902 T15903 arg1Of gel,was
R11338 T15902 T15904 arg2Of gel,dried
R11339 T15902 T15911 arg2Of gel,exposed
R1134 T2058 T2057 arg2Of shown,been
R11340 T15904 T15905 arg1Of dried,for
R11341 T15904 T15908 arg1Of dried,at
R11342 T15904 T15910 arg1Of dried,and
R11343 T15907 T15905 arg2Of h,for
R11344 T15907 T15906 arg1Of h,1
R11345 T15909 T15908 arg2Of 80°C,at
R11346 T15910 T15903 arg2Of and,was
R11347 T15911 T15910 arg2Of exposed,and
R11348 T15911 T15912 modOf exposed,to
R11349 T15913 T15912 arg1Of film,to
R1135 T2060 T2058 arg3Of inhibit,shown
R11350 T15913 T15915 arg1Of film,at
R11351 T15914 T15913 arg2Of overnight,film
R11352 T15916 T15915 arg2Of -70°C,at
R1136 T2060 T2059 arg1Of inhibit,to
R1137 T2060 T2063 arg1Of inhibit,by
R1138 T2060 T2069 arg1Of inhibit,by
R1139 T2062 T2060 arg2Of progression,inhibit
R114 T333 T331 arg2Of mice,to
R1140 T2062 T2061 arg1Of progression,tumor
R1141 T2063 T2068 arg1Of by,and
R1142 T2064 T2063 arg2Of promoting,by
R1143 T2067 T2064 arg2Of responses,promoting
R1144 T2067 T2065 arg1Of responses,antitumor
R1145 T2067 T2066 arg1Of responses,immune
R1146 T2069 T2068 arg2Of by,and
R1147 T2070 T2069 arg2Of enhancing,by
R1148 T2072 T2070 arg2Of activity,enhancing
R1149 T2072 T2071 arg1Of activity,the
R115 T333 T332 arg1Of mice,CCR5+/+
R1150 T2072 T2073 arg1Of activity,of
R1151 T2074 T2073 arg2Of chemotherapy,of
R1152 T2077 T2076 arg1Of studies,numerous
R1153 T2077 T2078 arg1Of studies,have
R1154 T2077 T2079 arg1Of studies,examined
R1155 T2079 T2054 arg1Of examined,Because
R1156 T2079 T2075 arg1Of examined,","
R1157 T2079 T2078 arg2Of examined,have
R1158 T2081 T2079 arg2Of ability,examined
R11588 T16225 T16223 arg1Of Analysis,Flow
R11589 T16225 T16224 arg1Of Analysis,Cytometric
R1159 T2081 T2080 arg1Of ability,the
R11590 T16226 T16227 arg1Of Lymphocytes,were
R11591 T16226 T16228 arg2Of Lymphocytes,obtained
R11592 T16228 T16227 arg2Of obtained,were
R11593 T16228 T16229 arg1Of obtained,from
R11594 T16230 T16231 arg1Of tumor,and
R11595 T16232 T16231 arg2Of spleen,and
R11596 T16233 T16229 arg2Of tissues,from
R11597 T16233 T16230 arg1Of tissues,tumor
R11598 T16233 T16232 arg1Of tissues,spleen
R11599 T16233 T16234 arg1Of tissues,for
R116 T334 T335 arg1Of We,investigated
R1160 T2081 T2082 arg1Of ability,of
R11600 T16236 T16234 arg2Of analysis,for
R11601 T16236 T16235 arg1Of analysis,phenotype
R11602 T16237 T16238 arg1Of Spleen,and
R11603 T16239 T16238 arg2Of tumor,and
R11604 T16240 T16237 arg1Of lymphocytes,Spleen
R11605 T16240 T16239 arg1Of lymphocytes,tumor
R11606 T16240 T16241 arg1Of lymphocytes,were
R11607 T16240 T16242 arg2Of lymphocytes,isolated
R11608 T16242 T16241 arg2Of isolated,were
R11609 T16242 T16243 arg1Of isolated,from
R1161 T2081 T2084 modOf ability,to
R11610 T16245 T16246 arg1Of spleen,and
R11611 T16247 T16246 arg2Of tumor,and
R11612 T16248 T16243 arg2Of biopsies,from
R11613 T16248 T16244 arg1Of biopsies,fresh
R11614 T16248 T16245 arg1Of biopsies,spleen
R11615 T16248 T16247 arg1Of biopsies,tumor
R11616 T16248 T16249 arg2Of biopsies,obtained
R11617 T16249 T16250 arg1Of obtained,from
R11618 T16252 T16250 arg2Of mice,from
R11619 T16252 T16251 arg1Of mice,three
R1162 T2083 T2082 arg2Of IL-1Ra,of
R11620 T16252 T16253 arg1Of mice,per
R11621 T16254 T16253 arg2Of group,per
R11622 T16255 T16256 arg1Of Spleen,and
R11623 T16257 T16256 arg2Of tumor,and
R11624 T16258 T16255 arg1Of biopsies,Spleen
R11625 T16258 T16257 arg1Of biopsies,tumor
R11626 T16258 T16259 arg1Of biopsies,were
R11627 T16258 T16261 arg2Of biopsies,homogenized
R11628 T16258 T16278 arg2Of biopsies,placed
R11629 T16261 T16262 arg1Of homogenized,mechanically
R1163 T2085 T2084 arg1Of block,to
R11630 T16261 T16263 arg1Of homogenized,in
R11631 T16261 T16267 arg1Of homogenized,(
R11632 T16261 T16276 arg1Of homogenized,and
R11633 T16264 T16263 arg2Of PBS,in
R11634 T16264 T16265 arg1Of PBS,","
R11635 T16264 T16266 arg2Of PBS,filtered
R11636 T16271 T16268 arg1Of strainer,100
R11637 T16271 T16269 arg1Of strainer,µm
R11638 T16271 T16270 arg1Of strainer,cell
R11639 T16271 T16272 arg1Of strainer,;
R1164 T2087 T2085 arg2Of progression,block
R11640 T16272 T16267 arg2Of ;,(
R11641 T16274 T16272 arg2Of PharMingen,;
R11642 T16274 T16273 arg1Of PharMingen,BD
R11643 T16275 T16267 arg3Of ),(
R11644 T16276 T16259 arg2Of and,were
R11645 T16276 T16260 arg1Of and,briefly
R11646 T16278 T16276 arg2Of placed,and
R11647 T16278 T16277 arg1Of placed,then
R11648 T16278 T16279 arg1Of placed,in
R11649 T16278 T16289 modOf placed,to
R1165 T2087 T2086 arg1Of progression,tumor
R11650 T16281 T16279 arg2Of buffer,in
R11651 T16281 T16280 arg1Of buffer,lysis
R11652 T16281 T16282 arg1Of buffer,(
R11653 T16285 T16282 arg2Of buffer,(
R11654 T16285 T16283 arg1Of buffer,ACK
R11655 T16285 T16284 arg1Of buffer,lysing
R11656 T16285 T16286 arg1Of buffer,","
R11657 T16287 T16286 arg2Of LONZA,","
R11658 T16288 T16282 arg3Of ),(
R11659 T16290 T16289 arg1Of remove,to
R1166 T2089 T2088 arg1Of expression,IL-1Ra
R11660 T16293 T16290 arg2Of cells,remove
R11661 T16293 T16291 arg1Of cells,red
R11662 T16293 T16292 arg1Of cells,blood
R11663 T16295 T16294 arg1Of million,One
R11664 T16296 T16295 arg1Of splenocytes,million
R11665 T16296 T16297 arg1Of splenocytes,were
R11666 T16296 T16298 arg2Of splenocytes,washed
R11667 T16296 T16312 arg1Of splenocytes,re-suspended
R11668 T16298 T16299 arg1Of washed,once
R11669 T16298 T16300 arg1Of washed,in
R1167 T2089 T2090 arg1Of expression,was
R11670 T16298 T16311 arg1Of washed,and
R11671 T16301 T16300 arg2Of PBS,in
R11672 T16301 T16302 arg1Of PBS,containing
R11673 T16303 T16304 arg1Of 1,%
R11674 T16307 T16302 arg2Of albumin,containing
R11675 T16307 T16303 arg1Of albumin,1
R11676 T16307 T16305 arg1Of albumin,bovine
R11677 T16307 T16306 arg1Of albumin,serum
R11678 T16307 T16308 arg1Of albumin,(
R11679 T16309 T16308 arg2Of BSA,(
R1168 T2089 T2091 arg2Of expression,reduced
R11680 T16310 T16308 arg3Of ),(
R11681 T16311 T16297 arg2Of and,were
R11682 T16312 T16311 arg2Of re-suspended,and
R11683 T16312 T16313 arg1Of re-suspended,in
R11684 T16315 T16313 arg2Of µl,in
R11685 T16315 T16314 arg1Of µl,100
R11686 T16315 T16316 arg1Of µl,of
R11687 T16318 T16316 arg2Of buffer,of
R11688 T16318 T16317 arg1Of buffer,PBS/BSA
R11689 T16322 T16321 arg1Of million,one
R1169 T2091 T2090 arg2Of reduced,was
R11690 T16323 T16322 arg1Of cells,million
R11691 T16323 T16324 arg2Of cells,obtained
R11692 T16323 T16328 arg1Of cells,were
R11693 T16323 T16329 arg2Of cells,placed
R11694 T16323 T16334 arg2Of cells,incubated
R11695 T16323 T16354 arg2Of cells,washed
R11696 T16324 T16325 arg1Of obtained,from
R11697 T16327 T16325 arg2Of tissues,from
R11698 T16327 T16326 arg1Of tissues,tumor
R11699 T16329 T16330 arg1Of placed,in
R117 T335 T340 arg1Of investigated,since
R1170 T2091 T2092 arg1Of reduced,in
R11700 T16329 T16334 modOf placed,incubated
R11701 T16329 T16352 arg1Of placed,and
R11702 T16332 T16330 arg2Of medium,in
R11703 T16332 T16331 arg1Of medium,RPMI
R11704 T16334 T16333 arg1Of incubated,","
R11705 T16334 T16335 modOf incubated,to
R11706 T16336 T16335 arg1Of obtain,to
R11707 T16338 T16336 arg2Of cell,obtain
R11708 T16338 T16337 arg1Of cell,suspension
R11709 T16338 T16339 arg1Of cell,for
R1171 T2093 T2094 arg1Of prostate,[
R11710 T16340 T16339 arg2Of 1hour,for
R11711 T16340 T16341 arg1Of 1hour,at
R11712 T16340 T16343 arg1Of 1hour,","
R11713 T16340 T16344 arg2Of 1hour,centrifuged
R11714 T16340 T16345 arg1Of 1hour,(
R11715 T16342 T16341 arg2Of 37°C,at
R11716 T16347 T16345 arg2Of rpm,(
R11717 T16347 T16346 arg1Of rpm,1200
R11718 T16347 T16348 arg1Of rpm,","
R11719 T16350 T16348 arg2Of min,","
R1172 T2093 T2097 arg1Of prostate,","
R11720 T16350 T16349 arg1Of min,3
R11721 T16351 T16345 arg3Of ),(
R11722 T16352 T16319 arg1Of and,Meanwhile
R11723 T16352 T16320 arg1Of and,","
R11724 T16352 T16328 arg2Of and,were
R11725 T16354 T16352 arg2Of washed,and
R11726 T16354 T16353 arg1Of washed,then
R11727 T16354 T16355 arg1Of washed,in
R11728 T16356 T16355 arg2Of PBS,in
R11729 T16360 T16359 arg1Of lymphocytes,the
R1173 T2095 T2094 arg2Of 14,[
R11730 T16360 T16361 arg1Of lymphocytes,were
R11731 T16360 T16362 arg2Of lymphocytes,incubated
R11732 T16360 T16386 arg1Of lymphocytes,re-suspended
R11733 T16362 T16363 arg1Of incubated,with
R11734 T16362 T16385 arg1Of incubated,and
R11735 T16367 T16363 arg2Of antibodies,with
R11736 T16367 T16364 arg1Of antibodies,various
R11737 T16367 T16365 arg2Of antibodies,conjugated
R11738 T16367 T16366 arg1Of antibodies,monoclonal
R11739 T16367 T16368 arg1Of antibodies,","
R1174 T2096 T2094 arg3Of ],[
R11740 T16367 T16369 arg1Of antibodies,including
R11741 T16370 T16371 arg1Of CD4-APC,","
R11742 T16371 T16373 arg1Of ",",and
R11743 T16372 T16371 arg2Of CD8-FITC,","
R11744 T16373 T16369 arg2Of and,including
R11745 T16373 T16375 arg1Of and,for
R11746 T16373 T16377 arg1Of and,at
R11747 T16373 T16379 arg1Of and,","
R11748 T16373 T16380 arg2Of and,washed
R11749 T16374 T16373 arg2Of CD19-PE,and
R1175 T2097 T2103 arg1Of ",",and
R11750 T16376 T16375 arg2Of 20min,for
R11751 T16378 T16377 arg2Of 4°C,at
R11752 T16380 T16381 arg1Of washed,twice
R11753 T16380 T16382 arg1Of washed,in
R11754 T16383 T16382 arg2Of PBS,in
R11755 T16385 T16357 arg1Of and,Next
R11756 T16385 T16358 arg1Of and,","
R11757 T16385 T16361 arg2Of and,were
R11758 T16385 T16384 arg1Of and,","
R11759 T16386 T16385 arg2Of re-suspended,and
R1176 T2098 T2097 arg2Of breast,","
R11760 T16386 T16387 arg1Of re-suspended,in
R11761 T16389 T16387 arg2Of µl,in
R11762 T16389 T16388 arg1Of µl,400
R11763 T16389 T16390 arg1Of µl,of
R11764 T16391 T16390 arg2Of PBS,of
R11765 T16395 T16392 arg1Of analysis,A
R11766 T16395 T16393 arg1Of analysis,flow
R11767 T16395 T16394 arg1Of analysis,cytometric
R11768 T16395 T16396 arg1Of analysis,was
R11769 T16395 T16397 arg2Of analysis,performed
R1177 T2098 T2099 arg1Of breast,[
R11770 T16397 T16396 arg2Of performed,was
R11771 T16397 T16398 arg1Of performed,on
R11772 T16397 T16408 arg1Of performed,and
R11773 T16402 T16398 arg2Of cytometry,on
R11774 T16402 T16399 arg1Of cytometry,a
R11775 T16402 T16400 arg1Of cytometry,FACSAria
R11776 T16402 T16401 arg1Of cytometry,flow
R11777 T16402 T16403 arg1Of cytometry,(
R11778 T16405 T16403 arg2Of Biosciences,(
R11779 T16405 T16404 arg1Of Biosciences,BD
R1178 T2100 T2099 arg2Of 15,[
R11780 T16406 T16403 arg3Of ),(
R11781 T16408 T16407 arg1Of and,","
R11782 T16410 T16409 arg1Of data,the
R11783 T16410 T16411 arg1Of data,were
R11784 T16410 T16412 arg2Of data,analyzed
R11785 T16412 T16408 arg2Of analyzed,and
R11786 T16412 T16411 arg2Of analyzed,were
R11787 T16413 T16412 arg3Of using,analyzed
R11788 T16413 T16418 arg1Of using,(
R11789 T16417 T16413 arg2Of software,using
R1179 T2101 T2099 arg3Of ],[
R11790 T16417 T16414 arg1Of software,the
R11791 T16417 T16415 arg1Of software,WinMDI
R11792 T16417 T16416 arg1Of software,statistical
R11793 T16419 T16420 arg1Of Scripps,","
R11794 T16420 T16423 arg1Of ",",","
R11795 T16422 T16420 arg2Of Jolla,","
R11796 T16422 T16421 arg1Of Jolla,La
R11797 T16423 T16418 arg2Of ",",(
R11798 T16423 T16425 arg1Of ",",","
R11799 T16424 T16423 arg2Of CA,","
R118 T337 T335 arg2Of activation,investigated
R1180 T2103 T2092 arg2Of and,in
R11800 T16426 T16425 arg2Of USA,","
R11801 T16427 T16418 arg3Of ),(
R11802 T16432 T16428 arg1Of parameters,Forward
R11803 T16432 T16429 arg1Of parameters,and
R11804 T16432 T16430 arg1Of parameters,side
R11805 T16432 T16431 arg1Of parameters,scatter
R11806 T16432 T16433 arg1Of parameters,were
R11807 T16432 T16434 arg2Of parameters,used
R11808 T16434 T16433 arg2Of used,were
R11809 T16436 T16434 arg3Of gate,used
R1181 T2103 T2102 arg1Of and,","
R11810 T16436 T16435 arg1Of gate,to
R11811 T16436 T16437 arg1Of gate,on
R11812 T16438 T16437 arg2Of lymphocytes,on
R1182 T2105 T2103 arg2Of cancer,and
R1183 T2105 T2104 arg1Of cancer,skin
R1184 T2105 T2106 arg1Of cancer,[
R1185 T2107 T2106 arg2Of 16,[
R1186 T2108 T2106 arg3Of ],[
R1187 T2109 T2110 arg1Of It,was
R1188 T2109 T2112 arg2Of It,reported
R1189 T2112 T2110 arg2Of reported,was
R119 T337 T336 arg1Of activation,the
R1190 T2112 T2111 arg1Of reported,also
R1191 T2117 T2114 arg1Of mice,endogenous
R1192 T2117 T2115 arg1Of mice,IL-1Ra
R1193 T2117 T2116 arg1Of mice,deficient
R1194 T2117 T2118 arg1Of mice,developed
R1195 T2118 T2112 arg3Of developed,reported
R1196 T2118 T2113 arg1Of developed,that
R1197 T2118 T2121 arg1Of developed,following
R1198 T2120 T2118 arg2Of tumors,developed
R1199 T2120 T2119 arg1Of tumors,aggressive
R120 T337 T338 arg1Of activation,of
R1200 T2122 T2121 arg2Of exposure,following
R1201 T2122 T2123 arg1Of exposure,to
R1202 T2124 T2123 arg2Of carcinogens,to
R1203 T2124 T2125 arg1Of carcinogens,[
R1204 T2126 T2125 arg2Of 17,[
R12041 T16735 T16734 arg1Of Immuno-arrays,Protein
R12042 T16737 T16738 arg1Of tumor,and
R12043 T16739 T16738 arg2Of spleen,and
R12044 T16740 T16736 arg1Of tissues,The
R12045 T16740 T16737 arg1Of tissues,tumor
R12046 T16740 T16739 arg1Of tissues,spleen
R12047 T16740 T16741 arg1Of tissues,were
R12048 T16740 T16742 arg2Of tissues,excised
R12049 T16740 T16744 arg2Of tissues,homogenized
R1205 T2127 T2125 arg3Of ],[
R12050 T16742 T16743 arg1Of excised,and
R12051 T16743 T16741 arg2Of and,were
R12052 T16744 T16743 arg2Of homogenized,and
R12053 T16744 T16745 arg1Of homogenized,in
R12054 T16744 T16747 arg1Of homogenized,with
R12055 T16746 T16745 arg2Of PBS,in
R12056 T16750 T16748 arg1Of cocktail,protease
R12057 T16750 T16749 arg1Of cocktail,inhibitor
R12058 T16750 T16751 arg1Of cocktail,(
R12059 T16750 T16756 arg1Of cocktail,and
R1206 T2130 T2131 arg1Of proliferation,of
R12060 T16752 T16751 arg2Of Sigma-Aldrich,(
R12061 T16752 T16753 arg1Of Sigma-Aldrich,","
R12062 T16752 T16754 arg1Of Sigma-Aldrich,USA
R12063 T16755 T16751 arg3Of ),(
R12064 T16756 T16747 arg2Of and,with
R12065 T16758 T16756 arg2Of X-100,and
R12066 T16758 T16757 arg1Of X-100,Triton
R12067 T16758 T16759 arg1Of X-100,(
R12068 T16763 T16759 arg2Of %,(
R12069 T16763 T16760 arg1Of %,final
R1207 T2130 T2141 arg1Of proliferation,was
R12070 T16763 T16761 arg1Of %,concentration
R12071 T16763 T16762 arg1Of %,1
R12072 T16764 T16759 arg3Of ),(
R12073 T16766 T16765 arg1Of samples,The
R12074 T16766 T16767 arg1Of samples,were
R12075 T16766 T16768 arg2Of samples,frozen
R12076 T16766 T16772 arg2Of samples,thawed
R12077 T16766 T16775 arg2Of samples,centrifuged
R12078 T16768 T16769 arg1Of frozen,at
R12079 T16768 T16771 arg1Of frozen,","
R1208 T2130 T2142 arg2Of proliferation,reduced
R12080 T16770 T16769 arg2Of −70°C,at
R12081 T16771 T16774 arg1Of ",",and
R12082 T16772 T16771 arg2Of thawed,","
R12083 T16774 T16767 arg2Of and,were
R12084 T16774 T16773 arg1Of and,","
R12085 T16775 T16774 arg2Of centrifuged,and
R12086 T16775 T16776 arg1Of centrifuged,at
R12087 T16775 T16778 arg1Of centrifuged,for
R12088 T16775 T16781 modOf centrifuged,to
R12089 T16777 T16776 arg2Of "10,000×g",at
R1209 T2130 T2144 arg1Of proliferation,inhibited
R12090 T16780 T16778 arg2Of min,for
R12091 T16780 T16779 arg1Of min,5
R12092 T16782 T16781 arg1Of remove,to
R12093 T16784 T16782 arg2Of debris,remove
R12094 T16784 T16783 arg1Of debris,cellular
R12095 T16787 T16785 arg1Of lysates,The
R12096 T16787 T16786 arg1Of lysates,tissue
R12097 T16787 T16788 arg1Of lysates,were
R12098 T16788 T16792 arg1Of were,in
R12099 T16791 T16788 arg2Of assay,were
R121 T339 T338 arg2Of NF-κB,of
R1210 T2134 T2131 arg2Of cells,of
R12100 T16791 T16789 arg2Of assay,performed
R12101 T16791 T16790 arg1Of assay,protein
R12102 T16792 T16797 arg1Of in,for
R12103 T16795 T16792 arg2Of way,in
R12104 T16795 T16793 arg1Of way,the
R12105 T16795 T16794 arg1Of way,same
R12106 T16797 T16796 arg1Of for,as
R12107 T16799 T16797 arg2Of blotting,for
R12108 T16799 T16798 arg1Of blotting,western
R12109 T16801 T16800 arg1Of mg,4.5
R1211 T2134 T2132 arg1Of cells,the
R12110 T16801 T16802 arg1Of mg,of
R12111 T16801 T16804 arg1Of mg,","
R12112 T16801 T16805 arg2Of mg,collected
R12113 T16801 T16812 arg1Of mg,were
R12114 T16801 T16813 arg2Of mg,used
R12115 T16803 T16802 arg2Of proteins,of
R12116 T16805 T16806 arg1Of collected,from
R12117 T16808 T16806 arg2Of samples,from
R12118 T16808 T16807 arg1Of samples,three
R12119 T16808 T16809 arg1Of samples,per
R1212 T2134 T2133 arg1Of cells,melanoma
R12120 T16810 T16809 arg2Of group,per
R12121 T16813 T16811 arg1Of used,","
R12122 T16813 T16812 arg2Of used,were
R12123 T16813 T16814 arg1Of used,for
R12124 T16817 T16814 arg2Of array,for
R12125 T16817 T16815 arg1Of array,Mouse
R12126 T16817 T16816 arg1Of array,cytokine
R12127 T16817 T16818 arg1Of array,as
R12128 T16820 T16818 arg2Of protocol,as
R12129 T16820 T16819 arg1Of protocol,the
R1213 T2134 T2135 arg1Of cells,that
R12130 T16820 T16821 arg2Of protocol,provided
R12131 T16823 T16821 arg1Of supplier,provided
R12132 T16823 T16822 arg2Of supplier,by
R12133 T16823 T16824 arg1Of supplier,(
R12134 T16826 T16825 arg1Of Profiler™,Proteome
R12135 T16826 T16827 arg1Of Profiler™,","
R12136 T16827 T16830 arg1Of ",",","
R12137 T16829 T16827 arg2Of ARY006,","
R12138 T16829 T16828 arg1Of ARY006,#
R12139 T16830 T16824 arg2Of ",",(
R1214 T2134 T2136 arg1Of cells,were
R12140 T16830 T16835 arg1Of ",",","
R12141 T16834 T16830 arg2Of Systems,","
R12142 T16834 T16831 arg1Of Systems,R
R12143 T16834 T16832 arg1Of Systems,&
R12144 T16834 T16833 arg1Of Systems,D
R12145 T16836 T16835 arg2Of USA,","
R12146 T16837 T16824 arg3Of ),(
R1215 T2134 T2137 arg2Of cells,transduced
R1216 T2137 T2136 arg2Of transduced,were
R1217 T2137 T2138 arg1Of transduced,with
R1218 T2140 T2138 arg2Of gene,with
R1219 T2140 T2139 arg1Of gene,IL-1Ra
R122 T341 T342 arg1Of it,is
R1220 T2142 T2141 arg2Of reduced,was
R1221 T2142 T2143 arg1Of reduced,and
R1222 T2143 T2128 arg1Of and,Meanwhile
R1223 T2143 T2129 arg1Of and,","
R1224 T2143 T2147 arg1Of and,[
R1225 T2144 T2143 arg2Of inhibited,and
R12259 T16986 T16985 arg1Of Analysis,Statistical
R1226 T2146 T2144 arg2Of development,inhibited
R12260 T16988 T16987 arg1Of data,The
R12261 T16988 T16989 arg1Of data,were
R12262 T16988 T16990 arg2Of data,analyzed
R12263 T16990 T16989 arg2Of analyzed,were
R12264 T16991 T16990 arg3Of using,analyzed
R12265 T16994 T16993 arg1Of Prism,GraphPad
R12266 T16994 T16995 arg1Of Prism,4
R12267 T16996 T16991 arg2Of ver,using
R12268 T16996 T16992 arg1Of ver,the
R12269 T16996 T16994 arg1Of ver,Prism
R1227 T2146 T2145 arg1Of development,melanoma
R12270 T16998 T16997 arg1Of software,4.03
R12271 T16998 T16999 arg1Of software,(
R12272 T17001 T16999 arg2Of Software,(
R12273 T17001 T17000 arg1Of Software,GraphPad
R12274 T17001 T17002 arg1Of Software,","
R12275 T17004 T17002 arg2Of Jolla,","
R12276 T17004 T17003 arg1Of Jolla,La
R12277 T17004 T17005 arg1Of Jolla,","
R12278 T17006 T17005 arg2Of CA,","
R12279 T17007 T16999 arg3Of ),(
R1228 T2148 T2147 arg2Of 18,[
R12280 T17008 T17009 arg1Of Data,are
R12281 T17008 T17010 arg2Of Data,presented
R12282 T17010 T17009 arg2Of presented,are
R12283 T17010 T17011 arg1Of presented,as
R12284 T17014 T17011 arg2Of SD,as
R12285 T17014 T17012 arg1Of SD,mean
R12286 T17014 T17013 arg1Of SD,±
R12287 T17015 T17016 arg1Of Difference,between
R12288 T17015 T17022 arg1Of Difference,were
R12289 T17015 T17023 arg2Of Difference,compared
R1229 T2149 T2147 arg3Of ],[
R12290 T17018 T17017 arg1Of mice,CCR5−/−
R12291 T17018 T17019 arg1Of mice,and
R12292 T17019 T17016 arg2Of and,between
R12293 T17021 T17019 arg2Of mice,and
R12294 T17021 T17020 arg1Of mice,CCR5+/+
R12295 T17023 T17022 arg2Of compared,were
R12296 T17023 T17024 modOf compared,using
R12297 T17026 T17024 arg2Of test,using
R12298 T17026 T17025 arg1Of test,t
R12299 T17028 T17027 arg1Of value,A
R123 T342 T340 arg2Of is,since
R1230 T2151 T2150 arg1Of blockade,IL-1R
R12300 T17028 T17029 arg1Of value,of
R12301 T17028 T17033 arg1Of value,was
R12302 T17028 T17034 arg2Of value,considered
R12303 T17028 T17036 arg1Of value,be
R12304 T17028 T17038 arg1Of value,significant
R12305 T17030 T17029 arg2Of p,of
R12306 T17030 T17032 arg1Of p,0.05
R12307 T17032 T17031 arg1Of 0.05,<
R12308 T17034 T17033 arg2Of considered,was
R12309 T17036 T17034 arg3Of be,considered
R1231 T2151 T2153 arg1Of blockade,reduced
R12310 T17036 T17035 arg1Of be,to
R12311 T17038 T17036 arg2Of significant,be
R12312 T17038 T17037 arg1Of significant,statistically
R12313 T17040 T17039 arg1Of data,Survival
R12314 T17040 T17041 arg1Of data,were
R12315 T17040 T17042 arg2Of data,presented
R12316 T17040 T17048 arg2Of data,compared
R12317 T17040 T17050 arg2Of data,calculated
R12318 T17042 T17047 arg1Of presented,and
R12319 T17046 T17042 arg1Of estimates,presented
R1232 T2153 T2152 arg1Of reduced,also
R12320 T17046 T17043 arg2Of estimates,by
R12321 T17046 T17044 arg1Of estimates,Kaplan-Meier
R12322 T17046 T17045 arg1Of estimates,survival
R12323 T17047 T17041 arg2Of and,were
R12324 T17048 T17049 arg1Of compared,and
R12325 T17049 T17047 arg2Of and,and
R12326 T17050 T17049 arg2Of calculated,and
R12327 T17054 T17053 arg2Of Mantel-Cox,(
R12328 T17055 T17053 arg3Of ),(
R12329 T17056 T17048 arg1Of Test,compared
R1233 T2156 T2153 arg2Of growth,reduced
R12330 T17056 T17050 arg1Of Test,calculated
R12331 T17056 T17051 arg2Of Test,by
R12332 T17056 T17052 arg1Of Test,Log-rank
R12333 T17056 T17053 arg1Of Test,(
R12334 T17056 T17057 arg1Of Test,in
R12335 T17059 T17057 arg2Of Prism,in
R12336 T17059 T17058 arg1Of Prism,GraphPad
R1234 T2156 T2154 arg1Of growth,hepatic
R1235 T2156 T2155 arg1Of growth,tumor
R1236 T2156 T2157 arg1Of growth,[
R1237 T2158 T2157 arg2Of 19,[
R1238 T2159 T2157 arg3Of ],[
R1239 T2162 T2163 arg1Of it,has
R124 T346 T342 arg2Of factor,is
R1240 T2162 T2165 arg1Of it,been
R1241 T2162 T2166 arg2Of it,reported
R1242 T2166 T2160 arg1Of reported,Moreover
R12424 T17257 T17258 arg1Of Inhibition,of
R12425 T17257 T17261 arg1Of Inhibition,in
R12426 T17260 T17258 arg2Of development,of
R12427 T17260 T17259 arg1Of development,tumor
R12428 T17263 T17261 arg2Of mice,in
R12429 T17263 T17262 arg1Of mice,CCR5−/−
R1243 T2166 T2161 arg1Of reported,","
R12430 T17264 T17265 arg1Of A–C,","
R12431 T17265 T17268 arg1Of ",",","
R12432 T17267 T17265 arg2Of images,","
R12433 T17267 T17266 arg1Of images,Tumor
R12434 T17268 T17271 arg1Of ",",and
R12435 T17269 T17268 arg2Of volumes,","
R12436 T17271 T17270 arg1Of and,","
R12437 T17272 T17271 arg2Of weights,and
R12438 T17275 T17273 arg1Of cells,B16
R12439 T17275 T17274 arg1Of cells,melanoma
R1244 T2166 T2163 arg2Of reported,has
R12440 T17275 T17276 arg1Of cells,(
R12441 T17275 T17280 arg1Of cells,were
R12442 T17275 T17281 arg2Of cells,inoculated
R12443 T17278 T17276 arg2Of cells/mouse,(
R12444 T17278 T17277 arg1Of cells/mouse,5×105
R12445 T17279 T17276 arg3Of ),(
R12446 T17281 T17280 arg2Of inoculated,were
R12447 T17281 T17282 arg1Of inoculated,s.c.
R12448 T17281 T17283 arg1Of inoculated,into
R12449 T17285 T17284 arg1Of mice,CCR5+/+
R1245 T2166 T2164 arg1Of reported,also
R12450 T17285 T17286 arg1Of mice,and
R12451 T17286 T17283 arg2Of and,into
R12452 T17288 T17286 arg2Of mice,and
R12453 T17288 T17287 arg1Of mice,CCR5−/−
R12454 T17288 T17289 arg1Of mice,(
R12455 T17290 T17289 arg2Of n = 20,(
R12456 T17291 T17289 arg3Of ),(
R12457 T17293 T17292 arg1Of volumes,Tumor
R12458 T17293 T17294 arg1Of volumes,were
R12459 T17293 T17295 arg2Of volumes,measured
R1246 T2166 T2165 arg2Of reported,been
R12460 T17295 T17294 arg2Of measured,were
R12461 T17295 T17297 arg1Of measured,day
R12462 T17295 T17298 arg1Of measured,and
R12463 T17297 T17296 arg1Of day,every
R12464 T17300 T17299 arg1Of weights,tumor
R12465 T17300 T17301 arg1Of weights,were
R12466 T17300 T17302 arg2Of weights,measured
R12467 T17302 T17298 arg2Of measured,and
R12468 T17302 T17301 arg2Of measured,were
R12469 T17302 T17303 arg1Of measured,at
R1247 T2168 T2169 arg1Of IL-1Ra,reduces
R12470 T17305 T17303 arg2Of termination,at
R12471 T17305 T17304 arg1Of termination,study
R12472 T17305 T17306 arg1Of termination,(
R12473 T17307 T17306 arg2Of Day,(
R12474 T17307 T17308 arg1Of Day,31
R12475 T17309 T17306 arg3Of ),(
R12476 T17312 T17310 arg1Of mice,The
R12477 T17312 T17311 arg1Of mice,CCR5−/−
R12478 T17312 T17313 arg1Of mice,had
R12479 T17313 T17322 arg1Of had,as
R1248 T2169 T2166 arg3Of reduces,reported
R12480 T17316 T17313 arg2Of reduction,had
R12481 T17316 T17314 arg1Of reduction,a
R12482 T17316 T17315 arg1Of reduction,significant
R12483 T17316 T17317 arg1Of reduction,in
R12484 T17319 T17320 arg1Of growth,and
R12485 T17320 T17317 arg2Of and,in
R12486 T17320 T17318 arg1Of and,tumor
R12487 T17321 T17320 arg2Of volume,and
R12488 T17323 T17322 arg2Of compared,as
R12489 T17323 T17324 arg1Of compared,to
R1249 T2169 T2167 arg1Of reduces,that
R12490 T17326 T17324 arg2Of mice,to
R12491 T17326 T17325 arg1Of mice,CCR5+/+
R12492 T17328 T17327 arg1Of results,The
R12493 T17328 T17329 arg1Of results,are
R12494 T17328 T17330 arg2Of results,expressed
R12495 T17330 T17329 arg2Of expressed,are
R12496 T17330 T17331 arg1Of expressed,as
R12497 T17334 T17332 arg1Of SD.,mean
R12498 T17334 T17333 arg1Of SD.,±
R12499 T17334 T17335 arg1Of SD.,*
R125 T346 T343 arg1Of factor,an
R1250 T2169 T2196 arg1Of reduces,[
R12500 T17334 T17336 arg1Of SD.,indicates
R12501 T17336 T17331 arg2Of indicates,as
R12502 T17338 T17336 arg2Of difference,indicates
R12503 T17338 T17337 arg1Of difference,significant
R12504 T17338 T17339 arg1Of difference,from
R12505 T17341 T17339 arg2Of mice,from
R12506 T17341 T17340 arg1Of mice,CCR5+/+
R12507 T17341 T17342 arg1Of mice,(
R12508 T17343 T17342 arg2Of P,(
R12509 T17343 T17344 arg1Of P,<
R1251 T2171 T2172 arg1Of development,[
R12510 T17343 T17345 arg1Of P,0.05
R12511 T17346 T17342 arg3Of ),(
R12512 T17347 T17348 arg1Of D,","
R12513 T17347 T17352 arg1Of D,demonstrated
R12514 T17351 T17348 arg2Of mice,","
R12515 T17351 T17349 arg1Of mice,The
R12516 T17351 T17350 arg1Of mice,CCR5−/−
R12517 T17354 T17353 arg1Of higher,significantly
R12518 T17356 T17352 arg2Of rates,demonstrated
R12519 T17356 T17354 arg1Of rates,higher
R1252 T2171 T2175 arg1Of development,","
R12520 T17356 T17355 arg1Of rates,survival
R12521 T17356 T17357 arg1Of rates,compared
R12522 T17358 T17357 arg2Of to,compared
R12523 T17360 T17358 arg2Of mice,to
R12524 T17360 T17359 arg1Of mice,CCR5+/+
R12525 T17360 T17361 arg1Of mice,(
R12526 T17362 T17361 arg2Of by,(
R12527 T17364 T17362 arg2Of Test,by
R12528 T17364 T17363 arg1Of Test,Log-rank
R12529 T17365 T17361 arg3Of ),(
R1253 T2173 T2172 arg2Of 20,[
R12530 T17368 T17366 arg1Of sections,E.
R12531 T17368 T17367 arg1Of sections,Tumor
R12532 T17368 T17369 arg1Of sections,were
R12533 T17368 T17370 arg2Of sections,analyzed
R12534 T17370 T17369 arg2Of analyzed,were
R12535 T17375 T17372 arg1Of stain,H
R12536 T17375 T17373 arg1Of stain,&
R12537 T17375 T17374 arg1Of stain,E
R12538 T17375 T17376 arg1Of stain,and
R12539 T17376 T17370 arg1Of and,analyzed
R1254 T2174 T2172 arg3Of ],[
R12540 T17376 T17371 arg2Of and,by
R12541 T17377 T17376 arg2Of expression,and
R12542 T17377 T17378 arg1Of expression,of
R12543 T17379 T17378 arg2Of proliferating,of
R12544 T17379 T17386 arg1Of proliferating,by
R12545 T17382 T17379 arg2Of antigen,proliferating
R12546 T17382 T17380 arg1Of antigen,cell
R12547 T17382 T17381 arg1Of antigen,nuclear
R12548 T17382 T17383 arg1Of antigen,(
R12549 T17384 T17383 arg2Of PCNA,(
R1255 T2177 T2175 arg2Of melanoma,","
R12550 T17385 T17383 arg3Of ),(
R12551 T17387 T17386 arg2Of immunohistochemistry,by
R12552 T17388 T17389 arg1Of Data,are
R12553 T17390 T17391 arg1Of means,±
R12554 T17391 T17389 arg2Of ±,are
R12555 T17392 T17393 arg1Of S.D.,of
R12556 T17392 T17397 arg1Of S.D.,*
R12557 T17392 T17398 arg1Of S.D.,indicates
R12558 T17396 T17393 arg2Of animals.,of
R12559 T17396 T17394 arg1Of animals.,four
R1256 T2177 T2176 arg1Of melanoma,B16
R12560 T17396 T17395 arg1Of animals.,experimental
R12561 T17398 T17391 arg2Of indicates,±
R12562 T17400 T17398 arg2Of difference,indicates
R12563 T17400 T17399 arg1Of difference,significant
R12564 T17400 T17401 arg1Of difference,from
R12565 T17403 T17401 arg2Of mice,from
R12566 T17403 T17402 arg1Of mice,CCR5+/+
R12567 T17403 T17404 arg1Of mice,(
R12568 T17405 T17404 arg2Of P,(
R12569 T17405 T17406 arg1Of P,<
R1257 T2178 T2179 arg1Of growth,and
R12570 T17405 T17407 arg1Of P,0.05
R12571 T17408 T17404 arg3Of ),(
R12572 T17410 T17409 arg1Of bar,Scale
R12573 T17410 T17411 arg1Of bar,indicates
R12574 T17413 T17411 arg2Of m,indicates
R12575 T17413 T17412 arg1Of m,50
R1258 T2179 T2170 arg1Of and,fibrosarcoma
R1259 T2179 T2171 arg1Of and,development
R126 T346 T344 arg2Of factor,implicated
R1260 T2179 T2177 arg1Of and,melanoma
R1261 T2179 T2181 arg1Of and,[
R1262 T2179 T2184 arg1Of and,","
R1263 T2180 T2179 arg2Of metastasis,and
R1264 T2182 T2181 arg2Of 21,[
R1265 T2183 T2181 arg3Of ],[
R1266 T2184 T2192 arg1Of ",",and
R1267 T2187 T2184 arg2Of growth,","
R1268 T2187 T2185 arg1Of growth,colon
R1269 T2187 T2186 arg1Of growth,adenocarcinoma
R127 T346 T345 arg1Of factor,transcription
R1270 T2187 T2188 arg1Of growth,[
R1271 T2189 T2188 arg2Of 22,[
R1272 T2190 T2188 arg3Of ],[
R1273 T2192 T2169 arg2Of and,reduces
R1274 T2192 T2191 arg1Of and,","
R1275 T2195 T2192 arg2Of development,and
R1276 T2195 T2193 arg1Of development,skin
R1277 T2195 T2194 arg1Of development,cancer
R1278 T2197 T2196 arg2Of 23,[
R12787 T17786 T17787 arg1Of Decrease,of
R12788 T17786 T17790 arg1Of Decrease,in
R12789 T17789 T17787 arg2Of Activity,of
R1279 T2198 T2196 arg3Of ],[
R12790 T17789 T17788 arg1Of Activity,NF-κB
R12791 T17792 T17790 arg2Of Tissue,in
R12792 T17792 T17791 arg1Of Tissue,Tumor
R12793 T17792 T17793 arg1Of Tissue,of
R12794 T17795 T17793 arg2Of Mice,of
R12795 T17795 T17794 arg1Of Mice,CCR5−/−
R12796 T17801 T17798 arg1Of activity,The
R12797 T17801 T17799 arg1Of activity,DNA
R12798 T17801 T17800 arg1Of activity,binding
R12799 T17801 T17802 arg1Of activity,of
R128 T346 T347 arg1Of factor,in
R1280 T2201 T2199 arg1Of mice,IL-1
R12800 T17801 T17804 arg1Of activity,was
R12801 T17801 T17805 arg2Of activity,determined
R12802 T17803 T17802 arg2Of NF-κB,of
R12803 T17805 T17796 arg1Of determined,A
R12804 T17805 T17797 arg1Of determined,","
R12805 T17805 T17804 arg2Of determined,was
R12806 T17805 T17806 arg1Of determined,in
R12807 T17805 T17819 arg1Of determined,by
R12808 T17809 T17806 arg2Of extracts,in
R12809 T17809 T17807 arg1Of extracts,the
R1281 T2201 T2200 arg1Of mice,knockout
R12810 T17809 T17808 arg1Of extracts,nuclear
R12811 T17809 T17810 arg1Of extracts,of
R12812 T17813 T17812 arg1Of mice,CCR5−/−
R12813 T17813 T17814 arg1Of mice,and
R12814 T17814 T17810 arg2Of and,of
R12815 T17814 T17811 arg1Of and,the
R12816 T17818 T17814 arg2Of tissues,and
R12817 T17818 T17815 arg1Of tissues,CCR5+/+
R12818 T17818 T17816 arg1Of tissues,mice
R12819 T17818 T17817 arg1Of tissues,tumor
R1282 T2201 T2202 arg2Of mice,injected
R12820 T17820 T17819 arg2Of EMSA,by
R12821 T17820 T17821 arg2Of EMSA,described
R12822 T17821 T17822 arg1Of described,in
R12823 T17823 T17824 arg1Of material,and
R12824 T17824 T17822 arg2Of and,in
R12825 T17825 T17824 arg2Of methods,and
R12826 T17826 T17827 arg1Of B,","
R12827 T17827 T17831 arg1Of ",",and
R12828 T17828 T17827 arg2Of Expression,","
R12829 T17828 T17829 arg1Of Expression,of
R1283 T2201 T2205 arg1Of mice,failed
R12830 T17830 T17829 arg2Of p50,of
R12831 T17831 T17834 arg1Of and,in
R12832 T17831 T17841 arg1Of and,and
R12833 T17833 T17831 arg2Of phosphorylation,and
R12834 T17833 T17832 arg1Of phosphorylation,p65
R12835 T17836 T17834 arg2Of extracts,in
R12836 T17836 T17835 arg1Of extracts,nuclear
R12837 T17836 T17837 arg1Of extracts,(
R12838 T17838 T17837 arg2Of NE,(
R12839 T17839 T17837 arg3Of ),(
R1284 T2201 T2207 arg1Of mice,develop
R12840 T17841 T17840 arg1Of and,","
R12841 T17841 T17849 arg1Of and,(
R12842 T17841 T17852 arg2Of and,determined
R12843 T17842 T17843 arg1Of IκB,and
R12844 T17843 T17841 arg2Of and,and
R12845 T17843 T17846 arg1Of and,in
R12846 T17845 T17843 arg2Of phosphorylation,and
R12847 T17845 T17844 arg1Of phosphorylation,IκB
R12848 T17848 T17846 arg2Of cytosol,in
R12849 T17848 T17847 arg1Of cytosol,the
R1285 T2202 T2203 arg1Of injected,with
R12850 T17850 T17849 arg2Of CE,(
R12851 T17851 T17849 arg3Of ),(
R12852 T17855 T17852 arg1Of blotting,determined
R12853 T17855 T17853 arg2Of blotting,by
R12854 T17855 T17854 arg1Of blotting,Western
R12855 T17856 T17857 arg1Of C,","
R12856 T17856 T17862 arg1Of C,confirmed
R12857 T17859 T17857 arg2Of analysis,","
R12858 T17859 T17858 arg1Of analysis,Immunolfluorescence
R12859 T17859 T17860 arg1Of analysis,of
R1286 T2204 T2203 arg2Of melanoma,with
R12860 T17861 T17860 arg2Of p50,of
R12861 T17865 T17864 arg1Of intensities,the
R12862 T17865 T17866 arg1Of intensities,of
R12863 T17865 T17871 arg1Of intensities,were
R12864 T17865 T17872 arg2Of intensities,decreased
R12865 T17868 T17866 arg2Of staining,of
R12866 T17868 T17867 arg1Of staining,nuclear
R12867 T17868 T17869 arg1Of staining,for
R12868 T17870 T17869 arg2Of p50,for
R12869 T17872 T17862 arg2Of decreased,confirmed
R1287 T2207 T2205 arg2Of develop,failed
R12870 T17872 T17863 arg1Of decreased,that
R12871 T17872 T17871 arg2Of decreased,were
R12872 T17872 T17873 arg1Of decreased,in
R12873 T17876 T17873 arg2Of tissues,in
R12874 T17876 T17874 arg1Of tissues,the
R12875 T17876 T17875 arg1Of tissues,tumor
R12876 T17876 T17877 arg1Of tissues,of
R12877 T17879 T17877 arg2Of mice,of
R12878 T17879 T17878 arg1Of mice,CCR5−/−
R12879 T17880 T17881 arg1Of Data,are
R1288 T2207 T2206 arg1Of develop,to
R12880 T17882 T17883 arg1Of means,±
R12881 T17883 T17881 arg2Of ±,are
R12882 T17884 T17885 arg1Of S.D.,of
R12883 T17884 T17889 arg1Of S.D.,*
R12884 T17884 T17890 arg1Of S.D.,indicates
R12885 T17888 T17885 arg2Of animals.,of
R12886 T17888 T17886 arg1Of animals.,four
R12887 T17888 T17887 arg1Of animals.,experimental
R12888 T17890 T17883 arg2Of indicates,±
R12889 T17892 T17890 arg2Of difference,indicates
R1289 T2209 T2207 arg2Of tumors,develop
R12890 T17892 T17891 arg1Of difference,significant
R12891 T17892 T17893 arg1Of difference,from
R12892 T17895 T17893 arg2Of mice,from
R12893 T17895 T17894 arg1Of mice,CCR5+/+
R12894 T17895 T17896 arg1Of mice,(
R12895 T17897 T17896 arg2Of p,(
R12896 T17897 T17898 arg1Of p,<
R12897 T17897 T17899 arg1Of p,0.05
R12898 T17900 T17896 arg3Of ),(
R12899 T17902 T17901 arg1Of bar,Scale
R129 T349 T347 arg2Of regulation,in
R1290 T2209 T2208 arg1Of tumors,solid
R12900 T17902 T17903 arg1Of bar,indicates
R12901 T17905 T17903 arg2Of µm,indicates
R12902 T17905 T17904 arg1Of µm,50
R1291 T2209 T2210 arg1Of tumors,[
R1292 T2211 T2210 arg2Of 24,[
R1293 T2212 T2210 arg3Of ],[
R1294 T2213 T2214 arg1Of It,was
R1295 T2213 T2216 arg2Of It,found
R1296 T2216 T2214 arg2Of found,was
R1297 T2216 T2215 arg1Of found,also
R1298 T2218 T2219 arg1Of IL-1Ra,","
R1299 T2218 T2220 arg2Of IL-1Ra,combined
R130 T349 T348 arg1Of regulation,the
R1300 T2218 T2223 arg1Of IL-1Ra,and
R1301 T2220 T2221 arg1Of combined,with
R1302 T2222 T2221 arg2Of temozolomide,with
R1303 T2223 T2227 arg1Of and,demonstrated
R1304 T2225 T2223 arg2Of chemotherapy,and
R1305 T2225 T2224 arg1Of chemotherapy,docetaxel
R1306 T2227 T2216 arg3Of demonstrated,found
R1307 T2227 T2217 arg1Of demonstrated,that
R1308 T2227 T2226 arg1Of demonstrated,","
R13085 T18249 T18250 arg1Of Induction,of
R13086 T18249 T18254 arg1Of Induction,in
R13087 T18253 T18250 arg2Of Death,of
R13088 T18253 T18251 arg1Of Death,Apoptotic
R13089 T18253 T18252 arg1Of Death,Cell
R1309 T2227 T2232 arg1Of demonstrated,against
R13090 T18256 T18254 arg2Of tissues,in
R13091 T18256 T18255 arg1Of tissues,tumor
R13092 T18256 T18257 arg1Of tissues,of
R13093 T18260 T18257 arg2Of mice,of
R13094 T18260 T18258 arg1Of mice,CCR5
R13095 T18260 T18259 arg1Of mice,−/−
R13096 T18264 T18261 arg1Of cells,A
R13097 T18264 T18262 arg1Of cells,","
R13098 T18264 T18263 arg1Of cells,Apoptotic
R13099 T18264 T18265 arg1Of cells,in
R131 T349 T350 arg1Of regulation,of
R1310 T2227 T2238 arg1Of demonstrated,[
R13100 T18264 T18268 arg1Of cells,were
R13101 T18264 T18269 arg2Of cells,examined
R13102 T18267 T18265 arg2Of sections,in
R13103 T18267 T18266 arg1Of sections,tumor
R13104 T18269 T18268 arg2Of examined,were
R13105 T18269 T18273 arg1Of examined,after
R13106 T18269 T18278 arg1Of examined,as
R13107 T18272 T18269 arg1Of microscopy,examined
R13108 T18272 T18270 arg2Of microscopy,by
R13109 T18272 T18271 arg1Of microscopy,fluorescence
R1311 T2229 T2228 arg1Of significant,more
R13110 T18274 T18275 arg1Of DAPI,and
R13111 T18276 T18275 arg2Of TUNEL,and
R13112 T18277 T18273 arg2Of staining,after
R13113 T18277 T18274 arg1Of staining,DAPI
R13114 T18277 T18276 arg1Of staining,TUNEL
R13115 T18279 T18278 arg2Of described,as
R13116 T18279 T18280 arg1Of described,in
R13117 T18281 T18282 arg1Of material,and
R13118 T18282 T18280 arg2Of and,in
R13119 T18283 T18282 arg2Of methods,and
R1312 T2231 T2227 arg2Of activity,demonstrated
R13120 T18286 T18284 arg1Of index,The
R13121 T18286 T18285 arg1Of index,apoptotic
R13122 T18286 T18287 arg1Of index,was
R13123 T18286 T18288 arg2Of index,determined
R13124 T18288 T18287 arg2Of determined,was
R13125 T18288 T18289 arg1Of determined,as
R13126 T18291 T18289 arg2Of number,as
R13127 T18291 T18290 arg1Of number,the
R13128 T18291 T18292 arg1Of number,of
R13129 T18293 T18294 arg1Of DAPI-stained,","
R1313 T2231 T2229 arg1Of activity,significant
R13130 T18295 T18294 arg2Of TUNEL-positive,","
R13131 T18296 T18292 arg2Of cells,of
R13132 T18296 T18293 arg1Of cells,DAPI-stained
R13133 T18296 T18295 arg1Of cells,TUNEL-positive
R13134 T18296 T18297 arg1Of cells,that
R13135 T18296 T18298 arg1Of cells,were
R13136 T18296 T18299 arg2Of cells,counted
R13137 T18299 T18298 arg2Of counted,were
R13138 T18300 T18301 arg1Of Values,are
R13139 T18301 T18311 arg3Of are,indicates
R1314 T2231 T2230 arg1Of activity,antitumor
R13140 T18305 T18301 arg2Of S.D.,are
R13141 T18305 T18302 arg1Of S.D.,the
R13142 T18305 T18303 arg1Of S.D.,mean
R13143 T18305 T18304 arg1Of S.D.,±
R13144 T18305 T18306 arg1Of S.D.,of
R13145 T18309 T18306 arg2Of animals.,of
R13146 T18309 T18307 arg1Of animals.,four
R13147 T18309 T18308 arg1Of animals.,experimental
R13148 T18310 T18311 arg1Of *,indicates
R13149 T18311 T18312 arg1Of indicates,statistically
R1315 T2235 T2232 arg2Of cells,against
R13150 T18314 T18311 arg2Of differences,indicates
R13151 T18314 T18313 arg1Of differences,significant
R13152 T18314 T18315 arg1Of differences,from
R13153 T18317 T18315 arg2Of mice,from
R13154 T18317 T18316 arg1Of mice,CCR5+/+
R13155 T18319 T18318 arg1Of bar,Scale
R13156 T18319 T18320 arg1Of bar,indicates
R13157 T18322 T18320 arg2Of µm,indicates
R13158 T18322 T18321 arg1Of µm,50
R13159 T18323 T18324 arg1Of B,and
R1316 T2235 T2233 arg1Of cells,B16
R13160 T18324 T18326 arg1Of and,","
R13161 T18324 T18338 arg1Of and,were
R13162 T18324 T18339 arg2Of and,detected
R13163 T18325 T18324 arg2Of C,and
R13164 T18328 T18326 arg2Of protein,","
R13165 T18328 T18327 arg1Of protein,Apoptotic
R13166 T18328 T18329 arg1Of protein,(
R13167 T18328 T18335 arg1Of protein,in
R13168 T18331 T18332 arg1Of caspase-3,and
R13169 T18332 T18329 arg2Of and,(
R1317 T2235 T2234 arg1Of cells,melanoma
R13170 T18332 T18330 arg2Of and,cleaved
R13171 T18333 T18332 arg2Of Bax,and
R13172 T18334 T18329 arg3Of ),(
R13173 T18337 T18335 arg2Of sections,in
R13174 T18337 T18336 arg1Of sections,tumor
R13175 T18339 T18338 arg2Of detected,were
R13176 T18342 T18339 arg1Of assay,detected
R13177 T18342 T18340 arg2Of assay,by
R13178 T18342 T18341 arg1Of assay,immunofluorescence
R13179 T18346 T18343 arg1Of number,The
R1318 T2235 T2237 arg1Of cells,vivo
R13180 T18346 T18344 arg1Of number,reactive
R13181 T18346 T18345 arg1Of number,cell
R13182 T18346 T18347 arg1Of number,was
R13183 T18346 T18348 arg2Of number,determined
R13184 T18348 T18347 arg2Of determined,was
R13185 T18348 T18349 arg1Of determined,as
R13186 T18351 T18349 arg2Of number,as
R13187 T18351 T18350 arg1Of number,the
R13188 T18351 T18352 arg1Of number,of
R13189 T18353 T18354 arg1Of DAPI-stained,","
R1319 T2237 T2236 arg1Of vivo,in
R13190 T18355 T18354 arg2Of Specific,","
R13191 T18356 T18357 arg1Of antibody,(
R13192 T18359 T18360 arg1Of caspase-3,and
R13193 T18360 T18357 arg2Of and,(
R13194 T18360 T18358 arg2Of and,cleaved
R13195 T18361 T18360 arg2Of Bax,and
R13196 T18362 T18357 arg3Of ),(
R13197 T18364 T18352 arg2Of cells,of
R13198 T18364 T18353 arg1Of cells,DAPI-stained
R13199 T18364 T18355 arg1Of cells,Specific
R132 T351 T350 arg2Of genes,of
R1320 T2239 T2238 arg2Of 25,[
R13200 T18364 T18356 arg1Of cells,antibody
R13201 T18364 T18363 arg1Of cells,-positive
R13202 T18364 T18365 arg1Of cells,that
R13203 T18364 T18366 arg1Of cells,were
R13204 T18364 T18367 arg2Of cells,counted
R13205 T18367 T18366 arg2Of counted,were
R13206 T18368 T18369 arg1Of Values,are
R13207 T18369 T18379 arg3Of are,indicates
R13208 T18373 T18369 arg2Of S.D.,are
R13209 T18373 T18370 arg1Of S.D.,the
R1321 T2240 T2238 arg3Of ],[
R13210 T18373 T18371 arg1Of S.D.,mean
R13211 T18373 T18372 arg1Of S.D.,±
R13212 T18373 T18374 arg1Of S.D.,of
R13213 T18377 T18374 arg2Of animals.,of
R13214 T18377 T18375 arg1Of animals.,four
R13215 T18377 T18376 arg1Of animals.,experimental
R13216 T18378 T18379 arg1Of *,indicates
R13217 T18379 T18380 arg1Of indicates,statistically
R13218 T18382 T18379 arg2Of differences,indicates
R13219 T18382 T18381 arg1Of differences,significant
R1322 T2242 T2241 arg1Of data,These
R13220 T18382 T18383 arg1Of differences,from
R13221 T18385 T18383 arg2Of mice,from
R13222 T18385 T18384 arg1Of mice,CCR5+/+
R13223 T18387 T18386 arg1Of bar,Scale
R13224 T18387 T18388 arg1Of bar,indicates
R13225 T18390 T18388 arg2Of µm,indicates
R13226 T18390 T18389 arg1Of µm,50
R13227 T18391 T18392 arg1Of D,","
R13228 T18391 T18398 arg1Of D,was
R13229 T18391 T18399 arg2Of D,detected
R1323 T2242 T2243 arg1Of data,indicate
R13230 T18394 T18392 arg2Of expression,","
R13231 T18394 T18393 arg1Of expression,The
R13232 T18394 T18395 arg1Of expression,of
R13233 T18397 T18395 arg2Of proteins,of
R13234 T18397 T18396 arg1Of proteins,apoptotic
R13235 T18399 T18398 arg2Of detected,was
R13236 T18399 T18406 arg1Of detected,;
R13237 T18402 T18399 arg1Of blotting,detected
R13238 T18402 T18400 arg2Of blotting,by
R13239 T18402 T18401 arg1Of blotting,Western
R1324 T2245 T2246 arg1Of IL-1Ra,is
R13240 T18402 T18403 arg1Of blotting,using
R13241 T18405 T18403 arg2Of antibodies,using
R13242 T18405 T18404 arg1Of antibodies,specific
R13243 T18408 T18407 arg2Of caspase-3,cleaved
R13244 T18408 T18410 arg2Of caspase-3,cleaved
R13245 T18408 T18413 arg1Of caspase-3,cleaved
R13246 T18410 T18409 arg1Of cleaved,","
R13247 T18411 T18410 arg3Of caspase-9,cleaved
R13248 T18413 T18406 arg2Of cleaved,;
R13249 T18413 T18412 arg1Of cleaved,","
R1325 T2245 T2247 arg1Of IL-1Ra,important
R13250 T18414 T18415 arg1Of PARP,","
R13251 T18415 T18417 arg1Of ",",","
R13252 T18416 T18415 arg2Of Bax,","
R13253 T18417 T18419 arg1Of ",",and
R13254 T18418 T18417 arg2Of Bcl-2,","
R13255 T18419 T18413 arg2Of and,cleaved
R13256 T18419 T18421 arg1Of and,in
R13257 T18420 T18419 arg2Of c-IAP1,and
R13258 T18424 T18421 arg2Of tissues,in
R13259 T18424 T18422 arg1Of tissues,the
R1326 T2246 T2243 arg2Of is,indicate
R13260 T18424 T18423 arg1Of tissues,tumor
R13261 T18427 T18425 arg1Of protein,The
R13262 T18427 T18426 arg1Of protein,β-actin
R13263 T18427 T18428 arg1Of protein,was
R13264 T18427 T18429 arg2Of protein,used
R13265 T18429 T18428 arg2Of used,was
R13266 T18429 T18430 arg1Of used,as
R13267 T18433 T18430 arg2Of control,as
R13268 T18433 T18431 arg1Of control,an
R13269 T18433 T18432 arg1Of control,internal
R1327 T2246 T2244 arg1Of is,that
R13270 T18435 T18434 arg1Of band,Each
R13271 T18435 T18436 arg1Of band,is
R13272 T18435 T18437 arg1Of band,representative
R13273 T18437 T18436 arg2Of representative,is
R13274 T18437 T18438 arg1Of representative,of
R13275 T18442 T18438 arg2Of results,of
R13276 T18442 T18439 arg1Of results,three
R13277 T18442 T18440 arg1Of results,independent
R13278 T18442 T18441 arg1Of results,experimental
R13279 T18443 T18444 arg1Of Data,are
R1328 T2247 T2246 arg2Of important,is
R13280 T18445 T18446 arg1Of means,±
R13281 T18446 T18444 arg2Of ±,are
R13282 T18447 T18448 arg1Of S.D.,of
R13283 T18447 T18452 arg1Of S.D.,*
R13284 T18447 T18453 arg1Of S.D.,indicates
R13285 T18451 T18448 arg2Of animals.,of
R13286 T18451 T18449 arg1Of animals.,three
R13287 T18451 T18450 arg1Of animals.,experimental
R13288 T18453 T18446 arg2Of indicates,±
R13289 T18455 T18453 arg2Of difference,indicates
R1329 T2247 T2248 arg1Of important,as
R13290 T18455 T18454 arg1Of difference,significant
R13291 T18455 T18456 arg1Of difference,from
R13292 T18458 T18456 arg2Of mice,from
R13293 T18458 T18457 arg1Of mice,CCR5+/+
R13294 T18458 T18459 arg1Of mice,(
R13295 T18460 T18459 arg2Of p,(
R13296 T18460 T18461 arg1Of p,<
R13297 T18460 T18462 arg1Of p,0.05
R13298 T18463 T18459 arg3Of ),(
R133 T351 T352 arg1Of genes,involving
R1330 T2253 T2248 arg2Of cytokine,as
R1331 T2253 T2249 arg1Of cytokine,a
R1332 T2253 T2250 arg1Of cytokine,tumor
R1333 T2253 T2251 arg1Of cytokine,growth
R1334 T2253 T2252 arg1Of cytokine,suppressing
R1335 T2254 T2255 arg1Of NF-κB,plays
R1336 T2254 T2277 arg1Of NF-κB,is
R1337 T2254 T2279 arg2Of NF-κB,associated
R1338 T2255 T2259 arg1Of plays,in
R1339 T2255 T2276 arg1Of plays,and
R134 T354 T353 arg1Of growth,cell
R1340 T2258 T2255 arg2Of role,plays
R1341 T2258 T2256 arg1Of role,a
R1342 T2258 T2257 arg1Of role,crucial
R1343 T2261 T2260 arg1Of suppression,the
R1344 T2261 T2262 arg1Of suppression,of
R1345 T2261 T2267 arg1Of suppression,as
R1346 T2263 T2262 arg2Of apoptosis,of
R1347 T2267 T2259 arg2Of as,in
R1348 T2267 T2264 arg1Of as,","
R1349 T2267 T2265 arg1Of as,as
R135 T354 T355 arg1Of growth,","
R1350 T2267 T2266 arg1Of as,well
R1351 T2269 T2267 arg2Of induction,as
R1352 T2269 T2268 arg1Of induction,the
R1353 T2269 T2270 arg1Of induction,of
R1354 T2272 T2273 arg1Of proliferation,and
R1355 T2273 T2270 arg2Of and,of
R13556 T18934 T18935 arg1Of Upregulation,of
R13557 T18934 T18937 arg1Of Upregulation,in
R13558 T18936 T18935 arg2Of IL-1Ra,of
R13559 T18939 T18940 arg1Of Tumor,and
R1356 T2273 T2271 arg1Of and,cell
R13560 T18940 T18937 arg2Of and,in
R13561 T18940 T18938 arg1Of and,the
R13562 T18940 T18942 arg1Of and,of
R13563 T18941 T18940 arg2Of Spleen,and
R13564 T18944 T18942 arg2Of Mice,of
R13565 T18944 T18943 arg1Of Mice,CCR5−/−
R13566 T18948 T18945 arg1Of 4A,A
R13567 T18948 T18946 arg1Of 4A,","
R13568 T18948 T18947 arg1Of 4A,Figure
R13569 T18948 T18949 arg1Of 4A,indicates
R1357 T2274 T2273 arg2Of inflammation,and
R13570 T18953 T18950 arg1Of panel,mouse
R13571 T18953 T18951 arg1Of panel,cytokine
R13572 T18953 T18952 arg1Of panel,array
R13573 T18953 T18954 arg1Of panel,coordinates
R13574 T18954 T18949 arg2Of coordinates,indicates
R13575 T18956 T18955 arg1Of membranes,Nitrocellulose
R13576 T18956 T18957 arg1Of membranes,contain
R13577 T18961 T18957 arg2Of antibodies,contain
R13578 T18961 T18958 arg1Of antibodies,40
R13579 T18961 T18959 arg1Of antibodies,different
R1358 T2276 T2275 arg1Of and,","
R13580 T18961 T18960 arg1Of antibodies,anti-cytokine
R13581 T18961 T18962 arg2Of antibodies,printed
R13582 T18962 T18963 arg1Of printed,in
R13583 T18964 T18963 arg2Of duplicate,in
R13584 T18965 T18966 arg1Of B,","
R13585 T18969 T18966 arg2Of array,","
R13586 T18969 T18967 arg1Of array,Mouse
R13587 T18969 T18968 arg1Of array,cytokine
R13588 T18970 T18965 arg1Of panel,B
R13589 T18970 T18969 arg1Of panel,array
R1359 T2279 T2276 arg2Of associated,and
R13590 T18970 T18971 arg1Of panel,indicate
R13591 T18975 T18971 arg2Of difference,indicate
R13592 T18975 T18972 arg1Of difference,the
R13593 T18975 T18973 arg1Of difference,cytokine
R13594 T18975 T18974 arg1Of difference,expression
R13595 T18975 T18976 arg1Of difference,in
R13596 T18978 T18976 arg2Of tissues,in
R13597 T18978 T18977 arg1Of tissues,tumor
R13598 T18978 T18979 arg1Of tissues,of
R13599 T18981 T18980 arg1Of mice,CCR5+/+
R136 T355 T358 arg1Of ",",and
R1360 T2279 T2277 arg2Of associated,is
R13600 T18981 T18982 arg1Of mice,and
R13601 T18982 T18979 arg2Of and,of
R13602 T18982 T18985 arg1Of and,","
R13603 T18984 T18982 arg2Of mice,and
R13604 T18984 T18983 arg1Of mice,CCR5−/−
R13605 T18987 T18985 arg2Of IL-1Ra,","
R13606 T18987 T18986 arg1Of IL-1Ra,especially
R13607 T18989 T18988 arg1Of blot,Representative
R13608 T18989 T18990 arg1Of blot,from
R13609 T18989 T18994 arg1Of blot,is
R1361 T2279 T2278 arg1Of associated,closely
R13610 T18989 T18995 arg2Of blot,shown
R13611 T18993 T18990 arg2Of experiments,from
R13612 T18993 T18991 arg1Of experiments,three
R13613 T18993 T18992 arg1Of experiments,independent
R13614 T18995 T18994 arg2Of shown,is
R13615 T18997 T18996 arg1Of controls,Positive
R13616 T18997 T18998 arg1Of controls,show
R13617 T18998 T19005 arg1Of show,on
R13618 T19001 T19000 arg1Of internal,manufacturer’s
R13619 T19004 T18998 arg2Of samples,show
R1362 T2279 T2280 arg1Of associated,with
R13620 T19004 T18999 arg1Of samples,the
R13621 T19004 T19001 arg1Of samples,internal
R13622 T19004 T19002 arg1Of samples,positive
R13623 T19004 T19003 arg1Of samples,control
R13624 T19007 T19005 arg2Of membrane,on
R13625 T19007 T19006 arg1Of membrane,the
R13626 T19008 T19009 arg1Of C,","
R13627 T19010 T19009 arg2Of Protein,","
R13628 T19011 T19008 arg1Of immune-arrays,C
R13629 T19011 T19010 arg1Of immune-arrays,Protein
R1363 T2279 T2283 arg1Of associated,[
R13630 T19011 T19012 arg1Of immune-arrays,were
R13631 T19011 T19013 arg2Of immune-arrays,performed
R13632 T19013 T19012 arg2Of performed,were
R13633 T19014 T19013 arg3Of using,performed
R13634 T19014 T19018 arg1Of using,in
R13635 T19017 T19014 arg2Of array,using
R13636 T19017 T19015 arg1Of array,Mouse
R13637 T19017 T19016 arg1Of array,cytokine
R13638 T19020 T19018 arg2Of tissues,in
R13639 T19020 T19019 arg1Of tissues,spleen
R1364 T2282 T2280 arg2Of development,with
R13640 T19021 T19022 arg1Of There,were
R13641 T19023 T19022 arg2Of differences,were
R13642 T19023 T19024 arg1Of differences,in
R13643 T19025 T19024 arg2Of cytokines,in
R13644 T19025 T19026 arg1Of cytokines,between
R13645 T19025 T19032 arg1Of cytokines,","
R13646 T19028 T19027 arg1Of mice,CCR5+/+
R13647 T19028 T19029 arg1Of mice,and
R13648 T19029 T19026 arg2Of and,between
R13649 T19031 T19029 arg2Of mice,and
R1365 T2282 T2281 arg1Of development,cancer
R13650 T19031 T19030 arg1Of mice,CCR5−/−
R13651 T19034 T19032 arg2Of IL-1Ra,","
R13652 T19034 T19033 arg1Of IL-1Ra,especially
R13653 T19036 T19035 arg1Of blot,Representative
R13654 T19036 T19037 arg1Of blot,from
R13655 T19036 T19041 arg1Of blot,is
R13656 T19036 T19042 arg2Of blot,shown
R13657 T19040 T19037 arg2Of experiments,from
R13658 T19040 T19038 arg1Of experiments,three
R13659 T19040 T19039 arg1Of experiments,independent
R1366 T2284 T2283 arg2Of 26,[
R13660 T19042 T19041 arg2Of shown,is
R13661 T19044 T19043 arg1Of controls,Positive
R13662 T19044 T19045 arg1Of controls,show
R13663 T19045 T19052 arg1Of show,on
R13664 T19048 T19047 arg1Of internal,manufacturer’s
R13665 T19051 T19045 arg2Of samples,show
R13666 T19051 T19046 arg1Of samples,the
R13667 T19051 T19048 arg1Of samples,internal
R13668 T19051 T19049 arg1Of samples,positive
R13669 T19051 T19050 arg1Of samples,control
R1367 T2285 T2283 arg3Of ],[
R13670 T19054 T19052 arg2Of membrane,on
R13671 T19054 T19053 arg1Of membrane,the
R13672 T19055 T19056 arg1Of D,and
R13673 T19056 T19058 arg1Of and,","
R13674 T19056 T19061 arg1Of and,was
R13675 T19056 T19062 arg2Of and,used
R13676 T19057 T19056 arg2Of E,and
R13677 T19060 T19058 arg2Of analysis,","
R13678 T19060 T19059 arg1Of analysis,Immunolfluorescence
R13679 T19062 T19061 arg2Of used,was
R1368 T2287 T2286 arg1Of activation,Constitutive
R13680 T19064 T19062 arg3Of determine,used
R13681 T19064 T19063 arg1Of determine,to
R13682 T19067 T19064 arg2Of levels,determine
R13683 T19067 T19065 arg1Of levels,the
R13684 T19067 T19066 arg1Of levels,expression
R13685 T19067 T19068 arg1Of levels,of
R13686 T19067 T19070 arg1Of levels,in
R13687 T19069 T19068 arg2Of IL-1Ra,of
R13688 T19071 T19072 arg1Of tumor,and
R13689 T19073 T19072 arg2Of spleen,and
R1369 T2287 T2288 arg1Of activation,of
R13690 T19074 T19070 arg2Of tissues,in
R13691 T19074 T19071 arg1Of tissues,tumor
R13692 T19074 T19073 arg1Of tissues,spleen
R13693 T19078 T19075 arg1Of number,The
R13694 T19078 T19076 arg1Of number,reactive
R13695 T19078 T19077 arg1Of number,cell
R13696 T19078 T19079 arg1Of number,was
R13697 T19078 T19080 arg2Of number,determined
R13698 T19080 T19079 arg2Of determined,was
R13699 T19080 T19081 arg1Of determined,as
R137 T356 T355 arg2Of apoptosis,","
R1370 T2287 T2290 arg1Of activation,has
R13700 T19083 T19081 arg2Of number,as
R13701 T19083 T19082 arg1Of number,the
R13702 T19083 T19084 arg1Of number,of
R13703 T19085 T19086 arg1Of DAPI-stained,","
R13704 T19088 T19086 arg2Of antibody-positive,","
R13705 T19088 T19087 arg1Of antibody-positive,IL-1Ra
R13706 T19089 T19084 arg2Of cells,of
R13707 T19089 T19085 arg1Of cells,DAPI-stained
R13708 T19089 T19088 arg1Of cells,antibody-positive
R13709 T19089 T19090 arg1Of cells,that
R1371 T2287 T2291 arg1Of activation,been
R13710 T19089 T19091 arg1Of cells,were
R13711 T19089 T19092 arg2Of cells,counted
R13712 T19092 T19091 arg2Of counted,were
R13713 T19093 T19094 arg1Of Values,are
R13714 T19094 T19104 arg3Of are,indicates
R13715 T19098 T19094 arg2Of S.D.,are
R13716 T19098 T19095 arg1Of S.D.,the
R13717 T19098 T19096 arg1Of S.D.,mean
R13718 T19098 T19097 arg1Of S.D.,±
R13719 T19098 T19099 arg1Of S.D.,of
R1372 T2287 T2292 arg2Of activation,described
R13720 T19102 T19099 arg2Of animals.,of
R13721 T19102 T19100 arg1Of animals.,four
R13722 T19102 T19101 arg1Of animals.,experimental
R13723 T19103 T19104 arg1Of *,indicates
R13724 T19104 T19105 arg1Of indicates,statistically
R13725 T19107 T19104 arg2Of differences,indicates
R13726 T19107 T19106 arg1Of differences,significant
R13727 T19107 T19108 arg1Of differences,from
R13728 T19110 T19108 arg2Of mice,from
R13729 T19110 T19109 arg1Of mice,CCR5+/+
R1373 T2287 T2312 arg1Of activation,was
R13730 T19112 T19111 arg1Of bar,Scale
R13731 T19112 T19113 arg1Of bar,indicates
R13732 T19115 T19113 arg2Of µm,indicates
R13733 T19115 T19114 arg1Of µm,50
R13734 T19116 T19117 arg1Of F,and
R13735 T19117 T19119 arg1Of and,","
R13736 T19117 T19123 arg1Of and,was
R13737 T19117 T19124 arg2Of and,analyzed
R13738 T19118 T19117 arg2Of G,and
R13739 T19120 T19119 arg2Of Expression,","
R1374 T2287 T2313 arg2Of activation,found
R13740 T19120 T19121 arg1Of Expression,of
R13741 T19122 T19121 arg2Of IL-1Ra,of
R13742 T19124 T19123 arg2Of analyzed,was
R13743 T19127 T19124 arg1Of blotting,analyzed
R13744 T19127 T19125 arg2Of blotting,by
R13745 T19127 T19126 arg1Of blotting,western
R13746 T19127 T19128 arg1Of blotting,in
R13747 T19129 T19130 arg1Of tumor,and
R13748 T19131 T19130 arg2Of spleen,and
R13749 T19132 T19128 arg2Of tissues,in
R1375 T2287 T2315 arg1Of activation,up-regulate
R13750 T19132 T19129 arg1Of tissues,tumor
R13751 T19132 T19131 arg1Of tissues,spleen
R13752 T19134 T19133 arg1Of band,Each
R13753 T19134 T19135 arg1Of band,is
R13754 T19134 T19136 arg1Of band,representative
R13755 T19136 T19135 arg2Of representative,is
R13756 T19136 T19137 arg1Of representative,of
R13757 T19141 T19137 arg2Of results,of
R13758 T19141 T19138 arg1Of results,three
R13759 T19141 T19139 arg1Of results,independent
R1376 T2287 T2320 arg1Of activation,regulate
R13760 T19141 T19140 arg1Of results,experimental
R13761 T19142 T19143 arg1Of Data,are
R13762 T19144 T19145 arg1Of means,±
R13763 T19145 T19143 arg2Of ±,are
R13764 T19146 T19147 arg1Of S.D.,of
R13765 T19146 T19151 arg1Of S.D.,*
R13766 T19146 T19152 arg1Of S.D.,indicates
R13767 T19150 T19147 arg2Of animals.,of
R13768 T19150 T19148 arg1Of animals.,three
R13769 T19150 T19149 arg1Of animals.,experimental
R1377 T2289 T2288 arg2Of NF-κB,of
R13770 T19152 T19145 arg2Of indicates,±
R13771 T19154 T19152 arg2Of difference,indicates
R13772 T19154 T19153 arg1Of difference,significant
R13773 T19154 T19155 arg1Of difference,from
R13774 T19157 T19155 arg2Of mice,from
R13775 T19157 T19156 arg1Of mice,CCR5+/+
R13776 T19157 T19158 arg1Of mice,(
R13777 T19159 T19158 arg2Of p,(
R13778 T19159 T19160 arg1Of p,<
R13779 T19159 T19161 arg1Of p,0.05
R1378 T2292 T2290 arg2Of described,has
R13780 T19162 T19158 arg3Of ),(
R1379 T2292 T2291 arg2Of described,been
R138 T358 T352 arg2Of and,involving
R1380 T2292 T2293 arg1Of described,in
R1381 T2292 T2311 arg1Of described,and
R1382 T2296 T2293 arg2Of number,in
R1383 T2296 T2294 arg1Of number,a
R1384 T2296 T2295 arg1Of number,great
R1385 T2296 T2297 arg1Of number,of
R1386 T2298 T2297 arg2Of cancers,of
R1387 T2298 T2299 arg1Of cancers,including
R1388 T2301 T2300 arg1Of cancers,colon
R1389 T2301 T2302 arg1Of cancers,","
R139 T358 T357 arg1Of and,","
R1390 T2302 T2305 arg1Of ",",and
R1391 T2304 T2302 arg2Of cancers,","
R1392 T2304 T2303 arg1Of cancers,prostate
R1393 T2305 T2299 arg2Of and,including
R1394 T2306 T2305 arg2Of melanoma,and
R1395 T2306 T2307 arg1Of melanoma,[
R1396 T2308 T2307 arg2Of 27,[
R1397 T2309 T2307 arg3Of ],[
R1398 T2311 T2310 arg1Of and,","
R1399 T2311 T2324 arg1Of and,[
R140 T360 T358 arg2Of growth,and
R1400 T2313 T2312 arg2Of found,was
R1401 T2323 T2320 arg2Of expression,regulate
R1402 T2323 T2321 arg1Of expression,apoptotic
R1403 T2323 T2322 arg1Of expression,gene
R1404 T2313 T2318 arg1Of found,and/or
R1405 T2315 T2313 arg3Of up-regulate,found
R1406 T2325 T2324 arg2Of 28,[
R1407 T2326 T2324 arg3Of ],[
R14072 T19603 T19604 arg1Of Induction,of
R14073 T19603 T19614 arg1Of Induction,into
R14074 T19606 T19604 arg2Of infiltration,of
R14075 T19606 T19605 arg1Of infiltration,the
R14076 T19606 T19607 arg1Of infiltration,of
R14077 T19610 T19608 arg1Of cells,CD8+
R14078 T19610 T19609 arg1Of cells,T
R14079 T19610 T19611 arg1Of cells,and
R1408 T2328 T2329 arg1Of NF-κB,promotes
R14080 T19611 T19607 arg2Of and,of
R14081 T19613 T19611 arg2Of cells,and
R14082 T19613 T19612 arg1Of cells,NK
R14083 T19615 T19617 arg1Of tumor,and
R14084 T19617 T19614 arg2Of and,into
R14085 T19617 T19616 arg1Of and,","
R14086 T19618 T19617 arg2Of increase,and
R14087 T19618 T19619 arg1Of increase,in
R14088 T19620 T19619 arg2Of spleen,in
R14089 T19620 T19621 arg1Of spleen,of
R1409 T2315 T2314 arg1Of up-regulate,to
R14090 T19623 T19621 arg2Of mice,of
R14091 T19623 T19622 arg1Of mice,CCR5−/−
R14092 T19626 T19627 arg1Of B,","
R14093 T19627 T19625 arg1Of ",",and
R14094 T19628 T19627 arg2Of Immunolfluorescence,","
R14095 T19629 T19624 arg1Of analysis,A
R14096 T19629 T19626 arg1Of analysis,B
R14097 T19629 T19628 arg1Of analysis,Immunolfluorescence
R14098 T19629 T19630 arg1Of analysis,was
R14099 T19629 T19631 arg2Of analysis,used
R141 T360 T359 arg1Of growth,tumor
R1410 T2329 T2327 arg2Of promotes,Although
R14100 T19631 T19630 arg2Of used,was
R14101 T19631 T19632 modOf used,to
R14102 T19633 T19632 arg1Of determine,to
R14103 T19636 T19633 arg2Of levels,determine
R14104 T19636 T19634 arg1Of levels,the
R14105 T19636 T19635 arg1Of levels,expression
R14106 T19636 T19637 arg1Of levels,of
R14107 T19636 T19653 arg1Of levels,in
R14108 T19638 T19639 arg1Of CD8,(
R14109 T19638 T19646 arg1Of CD8,and
R1411 T2317 T2315 arg2Of genes,up-regulate
R14110 T19644 T19639 arg2Of marker,(
R14111 T19644 T19640 arg1Of marker,CD8+
R14112 T19644 T19641 arg1Of marker,cytotoxic
R14113 T19644 T19642 arg1Of marker,T-cell
R14114 T19644 T19643 arg1Of marker,surface
R14115 T19645 T19639 arg3Of ),(
R14116 T19646 T19637 arg2Of and,of
R14117 T19647 T19646 arg2Of CD57,and
R14118 T19647 T19648 arg1Of CD57,(
R14119 T19651 T19648 arg2Of marker,(
R1412 T2331 T2329 arg2Of growth,promotes
R14120 T19651 T19649 arg1Of marker,NK
R14121 T19651 T19650 arg1Of marker,cell
R14122 T19652 T19648 arg3Of ),(
R14123 T19654 T19655 arg1Of tumor,and
R14124 T19656 T19655 arg2Of spleen,and
R14125 T19657 T19653 arg2Of sections,in
R14126 T19657 T19654 arg1Of sections,tumor
R14127 T19657 T19656 arg1Of sections,spleen
R14128 T19659 T19658 arg1Of images,The
R14129 T19659 T19660 arg2Of images,shown
R1413 T2331 T2330 arg1Of growth,tumor
R14130 T19659 T19661 arg1Of images,are
R14131 T19659 T19662 arg1Of images,representative
R14132 T19662 T19661 arg2Of representative,are
R14133 T19662 T19663 arg1Of representative,of
R14134 T19666 T19663 arg2Of experiments,of
R14135 T19666 T19664 arg1Of experiments,three
R14136 T19666 T19665 arg1Of experiments,separate
R14137 T19666 T19667 arg2Of experiments,performed
R14138 T19667 T19668 arg1Of performed,in
R14139 T19669 T19668 arg2Of triplicate,in
R1414 T2333 T2334 arg1Of it,is
R14140 T19671 T19670 arg1Of bars,Scale
R14141 T19671 T19672 arg1Of bars,indicate
R14142 T19674 T19673 arg1Of µm,50
R14143 T19674 T19675 arg1Of µm,(
R14144 T19674 T19678 arg1Of µm,and
R14145 T19676 T19675 arg2Of A,(
R14146 T19677 T19675 arg3Of ),(
R14147 T19678 T19672 arg2Of and,indicate
R14148 T19680 T19678 arg2Of µm,and
R14149 T19680 T19679 arg1Of µm,100
R1415 T2333 T2335 arg2Of it,required
R14150 T19680 T19681 arg1Of µm,(
R14151 T19682 T19681 arg2Of B,(
R14152 T19683 T19681 arg3Of ),(
R14153 T19684 T19685 arg1Of C,and
R14154 T19685 T19687 arg1Of and,","
R14155 T19686 T19685 arg2Of D,and
R14156 T19688 T19687 arg2Of Analysis,","
R14157 T19688 T19689 arg1Of Analysis,of
R14158 T19691 T19689 arg2Of phenotypes,of
R14159 T19691 T19690 arg1Of phenotypes,lymphocyte
R1416 T2317 T2316 arg1Of genes,anti-apoptotic
R14160 T19693 T19694 arg1Of tumor,and
R14161 T19695 T19694 arg2Of spleen,and
R14162 T19696 T19692 arg1Of tissues,The
R14163 T19696 T19693 arg1Of tissues,tumor
R14164 T19696 T19695 arg1Of tissues,spleen
R14165 T19696 T19697 arg1Of tissues,were
R14166 T19696 T19698 arg2Of tissues,separated
R14167 T19698 T19697 arg2Of separated,were
R14168 T19698 T19699 arg1Of separated,at
R14169 T19701 T19699 arg2Of termination,at
R1417 T2318 T2311 arg2Of and/or,and
R14170 T19701 T19700 arg1Of termination,study
R14171 T19701 T19702 arg1Of termination,(
R14172 T19703 T19702 arg2Of Day,(
R14173 T19703 T19704 arg1Of Day,31
R14174 T19705 T19702 arg3Of ),(
R14175 T19708 T19706 arg1Of analysis,Flow
R14176 T19708 T19707 arg1Of analysis,cytometry
R14177 T19708 T19709 arg1Of analysis,was
R14178 T19708 T19710 arg2Of analysis,performed
R14179 T19710 T19709 arg2Of performed,was
R1418 T2335 T2327 arg1Of required,Although
R14180 T19711 T19710 arg3Of using,performed
R14181 T19712 T19711 arg2Of FACSAria,using
R14182 T19712 T19719 modOf FACSAria,were
R14183 T19714 T19713 arg1Of cytometry,flow
R14184 T19714 T19716 arg1Of cytometry,and
R14185 T19714 T19717 arg2Of cytometry,represent
R14186 T19714 T19719 arg1Of cytometry,were
R14187 T19714 T19720 arg2Of cytometry,shown
R14188 T19716 T19715 arg1Of and,","
R14189 T19718 T19717 arg1Of data,represent
R1419 T2335 T2332 arg1Of required,","
R14190 T19720 T19719 arg2Of shown,were
R14191 T19721 T19722 arg1Of Data,are
R14192 T19723 T19724 arg1Of means,±
R14193 T19724 T19722 arg2Of ±,are
R14194 T19725 T19724 arg2Of S.D.,±
R14195 T19725 T19726 arg1Of S.D.,of
R14196 T19729 T19726 arg2Of animals,of
R14197 T19729 T19727 arg1Of animals,four
R14198 T19729 T19728 arg1Of animals,experimental
R142 T362 T361 arg1Of inhibition,Significant
R1420 T2335 T2334 arg2Of required,is
R1421 T2335 T2336 arg1Of required,for
R1422 T2320 T2318 arg2Of regulate,and/or
R1423 T2339 T2336 arg2Of system,for
R1424 T2339 T2337 arg1Of system,the
R1425 T2339 T2338 arg1Of system,immune
R1426 T2339 T2340 modOf system,to
R1427 T2320 T2319 arg1Of regulate,down
R1428 T2423 T2419 arg2Of death,affecting
R1429 T2341 T2340 arg1Of function,to
R143 T362 T363 arg1Of inhibition,of
R1430 T2341 T2342 arg1Of function,normally
R1431 T2341 T2343 arg1Of function,[
R1432 T2344 T2343 arg2Of 29,[
R1433 T2345 T2343 arg3Of ],[
R1434 T2346 T2347 arg1Of Studies,on
R1435 T2346 T2350 arg1Of Studies,demonstrated
R1436 T2349 T2347 arg2Of mice,on
R1437 T2349 T2348 arg1Of mice,c-Rel-deficient
R1438 T2423 T2420 arg1Of death,apoptotic
R1439 T2423 T2421 arg1Of death,cancer
R144 T362 T370 arg1Of inhibition,and
R1440 T2423 T2422 arg1Of death,cell
R1441 T2423 T2424 arg1Of death,","
R1442 T2423 T2425 arg1Of death,(
R1443 T2352 T2353 arg1Of c-Rel,is
R1444 T2352 T2354 arg1Of c-Rel,essential
R1445 T2353 T2350 arg2Of is,demonstrated
R1446 T2353 T2351 arg1Of is,that
R1447 T2353 T2368 arg1Of is,[
R1448 T2354 T2353 arg2Of essential,is
R1449 T2354 T2355 arg1Of essential,for
R145 T366 T363 arg2Of activity,of
R1450 T2356 T2357 arg1Of IL-2,","
R1451 T2357 T2359 arg1Of ",",","
R1452 T2358 T2357 arg2Of IL-3,","
R1453 T2359 T2362 arg1Of ",",and
R1454 T2423 T2428 arg1Of death,stimulating
R1455 T2360 T2359 arg2Of GM-CSF,","
R1456 T2423 T2433 arg1Of death,or
R1457 T2423 T2434 arg1Of death,(
R1458 T2362 T2355 arg2Of and,for
R1459 T2362 T2361 arg1Of and,","
R146 T366 T364 arg1Of activity,DNA
R1460 T2362 T2365 arg1Of and,in
R1461 T2423 T2437 arg1Of death,increasing
R1462 T2364 T2362 arg2Of expression,and
R1463 T2364 T2363 arg1Of expression,IFNγ
R1464 T2426 T2425 arg2Of 2,(
R1465 T2367 T2365 arg2Of lymphocytes,in
R1466 T2367 T2366 arg1Of lymphocytes,T
R1467 T2369 T2368 arg2Of 30,[
R1468 T2370 T2368 arg3Of ],[
R1469 T2427 T2425 arg3Of ),(
R147 T366 T365 arg1Of activity,binding
R1470 T2372 T2371 arg1Of mice,C-Rel-deficient
R1471 T2372 T2374 arg1Of mice,have
R1472 T2432 T2428 arg2Of infiltration,stimulating
R1473 T2374 T2373 arg1Of have,also
R1474 T2374 T2384 arg1Of have,in
R1475 T2377 T2374 arg2Of deficiency,have
R1476 T2377 T2375 arg1Of deficiency,a
R1477 T2377 T2376 arg1Of deficiency,tissue-specific
R1478 T2377 T2378 arg1Of deficiency,of
R1479 T2380 T2379 arg1Of cytokines,various
R148 T366 T367 arg1Of activity,of
R1480 T2380 T2381 arg1Of cytokines,and
R1481 T2381 T2378 arg2Of and,of
R1482 T2432 T2429 arg1Of infiltration,tumor
R1483 T2383 T2381 arg2Of factors,and
R1484 T2383 T2382 arg1Of factors,growth
R1485 T2432 T2430 arg1Of infiltration,killing
R1486 T2432 T2431 arg1Of infiltration,lymphocytes
R1487 T2435 T2434 arg2Of 3,(
R1488 T2386 T2385 arg1Of cells,T
R1489 T2386 T2387 arg1Of cells,and
R149 T368 T367 arg2Of NF-κB,of
R1490 T2387 T2384 arg2Of and,in
R1491 T2387 T2389 arg1Of and,affecting
R1492 T2388 T2387 arg2Of macrophages,and
R1493 T2389 T2396 arg1Of affecting,in
R1494 T2389 T2399 arg1Of affecting,[
R1495 T2391 T2392 arg1Of innate,and
R1496 T2436 T2434 arg3Of ),(
R1497 T2392 T2390 arg1Of and,both
R1498 T2393 T2392 arg2Of humoral,and
R1499 T2395 T2389 arg2Of responses,affecting
R150 T370 T369 arg1Of and,","
R1500 T2395 T2391 arg1Of responses,innate
R1501 T2395 T2393 arg1Of responses,humoral
R1502 T2395 T2394 arg1Of responses,immune
R1503 T2398 T2396 arg2Of host,in
R1504 T2398 T2397 arg1Of host,the
R1505 T2439 T2437 arg2Of production,increasing
R1506 T2400 T2399 arg2Of 31,[
R1507 T2401 T2399 arg3Of ],[
R1508 T2439 T2438 arg1Of production,the
R1509 T2404 T2405 arg1Of NF-κB,can
R151 T370 T379 arg1Of and,through
R1510 T2404 T2406 arg1Of NF-κB,be
R1511 T2404 T2408 arg2Of NF-κB,targeted
R1512 T2404 T2410 arg1Of NF-κB,prevent
R1513 T2439 T2440 arg1Of production,of
R1514 T2443 T2440 arg2Of lymphokines,of
R1515 T2404 T2419 arg1Of NF-κB,affecting
R1516 T2443 T2441 arg1Of lymphokines,tumor
R1517 T2408 T2402 arg1Of targeted,Therefore
R1518 T2408 T2403 arg1Of targeted,","
R1519 T2408 T2405 arg2Of targeted,can
R152 T370 T386 arg1Of and,was
R1520 T2408 T2406 arg2Of targeted,be
R1521 T2408 T2407 arg1Of targeted,specially
R1522 T2410 T2408 arg3Of prevent,targeted
R1523 T2410 T2409 arg1Of prevent,to
R1524 T2410 T2414 arg1Of prevent,by
R1525 T2443 T2442 arg1Of lymphokines,killing
R1526 T2444 T2445 arg1Of Activation,of
R1527 T2413 T2410 arg2Of growth,prevent
R1528 T2413 T2411 arg1Of growth,cancer
R1529 T2413 T2412 arg1Of growth,cell
R153 T370 T387 arg2Of and,found
R1530 T2444 T2447 arg1Of Activation,is
R1531 T2444 T2448 arg1Of Activation,important
R1532 T2416 T2415 arg1Of 1,(
R1533 T2416 T2417 arg1Of 1,)
R1534 T2446 T2445 arg2Of NF-κB,of
R1535 T2419 T2414 arg2Of affecting,by
R1536 T2419 T2416 arg1Of affecting,1
R1537 T2419 T2418 arg1Of affecting,directly
R1538 T2448 T2447 arg2Of important,is
R1539 T2448 T2449 arg1Of important,in
R154 T371 T370 arg2Of translocation,and
R1540 T2451 T2449 arg2Of regulation,in
R1541 T2451 T2450 arg1Of regulation,the
R1542 T2451 T2452 arg1Of regulation,of
R1543 T2455 T2456 arg1Of growth,and
R1544 T2519 T2515 arg2Of development,in
R1545 T2519 T2516 arg1Of development,CCR5
R1546 T2519 T2517 arg2Of development,mediated
R1547 T2519 T2518 arg1Of development,tumor
R1548 T2524 T2520 arg1Of sites,NF-κB
R1549 T2524 T2521 arg1Of sites,transcription
R155 T371 T372 arg1Of translocation,of
R1550 T2524 T2522 arg1Of sites,factor
R1551 T2524 T2523 arg1Of sites,binding
R1552 T2524 T2525 arg1Of sites,are
R1553 T2524 T2526 arg1Of sites,present
R1554 T2456 T2452 arg2Of and,of
R1555 T2526 T2525 arg2Of present,are
R1556 T2526 T2527 arg1Of present,in
R1557 T2456 T2453 arg1Of and,CCR-mediated
R1558 T2456 T2454 arg1Of and,tumor
R1559 T2530 T2527 arg2Of region,in
R156 T371 T376 arg1Of translocation,into
R1560 T2530 T2528 arg1Of region,the
R1561 T2530 T2529 arg1Of region,promoter
R1562 T2530 T2531 arg1Of region,of
R1563 T2457 T2456 arg2Of metastasis,and
R1564 T2534 T2531 arg2Of genes,of
R1565 T2534 T2532 arg1Of genes,proinflammatory
R1566 T2534 T2533 arg1Of genes,cytokine
R1567 T2534 T2535 arg1Of genes,","
R1568 T2534 T2537 arg1Of genes,as
R1569 T2458 T2459 arg1Of It,was
R157 T373 T374 arg1Of p50,and
R1570 T2537 T2536 arg1Of as,such
R1571 T2538 T2539 arg1Of IL-1alpha,","
R1572 T2458 T2460 arg2Of It,reported
R1573 T2539 T2541 arg1Of ",",","
R1574 T2540 T2539 arg2Of IL-6,","
R1575 T2460 T2459 arg2Of reported,was
R1576 T2541 T2544 arg1Of ",",and
R1577 T2542 T2541 arg2Of GM-CSF,","
R1578 T2544 T2537 arg2Of and,as
R1579 T2544 T2543 arg1Of and,","
R158 T374 T372 arg2Of and,of
R1580 T2545 T2544 arg2Of KC,and
R1581 T2545 T2546 arg1Of KC,[
R1582 T2462 T2463 arg1Of inhibition,of
R1583 T2547 T2546 arg2Of 34,[
R1584 T2548 T2546 arg3Of ],[
R1585 T2462 T2465 arg1Of inhibition,by
R1586 T2462 T2470 arg1Of inhibition,induces
R1587 T2464 T2463 arg2Of NF-κB,of
R1588 T2552 T2549 arg2Of hand,On
R1589 T2552 T2550 arg1Of hand,the
R159 T375 T374 arg2Of p65,and
R1590 T2552 T2551 arg1Of hand,other
R1591 T2555 T2554 arg1Of IL-1Ra,the
R1592 T2555 T2556 arg1Of IL-1Ra,is
R1593 T2556 T2549 arg1Of is,On
R1594 T2556 T2553 arg1Of is,","
R1595 T2466 T2465 arg2Of dehydroxymethyl-epoxyquinomicin,by
R1596 T2559 T2556 arg2Of regulator,is
R1597 T2559 T2557 arg1Of regulator,a
R1598 T2559 T2558 arg1Of regulator,negative
R1599 T2559 T2560 arg1Of regulator,of
R160 T378 T376 arg2Of nucleus,into
R1600 T2563 T2560 arg2Of response,of
R1601 T2563 T2561 arg1Of response,the
R1602 T2466 T2467 arg1Of dehydroxymethyl-epoxyquinomicin,(
R1603 T2468 T2467 arg2Of DHMEQ,(
R1604 T2563 T2562 arg1Of response,inflammatory
R1605 T2565 T2564 arg1Of studies,Several
R1606 T2565 T2566 arg1Of studies,have
R1607 T2565 T2567 arg1Of studies,demonstrated
R1608 T2567 T2566 arg2Of demonstrated,have
R1609 T2469 T2467 arg3Of ),(
R161 T378 T377 arg1Of nucleus,the
R1610 T2569 T2567 arg2Of ability,demonstrated
R1611 T2569 T2568 arg1Of ability,the
R1612 T2569 T2570 arg1Of ability,of
R1613 T2569 T2572 modOf ability,to
R1614 T2470 T2460 arg3Of induces,reported
R1615 T2571 T2570 arg2Of IL-1Ra,of
R1616 T2470 T2461 arg1Of induces,that
R1617 T2573 T2572 arg1Of abrogate,to
R1618 T2470 T2477 arg1Of induces,by
R1619 T2470 T2482 arg1Of induces,[
R162 T381 T379 arg2Of inhibition,through
R1620 T2576 T2573 arg2Of effects,abrogate
R1621 T2576 T2574 arg1Of effects,the
R1622 T2576 T2575 arg1Of effects,proinflammatory
R1623 T2576 T2577 arg1Of effects,of
R1624 T2472 T2470 arg2Of death,induces
R1625 T2578 T2577 arg2Of IL-1,of
R1626 T2579 T2581 arg1Of Smith,al.
R1627 T2579 T2582 arg1Of Smith,suggested
R1628 T2581 T2580 arg1Of al.,et
R1629 T2472 T2471 arg1Of death,cell
R163 T381 T380 arg1Of inhibition,the
R1630 T2472 T2473 arg1Of death,of
R1631 T2476 T2473 arg2Of lymphoma,of
R1632 T2585 T2584 arg1Of regulation,the
R1633 T2585 T2586 arg1Of regulation,of
R1634 T2585 T2590 arg1Of regulation,is
R1635 T2589 T2586 arg2Of expression,of
R1636 T2589 T2587 arg1Of expression,IL-1Ra
R1637 T2589 T2588 arg1Of expression,gene
R1638 T2590 T2582 arg2Of is,suggested
R1639 T2590 T2583 arg1Of is,that
R164 T381 T382 arg1Of inhibition,of
R1640 T2590 T2607 arg1Of is,[
R1641 T2476 T2474 arg1Of lymphoma,primary
R1642 T2476 T2475 arg1Of lymphoma,effusion
R1643 T2593 T2590 arg2Of event,is
R1644 T2593 T2591 arg1Of event,a
R1645 T2593 T2592 arg1Of event,complex
R1646 T2593 T2594 arg1Of event,involving
R1647 T2593 T2602 arg1Of event,;
R1648 T2478 T2477 arg2Of inhibition,by
R1649 T2596 T2594 arg2Of interactions,involving
R165 T383 T382 arg2Of phosphorylation,of
R1650 T2596 T2595 arg1Of interactions,the
R1651 T2596 T2597 arg1Of interactions,of
R1652 T2601 T2597 arg2Of factors,of
R1653 T2601 T2598 arg1Of factors,three
R1654 T2601 T2599 arg1Of factors,different
R1655 T2601 T2600 arg1Of factors,transcription
R1656 T2478 T2479 arg1Of inhibition,of
R1657 T2481 T2479 arg2Of expression,of
R1658 T2606 T2602 arg2Of site,;
R1659 T2606 T2603 arg1Of site,NF-κB/PU.1/GA-binding
R166 T383 T384 arg1Of phosphorylation,of
R1660 T2606 T2604 arg1Of site,protein
R1661 T2606 T2605 arg1Of site,binding
R1662 T2608 T2607 arg2Of 35,[
R1663 T2609 T2607 arg3Of ],[
R1664 T2481 T2480 arg1Of expression,CCR5
R1665 T2611 T2610 arg1Of translocation,Nuclear
R1666 T2611 T2612 arg1Of translocation,of
R1667 T2611 T2617 arg1Of translocation,was
R1668 T2611 T2619 arg2Of translocation,enhanced
R1669 T2611 T2621 arg2Of translocation,prolonged
R167 T385 T384 arg2Of IκB,of
R1670 T2613 T2612 arg2Of NF-κB,of
R1671 T2613 T2614 arg1Of NF-κB,(
R1672 T2483 T2482 arg2Of 32,[
R1673 T2484 T2482 arg3Of ],[
R1674 T2615 T2614 arg2Of p65,(
R1675 T2485 T2486 arg1Of Activation,of
R1676 T2616 T2614 arg3Of ),(
R1677 T2485 T2489 arg1Of Activation,increases
R1678 T2619 T2620 arg1Of enhanced,and
R1679 T2487 T2486 arg2Of NF-κB,of
R168 T387 T386 arg2Of found,was
R1680 T2620 T2617 arg2Of and,was
R1681 T2620 T2618 arg1Of and,significantly
R1682 T2620 T2622 arg1Of and,in
R1683 T2620 T2625 arg1Of and,","
R1684 T2620 T2626 arg1Of and,compared
R1685 T2621 T2620 arg2Of prolonged,and
R1686 T2624 T2622 arg2Of mice,in
R1687 T2624 T2623 arg1Of mice,IL-1Ra-deficient
R1688 T2489 T2488 arg1Of increases,also
R1689 T2627 T2626 arg2Of to,compared
R169 T387 T388 arg1Of found,in
R1690 T2628 T2627 arg2Of that,to
R1691 T2628 T2629 arg1Of that,in
R1692 T2493 T2490 arg1Of motility,CCL5-mediated
R1693 T2632 T2629 arg2Of mice,in
R1694 T2632 T2630 arg1Of mice,wild
R1695 T2632 T2631 arg1Of mice,type
R1696 T2632 T2633 arg1Of mice,[
R1697 T2634 T2633 arg2Of 36,[
R1698 T2635 T2633 arg3Of ],[
R1699 T2637 T2636 arg1Of IL-1Ra,Intracellular
R170 T387 T395 arg1Of found,compared
R1700 T2637 T2638 arg1Of IL-1Ra,(
R1701 T2637 T2641 arg1Of IL-1Ra,was
R1702 T2637 T2642 arg2Of IL-1Ra,found
R1703 T2637 T2644 arg1Of IL-1Ra,inhibit
R1704 T2637 T2647 arg1Of IL-1Ra,blocking
R1705 T2493 T2491 arg1Of motility,oral
R1706 T2639 T2638 arg2Of icIL-1Ra,(
R1707 T2493 T2492 arg1Of motility,cancer
R1708 T2640 T2638 arg3Of ),(
R1709 T2493 T2494 arg1Of motility,(
R171 T391 T388 arg2Of tissues,in
R1710 T2642 T2641 arg2Of found,was
R1711 T2493 T2497 arg1Of motility,and
R1712 T2495 T2494 arg2Of 5,(
R1713 T2644 T2642 arg3Of inhibit,found
R1714 T2644 T2643 arg1Of inhibit,to
R1715 T2644 T2646 arg1Of inhibit,by
R1716 T2645 T2644 arg2Of IL-1,inhibit
R1717 T2647 T2646 arg2Of blocking,by
R1718 T2496 T2494 arg3Of ),(
R1719 T2651 T2647 arg2Of pathways,blocking
R172 T391 T389 arg1Of tissues,the
R1720 T2651 T2648 arg1Of pathways,NF-κB
R1721 T2651 T2649 arg1Of pathways,signal
R1722 T2651 T2650 arg1Of pathways,transduction
R1723 T2651 T2652 arg1Of pathways,in
R1724 T2497 T2489 arg2Of and,increases
R1725 T2654 T2652 arg2Of responses,in
R1726 T2654 T2653 arg1Of responses,inflammatory
R1727 T2654 T2655 arg1Of responses,[
R1728 T2499 T2497 arg2Of metastasis,and
R1729 T2656 T2655 arg2Of 37,[
R173 T391 T390 arg1Of tissues,melanoma
R1730 T2657 T2655 arg3Of ],[
R1731 T2659 T2660 arg1Of IL-1,has
R1732 T2659 T2661 arg1Of IL-1,been
R1733 T2659 T2662 arg2Of IL-1,shown
R1734 T2659 T2664 arg1Of IL-1,be
R1735 T2499 T2498 arg1Of metastasis,lung
R1736 T2662 T2658 arg2Of shown,Because
R1737 T2662 T2660 arg2Of shown,has
R1738 T2662 T2661 arg2Of shown,been
R1739 T2499 T2500 arg1Of metastasis,[
R174 T391 T392 arg1Of tissues,of
R1740 T2664 T2662 arg3Of be,shown
R1741 T2664 T2663 arg1Of be,to
R1742 T2501 T2500 arg2Of 33,[
R1743 T2666 T2664 arg2Of inducer,be
R1744 T2666 T2665 arg1Of inducer,an
R1745 T2666 T2667 arg1Of inducer,of
R1746 T2669 T2667 arg2Of activation,of
R1747 T2669 T2668 arg1Of activation,NF-κB
R1748 T2669 T2670 arg1Of activation,[
R1749 T2502 T2500 arg3Of ],[
R175 T394 T392 arg2Of mice,of
R1750 T2671 T2670 arg2Of 38,[
R1751 T2672 T2670 arg3Of ],[
R1752 T2674 T2675 arg1Of we,hypothesized
R1753 T2675 T2658 arg1Of hypothesized,Because
R1754 T2675 T2673 arg1Of hypothesized,","
R1755 T2506 T2503 arg1Of is,Thus
R1756 T2678 T2677 arg1Of expression,the
R1757 T2678 T2679 arg1Of expression,of
R1758 T2678 T2681 arg1Of expression,could
R1759 T2678 T2682 arg1Of expression,play
R176 T394 T393 arg1Of mice,CCR5−/−
R1760 T2680 T2679 arg2Of IL-1Ra,of
R1761 T2682 T2675 arg2Of play,hypothesized
R1762 T2682 T2676 arg1Of play,that
R1763 T2682 T2681 arg2Of play,could
R1764 T2682 T2686 arg1Of play,in
R1765 T2685 T2682 arg2Of role,play
R1766 T2685 T2683 arg1Of role,an
R1767 T2685 T2684 arg1Of role,important
R1768 T2506 T2504 arg1Of is,","
R1769 T2507 T2506 arg2Of possible,is
R177 T396 T395 arg2Of to,compared
R1770 T2689 T2686 arg2Of activation,in
R1771 T2689 T2687 arg1Of activation,the
R1772 T2689 T2688 arg1Of activation,autocrine
R1773 T2689 T2690 arg1Of activation,of
R1774 T2509 T2510 arg1Of inhibition,of
R1775 T2692 T2691 arg1Of factors,transcription
R1776 T2693 T2694 arg1Of NF-κB,or
R1777 T2694 T2690 arg2Of or,of
R1778 T2694 T2692 arg1Of or,factors
R1779 T2509 T2512 arg1Of inhibition,could
R178 T398 T396 arg2Of tissues,to
R1780 T2509 T2513 arg1Of inhibition,be
R1781 T2696 T2694 arg2Of versa,or
R1782 T2696 T2695 arg1Of versa,vice
R1783 T2509 T2514 arg2Of inhibition,involved
R1784 T2511 T2510 arg2Of NF-κB,of
R1785 T2700 T2699 arg1Of aim,the
R1786 T2700 T2701 arg1Of aim,of
R1787 T2700 T2704 arg1Of aim,was
R1788 T2703 T2701 arg2Of study,of
R1789 T2703 T2702 arg1Of study,this
R179 T398 T397 arg1Of tissues,melanoma
R1790 T2704 T2697 arg1Of was,Thus
R1791 T2704 T2698 arg1Of was,","
R1792 T2514 T2505 arg1Of involved,it
R1793 T2706 T2704 arg2Of evaluate,was
R1794 T2706 T2705 arg1Of evaluate,to
R1795 T2708 T2706 arg2Of roles,evaluate
R1796 T2708 T2707 arg1Of roles,the
R1797 T2708 T2709 arg1Of roles,of
R1798 T2708 T2713 arg1Of roles,in
R1799 T2514 T2506 arg1Of involved,is
R180 T398 T399 arg1Of tissues,of
R1800 T2710 T2711 arg1Of NF-κB,and
R1801 T2514 T2507 arg1Of involved,possible
R1802 T2514 T2508 arg1Of involved,that
R1803 T2514 T2512 arg2Of involved,could
R1804 T2514 T2513 arg2Of involved,be
R1805 T2514 T2515 arg1Of involved,in
R1807 T2711 T2709 arg2Of and,of
R1808 T2712 T2711 arg2Of IL-1Ra,and
R1809 T2718 T2713 arg2Of suppression,in
R181 T401 T399 arg2Of mice,of
R1810 T2718 T2714 arg1Of suppression,the
R1811 T2718 T2715 arg1Of suppression,chemokine
R1812 T2718 T2716 arg1Of suppression,receptor
R1813 T2718 T2717 arg1Of suppression,CCR5-mediated
R1814 T2718 T2719 arg1Of suppression,of
R1815 T2721 T2719 arg2Of development,of
R1816 T2721 T2720 arg1Of development,tumor
R182 T401 T400 arg1Of mice,CCR5+/+
R183 T406 T402 arg1Of expression,NF-κB
R184 T406 T403 arg1Of expression,target
R185 T406 T404 arg1Of expression,apoptotic
R186 T406 T405 arg1Of expression,protein
R187 T406 T407 arg1Of expression,","
R188 T406 T409 arg1Of expression,as
R189 T406 T419 arg1Of expression,was
R190 T406 T420 arg2Of expression,elevated
R191 T409 T408 arg1Of as,such
R192 T411 T410 arg2Of caspase-3,cleaved
R193 T411 T413 arg2Of caspase-3,cleaved
R194 T411 T416 arg1Of caspase-3,and
R195 T413 T412 arg1Of cleaved,","
R196 T414 T413 arg3Of PARP,cleaved
R197 T416 T409 arg2Of and,as
R198 T416 T415 arg1Of and,","
R199 T417 T416 arg2Of Bax,and
R200 T420 T418 arg1Of elevated,","
R201 T420 T419 arg2Of elevated,was
R202 T420 T421 arg1Of elevated,","
R203 T420 T422 arg1Of elevated,whereas
R204 T427 T423 arg1Of levels,the
R205 T427 T424 arg1Of levels,survival
R206 T427 T425 arg1Of levels,protein
R207 T427 T426 arg1Of levels,expression
R208 T427 T428 arg1Of levels,","
R209 T427 T430 arg1Of levels,as
R210 T427 T435 arg1Of levels,was
R211 T427 T436 arg2Of levels,decreased
R212 T430 T429 arg1Of as,such
R213 T431 T430 arg2Of Bcl-2,as
R214 T431 T432 arg1Of Bcl-2,","
R215 T433 T432 arg2Of C-IAP1,","
R216 T436 T422 arg2Of decreased,whereas
R217 T436 T434 arg1Of decreased,","
R218 T436 T435 arg2Of decreased,was
R219 T436 T437 arg1Of decreased,in
R220 T440 T437 arg2Of tissues,in
R221 T440 T438 arg1Of tissues,the
R222 T440 T439 arg1Of tissues,melanoma
R223 T440 T441 arg1Of tissues,of
R224 T443 T441 arg2Of mice,of
R225 T443 T442 arg1Of mice,CCR5−/−
R226 T446 T447 arg1Of we,found
R227 T447 T444 arg1Of found,Interestingly
R228 T447 T445 arg1Of found,","
R229 T450 T449 arg1Of level,the
R230 T450 T451 arg1Of level,of
R231 T450 T453 arg1Of level,","
R232 T450 T460 arg1Of level,was
R233 T450 T462 arg2Of level,elevated
R234 T452 T451 arg2Of IL-1Ra,of
R235 T458 T453 arg2Of cytokine,","
R236 T458 T454 arg1Of cytokine,a
R237 T458 T455 arg1Of cytokine,tumor
R238 T458 T456 arg1Of cytokine,growth
R239 T458 T457 arg1Of cytokine,suppressive
R240 T462 T447 arg2Of elevated,found
R241 T462 T448 arg1Of elevated,that
R242 T462 T459 arg1Of elevated,","
R243 T462 T460 arg2Of elevated,was
R244 T462 T461 arg1Of elevated,significantly
R245 T462 T463 arg1Of elevated,in
R246 T465 T464 arg1Of tissue,tumor
R247 T465 T466 arg1Of tissue,and
R248 T466 T463 arg2Of and,in
R249 T466 T471 arg1Of and,compared
R250 T467 T466 arg2Of spleen,and
R251 T467 T468 arg1Of spleen,of
R252 T470 T468 arg2Of mice,of
R253 T470 T469 arg1Of mice,CCR5−/−
R254 T472 T471 arg2Of to,compared
R255 T474 T472 arg2Of level,to
R256 T474 T473 arg1Of level,the
R257 T474 T475 arg1Of level,in
R258 T477 T475 arg2Of mice,in
R259 T477 T476 arg1Of mice,CCR5+/+
R260 T480 T481 arg1Of infiltration,of
R261 T480 T491 arg1Of infiltration,was
R262 T480 T493 arg2Of infiltration,increased
R263 T485 T482 arg1Of cell,CD8+
R264 T485 T483 arg1Of cell,cytotoxic
R265 T485 T484 arg1Of cell,T
R266 T485 T486 arg1Of cell,and
R267 T486 T481 arg2Of and,of
R268 T490 T486 arg2Of cells,and
R269 T490 T487 arg1Of cells,CD57+
R270 T490 T488 arg1Of cells,natural
R271 T490 T489 arg1Of cells,killer
R272 T493 T478 arg1Of increased,Moreover
R273 T493 T479 arg1Of increased,","
R274 T493 T491 arg2Of increased,was
R275 T493 T492 arg1Of increased,significantly
R276 T493 T494 arg1Of increased,in
R277 T496 T497 arg1Of tumor,and
R278 T498 T497 arg2Of spleen,and
R279 T499 T494 arg2Of tissue,in
R280 T499 T495 arg1Of tissue,melanoma
R281 T499 T496 arg1Of tissue,tumor
R282 T499 T498 arg1Of tissue,spleen
R283 T499 T500 arg1Of tissue,of
R284 T502 T500 arg2Of mice,of
R285 T502 T501 arg1Of mice,CCR5−/−
R286 T502 T503 arg2Of mice,compared
R287 T503 T504 arg1Of compared,to
R288 T505 T504 arg2Of that,to
R289 T505 T506 arg1Of that,of
R290 T508 T506 arg2Of mice,of
R291 T508 T507 arg1Of mice,CCR5+/+
R292 T512 T511 arg1Of results,these
R293 T512 T513 arg1Of results,showed
R294 T513 T509 arg1Of showed,Therefore
R295 T513 T510 arg1Of showed,","
R296 T516 T515 arg1Of deficiency,CCR5
R297 T516 T517 arg1Of deficiency,caused
R298 T517 T513 arg2Of caused,showed
R299 T517 T514 arg1Of caused,that
R300 T517 T523 arg1Of caused,through
R301 T520 T517 arg2Of death,caused
R302 T520 T518 arg1Of death,apoptotic
R303 T520 T519 arg1Of death,cell
R304 T520 T521 arg1Of death,of
R305 T522 T521 arg2Of melanoma,of
R306 T524 T523 arg2Of inhibition,through
R307 T524 T525 arg1Of inhibition,of
R3070 T4601 T4602 arg1Of Inhibition,of
R3071 T4601 T4605 arg1Of Inhibition,in
R3072 T4604 T4602 arg2Of Development,of
R3073 T4604 T4603 arg1Of Development,Tumor
R3074 T4607 T4605 arg2Of Mice,in
R3075 T4607 T4606 arg1Of Mice,CCR5−/−
R3076 T4609 T4608 arg1Of effect,The
R3077 T4609 T4610 arg1Of effect,of
R3078 T4609 T4612 arg1Of effect,in
R3079 T4609 T4615 arg1Of effect,was
R308 T526 T527 arg1Of NF-κB,and
R3080 T4609 T4616 arg2Of effect,investigated
R3081 T4611 T4610 arg2Of CCR5,of
R3082 T4614 T4612 arg2Of development,in
R3083 T4614 T4613 arg1Of development,tumor
R3084 T4616 T4615 arg2Of investigated,was
R3085 T4617 T4616 arg3Of using,investigated
R3086 T4618 T4619 arg1Of CCR5+/+,and
R3087 T4619 T4617 arg2Of and,using
R3088 T4621 T4619 arg2Of mice,and
R3089 T4621 T4620 arg1Of mice,CCR5−/−
R309 T527 T525 arg2Of and,of
R3090 T4624 T4622 arg1Of cells,B16-F0
R3091 T4624 T4623 arg1Of cells,melanoma
R3092 T4624 T4625 arg1Of cells,were
R3093 T4624 T4626 arg2Of cells,inoculated
R3094 T4626 T4625 arg2Of inoculated,were
R3095 T4626 T4627 arg1Of inoculated,subcutaneously
R3096 T4626 T4628 arg1Of inoculated,into
R3097 T4629 T4630 arg1Of CCR5+/+,and
R3098 T4631 T4630 arg2Of CCR5−/−,and
R3099 T4632 T4628 arg2Of mice,into
R310 T528 T527 arg2Of upregulation,and
R3100 T4632 T4629 arg1Of mice,CCR5+/+
R3101 T4632 T4631 arg1Of mice,CCR5−/−
R3102 T4632 T4633 arg1Of mice,(
R3103 T4634 T4633 arg2Of n = 20,(
R3104 T4635 T4633 arg3Of ),(
R3105 T4637 T4636 arg1Of growth,Tumor
R3106 T4637 T4638 arg1Of growth,was
R3107 T4637 T4639 arg2Of growth,monitored
R3108 T4639 T4638 arg2Of monitored,was
R3109 T4639 T4640 arg1Of monitored,for
R311 T528 T529 arg1Of upregulation,of
R3110 T4642 T4640 arg2Of days,for
R3111 T4642 T4641 arg1Of days,31
R3112 T4644 T4643 arg1Of growth,Tumor
R3113 T4644 T4645 arg1Of growth,in
R3114 T4644 T4649 arg1Of growth,was
R3115 T4644 T4651 arg1Of growth,lower
R3116 T4648 T4645 arg2Of mice,in
R3117 T4648 T4646 arg1Of mice,the
R3118 T4648 T4647 arg1Of mice,CCR5−/−
R3119 T4651 T4649 arg2Of lower,was
R312 T530 T529 arg2Of IL-1Ra,of
R3120 T4651 T4650 arg1Of lower,significantly
R3121 T4651 T4652 arg1Of lower,than
R3122 T4653 T4652 arg2Of that,than
R3123 T4653 T4654 arg1Of that,in
R3124 T4657 T4654 arg2Of mice,in
R3125 T4657 T4655 arg1Of mice,the
R3126 T4657 T4656 arg1Of mice,CCR5+/+
R3127 T4660 T4658 arg1Of growth,The
R3128 T4660 T4659 arg1Of growth,tumor
R3129 T4660 T4661 arg1Of growth,in
R3130 T4660 T4665 arg1Of growth,was
R3131 T4660 T4666 arg2Of growth,reduced
R3132 T4664 T4661 arg2Of mice,in
R3133 T4664 T4662 arg1Of mice,the
R3134 T4664 T4663 arg1Of mice,CCR5−/−
R3135 T4666 T4665 arg2Of reduced,was
R3136 T4666 T4667 arg1Of reduced,to
R3137 T4666 T4671 arg1Of reduced,whereas
R3138 T4669 T4667 arg2Of %,to
R3139 T4669 T4668 arg1Of %,19.1
R3140 T4671 T4670 arg1Of whereas,","
R3141 T4674 T4672 arg1Of growth,the
R3142 T4674 T4673 arg1Of growth,tumor
R3143 T4674 T4675 arg1Of growth,in
R3144 T4674 T4679 arg1Of growth,was
R3145 T4674 T4681 arg2Of growth,reduced
R3146 T4678 T4675 arg2Of mice,in
R3147 T4678 T4676 arg1Of mice,the
R3148 T4678 T4677 arg1Of mice,CCR5+/+
R3149 T4681 T4671 arg2Of reduced,whereas
R3150 T4681 T4679 arg2Of reduced,was
R3151 T4681 T4680 arg1Of reduced,only
R3152 T4681 T4682 arg1Of reduced,to
R3153 T4681 T4685 arg1Of reduced,","
R3154 T4681 T4686 arg1Of reduced,in
R3155 T4684 T4682 arg2Of %,to
R3156 T4684 T4683 arg1Of %,24.3
R3157 T4689 T4687 arg1Of weight,both
R3158 T4689 T4688 arg1Of weight,tumor
R3159 T4689 T4690 arg1Of weight,(
R3160 T4689 T4696 arg1Of weight,and
R3161 T4692 T4691 arg1Of 1A,Figure
R3162 T4692 T4693 arg1Of 1A,and
R3163 T4693 T4690 arg2Of and,(
R3164 T4694 T4693 arg2Of 1B,and
R3165 T4695 T4690 arg3Of ),(
R3166 T4696 T4686 arg2Of and,in
R3167 T4698 T4696 arg2Of volume,and
R3168 T4698 T4697 arg1Of volume,tumor
R3169 T4698 T4699 arg1Of volume,","
R3170 T4698 T4700 arg1Of volume,respectively
R3171 T4698 T4701 arg1Of volume,(
R3172 T4703 T4702 arg1Of 1A,Figure
R3173 T4703 T4704 arg1Of 1A,and
R3174 T4704 T4701 arg2Of and,(
R3175 T4705 T4704 arg2Of 1C,and
R3176 T4706 T4701 arg3Of ),(
R3177 T4708 T4707 arg1Of results,These
R3178 T4708 T4709 arg1Of results,correlated
R3179 T4709 T4710 arg1Of correlated,with
R3180 T4713 T4710 arg2Of rates,with
R3181 T4713 T4711 arg1Of rates,mice
R3182 T4713 T4712 arg1Of rates,survival
R3183 T4714 T4715 arg1Of There,was
R3184 T4715 T4719 arg1Of was,in
R3185 T4718 T4715 arg2Of difference,was
R3186 T4718 T4716 arg1Of difference,a
R3187 T4718 T4717 arg1Of difference,significant
R3188 T4721 T4719 arg2Of rates,in
R3189 T4721 T4720 arg1Of rates,survival
R3190 T4721 T4722 arg1Of rates,between
R3191 T4721 T4739 arg1Of rates,at
R3192 T4721 T4745 arg1Of rates,(
R3193 T4724 T4723 arg1Of mice,CCR5−/−
R3194 T4724 T4725 arg1Of mice,(
R3195 T4724 T4732 arg1Of mice,and
R3196 T4727 T4725 arg2Of %,(
R3197 T4727 T4726 arg1Of %,75
R3198 T4727 T4728 arg1Of %,of
R3199 T4729 T4728 arg2Of starting,of
R3200 T4730 T4729 arg2Of time,starting
R3201 T4731 T4725 arg3Of ),(
R3202 T4732 T4722 arg2Of and,between
R3203 T4734 T4732 arg2Of mice,and
R3204 T4734 T4733 arg1Of mice,CCR5+/+
R3205 T4734 T4735 arg1Of mice,(
R3206 T4737 T4735 arg2Of %,(
R3207 T4737 T4736 arg1Of %,15
R3208 T4738 T4735 arg3Of ),(
R3209 T4741 T4739 arg2Of end,at
R3210 T4741 T4740 arg1Of end,the
R3211 T4741 T4742 arg1Of end,of
R3212 T4744 T4742 arg2Of experiment,of
R3213 T4744 T4743 arg1Of experiment,the
R3214 T4747 T4745 arg2Of 1D,(
R3215 T4747 T4746 arg1Of 1D,Figure
R3216 T4748 T4745 arg3Of ),(
R3217 T4749 T4750 arg1Of There,was
R3218 T4753 T4750 arg2Of difference,was
R3219 T4753 T4751 arg1Of difference,a
R3220 T4753 T4752 arg1Of difference,significant
R3221 T4753 T4754 arg1Of difference,in
R3222 T4753 T4757 arg1Of difference,between
R3223 T4756 T4754 arg2Of rates,in
R3224 T4756 T4755 arg1Of rates,survival
R3225 T4759 T4758 arg1Of mice,CCR5−/−
R3226 T4759 T4760 arg1Of mice,and
R3227 T4760 T4757 arg2Of and,between
R3228 T4762 T4760 arg2Of mice,and
R3229 T4762 T4761 arg1Of mice,CCR5+/+
R3230 T4765 T4763 arg2Of end,At
R3231 T4765 T4764 arg1Of end,the
R3232 T4765 T4766 arg1Of end,of
R3233 T4768 T4766 arg2Of experiment,of
R3234 T4768 T4767 arg1Of experiment,the
R3235 T4771 T4770 arg1Of %,75
R3236 T4771 T4772 arg1Of %,of
R3237 T4771 T4776 arg1Of %,survived
R3238 T4775 T4772 arg2Of mice,of
R3239 T4775 T4773 arg1Of mice,the
R3240 T4775 T4774 arg1Of mice,CCR5−/−
R3241 T4776 T4763 arg1Of survived,At
R3242 T4776 T4769 arg1Of survived,","
R3243 T4776 T4777 arg1Of survived,while
R3244 T4779 T4778 arg1Of 15,only
R3245 T4780 T4779 arg1Of %,15
R3246 T4780 T4781 arg1Of %,of
R3247 T4780 T4785 arg1Of %,survived
R3248 T4784 T4781 arg2Of mice,of
R3249 T4784 T4782 arg1Of mice,the
R3250 T4784 T4783 arg1Of mice,CCR5+/+
R3251 T4785 T4777 arg2Of survived,while
R3252 T4787 T4786 arg1Of tumors,Subcutaneous
R3253 T4787 T4788 arg1Of tumors,were
R3254 T4787 T4789 arg2Of tumors,harvested
R3255 T4789 T4788 arg2Of harvested,were
R3256 T4789 T4790 arg1Of harvested,from
R3257 T4789 T4795 arg1Of harvested,days
R3258 T4793 T4790 arg2Of mice,from
R3259 T4793 T4791 arg1Of mice,the
R3260 T4793 T4792 arg2Of mice,sacrificed
R3261 T4795 T4794 arg1Of days,31
R3262 T4795 T4796 arg1Of days,after
R3263 T4797 T4796 arg2Of inoculation,after
R3264 T4800 T4798 arg1Of analysis,The
R3265 T4800 T4799 arg1Of analysis,immunohistochemical
R3266 T4800 T4801 arg1Of analysis,of
R3267 T4800 T4804 arg1Of analysis,","
R3268 T4800 T4805 arg2Of analysis,stained
R3269 T4800 T4816 arg1Of analysis,revealed
R3270 T4803 T4801 arg2Of sections,of
R3271 T4803 T4802 arg1Of sections,tumor
R3272 T4805 T4806 arg1Of stained,with
R3273 T4805 T4811 arg1Of stained,for
R3274 T4806 T4810 arg1Of with,and
R3275 T4809 T4806 arg2Of E,with
R3276 T4809 T4807 arg1Of E,H
R3277 T4809 T4808 arg1Of E,&
R3278 T4811 T4810 arg2Of for,and
R3279 T4814 T4811 arg2Of PCNA,for
R3280 T4814 T4812 arg1Of PCNA,proliferation
R3281 T4814 T4813 arg1Of PCNA,antigen
R3282 T4816 T4815 arg1Of revealed,","
R3283 T4818 T4816 arg2Of inhibition,revealed
R3284 T4818 T4817 arg1Of inhibition,greater
R3285 T4818 T4819 arg1Of inhibition,of
R3286 T4822 T4819 arg2Of growth,of
R3287 T4822 T4820 arg1Of growth,tumor
R3288 T4822 T4821 arg1Of growth,cell
R3289 T4822 T4823 arg1Of growth,in
R3290 T4825 T4823 arg2Of mice,in
R3291 T4825 T4824 arg1Of mice,CCR5−/−
R3292 T4828 T4826 arg1Of findings,The
R3293 T4828 T4827 arg1Of findings,histologic
R3294 T4828 T4829 arg1Of findings,after
R3295 T4828 T4834 arg1Of findings,indicated
R3296 T4833 T4829 arg2Of staining,after
R3297 T4833 T4830 arg1Of staining,H
R3298 T4833 T4831 arg1Of staining,&
R3299 T4833 T4832 arg1Of staining,E
R3300 T4838 T4836 arg1Of tissues,the
R3301 T4838 T4837 arg1Of tissues,tumor
R3302 T4838 T4839 arg1Of tissues,of
R3303 T4838 T4844 arg1Of tissues,but
R3304 T4842 T4839 arg2Of mice,of
R3305 T4842 T4840 arg1Of mice,the
R3306 T4842 T4841 arg1Of mice,CCR5−/−
R3307 T4844 T4843 arg1Of but,","
R3308 T4844 T4845 arg1Of but,not
R3309 T4844 T4852 arg1Of but,contained
R3310 T4846 T4844 arg2Of those,but
R3311 T4846 T4847 arg1Of those,of
R3312 T4850 T4847 arg2Of mice,of
R3313 T4850 T4848 arg1Of mice,the
R3314 T4850 T4849 arg1Of mice,CCR5+/+
R3315 T4852 T4834 arg2Of contained,indicated
R3316 T4852 T4835 arg1Of contained,that
R3317 T4852 T4851 arg1Of contained,","
R3318 T4854 T4852 arg2Of areas,contained
R3319 T4854 T4853 arg1Of areas,large
R3320 T4854 T4855 arg1Of areas,of
R3321 T4856 T4855 arg2Of necrosis,of
R3322 T4859 T4857 arg1Of cells,PCNA
R3323 T4859 T4858 arg1Of cells,reactive
R3324 T4859 T4860 arg1Of cells,were
R3325 T4859 T4862 arg2Of cells,reduced
R3326 T4862 T4860 arg2Of reduced,were
R3327 T4862 T4861 arg1Of reduced,significantly
R3328 T4862 T4863 arg1Of reduced,in
R3329 T4866 T4863 arg2Of mice,in
R3330 T4866 T4864 arg1Of mice,the
R3331 T4866 T4865 arg1Of mice,CCR5−/−
R3332 T4866 T4867 arg1Of mice,(
R3333 T4869 T4867 arg2Of 1E,(
R3334 T4869 T4868 arg1Of 1E,Figure
R3335 T4870 T4867 arg3Of ),(
R3696 T5481 T5482 arg1Of Decrease,of
R3697 T5481 T5485 arg1Of Decrease,in
R3698 T5484 T5482 arg2Of Activity,of
R3699 T5484 T5483 arg1Of Activity,NF-κB
R3700 T5487 T5485 arg2Of Tissue,in
R3701 T5487 T5486 arg1Of Tissue,Tumor
R3702 T5487 T5488 arg1Of Tissue,of
R3703 T5490 T5488 arg2Of Mice,of
R3704 T5490 T5489 arg1Of Mice,CCR5−/−
R3705 T5492 T5491 arg1Of activation,The
R3706 T5492 T5493 arg1Of activation,of
R3707 T5492 T5495 arg1Of activation,plays
R3708 T5494 T5493 arg2Of NF-κB,of
R3709 T5495 T5499 arg1Of plays,in
R3710 T5495 T5509 arg1Of plays,in
R3711 T5498 T5495 arg2Of role,plays
R3712 T5498 T5496 arg1Of role,a
R3713 T5498 T5497 arg1Of role,critical
R3714 T5499 T5508 arg1Of in,and
R3715 T5502 T5500 arg1Of survival,cancer
R3716 T5502 T5501 arg1Of survival,cell
R3717 T5502 T5503 arg1Of survival,","
R3718 T5503 T5499 arg2Of ",",in
R3719 T5507 T5503 arg2Of cells,","
R3720 T5507 T5504 arg1Of cells,especially
R3721 T5507 T5505 arg1Of cells,melanoma
R3722 T5507 T5506 arg1Of cells,cancer
R3723 T5509 T5508 arg2Of in,and
R3724 T5511 T5509 arg2Of expression,in
R3725 T5511 T5510 arg1Of expression,CCR5
R3726 T5513 T5512 arg1Of evaluate,To
R3727 T5517 T5515 arg1Of inhibition,the
R3728 T5517 T5516 arg1Of inhibition,tumor
R3729 T5517 T5518 arg1Of inhibition,was
R3730 T5517 T5519 arg2Of inhibition,related
R3731 T5519 T5513 arg2Of related,evaluate
R3732 T5519 T5514 arg1Of related,whether
R3733 T5519 T5518 arg2Of related,was
R3734 T5519 T5520 arg1Of related,with
R3735 T5522 T5520 arg2Of inactivation,with
R3736 T5522 T5521 arg1Of inactivation,the
R3737 T5522 T5523 arg1Of inactivation,of
R3738 T5522 T5525 arg1Of inactivation,in
R3739 T5524 T5523 arg2Of NF-κB,of
R3740 T5526 T5525 arg2Of melanoma,in
R3741 T5531 T5528 arg1Of activity,the
R3742 T5531 T5529 arg1Of activity,DNA
R3743 T5531 T5530 arg1Of activity,binding
R3744 T5531 T5532 arg1Of activity,of
R3745 T5531 T5534 arg1Of activity,was
R3746 T5531 T5535 arg2Of activity,determined
R3747 T5533 T5532 arg2Of NF-κB,of
R3748 T5535 T5512 modOf determined,To
R3749 T5535 T5527 arg1Of determined,","
R3750 T5535 T5534 arg2Of determined,was
R3751 T5539 T5535 arg1Of assay,determined
R3752 T5539 T5536 arg2Of assay,by
R3753 T5539 T5537 arg1Of assay,electromobility
R3754 T5539 T5538 arg1Of assay,shift
R3755 T5539 T5540 arg1Of assay,(
R3756 T5539 T5543 arg1Of assay,in
R3757 T5541 T5540 arg2Of EMSA,(
R3758 T5542 T5540 arg3Of ),(
R3759 T5545 T5543 arg2Of tissue,in
R3760 T5545 T5544 arg1Of tissue,melanoma
R3761 T5548 T5547 arg1Of activated,constitutively
R3762 T5551 T5546 arg1Of activity,The
R3763 T5551 T5548 arg1Of activity,activated
R3764 T5551 T5549 arg1Of activity,DNA
R3765 T5551 T5550 arg1Of activity,binding
R3766 T5551 T5552 arg1Of activity,was
R3767 T5551 T5553 arg2Of activity,reduced
R3768 T5553 T5552 arg2Of reduced,was
R3769 T5553 T5554 arg1Of reduced,in
R3770 T5559 T5554 arg2Of tissue,in
R3771 T5559 T5555 arg1Of tissue,the
R3772 T5559 T5556 arg1Of tissue,CCR5−/−
R3773 T5559 T5557 arg1Of tissue,mice
R3774 T5559 T5558 arg1Of tissue,tumor
R3775 T5559 T5560 arg1Of tissue,(
R3776 T5562 T5560 arg2Of 2A,(
R3777 T5562 T5561 arg1Of 2A,Figure
R3778 T5563 T5560 arg3Of ),(
R3779 T5567 T5566 arg1Of translocation,the
R3780 T5567 T5568 arg1Of translocation,of
R3781 T5567 T5582 arg1Of translocation,was
R3782 T5567 T5584 arg2Of translocation,prevented
R3783 T5569 T5570 arg1Of p50,and
R3784 T5570 T5568 arg2Of and,of
R3785 T5570 T5572 arg1Of and,into
R3786 T5570 T5575 arg1Of and,through
R3787 T5571 T5570 arg2Of p-p65,and
R3788 T5574 T5572 arg2Of nucleus,into
R3789 T5574 T5573 arg1Of nucleus,the
R3790 T5577 T5575 arg2Of inhibition,through
R3791 T5577 T5576 arg1Of inhibition,the
R3792 T5577 T5578 arg1Of inhibition,of
R3793 T5579 T5578 arg2Of phosphorylation,of
R3794 T5579 T5580 arg1Of phosphorylation,of
R3795 T5581 T5580 arg2Of IκB,of
R3796 T5584 T5564 arg1Of prevented,Moreover
R3797 T5584 T5565 arg1Of prevented,","
R3798 T5584 T5582 arg2Of prevented,was
R3799 T5584 T5583 arg1Of prevented,also
R3800 T5584 T5585 arg1Of prevented,in
R3801 T5588 T5585 arg2Of tissues,in
R3802 T5588 T5586 arg1Of tissues,the
R3803 T5588 T5587 arg1Of tissues,tumor
R3804 T5588 T5589 arg1Of tissues,of
R3805 T5591 T5589 arg2Of mice,of
R3806 T5591 T5590 arg1Of mice,CCR5−/−
R3807 T5591 T5592 arg1Of mice,(
R3808 T5594 T5592 arg2Of 2B,(
R3809 T5594 T5593 arg1Of 2B,Figure
R3810 T5595 T5592 arg3Of ),(
R3811 T5597 T5596 arg1Of analysis,Immunofluorescence
R3812 T5597 T5599 arg1Of analysis,confirmed
R3813 T5599 T5598 arg1Of confirmed,also
R3814 T5602 T5601 arg1Of intensity,the
R3815 T5602 T5603 arg1Of intensity,of
R3816 T5602 T5606 arg1Of intensity,for
R3817 T5602 T5608 arg1Of intensity,had
R3818 T5602 T5609 arg1Of intensity,decreased
R3819 T5605 T5603 arg2Of staining,of
R3820 T5605 T5604 arg1Of staining,nuclear
R3821 T5607 T5606 arg2Of p50,for
R3822 T5609 T5599 arg2Of decreased,confirmed
R3823 T5609 T5600 arg1Of decreased,that
R3824 T5609 T5608 arg2Of decreased,had
R3825 T5609 T5610 arg1Of decreased,in
R3826 T5613 T5610 arg2Of tissues,in
R3827 T5613 T5611 arg1Of tissues,the
R3828 T5613 T5612 arg1Of tissues,tumor
R3829 T5613 T5614 arg1Of tissues,of
R3830 T5616 T5614 arg2Of mice,of
R3831 T5616 T5615 arg1Of mice,CCR5−/−
R3832 T5616 T5617 arg1Of mice,(
R3833 T5619 T5617 arg2Of 2C,(
R3834 T5619 T5618 arg1Of 2C,Figure
R3835 T5620 T5617 arg3Of ),(
R4059 T6030 T6031 arg1Of Induction,of
R4060 T6030 T6035 arg1Of Induction,and
R4061 T6034 T6031 arg2Of Death,of
R4062 T6034 T6032 arg1Of Death,Apoptotic
R4063 T6034 T6033 arg1Of Death,Cell
R4064 T6036 T6035 arg2Of Inhibition,and
R4065 T6036 T6037 arg1Of Inhibition,of
R4066 T6039 T6037 arg2Of Expression,of
R4067 T6039 T6038 arg1Of Expression,the
R4068 T6039 T6040 arg1Of Expression,of
R4069 T6039 T6043 arg1Of Expression,in
R4070 T6042 T6040 arg2Of Proteins,of
R4071 T6042 T6041 arg1Of Proteins,Anti-apoptotic
R4072 T6045 T6043 arg2Of Mice,in
R4073 T6045 T6044 arg1Of Mice,CCR5−/−
R4074 T6047 T6046 arg1Of see,To
R4075 T6049 T6050 arg1Of inhibition,of
R4076 T6049 T6053 arg1Of inhibition,results
R4077 T6052 T6050 arg2Of activity,of
R4078 T6052 T6051 arg1Of activity,NF-κB
R4079 T6053 T6047 arg2Of results,see
R4080 T6053 T6048 arg1Of results,whether
R4081 T6053 T6054 arg1Of results,in
R4082 T6056 T6057 arg1Of induction,of
R4083 T6056 T6061 arg1Of induction,and
R4084 T6060 T6057 arg2Of death,of
R4085 T6060 T6058 arg1Of death,apoptotic
R4086 T6060 T6059 arg1Of death,cell
R4087 T6061 T6054 arg2Of and,in
R4088 T6061 T6055 arg1Of and,the
R4089 T6062 T6061 arg2Of expression,and
R4090 T6062 T6063 arg1Of expression,of
R4091 T6070 T6063 arg2Of protein,of
R4092 T6070 T6064 arg1Of protein,NF-κB
R4093 T6070 T6065 arg1Of protein,target
R4094 T6070 T6066 arg1Of protein,apoptotic
R4095 T6070 T6067 arg1Of protein,cell
R4096 T6070 T6068 arg1Of protein,death
R4097 T6070 T6069 arg1Of protein,regulatory
R4098 T6073 T6047 arg1Of levels,see
R4099 T6073 T6072 arg1Of levels,the
R4100 T6073 T6074 arg1Of levels,of
R4101 T6073 T6086 arg1Of levels,were
R4102 T6073 T6087 arg2Of levels,assessed
R4103 T6077 T6075 arg1Of death,apoptotic
R4104 T6077 T6076 arg1Of death,cell
R4105 T6077 T6078 arg1Of death,and
R4106 T6078 T6074 arg2Of and,of
R4107 T6079 T6078 arg2Of expression,and
R4108 T6079 T6080 arg1Of expression,of
R4109 T6085 T6080 arg2Of proteins,of
R4110 T6085 T6081 arg1Of proteins,apoptotic
R4111 T6085 T6082 arg1Of proteins,cell
R4112 T6085 T6083 arg1Of proteins,death
R4113 T6085 T6084 arg1Of proteins,regulatory
R4114 T6087 T6046 modOf assessed,To
R4115 T6087 T6071 arg1Of assessed,","
R4116 T6087 T6086 arg2Of assessed,were
R4117 T6090 T6088 arg1Of death,Apoptotic
R4118 T6090 T6089 arg1Of death,cell
R4119 T6090 T6091 arg1Of death,in
R4120 T6090 T6095 arg1Of death,were
R4121 T6090 T6096 arg2Of death,evaluated
R4122 T6094 T6091 arg2Of sections,in
R4123 T6094 T6092 arg1Of sections,the
R4124 T6094 T6093 arg1Of sections,tumor
R4125 T6096 T6095 arg2Of evaluated,were
R4126 T6096 T6097 arg1Of evaluated,in
R4127 T6099 T6100 arg1Of CCR5+/+,and
R4128 T6101 T6100 arg2Of CCR5−/−,and
R4129 T6102 T6097 arg2Of mice,in
R4130 T6102 T6098 arg1Of mice,the
R4131 T6102 T6099 arg1Of mice,CCR5+/+
R4132 T6102 T6101 arg1Of mice,CCR5−/−
R4133 T6102 T6103 arg1Of mice,that
R4134 T6102 T6104 arg1Of mice,were
R4135 T6102 T6105 arg2Of mice,inoculated
R4136 T6105 T6104 arg2Of inoculated,were
R4137 T6105 T6106 arg1Of inoculated,with
R4138 T6108 T6106 arg2Of cells,with
R4139 T6108 T6107 arg1Of cells,melanoma
R4140 T6110 T6109 arg1Of staining,TUNEL
R4141 T6110 T6111 arg1Of staining,revealed
R4142 T6114 T6111 arg2Of frequency,revealed
R4143 T6114 T6112 arg1Of frequency,a
R4144 T6114 T6113 arg1Of frequency,higher
R4145 T6114 T6115 arg1Of frequency,of
R4146 T6114 T6119 arg1Of frequency,in
R4147 T6118 T6115 arg2Of death,of
R4148 T6118 T6116 arg1Of death,apoptotic
R4149 T6118 T6117 arg1Of death,cell
R4150 T6122 T6119 arg2Of tissues,in
R4151 T6122 T6120 arg1Of tissues,the
R4152 T6122 T6121 arg1Of tissues,tumor
R4153 T6122 T6123 arg1Of tissues,of
R4154 T6122 T6127 arg1Of tissues,than
R4155 T6126 T6123 arg2Of mice,of
R4156 T6126 T6124 arg1Of mice,the
R4157 T6126 T6125 arg1Of mice,CCR5−/−
R4158 T6128 T6127 arg2Of that,than
R4159 T6128 T6129 arg1Of that,of
R4160 T6132 T6129 arg2Of mice,of
R4161 T6132 T6130 arg1Of mice,the
R4162 T6132 T6131 arg1Of mice,CCR5+/+
R4163 T6132 T6133 arg1Of mice,(
R4164 T6135 T6133 arg2Of 3A,(
R4165 T6135 T6134 arg1Of 3A,Figure
R4166 T6136 T6133 arg3Of ),(
R4167 T6137 T6138 arg1Of Immunohistochemical,and
R4168 T6138 T6140 arg1Of and,showed
R4169 T6139 T6138 arg2Of immunofluorescence,and
R4170 T6143 T6142 arg1Of levels,high
R4171 T6143 T6144 arg1Of levels,of
R4172 T6143 T6149 arg1Of levels,were
R4173 T6143 T6150 arg2Of levels,found
R4174 T6146 T6147 arg1Of caspase-3,and
R4175 T6147 T6144 arg2Of and,of
R4176 T6147 T6145 arg2Of and,cleaved
R4177 T6148 T6147 arg2Of Bax,and
R4178 T6150 T6140 arg2Of found,showed
R4179 T6150 T6141 arg1Of found,that
R4180 T6150 T6149 arg2Of found,were
R4181 T6150 T6152 arg1Of found,frequently
R4182 T6150 T6153 arg1Of found,in
R4183 T6152 T6151 arg1Of frequently,more
R4184 T6156 T6153 arg2Of mice,in
R4185 T6156 T6154 arg1Of mice,the
R4186 T6156 T6155 arg1Of mice,CCR5−/−
R4187 T6156 T6157 arg1Of mice,than
R4188 T6158 T6157 arg2Of in,than
R4189 T6161 T6158 arg2Of mice,in
R4190 T6161 T6159 arg1Of mice,the
R4191 T6161 T6160 arg1Of mice,CCR5+/+
R4192 T6161 T6162 arg1Of mice,(
R4193 T6164 T6163 arg1Of 3B,Figure
R4194 T6164 T6165 arg1Of 3B,and
R4195 T6165 T6162 arg2Of and,(
R4196 T6166 T6165 arg2Of 3C,and
R4197 T6167 T6162 arg3Of ),(
R4198 T6168 T6169 arg1Of Consistent,with
R4199 T6172 T6169 arg2Of data,with
R4200 T6172 T6170 arg1Of data,the
R4201 T6172 T6171 arg1Of data,immunohistochemical
R4202 T6176 T6174 arg1Of analysis,Western
R4203 T6176 T6175 arg1Of analysis,blot
R4204 T6176 T6177 arg1Of analysis,of
R4205 T6176 T6180 arg1Of analysis,showed
R4206 T6179 T6177 arg2Of proteins,of
R4207 T6179 T6178 arg1Of proteins,tumor
R4208 T6180 T6168 arg1Of showed,Consistent
R4209 T6180 T6173 arg1Of showed,","
R4210 T6183 T6180 arg2Of levels,showed
R4211 T6183 T6181 arg1Of levels,greater
R4212 T6183 T6182 arg2Of levels,increased
R4213 T6183 T6184 arg1Of levels,of
R4214 T6183 T6188 arg2Of levels,cleaved
R4215 T6186 T6184 arg2Of caspase-3,of
R4216 T6186 T6185 arg2Of caspase-3,cleaved
R4217 T6188 T6187 arg1Of cleaved,","
R4218 T6189 T6188 arg3Of caspase-9,cleaved
R4219 T6189 T6191 arg2Of caspase-9,cleaved
R4220 T6191 T6190 arg1Of cleaved,","
R4221 T6191 T6195 arg1Of cleaved,","
R4222 T6191 T6196 arg1Of cleaved,whereas
R4223 T6192 T6193 arg1Of PARP,and
R4224 T6193 T6191 arg3Of and,cleaved
R4225 T6194 T6193 arg2Of Bax,and
R4226 T6198 T6197 arg1Of levels,the
R4227 T6198 T6199 arg1Of levels,of
R4228 T6198 T6203 arg1Of levels,were
R4229 T6198 T6205 arg2Of levels,decreased
R4230 T6200 T6201 arg1Of Bcl-2,and
R4231 T6201 T6199 arg2Of and,of
R4232 T6202 T6201 arg2Of C-IAP1,and
R4233 T6205 T6196 arg2Of decreased,whereas
R4234 T6205 T6203 arg2Of decreased,were
R4235 T6205 T6204 arg1Of decreased,significantly
R4236 T6205 T6206 arg1Of decreased,in
R4237 T6209 T6206 arg2Of tissues,in
R4238 T6209 T6207 arg1Of tissues,CCR5−/−
R4239 T6209 T6208 arg1Of tissues,mice
R4240 T6209 T6210 arg1Of tissues,(
R4241 T6212 T6210 arg2Of 3D,(
R4242 T6212 T6211 arg1Of 3D,Figure
R4243 T6213 T6210 arg3Of ),(
R43 T260 T261 arg1Of Deficiency,of
R44 T260 T266 arg1Of Deficiency,Suppresses
R45 T264 T261 arg2Of Receptor,of
R4504 T6715 T6716 arg1Of Upregulation,of
R4505 T6715 T6718 arg1Of Upregulation,in
R4506 T6717 T6716 arg2Of IL-1Ra,of
R4507 T6720 T6721 arg1Of Tumor,and
R4508 T6721 T6718 arg2Of and,in
R4509 T6721 T6719 arg1Of and,the
R4510 T6721 T6723 arg1Of and,of
R4511 T6722 T6721 arg2Of Spleen,and
R4512 T6725 T6723 arg2Of Mice,of
R4513 T6725 T6724 arg1Of Mice,CCR5−/−
R4514 T6727 T6726 arg1Of investigate,To
R4515 T6729 T6727 arg2Of difference,investigate
R4516 T6729 T6728 arg1Of difference,the
R4517 T6729 T6730 arg1Of difference,in
R4518 T6733 T6730 arg2Of levels,in
R4519 T6733 T6731 arg1Of levels,the
R4520 T6733 T6732 arg1Of levels,cytokine
R4521 T6733 T6734 arg1Of levels,between
R4522 T6736 T6737 arg1Of tumor,and
R4523 T6738 T6737 arg2Of spleen,and
R4524 T6739 T6734 arg2Of tissues,between
R4525 T6739 T6735 arg1Of tissues,the
R4526 T6739 T6736 arg1Of tissues,tumor
R4527 T6739 T6738 arg1Of tissues,spleen
R4528 T6739 T6740 arg1Of tissues,of
R4529 T6742 T6743 arg1Of CCR5+/+,and
R4530 T6744 T6743 arg2Of CCR5−/−,and
R4531 T6745 T6740 arg2Of mice,of
R4532 T6745 T6741 arg1Of mice,the
R4533 T6745 T6742 arg1Of mice,CCR5+/+
R4534 T6745 T6744 arg1Of mice,CCR5−/−
R4535 T6747 T6727 arg1Of we,investigate
R4536 T6747 T6748 arg1Of we,conducted
R4537 T6748 T6726 modOf conducted,To
R4538 T6748 T6746 arg1Of conducted,","
R4539 T6752 T6748 arg2Of assay,conducted
R4540 T6752 T6749 arg1Of assay,a
R4541 T6752 T6750 arg1Of assay,cytokine
R4542 T6752 T6751 arg1Of assay,array
R4543 T6752 T6753 arg1Of assay,using
R4544 T6757 T6753 arg2Of Array,using
R4545 T6757 T6754 arg1Of Array,a
R4546 T6757 T6755 arg1Of Array,Mouse
R4547 T6757 T6756 arg1Of Array,Proteome
R4548 T6757 T6758 arg1Of Array,(
R4549 T6760 T6758 arg2Of 4A,(
R4550 T6760 T6759 arg1Of 4A,Figure
R4551 T6761 T6758 arg3Of ),(
R4552 T6765 T6762 arg2Of cytokines,Among
R4553 T6765 T6763 arg1Of cytokines,40
R4554 T6765 T6764 arg2Of cytokines,tested
R4555 T6768 T6767 arg1Of levels,the
R4556 T6768 T6769 arg1Of levels,of
R4557 T6768 T6775 arg1Of levels,increased
R4558 T6770 T6771 arg1Of IL-1Ra,","
R4559 T6771 T6773 arg1Of ",",","
R4560 T6772 T6771 arg2Of MIG,","
R4561 T6773 T6769 arg2Of ",",of
R4562 T6774 T6773 arg2Of MIP-1α,","
R4563 T6775 T6762 arg1Of increased,Among
R4564 T6775 T6766 arg1Of increased,","
R4565 T6775 T6783 arg1Of increased,","
R4566 T6775 T6784 arg1Of increased,in
R4567 T6777 T6776 arg1Of 686,about
R4568 T6777 T6778 arg1Of 686,","
R4569 T6778 T6775 arg2Of ",",increased
R4570 T6778 T6780 arg1Of ",",and
R4571 T6778 T6782 arg1Of ",",respectively
R4572 T6779 T6778 arg2Of 9,","
R4573 T6782 T6781 arg1Of respectively,25-fold
R4574 T6786 T6784 arg2Of mice,in
R4575 T6786 T6785 arg1Of mice,CCR5−/−
R4576 T6786 T6787 arg1Of mice,compared
R4577 T6788 T6787 arg2Of to,compared
R4578 T6790 T6788 arg2Of mice,to
R4579 T6790 T6789 arg1Of mice,CCR5+/+
R4580 T6793 T6791 arg2Of technique,Using
R4581 T6793 T6792 arg1Of technique,this
R4582 T6797 T6791 arg1Of cytokines,Using
R4583 T6797 T6795 arg1Of cytokines,no
R4584 T6797 T6796 arg1Of cytokines,other
R4585 T6797 T6798 arg1Of cytokines,were
R4586 T6797 T6799 arg2Of cytokines,found
R4587 T6797 T6801 arg1Of cytokines,be
R4588 T6797 T6802 arg1Of cytokines,different
R4589 T6799 T6791 modOf found,Using
R4590 T6799 T6794 arg1Of found,","
R4591 T6799 T6798 arg2Of found,were
R4592 T6801 T6799 arg3Of be,found
R4593 T6801 T6800 arg1Of be,to
R4594 T6802 T6801 arg2Of different,be
R4595 T6802 T6803 arg1Of different,between
R4596 T6806 T6804 arg1Of mice,the
R4597 T6806 T6805 arg1Of mice,CCR5−/−
R4598 T6806 T6807 arg1Of mice,and
R4599 T6807 T6803 arg2Of and,between
R46 T264 T262 arg1Of Receptor,C-C
R4600 T6810 T6807 arg2Of mice,and
R4601 T6810 T6808 arg1Of mice,the
R4602 T6810 T6809 arg1Of mice,CCR5+/+
R4603 T6810 T6811 arg1Of mice,(
R4604 T6813 T6811 arg2Of 4B,(
R4605 T6813 T6812 arg1Of 4B,Figure
R4606 T6814 T6811 arg3Of ),(
R4607 T6818 T6815 arg1Of levels,Similar
R4608 T6818 T6816 arg1Of levels,altered
R4609 T6818 T6817 arg1Of levels,cytokine
R4610 T6818 T6819 arg1Of levels,were
R4611 T6818 T6820 arg2Of levels,found
R4612 T6820 T6819 arg2Of found,were
R4613 T6820 T6821 arg1Of found,in
R4614 T6823 T6821 arg2Of spleens,in
R4615 T6823 T6822 arg1Of spleens,the
R4616 T6823 T6824 arg1Of spleens,of
R4617 T6826 T6824 arg2Of mice,of
R4618 T6826 T6825 arg1Of mice,CCR5−/−
R4619 T6826 T6827 arg1Of mice,(
R4620 T6829 T6827 arg2Of 4C,(
R4621 T6829 T6828 arg1Of 4C,Figure
R4622 T6830 T6827 arg3Of ),(
R4623 T6834 T6832 arg1Of level,the
R4624 T6834 T6833 arg1Of level,IL-1Ra
R4625 T6834 T6835 arg1Of level,was
R4626 T6834 T6839 arg2Of level,elevated
R4627 T6838 T6837 arg1Of significantly,most
R4628 T6839 T6831 arg2Of elevated,Since
R4629 T6839 T6835 arg2Of elevated,was
R4630 T6839 T6836 arg1Of elevated,the
R4631 T6839 T6838 arg1Of elevated,significantly
R4632 T6842 T6841 arg1Of expression,the
R4633 T6842 T6843 arg1Of expression,of
R4634 T6842 T6845 arg1Of expression,in
R4635 T6842 T6850 arg1Of expression,was
R4636 T6842 T6851 arg2Of expression,analyzed
R4637 T6844 T6843 arg2Of IL-1Ra,of
R4638 T6846 T6847 arg1Of tumor,and
R4639 T6848 T6847 arg2Of spleen,and
R4640 T6849 T6845 arg2Of tissues,in
R4641 T6849 T6846 arg1Of tissues,tumor
R4642 T6849 T6848 arg1Of tissues,spleen
R4643 T6851 T6831 arg1Of analyzed,Since
R4644 T6851 T6840 arg1Of analyzed,","
R4645 T6851 T6850 arg2Of analyzed,was
R4646 T6853 T6854 arg1Of immunofluorescence,and
R4647 T6855 T6854 arg2Of western,and
R4648 T6856 T6851 arg1Of blotting,analyzed
R4649 T6856 T6852 arg2Of blotting,by
R4650 T6856 T6853 arg1Of blotting,immunofluorescence
R4651 T6856 T6855 arg1Of blotting,western
R4652 T6858 T6857 arg1Of expression,The
R4653 T6858 T6859 arg1Of expression,of
R4654 T6858 T6861 arg1Of expression,was
R4655 T6858 T6862 arg2Of expression,upregulated
R4656 T6860 T6859 arg2Of IL-1Ra,of
R4657 T6862 T6861 arg2Of upregulated,was
R4658 T6862 T6863 arg1Of upregulated,in
R4659 T6864 T6865 arg1Of tumor,and
R4660 T6866 T6865 arg2Of spleen,and
R4661 T6867 T6863 arg2Of tissues,in
R4662 T6867 T6864 arg1Of tissues,tumor
R4663 T6867 T6866 arg1Of tissues,spleen
R4664 T6867 T6868 arg1Of tissues,of
R4665 T6871 T6868 arg2Of mice,of
R4666 T6871 T6869 arg1Of mice,the
R4667 T6871 T6870 arg1Of mice,CCR5−/−
R4668 T6871 T6872 arg1Of mice,(
R4669 T6874 T6872 arg2Of 4D-G,(
R4670 T6874 T6873 arg1Of 4D-G,Figure
R4671 T6875 T6872 arg3Of ),(
R47 T264 T263 arg1Of Receptor,Chemokine
R48 T264 T265 arg1Of Receptor,5
R49 T268 T267 arg1Of Development via Inactivation,Tumor
R4913 T7434 T7435 arg1Of Induction,of
R4914 T7434 T7439 arg1Of Induction,and
R4915 T7438 T7435 arg2Of cells,of
R4916 T7438 T7436 arg1Of cells,CD8
R4917 T7438 T7437 arg1Of cells,T
R4918 T7442 T7439 arg2Of Infiltration,and
R4919 T7442 T7440 arg1Of Infiltration,NK
R4920 T7442 T7441 arg1Of Infiltration,Cell
R4921 T7442 T7443 arg1Of Infiltration,into
R4922 T7444 T7445 arg1Of Tumor,and
R4923 T7445 T7443 arg2Of and,into
R4924 T7445 T7447 arg1Of and,of
R4925 T7446 T7445 arg2Of Spleen,and
R4926 T7449 T7447 arg2Of Mice,of
R4927 T7449 T7448 arg1Of Mice,CCR5−/−
R4928 T7451 T7450 arg1Of investigate,To
R4929 T7454 T7453 arg1Of inhibition,the
R4930 T7454 T7455 arg1Of inhibition,of
R4931 T7454 T7461 arg1Of inhibition,is
R4932 T7454 T7462 arg1Of inhibition,related
R4933 T7457 T7455 arg2Of growth,of
R4934 T7457 T7456 arg1Of growth,tumor
R4935 T7457 T7458 arg1Of growth,in
R4936 T7460 T7458 arg2Of mice,in
R4937 T7460 T7459 arg1Of mice,CCR5−/−
R4938 T7461 T7451 arg2Of is,investigate
R4939 T7461 T7452 arg1Of is,whether
R4940 T7462 T7461 arg2Of related,is
R4941 T7462 T7463 arg1Of related,to
R4942 T7466 T7463 arg2Of responses,to
R4943 T7466 T7464 arg1Of responses,tumor-specific
R4944 T7466 T7465 arg1Of responses,immune
R4945 T7468 T7451 arg1Of we,investigate
R4946 T7468 T7469 arg1Of we,analyzed
R4947 T7469 T7450 modOf analyzed,To
R4948 T7469 T7467 arg1Of analyzed,","
R4949 T7469 T7483 arg1Of analyzed,in
R4950 T7472 T7469 arg2Of patterns,analyzed
R4951 T7472 T7470 arg1Of patterns,the
R4952 T7472 T7471 arg1Of patterns,distribution
R4953 T7472 T7473 arg1Of patterns,of
R4954 T7477 T7474 arg1Of cell,CD8+
R4955 T7477 T7475 arg1Of cell,cytotoxic
R4956 T7477 T7476 arg1Of cell,T
R4957 T7477 T7478 arg1Of cell,and
R4958 T7478 T7473 arg2Of and,of
R4959 T7482 T7478 arg2Of cells,and
R4960 T7482 T7479 arg1Of cells,CD57+
R4961 T7482 T7480 arg1Of cells,Natural
R4962 T7482 T7481 arg1Of cells,Killer
R4963 T7484 T7485 arg1Of tumor,and
R4964 T7486 T7485 arg2Of spleen,and
R4965 T7487 T7483 arg2Of tissues,in
R4966 T7487 T7484 arg1Of tissues,tumor
R4967 T7487 T7486 arg1Of tissues,spleen
R4968 T7489 T7488 arg2Of staining,By
R4969 T7492 T7489 arg2Of sections,staining
R4970 T7492 T7490 arg1Of sections,the
R4971 T7492 T7491 arg1Of sections,tumor
R4972 T7492 T7493 arg1Of sections,from
R4973 T7495 T7493 arg2Of mice,from
R4974 T7495 T7494 arg1Of mice,CCR5−/−
R4975 T7497 T7489 arg1Of we,staining
R4976 T7497 T7498 arg1Of we,found
R4977 T7498 T7488 arg1Of found,By
R4978 T7498 T7496 arg1Of found,","
R4979 T7500 T7501 arg1Of there,was
R4980 T7501 T7498 arg2Of was,found
R4981 T7501 T7499 arg1Of was,that
R4982 T7504 T7502 arg1Of influx,a
R4983 T7504 T7503 arg1Of influx,significant
R4984 T7504 T7505 arg1Of influx,of
R4985 T7504 T7508 arg1Of influx,into
R4986 T7504 T7514 arg1Of influx,as
R4987 T7507 T7505 arg2Of cells,of
R4988 T7507 T7506 arg1Of cells,CD8+
R4989 T7510 T7508 arg2Of tumor,into
R4990 T7510 T7509 arg1Of tumor,the
R4991 T7514 T7501 arg2Of as,was
R4992 T7514 T7511 arg1Of as,","
R4993 T7514 T7512 arg1Of as,as
R4994 T7514 T7513 arg1Of as,well
R4995 T7516 T7514 arg2Of increase,as
R4996 T7516 T7515 arg1Of increase,an
R4997 T7516 T7517 arg1Of increase,in
R4998 T7519 T7517 arg2Of number,in
R4999 T7519 T7518 arg1Of number,the
R50 T268 T269 arg1Of Development via Inactivation,of
R5000 T7519 T7520 arg1Of number,of
R5001 T7523 T7520 arg2Of cells,of
R5002 T7523 T7521 arg1Of cells,infiltrating
R5003 T7523 T7522 arg1Of cells,NK
R5004 T7523 T7524 arg1Of cells,(
R5005 T7526 T7524 arg2Of 5A,(
R5006 T7526 T7525 arg1Of 5A,Figure
R5007 T7527 T7524 arg3Of ),(
R5008 T7530 T7528 arg1Of cells,CD8+
R5009 T7530 T7529 arg1Of cells,T
R5010 T7530 T7531 arg1Of cells,and
R5011 T7531 T7535 arg1Of and,were
R5012 T7531 T7536 arg2Of and,spread
R5013 T7534 T7531 arg2Of cells,and
R5014 T7534 T7532 arg1Of cells,CD57+
R5015 T7534 T7533 arg1Of cells,NK
R5016 T7536 T7535 arg2Of spread,were
R5017 T7536 T7537 arg1Of spread,diffusely
R5018 T7536 T7538 arg1Of spread,throughout
R5019 T7541 T7538 arg2Of sections,throughout
R5020 T7541 T7539 arg1Of sections,the
R5021 T7541 T7540 arg1Of sections,entire
R5022 T7544 T7542 arg1Of investigate,To
R5023 T7544 T7543 arg1Of investigate,further
R5024 T7546 T7544 arg2Of differences,investigate
R5025 T7546 T7545 arg1Of differences,the
R5026 T7546 T7547 arg1Of differences,in
R5027 T7546 T7558 arg1Of differences,between
R5028 T7549 T7547 arg2Of numbers,in
R5029 T7549 T7548 arg1Of numbers,the
R5030 T7549 T7550 arg1Of numbers,of
R5031 T7553 T7551 arg1Of cells,CD8+
R5032 T7553 T7552 arg1Of cells,T
R5033 T7553 T7554 arg1Of cells,and
R5034 T7554 T7550 arg2Of and,of
R5035 T7557 T7554 arg2Of cells,and
R5036 T7557 T7555 arg1Of cells,CD57+
R5037 T7557 T7556 arg1Of cells,NK
R5038 T7560 T7559 arg1Of mice,CCR5+/+
R5039 T7560 T7561 arg1Of mice,and
R5040 T7561 T7558 arg2Of and,between
R5041 T7561 T7564 arg1Of and,in
R5042 T7563 T7561 arg2Of mice,and
R5043 T7563 T7562 arg1Of mice,CCR5−/−
R5044 T7566 T7564 arg2Of organ,in
R5045 T7566 T7565 arg1Of organ,immunity-related
R5046 T7568 T7544 arg1Of we,investigate
R5047 T7568 T7570 arg1Of we,analyzed
R5048 T7570 T7542 modOf analyzed,To
R5049 T7570 T7567 arg1Of analyzed,","
R5050 T7570 T7569 arg1Of analyzed,also
R5051 T7572 T7573 arg1Of CD8,and
R5052 T7574 T7573 arg2Of CD57,and
R5053 T7577 T7570 arg2Of number,analyzed
R5054 T7577 T7571 arg1Of number,the
R5055 T7577 T7572 arg1Of number,CD8
R5056 T7577 T7574 arg1Of number,CD57
R5057 T7577 T7575 arg1Of number,reactive
R5058 T7577 T7576 arg1Of number,cell
R5059 T7577 T7578 arg1Of number,in
R5060 T7580 T7578 arg2Of tissues,in
R5061 T7580 T7579 arg1Of tissues,spleen
R5062 T7582 T7581 arg1Of number,The
R5063 T7582 T7583 arg1Of number,of
R5064 T7582 T7591 arg1Of number,were
R5065 T7582 T7592 arg1Of number,higher
R5066 T7586 T7584 arg1Of cells,CD8+
R5067 T7586 T7585 arg1Of cells,T
R5068 T7586 T7587 arg1Of cells,and
R5069 T7587 T7583 arg2Of and,of
R5070 T7590 T7587 arg2Of cells,and
R5071 T7590 T7588 arg1Of cells,CD57+
R5072 T7590 T7589 arg1Of cells,NK
R5073 T7592 T7591 arg2Of higher,were
R5074 T7592 T7593 arg1Of higher,in
R5075 T7592 T7600 arg1Of higher,than
R5076 T7595 T7593 arg2Of spleen,in
R5077 T7595 T7594 arg1Of spleen,the
R5078 T7595 T7596 arg1Of spleen,of
R5079 T7599 T7596 arg2Of mice,of
R5080 T7599 T7597 arg1Of mice,the
R5081 T7599 T7598 arg1Of mice,CCR5−/−
R5082 T7601 T7600 arg2Of in,than
R5083 T7603 T7601 arg2Of spleen,in
R5084 T7603 T7602 arg1Of spleen,the
R5085 T7603 T7604 arg1Of spleen,of
R5086 T7607 T7604 arg2Of mice,of
R5087 T7607 T7605 arg1Of mice,the
R5088 T7607 T7606 arg1Of mice,CCR5+/+
R5089 T7607 T7608 arg1Of mice,(
R5090 T7610 T7608 arg2Of 5B,(
R5091 T7610 T7609 arg1Of 5B,Figure
R5092 T7611 T7608 arg3Of ),(
R5093 T7613 T7612 arg1Of data,These
R5094 T7613 T7614 arg1Of data,suggest
R5095 T7617 T7616 arg2Of promoting,by
R5096 T7619 T7617 arg2Of infiltration,promoting
R5097 T7619 T7618 arg1Of infiltration,the
R5098 T7619 T7620 arg1Of infiltration,of
R5099 T7623 T7621 arg1Of cells,CD8
R51 T268 T272 arg1Of Development via Inactivation,B a
R5100 T7623 T7622 arg1Of cells,T
R5101 T7623 T7624 arg1Of cells,and
R5102 T7624 T7620 arg2Of and,of
R5103 T7624 T7627 arg1Of and,","
R5104 T7624 T7628 arg1Of and,which
R5105 T7624 T7629 arg1Of and,are
R5106 T7626 T7624 arg2Of cells,and
R5107 T7626 T7625 arg1Of cells,NK
R5108 T7632 T7629 arg2Of effectors,are
R5109 T7632 T7630 arg1Of effectors,potent
R5110 T7632 T7631 arg1Of effectors,cytotoxic
R5111 T7634 T7633 arg1Of tumors,for
R5112 T7634 T7636 arg1Of tumors,could
R5113 T7634 T7637 arg1Of tumors,play
R5114 T7637 T7614 arg2Of play,suggest
R5115 T7637 T7615 arg1Of play,that
R5116 T7637 T7616 arg1Of play,by
R5117 T7637 T7635 arg1Of play,","
R5118 T7637 T7636 arg2Of play,could
R5119 T7637 T7640 arg1Of play,in
R5120 T7639 T7637 arg2Of role,play
R5121 T7639 T7638 arg1Of role,a
R5122 T7643 T7640 arg2Of effect,in
R5123 T7643 T7641 arg1Of effect,an
R5124 T7643 T7642 arg1Of effect,anti-tumor
R5125 T7643 T7644 arg1Of effect,in
R5126 T7646 T7644 arg2Of mice,in
R5127 T7646 T7645 arg1Of mice,CCR5−/−
R5128 T7648 T7647 arg1Of analyze,To
R5129 T7648 T7659 arg1Of analyze,by
R5130 T7652 T7648 arg2Of change,analyze
R5131 T7652 T7649 arg1Of change,the
R5132 T7652 T7650 arg1Of change,cell
R5133 T7652 T7651 arg1Of change,phenotype
R5134 T7652 T7653 arg1Of change,in
R5135 T7655 T7654 arg1Of mice,CCR5−/−
R5136 T7655 T7656 arg1Of mice,and
R5137 T7656 T7653 arg2Of and,in
R5138 T7658 T7656 arg2Of mice,and
R5139 T7658 T7657 arg1Of mice,CCR5+/+
R5140 T7660 T7659 arg2Of inoculation,by
R5141 T7660 T7661 arg1Of inoculation,of
R5142 T7664 T7661 arg2Of cell,of
R5143 T7664 T7662 arg1Of cell,the
R5144 T7664 T7663 arg1Of cell,melanoma
R5145 T7666 T7667 arg1Of lymphocytes,were
R5146 T7666 T7668 arg2Of lymphocytes,isolated
R5147 T7668 T7647 modOf isolated,To
R5148 T7668 T7665 arg1Of isolated,","
R5149 T7668 T7667 arg2Of isolated,were
R5150 T7668 T7669 arg1Of isolated,from
R5151 T7671 T7672 arg1Of tumor,and
R5152 T7673 T7672 arg2Of spleen,and
R5153 T7674 T7669 arg2Of tissues,from
R5154 T7674 T7670 arg1Of tissues,the
R5155 T7674 T7671 arg1Of tissues,tumor
R5156 T7674 T7673 arg1Of tissues,spleen
R5157 T7676 T7675 arg1Of B,The
R5158 T7676 T7677 arg1Of B,","
R5159 T7676 T7680 arg1Of B,","
R5160 T7676 T7683 arg1Of B,","
R5161 T7679 T7677 arg2Of T,","
R5162 T7679 T7678 arg1Of T,CD3
R5163 T7682 T7680 arg2Of T,","
R5164 T7682 T7681 arg1Of T,CD4
R5165 T7683 T7696 arg1Of ",",were
R5166 T7686 T7687 arg1Of T,and
R5167 T7688 T7687 arg2Of NK,and
R5168 T7690 T7683 arg2Of portion,","
R5169 T7690 T7684 arg1Of portion,CD
R5170 T7690 T7685 arg1Of portion,8
R5171 T7690 T7686 arg1Of portion,T
R5172 T7690 T7688 arg1Of portion,NK
R5173 T7690 T7689 arg1Of portion,cell
R5174 T7690 T7691 arg1Of portion,of
R5175 T7695 T7691 arg2Of tissue,of
R5176 T7695 T7692 arg1Of tissue,CCR5−/−
R5177 T7695 T7693 arg1Of tissue,mice
R5178 T7695 T7694 arg1Of tissue,tumor
R5179 T7696 T7711 arg1Of were,","
R5180 T7696 T7712 arg1Of were,respectively
R5181 T7696 T7713 arg1Of were,","
R5182 T7696 T7714 arg1Of were,compared
R5183 T7698 T7697 arg1Of %,7.2
R5184 T7698 T7699 arg1Of %,","
R5185 T7699 T7702 arg1Of ",",","
R5186 T7701 T7699 arg2Of %,","
R5187 T7701 T7700 arg1Of %,48.2
R5188 T7702 T7705 arg1Of ",",","
R5189 T7704 T7702 arg2Of %,","
R5190 T7704 T7703 arg1Of %,16.9
R5191 T7705 T7696 arg2Of ",",were
R5192 T7707 T7706 arg1Of %,32.1
R5193 T7707 T7708 arg1Of %,and
R5194 T7709 T7708 arg2Of 7.8,and
R5195 T7710 T7705 arg2Of %,","
R5196 T7710 T7707 arg1Of %,%
R5197 T7710 T7709 arg1Of %,7.8
R5198 T7715 T7714 arg2Of to,compared
R5199 T7717 T7716 arg1Of %,2.9
R52 T271 T269 arg2Of κ,of
R5200 T7717 T7718 arg1Of %,","
R5201 T7718 T7721 arg1Of ",",","
R5202 T7720 T7718 arg2Of %,","
R5203 T7720 T7719 arg1Of %,11.1
R5204 T7721 T7724 arg1Of ",",","
R5205 T7723 T7721 arg2Of %,","
R5206 T7723 T7722 arg1Of %,2.3
R5207 T7724 T7727 arg1Of ",",and
R5208 T7726 T7724 arg2Of %,","
R5209 T7726 T7725 arg1Of %,0.6
R5210 T7727 T7715 arg2Of and,to
R5211 T7729 T7727 arg2Of %,and
R5212 T7729 T7728 arg1Of %,3.1
R5213 T7729 T7730 arg1Of %,of
R5214 T7732 T7730 arg2Of mice,of
R5215 T7732 T7731 arg1Of mice,CCR5+/+
R5216 T7732 T7733 arg1Of mice,(
R5217 T7735 T7733 arg2Of 5C,(
R5218 T7735 T7734 arg1Of 5C,Figure
R5219 T7736 T7733 arg3Of ),(
R5220 T7738 T7737 arg1Of lymphocytes,The
R5221 T7738 T7739 arg1Of lymphocytes,that
R5222 T7738 T7740 arg1Of lymphocytes,infiltrated
R5223 T7738 T7749 arg1Of lymphocytes,had
R5224 T7743 T7740 arg2Of tissue,infiltrated
R5225 T7743 T7741 arg1Of tissue,the
R5226 T7743 T7742 arg1Of tissue,tumor
R5227 T7743 T7744 arg1Of tissue,of
R5228 T7747 T7744 arg2Of mice,of
R5229 T7747 T7745 arg1Of mice,the
R5230 T7747 T7746 arg1Of mice,CCR5−/−
R5231 T7749 T7748 arg1Of had,also
R5232 T7749 T7762 arg1Of had,when
R5233 T7751 T7749 arg2Of levels,had
R5234 T7751 T7750 arg1Of levels,higher
R5235 T7751 T7752 arg1Of levels,of
R5236 T7753 T7754 arg1Of CD19,","
R5237 T7754 T7756 arg1Of ",",","
R5238 T7755 T7754 arg2Of CD3,","
R5239 T7756 T7758 arg1Of ",",","
R5240 T7757 T7756 arg2Of CD4,","
R5241 T7758 T7760 arg1Of ",",and
R5242 T7759 T7758 arg2Of CD8,","
R5243 T7760 T7752 arg2Of and,of
R5244 T7761 T7760 arg2Of CD57,and
R5245 T7763 T7762 arg2Of compared,when
R5246 T7763 T7764 arg1Of compared,to
R5247 T7767 T7764 arg2Of mice,to
R5248 T7767 T7765 arg1Of mice,the
R5249 T7767 T7766 arg1Of mice,CCR5+/+
R5250 T7769 T7768 arg1Of B,The
R5251 T7769 T7770 arg1Of B,","
R5252 T7769 T7773 arg1Of B,","
R5253 T7769 T7776 arg1Of B,","
R5254 T7772 T7770 arg2Of T,","
R5255 T7772 T7771 arg1Of T,CD3
R5256 T7775 T7773 arg2Of T,","
R5257 T7775 T7774 arg1Of T,CD4
R5258 T7776 T7789 arg1Of ",",were
R5259 T7779 T7780 arg1Of T,and
R5260 T7781 T7780 arg2Of NK,and
R5261 T7783 T7776 arg2Of portion,","
R5262 T7783 T7777 arg1Of portion,CD
R5263 T7783 T7778 arg1Of portion,8
R5264 T7783 T7779 arg1Of portion,T
R5265 T7783 T7781 arg1Of portion,NK
R5266 T7783 T7782 arg1Of portion,cell
R5267 T7783 T7784 arg1Of portion,of
R5268 T7788 T7784 arg2Of spleen,of
R5269 T7788 T7785 arg1Of spleen,the
R5270 T7788 T7786 arg1Of spleen,CCR5−/−
R5271 T7788 T7787 arg1Of spleen,mice
R5272 T7789 T7806 arg1Of were,compared
R5273 T7791 T7790 arg1Of %,61.3
R5274 T7791 T7792 arg1Of %,","
R5275 T7792 T7795 arg1Of ",",","
R5276 T7794 T7792 arg2Of %,","
R5277 T7794 T7793 arg1Of %,33.4
R5278 T7795 T7798 arg1Of ",",","
R5279 T7797 T7795 arg2Of %,","
R5280 T7797 T7796 arg1Of %,17.6
R5281 T7798 T7789 arg2Of ",",were
R5282 T7798 T7804 arg1Of ",",","
R5283 T7798 T7805 arg1Of ",",respectively
R5284 T7800 T7799 arg1Of %,9.2
R5285 T7800 T7801 arg1Of %,and
R5286 T7802 T7801 arg2Of 0.6,and
R5287 T7803 T7798 arg2Of %,","
R5288 T7803 T7800 arg1Of %,%
R5289 T7803 T7802 arg1Of %,0.6
R5290 T7807 T7806 arg2Of to,compared
R5291 T7809 T7808 arg1Of %,38.3
R5292 T7809 T7810 arg1Of %,","
R5293 T7810 T7813 arg1Of ",",","
R5294 T7812 T7810 arg2Of %,","
R5295 T7812 T7811 arg1Of %,5.9
R5296 T7813 T7816 arg1Of ",",","
R5297 T7815 T7813 arg2Of %,","
R5298 T7815 T7814 arg1Of %,4.0
R5299 T7816 T7807 arg2Of ",",to
R53 T271 T270 arg1Of κ,NF-
R5300 T7818 T7817 arg1Of %,1.0
R5301 T7818 T7819 arg1Of %,and
R5302 T7820 T7819 arg2Of 3.9,and
R5303 T7821 T7816 arg2Of %,","
R5304 T7821 T7818 arg1Of %,%
R5305 T7821 T7820 arg1Of %,3.9
R5306 T7821 T7822 arg1Of %,of
R5307 T7825 T7822 arg2Of mice,of
R5308 T7825 T7823 arg1Of mice,the
R5309 T7825 T7824 arg1Of mice,CCR5+/+
R5310 T7825 T7826 arg1Of mice,(
R5311 T7828 T7826 arg2Of 5D,(
R5312 T7828 T7827 arg1Of 5D,Figure
R5313 T7829 T7826 arg3Of ),(
R5314 T7831 T7830 arg1Of data,These
R5315 T7831 T7832 arg1Of data,suggest
R5316 T7835 T7834 arg2Of promoting,by
R5317 T7837 T7835 arg2Of infiltration,promoting
R5318 T7837 T7836 arg1Of infiltration,the
R5319 T7837 T7838 arg1Of infiltration,of
R5320 T7841 T7839 arg1Of cells,CD8
R5321 T7841 T7840 arg1Of cells,T
R5322 T7841 T7842 arg1Of cells,and
R5323 T7842 T7838 arg2Of and,of
R5324 T7842 T7845 arg1Of and,","
R5325 T7842 T7846 arg1Of and,which
R5326 T7842 T7847 arg1Of and,are
R5327 T7844 T7842 arg2Of cells,and
R5328 T7844 T7843 arg1Of cells,NK
R5329 T7850 T7847 arg2Of effectors,are
R5330 T7850 T7848 arg1Of effectors,potent
R5331 T7850 T7849 arg1Of effectors,cytotoxic
R5332 T7852 T7851 arg1Of tumors,for
R5333 T7852 T7854 arg1Of tumors,could
R5334 T7852 T7855 arg1Of tumors,play
R5335 T7855 T7832 arg2Of play,suggest
R5336 T7855 T7833 arg1Of play,that
R5337 T7855 T7834 arg1Of play,by
R5338 T7855 T7853 arg1Of play,","
R5339 T7855 T7854 arg2Of play,could
R5340 T7855 T7858 arg1Of play,in
R5341 T7857 T7855 arg2Of role,play
R5342 T7857 T7856 arg1Of role,a
R5343 T7860 T7858 arg2Of inhibition,in
R5344 T7860 T7859 arg1Of inhibition,the
R5345 T7860 T7861 arg1Of inhibition,of
R5346 T7863 T7861 arg2Of growth,of
R5347 T7863 T7862 arg1Of growth,tumor
R5348 T7863 T7864 arg1Of growth,in
R5349 T7866 T7864 arg2Of mice,in
R5350 T7866 T7865 arg1Of mice,CCR5−/−
R54 T272 T266 arg2Of B a,Suppresses
R55 T273 T272 arg2Of nd Upregulat,B a
R56 T273 T274 arg1Of nd Upregulat,io
R57 T273 T276 arg1Of nd Upregulat,L-
R58 T275 T274 arg2Of n of I,io
R59 T278 T276 arg2Of elano,L-
R5958 T9415 T9412 arg2Of study,In
R5959 T9415 T9413 arg1Of study,the
R5960 T9415 T9414 arg1Of study,present
R5961 T9417 T9418 arg1Of we,found
R5962 T9418 T9412 arg1Of found,In
R5963 T9418 T9416 arg1Of found,","
R5964 T9421 T9420 arg1Of weight,tumor
R5965 T9421 T9422 arg1Of weight,and
R5966 T9422 T9424 arg1Of and,were
R5967 T9422 T9426 arg1Of and,smaller
R5968 T9423 T9422 arg2Of volume,and
R5969 T9424 T9418 arg2Of were,found
R5970 T9424 T9419 arg1Of were,that
R5971 T9424 T9427 arg1Of were,in
R5972 T9424 T9431 arg1Of were,compared
R5973 T9426 T9424 arg2Of smaller,were
R5974 T9426 T9425 arg1Of smaller,much
R5975 T9430 T9427 arg2Of mice,in
R5976 T9430 T9428 arg1Of mice,the
R5977 T9430 T9429 arg1Of mice,CCR5−/−
R5978 T9432 T9431 arg2Of to,compared
R5979 T9435 T9432 arg2Of mice,to
R5980 T9435 T9433 arg1Of mice,the
R5981 T9435 T9434 arg1Of mice,CCR5+/+
R5982 T9435 T9436 arg2Of mice,inoculated
R5983 T9436 T9437 arg1Of inoculated,with
R5984 T9440 T9437 arg2Of cells,with
R5985 T9440 T9438 arg1Of cells,B16
R5986 T9440 T9439 arg1Of cells,melanoma
R5987 T9440 T9441 arg1Of cells,(
R5988 T9443 T9442 arg1Of 1A,Figure
R5989 T9443 T9444 arg1Of 1A,and
R5990 T9444 T9441 arg2Of and,(
R5991 T9445 T9444 arg2Of 1B,and
R5992 T9446 T9441 arg3Of ),(
R5993 T9450 T9447 arg1Of inhibition,The
R5994 T9450 T9448 arg1Of inhibition,tumor
R5995 T9450 T9449 arg1Of inhibition,growth
R5996 T9450 T9451 arg1Of inhibition,in
R5997 T9450 T9455 arg1Of inhibition,was
R5998 T9450 T9456 arg2Of inhibition,associated
R5999 T9454 T9451 arg2Of mice,in
R60 T278 T277 arg1Of elano,1Ra in M
R6000 T9454 T9452 arg1Of mice,the
R6001 T9454 T9453 arg1Of mice,CCR5−/−
R6002 T9456 T9455 arg2Of associated,was
R6003 T9456 T9457 arg1Of associated,with
R6004 T9459 T9457 arg2Of inhibition,with
R6005 T9459 T9458 arg1Of inhibition,the
R6006 T9459 T9460 arg1Of inhibition,of
R6007 T9463 T9462 arg2Of NF-κB,activated
R6008 T9463 T9464 arg1Of NF-κB,and
R6009 T9464 T9460 arg2Of and,of
R6010 T9464 T9461 arg1Of and,constitutively
R6011 T9464 T9468 arg1Of and,in
R6012 T9465 T9464 arg2Of elevation,and
R6013 T9465 T9466 arg1Of elevation,of
R6014 T9467 T9466 arg2Of IL-1Ra,of
R6015 T9471 T9468 arg2Of tissue,in
R6016 T9471 T9469 arg1Of tissue,the
R6017 T9471 T9470 arg1Of tissue,tumor
R6018 T9474 T9472 arg1Of activity,This
R6019 T9474 T9473 arg1Of activity,anti-tumor
R6020 T9474 T9475 arg1Of activity,was
R6021 T9474 T9477 arg2Of activity,associated
R6022 T9474 T9508 arg1Of activity,cleaved
R6023 T9477 T9475 arg2Of associated,was
R6024 T9477 T9476 arg1Of associated,also
R6025 T9477 T9478 arg1Of associated,with
R6026 T9477 T9499 arg1Of associated,with
R6027 T9477 T9507 arg1Of associated,;
R6028 T9478 T9498 arg1Of with,but
R6029 T9480 T9479 arg2Of expression,decreased
R6030 T9480 T9481 arg1Of expression,of
R6031 T9480 T9489 arg1Of expression,and
R6032 T9483 T9481 arg2Of target,of
R6033 T9483 T9482 arg1Of target,NF-κB
R6034 T9483 T9484 arg1Of target,anti-apoptotic
R6035 T9483 T9487 arg1Of target,proliferative
R6036 T9484 T9485 arg1Of anti-apoptotic,","
R6037 T9487 T9485 arg2Of proliferative,","
R6038 T9487 T9486 arg1Of proliferative,cell
R6039 T9489 T9478 arg2Of and,with
R6040 T9489 T9488 arg1Of and,","
R6041 T9490 T9489 arg2Of tumor,and
R6042 T9490 T9491 arg1Of tumor,promoting
R6043 T9492 T9491 arg2Of genes,promoting
R6044 T9492 T9493 arg1Of genes,(
R6045 T9494 T9495 arg1Of Bcl-2,and
R6046 T9495 T9493 arg2Of and,(
R6047 T9496 T9495 arg2Of C-IAP1,and
R6048 T9497 T9493 arg3Of ),(
R6049 T9499 T9498 arg2Of with,but
R6050 T9501 T9499 arg2Of expression,with
R6051 T9501 T9500 arg2Of expression,increased
R6052 T9501 T9502 arg1Of expression,of
R6053 T9506 T9502 arg2Of genes,of
R6054 T9506 T9503 arg1Of genes,their
R6055 T9506 T9504 arg1Of genes,target
R6056 T9506 T9505 arg1Of genes,apoptotic
R6057 T9508 T9507 arg2Of cleaved,;
R6058 T9509 T9510 arg1Of caspase-3,and
R6059 T9510 T9513 arg1Of and,and
R6060 T9511 T9510 arg2Of 9,and
R6061 T9513 T9508 arg2Of and,cleaved
R6062 T9513 T9512 arg1Of and,","
R6063 T9514 T9513 arg2Of Bax,and
R6064 T9514 T9515 arg1Of Bax,(
R6065 T9517 T9515 arg2Of 3A-D,(
R6066 T9517 T9516 arg1Of 3A-D,Figure
R6067 T9518 T9515 arg3Of ),(
R6068 T9521 T9520 arg1Of tumor,the
R6069 T9521 T9522 arg1Of tumor,and
R6070 T9522 T9519 arg2Of and,In
R6071 T9524 T9522 arg2Of spleen,and
R6072 T9524 T9523 arg1Of spleen,the
R6073 T9527 T9526 arg1Of number,the
R6074 T9527 T9528 arg1Of number,of
R6075 T9527 T9533 arg1Of number,","
R6076 T9532 T9528 arg2Of cells,of
R6077 T9532 T9529 arg1Of cells,cytotoxic
R6078 T9532 T9530 arg1Of cells,CD8+
R6079 T9532 T9531 arg1Of cells,T
R6080 T9533 T9539 arg1Of ",",and
R6081 T9537 T9533 arg2Of cells,","
R6082 T9537 T9534 arg1Of cells,CD57+
R6083 T9537 T9535 arg1Of cells,natural
R6084 T9537 T9536 arg1Of cells,killer
R6085 T9539 T9538 arg1Of and,","
R6086 T9539 T9544 arg1Of and,were
R6087 T9539 T9545 arg2Of and,increased
R6088 T9541 T9539 arg2Of levels,and
R6089 T9541 T9540 arg1Of levels,the
R6090 T9541 T9542 arg1Of levels,of
R6091 T9543 T9542 arg2Of IL-1Ra,of
R6092 T9545 T9519 arg1Of increased,In
R6093 T9545 T9525 arg1Of increased,","
R6094 T9545 T9544 arg2Of increased,were
R6095 T9545 T9546 arg1Of increased,(
R6096 T9547 T9548 arg1Of Figure,4
R6097 T9547 T9549 arg1Of Figure,and
R6098 T9549 T9546 arg2Of and,(
R6099 T9550 T9549 arg2Of 5,and
R61 T280 T279 arg1Of evaluate,To
R6100 T9551 T9546 arg3Of ),(
R6101 T9553 T9552 arg1Of findings,These
R6102 T9553 T9554 arg1Of findings,suggest
R6103 T9557 T9556 arg1Of growth,melanoma
R6104 T9557 T9558 arg1Of growth,was
R6105 T9557 T9559 arg2Of growth,inhibited
R6106 T9559 T9555 arg1Of inhibited,that
R6107 T9559 T9558 arg2Of inhibited,was
R6108 T9559 T9560 arg1Of inhibited,in
R6109 T9559 T9565 arg1Of inhibited,and
R6110 T9563 T9560 arg2Of mice,in
R6111 T9563 T9561 arg1Of mice,the
R6112 T9563 T9562 arg1Of mice,CCR5−/−
R6113 T9565 T9554 arg2Of and,suggest
R6114 T9565 T9564 arg1Of and,","
R6115 T9566 T9565 arg2Of that,and
R6116 T9568 T9567 arg1Of elevation,the
R6117 T9568 T9569 arg1Of elevation,of
R6118 T9568 T9571 arg1Of elevation,","
R6119 T9568 T9572 arg2Of elevation,accompanied
R6120 T9568 T9577 arg1Of elevation,is
R6121 T9568 T9578 arg1Of elevation,significant
R6122 T9570 T9569 arg2Of IL-1Ra,of
R6123 T9572 T9573 arg1Of accompanied,with
R6124 T9575 T9573 arg2Of NF-κB,with
R6125 T9575 T9574 arg2Of NF-κB,decreased
R6126 T9577 T9566 arg2Of is,that
R6127 T9577 T9576 arg1Of is,","
R6128 T9578 T9577 arg2Of significant,is
R6129 T9578 T9579 arg1Of significant,in
R6130 T9581 T9579 arg2Of inhibition,in
R6131 T9581 T9580 arg1Of inhibition,the
R6132 T9581 T9582 arg1Of inhibition,of
R6133 T9584 T9582 arg2Of growth,of
R6134 T9584 T9583 arg1Of growth,melanoma
R6135 T9584 T9585 arg1Of growth,in
R6136 T9587 T9585 arg2Of mice,in
R6137 T9587 T9586 arg1Of mice,CCR5−/−
R6138 T9588 T9589 arg1Of NF-κB,regulates
R6139 T9589 T9607 arg1Of regulates,[
R6140 T9591 T9589 arg2Of expression,regulates
R6141 T9591 T9590 arg1Of expression,the
R6142 T9591 T9592 arg1Of expression,of
R6143 T9594 T9593 arg1Of 200,over
R6144 T9595 T9592 arg2Of genes,of
R6145 T9595 T9594 arg1Of genes,200
R6146 T9595 T9596 arg1Of genes,that
R6147 T9595 T9597 arg1Of genes,control
R6148 T9600 T9599 arg1Of system,immune
R6149 T9600 T9601 arg1Of system,","
R6150 T9601 T9605 arg1Of ",",and
R6151 T9604 T9601 arg2Of growth,","
R6152 T9604 T9602 arg1Of growth,cancer
R6153 T9604 T9603 arg1Of growth,cell
R6154 T9605 T9597 arg2Of and,control
R6155 T9605 T9598 arg1Of and,the
R6156 T9606 T9605 arg2Of inflammation,and
R6157 T9608 T9607 arg2Of 39,[
R6158 T9609 T9607 arg3Of ],[
R6159 T9610 T9611 arg1Of Because,of
R6160 T9613 T9610 arg2Of abilities,Because
R6161 T9613 T9612 arg1Of abilities,its
R6162 T9613 T9614 modOf abilities,to
R6163 T9615 T9614 arg1Of induce,to
R6164 T9617 T9615 arg2Of expression,induce
R6165 T9617 T9616 arg1Of expression,the
R6166 T9617 T9618 arg1Of expression,of
R6167 T9617 T9628 arg1Of expression,as
R6168 T9617 T9632 arg1Of expression,in
R6169 T9621 T9618 arg2Of array,of
R6170 T9621 T9619 arg1Of array,a
R6171 T9621 T9620 arg1Of array,large
R6172 T9621 T9622 arg1Of array,of
R6173 T9624 T9623 arg1Of mediators,inflammatory
R6174 T9624 T9625 arg1Of mediators,and
R6175 T9625 T9622 arg2Of and,of
R6176 T9627 T9625 arg2Of roles,and
R6177 T9627 T9626 arg1Of roles,its
R6178 T9631 T9628 arg2Of factors,as
R6179 T9631 T9629 arg1Of factors,core
R6180 T9631 T9630 arg1Of factors,transcription
R6181 T9635 T9632 arg2Of responses,in
R6182 T9635 T9633 arg1Of responses,diverse
R6183 T9635 T9634 arg1Of responses,immune
R6184 T9637 T9638 arg1Of NF-κB,has
R6185 T9637 T9639 arg1Of NF-κB,been
R6186 T9637 T9640 arg2Of NF-κB,recognized
R6187 T9640 T9610 arg1Of recognized,Because
R6188 T9640 T9636 arg1Of recognized,","
R6189 T9640 T9638 arg2Of recognized,has
R6190 T9640 T9639 arg2Of recognized,been
R6191 T9640 T9641 arg1Of recognized,as
R6192 T9644 T9641 arg2Of factor,as
R6193 T9644 T9642 arg1Of factor,a
R6194 T9644 T9643 arg1Of factor,major
R6195 T9644 T9645 arg1Of factor,responsible
R6196 T9645 T9646 arg1Of responsible,for
R6197 T9649 T9647 arg1Of development,cytokine-associated
R6198 T9649 T9648 arg1Of development,cancer
R6199 T9649 T9650 arg1Of development,or
R62 T282 T280 arg2Of relevance,evaluate
R6200 T9650 T9646 arg2Of or,for
R6201 T9652 T9650 arg2Of immunity,or
R6202 T9652 T9651 arg1Of immunity,anti-tumor
R6203 T9657 T9653 arg2Of tissues,In
R6204 T9657 T9654 arg1Of tissues,the
R6205 T9657 T9655 arg1Of tissues,melanoma
R6206 T9657 T9656 arg1Of tissues,tumor
R6207 T9657 T9658 arg1Of tissues,of
R6208 T9661 T9658 arg2Of mice,of
R6209 T9661 T9659 arg1Of mice,the
R6210 T9661 T9660 arg1Of mice,CCR5−/−
R6211 T9664 T9663 arg1Of expression,the
R6212 T9664 T9665 arg1Of expression,of
R6213 T9664 T9686 arg1Of expression,were
R6214 T9664 T9688 arg2Of expression,inhibited
R6215 T9670 T9666 arg1Of genes,NF-κB
R6216 T9670 T9667 arg1Of genes,target
R6217 T9670 T9668 arg1Of genes,cell
R6218 T9670 T9669 arg1Of genes,death
R6219 T9670 T9671 arg1Of genes,(
R6220 T9670 T9678 arg1Of genes,and
R6221 T9672 T9673 arg1Of Bax,","
R6222 T9673 T9675 arg1Of ",",and
R6223 T9674 T9673 arg2Of caspase-3,","
R6224 T9675 T9671 arg2Of and,(
R6225 T9676 T9675 arg2Of 9,and
R6226 T9677 T9671 arg3Of ),(
R6227 T9678 T9665 arg2Of and,of
R6228 T9682 T9678 arg2Of activity,and
R6229 T9682 T9679 arg1Of activity,the
R6230 T9682 T9680 arg1Of activity,DNA
R6231 T9682 T9681 arg1Of activity,binding
R6232 T9682 T9683 arg1Of activity,of
R6233 T9684 T9683 arg2Of NF-κB,of
R6234 T9688 T9653 arg1Of inhibited,In
R6235 T9688 T9662 arg1Of inhibited,","
R6236 T9688 T9685 arg1Of inhibited,","
R6237 T9688 T9686 arg2Of inhibited,were
R6238 T9688 T9687 arg1Of inhibited,significantly
R6239 T9688 T9690 arg1Of inhibited,but
R6240 T9690 T9689 arg1Of but,","
R6241 T9692 T9691 arg1Of expression,the
R6242 T9692 T9693 arg1Of expression,of
R6243 T9692 T9706 arg1Of expression,were
R6244 T9692 T9707 arg2Of expression,enhanced
R6245 T9699 T9693 arg2Of genes,of
R6246 T9699 T9694 arg1Of genes,cell
R6247 T9699 T9695 arg1Of genes,death
R6248 T9699 T9696 arg1Of genes,inhibitory
R6249 T9699 T9697 arg1Of genes,NF-κB
R6250 T9699 T9698 arg1Of genes,target
R6251 T9699 T9700 arg1Of genes,","
R6252 T9699 T9702 arg1Of genes,as
R6253 T9702 T9701 arg1Of as,such
R6254 T9703 T9704 arg1Of Bcl-2,and
R6255 T9704 T9702 arg2Of and,as
R6256 T9705 T9704 arg2Of cIAP,and
R6257 T9707 T9690 arg2Of enhanced,but
R6258 T9707 T9706 arg2Of enhanced,were
R6259 T9709 T9708 arg2Of addition,In
R6260 T9711 T9712 arg1Of CCR5−/−,prevented
R6261 T9712 T9708 arg1Of prevented,In
R6262 T9712 T9710 arg1Of prevented,","
R6263 T9714 T9712 arg2Of phosphorylation,prevented
R6264 T9714 T9713 arg1Of phosphorylation,the
R6265 T9714 T9715 arg1Of phosphorylation,of
R6266 T9714 T9717 arg1Of phosphorylation,","
R6267 T9714 T9718 arg2Of phosphorylation,accompanied
R6268 T9714 T9731 arg1Of phosphorylation,(
R6269 T9716 T9715 arg2Of IκB,of
R6270 T9718 T9719 arg1Of accompanied,with
R6271 T9721 T9719 arg2Of inhibition,with
R6272 T9721 T9720 arg1Of inhibition,the
R6273 T9721 T9722 arg1Of inhibition,of
R6274 T9721 T9728 arg1Of inhibition,into
R6275 T9724 T9725 arg1Of p50,and
R6276 T9726 T9725 arg2Of p65,and
R6277 T9727 T9722 arg2Of translocation,of
R6278 T9727 T9723 arg1Of translocation,the
R6279 T9727 T9724 arg1Of translocation,p50
R6280 T9727 T9726 arg1Of translocation,p65
R6281 T9730 T9728 arg2Of nucleus,into
R6282 T9730 T9729 arg1Of nucleus,the
R6283 T9733 T9731 arg2Of 2A-C,(
R6284 T9733 T9732 arg1Of 2A-C,Figure
R6285 T9734 T9731 arg3Of ),(
R6286 T9736 T9735 arg1Of tumors,Many
R6287 T9736 T9737 arg1Of tumors,","
R6288 T9736 T9738 arg1Of tumors,including
R6289 T9736 T9741 arg1Of tumors,have
R6290 T9736 T9742 arg1Of tumors,increased
R6291 T9739 T9738 arg2Of melanoma,including
R6292 T9742 T9740 arg1Of increased,","
R6293 T9742 T9741 arg2Of increased,have
R6294 T9743 T9742 arg2Of levels,increased
R6295 T9743 T9744 arg1Of levels,of
R6296 T9745 T9744 arg2Of NF-κB,of
R6297 T9745 T9746 arg1Of NF-κB,[
R6298 T9745 T9749 arg1Of NF-κB,","
R6299 T9745 T9750 arg1Of NF-κB,which
R63 T282 T281 arg1Of relevance,the
R6300 T9745 T9751 arg1Of NF-κB,is
R6301 T9745 T9753 arg1Of NF-κB,acting
R6302 T9747 T9746 arg2Of 40,[
R6303 T9748 T9746 arg3Of ],[
R6304 T9753 T9751 arg2Of acting,is
R6305 T9753 T9752 arg1Of acting,likely
R6306 T9753 T9754 arg1Of acting,as
R6307 T9757 T9754 arg2Of factor,as
R6308 T9757 T9755 arg1Of factor,a
R6309 T9757 T9756 arg1Of factor,survival
R6310 T9757 T9758 arg1Of factor,for
R6311 T9760 T9758 arg2Of growth,for
R6312 T9760 T9759 arg1Of growth,melanoma
R6313 T9764 T9763 arg1Of inhibitions,the
R6314 T9764 T9765 arg1Of inhibitions,of
R6315 T9764 T9768 arg1Of inhibitions,and
R6316 T9767 T9765 arg2Of activity,of
R6317 T9767 T9766 arg1Of activity,NF-κB
R6318 T9768 T9774 arg1Of and,are
R6319 T9768 T9775 arg1Of and,critical
R6320 T9770 T9768 arg2Of expression,and
R6321 T9770 T9769 arg1Of expression,the
R6322 T9770 T9771 arg1Of expression,of
R6323 T9773 T9771 arg2Of genes,of
R6324 T9773 T9772 arg1Of genes,target
R6325 T9774 T9761 arg1Of are,Thus
R6326 T9774 T9762 arg1Of are,","
R6327 T9775 T9774 arg2Of critical,are
R6328 T9775 T9776 arg1Of critical,in
R6329 T9778 T9776 arg2Of inhibition,in
R6330 T9778 T9777 arg1Of inhibition,the
R6331 T9778 T9779 arg1Of inhibition,of
R6332 T9781 T9779 arg2Of growth,of
R6333 T9781 T9780 arg1Of growth,tumor
R6334 T9781 T9782 arg1Of growth,in
R6335 T9784 T9782 arg2Of mice,in
R6336 T9784 T9783 arg1Of mice,CCR5−/−
R6337 T9787 T9786 arg1Of mechanism,the
R6338 T9787 T9788 arg1Of mechanism,is
R6339 T9787 T9790 arg1Of mechanism,clear
R6340 T9788 T9785 arg2Of is,Although
R6341 T9788 T9789 arg1Of is,not
R6342 T9790 T9788 arg2Of clear,is
R6343 T9790 T9792 arg1Of clear,to
R6344 T9792 T9791 arg1Of to,as
R6345 T9793 T9792 arg2Of how,to
R6346 T9794 T9795 arg1Of CCR5−/−,downregulates
R6347 T9795 T9793 arg1Of downregulates,how
R6348 T9796 T9795 arg2Of NF-κB,downregulates
R6349 T9799 T9785 arg1Of is,Although
R6350 T9799 T9797 arg1Of is,","
R6351 T9800 T9799 arg2Of noteworthy,is
R6352 T9802 T9803 arg1Of NF-κB,is
R6353 T9802 T9804 arg2Of NF-κB,activated
R6354 T9802 T9806 arg2Of NF-κB,inactivated
R6355 T9804 T9805 arg1Of activated,or
R6356 T9805 T9798 arg1Of or,it
R6357 T9805 T9799 arg1Of or,is
R6358 T9805 T9800 arg1Of or,noteworthy
R6359 T9805 T9801 arg1Of or,that
R6360 T9805 T9803 arg2Of or,is
R6361 T9806 T9805 arg2Of inactivated,or
R6362 T9809 T9804 arg1Of cytokines,activated
R6363 T9809 T9806 arg1Of cytokines,inactivated
R6364 T9809 T9807 arg2Of cytokines,by
R6365 T9809 T9808 arg1Of cytokines,many
R6366 T9811 T9810 arg1Of studies,Numerous
R6367 T9811 T9812 arg1Of studies,showed
R6368 T9814 T9815 arg1Of cytokine,affect
R6369 T9814 T9819 arg1Of cytokine,regulating
R6370 T9815 T9812 arg2Of affect,showed
R6371 T9815 T9813 arg1Of affect,that
R6372 T9815 T9818 arg1Of affect,by
R6373 T9817 T9815 arg2Of growth,affect
R6374 T9817 T9816 arg1Of growth,tumor
R6375 T9819 T9818 arg2Of regulating,by
R6376 T9820 T9819 arg2Of NF-κB,regulating
R6377 T9822 T9821 arg1Of cytokines,Inflammatory
R6378 T9822 T9823 arg1Of cytokines,","
R6379 T9822 T9824 arg1Of cytokines,including
R6380 T9822 T9831 arg1Of cytokines,activate
R6381 T9825 T9826 arg1Of IL-1,","
R6382 T9826 T9828 arg1Of ",",and
R6383 T9827 T9826 arg2Of IL-6,","
R6384 T9828 T9824 arg2Of and,including
R6385 T9829 T9828 arg2Of IL-8,and
R6386 T9831 T9830 arg1Of activate,","
R6387 T9833 T9831 arg2Of pathways,activate
R6388 T9833 T9832 arg1Of pathways,NF-κB
R6389 T9833 T9834 arg1Of pathways,in
R6390 T9836 T9834 arg2Of cells,in
R6391 T9836 T9835 arg1Of cells,tumor
R6392 T9836 T9837 arg1Of cells,[
R6393 T9838 T9837 arg2Of 41,[
R6394 T9839 T9837 arg3Of ],[
R6395 T9841 T9840 arg1Of interleukin,The
R6396 T9841 T9842 arg1Of interleukin,10
R6397 T9841 T9843 arg1Of interleukin,(
R6398 T9841 T9846 arg1Of interleukin,is
R6399 T9841 T9848 arg2Of interleukin,known
R64 T282 T283 arg1Of relevance,of
R6400 T9844 T9843 arg2Of IL-10,(
R6401 T9845 T9843 arg3Of ),(
R6402 T9848 T9846 arg2Of known,is
R6403 T9848 T9847 arg1Of known,well
R6404 T9848 T9849 arg1Of known,as
R6405 T9848 T9862 arg1Of known,","
R6406 T9848 T9863 arg1Of known,[
R6407 T9852 T9850 arg1Of factor,an
R6408 T9852 T9851 arg1Of factor,anti-tumor
R6409 T9852 T9855 arg1Of factor,as
R6410 T9855 T9849 arg2Of as,as
R6411 T9855 T9853 arg1Of as,as
R6412 T9855 T9854 arg1Of as,well
R6413 T9858 T9855 arg2Of factor,as
R6414 T9858 T9856 arg1Of factor,an
R6415 T9858 T9857 arg1Of factor,anti-inflammatory
R6416 T9858 T9859 arg1Of factor,[
R6417 T9860 T9859 arg2Of 42,[
R6418 T9861 T9859 arg3Of ],[
R6419 T9864 T9863 arg2Of 43,[
R6420 T9865 T9863 arg3Of ],[
R6421 T9866 T9867 arg1Of IL-10,inhibits
R6422 T9867 T9868 arg1Of inhibits,constitutively
R6423 T9867 T9880 arg1Of inhibits,[
R6424 T9870 T9867 arg2Of NF-κB,inhibits
R6425 T9870 T9869 arg2Of NF-κB,activated
R6426 T9870 T9873 arg1Of NF-κB,vitro
R6427 T9870 T9874 arg1Of NF-κB,[
R6428 T9870 T9879 arg1Of NF-κB,vivo
R6429 T9873 T9871 arg1Of vitro,both
R6430 T9873 T9872 arg1Of vitro,in
R6431 T9875 T9874 arg2Of 44,[
R6432 T9876 T9874 arg3Of ],[
R6433 T9879 T9877 arg1Of vivo,and
R6434 T9879 T9878 arg1Of vivo,in
R6435 T9881 T9880 arg2Of 45,[
R6436 T9882 T9880 arg3Of ],[
R6437 T9883 T9884 arg1Of Inhibition,of
R6438 T9883 T9886 arg1Of Inhibition,by
R6439 T9883 T9889 arg1Of Inhibition,contributes
R6440 T9885 T9884 arg2Of NF-κB,of
R6441 T9888 T9886 arg2Of IL-10,by
R6442 T9888 T9887 arg1Of IL-10,the
R6443 T9889 T9890 arg1Of contributes,to
R6444 T9889 T9894 arg1Of contributes,through
R6445 T9889 T9904 arg1Of contributes,[
R6446 T9893 T9890 arg2Of effects,to
R6447 T9893 T9891 arg1Of effects,the
R6448 T9893 T9892 arg1Of effects,anti-tumor
R6449 T9896 T9894 arg2Of activation,through
R6450 T9896 T9895 arg1Of activation,the
R6451 T9896 T9897 arg1Of activation,of
R6452 T9896 T9901 arg1Of activation,in
R6453 T9898 T9899 arg1Of caspase-3,and
R6454 T9899 T9897 arg2Of and,of
R6455 T9900 T9899 arg2Of apoptosis,and
R6456 T9903 T9901 arg2Of mice,in
R6457 T9903 T9902 arg1Of mice,Colon26-bearing
R6458 T9905 T9904 arg2Of 43,[
R6459 T9906 T9904 arg3Of ],[
R6460 T9910 T9909 arg1Of studies,several
R6461 T9910 T9911 arg1Of studies,have
R6462 T9910 T9912 arg1Of studies,demonstrated
R6463 T9912 T9907 arg1Of demonstrated,Similarly
R6464 T9912 T9908 arg1Of demonstrated,","
R6465 T9912 T9911 arg2Of demonstrated,have
R6466 T9914 T9912 arg2Of ability,demonstrated
R6467 T9914 T9913 arg1Of ability,the
R6468 T9914 T9915 arg1Of ability,of
R6469 T9914 T9917 modOf ability,to
R6470 T9916 T9915 arg2Of IL-1Ra,of
R6471 T9918 T9917 arg1Of abrogate,to
R6472 T9921 T9918 arg2Of effects,abrogate
R6473 T9921 T9919 arg1Of effects,the
R6474 T9921 T9920 arg1Of effects,proinflammatory
R6475 T9921 T9922 arg1Of effects,of
R6476 T9923 T9922 arg2Of IL-1,of
R6477 T9923 T9924 arg1Of IL-1,[
R6478 T9925 T9924 arg2Of 46,[
R6479 T9926 T9924 arg3Of ],[
R6480 T9927 T9928 arg1Of It,has
R6481 T9927 T9929 arg1Of It,been
R6482 T9927 T9930 arg2Of It,reported
R6483 T9930 T9928 arg2Of reported,has
R6484 T9930 T9929 arg2Of reported,been
R6485 T9932 T9933 arg1Of IL-1,induces
R6486 T9932 T9943 arg1Of IL-1,increases
R6487 T9933 T9938 arg1Of induces,in
R6488 T9933 T9942 arg1Of induces,and
R6489 T9935 T9933 arg2Of activation,induces
R6490 T9935 T9934 arg1Of activation,the
R6491 T9935 T9936 arg1Of activation,of
R6492 T9937 T9936 arg2Of NF-κB,of
R6493 T9940 T9938 arg2Of cancers,in
R6494 T9940 T9939 arg1Of cancers,several
R6495 T9942 T9930 arg3Of and,reported
R6496 T9942 T9931 arg1Of and,that
R6497 T9942 T9941 arg1Of and,","
R6498 T9943 T9942 arg2Of increases,and
R6499 T9946 T9944 arg1Of progression,cell
R65 T290 T289 arg2Of CCR5,(
R6500 T9946 T9945 arg1Of progression,cycle
R6501 T9946 T9948 arg1Of progression,and
R6502 T9948 T9943 arg2Of and,increases
R6503 T9948 T9947 arg1Of and,","
R6504 T9950 T9948 arg2Of suppression,and
R6505 T9950 T9949 arg1Of suppression,the
R6506 T9950 T9951 arg1Of suppression,of
R6507 T9950 T9955 arg1Of suppression,leading
R6508 T9954 T9951 arg2Of death,of
R6509 T9954 T9952 arg1Of death,apoptotic
R6510 T9954 T9953 arg1Of death,cell
R6511 T9955 T9956 arg1Of leading,to
R6512 T9958 T9956 arg2Of promotion,to
R6513 T9958 T9957 arg1Of promotion,tumor
R6514 T9960 T9959 arg1Of results,The
R6515 T9960 T9961 arg1Of results,of
R6516 T9960 T9964 arg1Of results,over
R6517 T9960 T9969 arg1Of results,indicate
R6518 T9963 T9961 arg2Of studies,of
R6519 T9963 T9962 arg1Of studies,various
R6520 T9968 T9964 arg2Of years,over
R6521 T9968 T9965 arg1Of years,the
R6522 T9968 T9966 arg1Of years,past
R6523 T9968 T9967 arg1Of years,10
R6524 T9973 T9971 arg1Of function,the
R6525 T9973 T9972 arg1Of function,major
R6526 T9973 T9974 arg1Of function,of
R6527 T9973 T9976 arg1Of function,is
R6528 T9975 T9974 arg2Of IL-1Ra,of
R6529 T9976 T9969 arg2Of is,indicate
R6530 T9976 T9970 arg1Of is,that
R6531 T9978 T9976 arg2Of regulate,is
R6532 T9978 T9977 arg1Of regulate,to
R6533 T9978 T9984 arg1Of regulate,by
R6534 T9981 T9978 arg2Of effects,regulate
R6535 T9981 T9979 arg1Of effects,the
R6536 T9981 T9980 arg1Of effects,pleiotropic
R6537 T9981 T9982 arg1Of effects,of
R6538 T9983 T9982 arg2Of IL-1,of
R6539 T9986 T9984 arg2Of blocking,by
R6540 T9986 T9985 arg1Of blocking,competitively
R6541 T9988 T9986 arg2Of functions,blocking
R6542 T9988 T9987 arg1Of functions,its
R6543 T9988 T9989 arg1Of functions,[
R6544 T9990 T9989 arg2Of 47,[
R6545 T9991 T9989 arg3Of ],[
R6546 T9993 T9992 arg1Of ability,The
R6547 T9993 T9994 arg1Of ability,of
R6548 T9993 T9996 modOf ability,to
R6549 T9993 T10001 arg1Of ability,is
R6550 T9993 T10002 arg1Of ability,of
R6551 T9995 T9994 arg2Of IL-1,of
R6552 T9997 T9996 arg1Of induce,to
R6553 T10000 T9997 arg2Of antagonist,induce
R6554 T10000 T9998 arg1Of antagonist,its
R6555 T10000 T9999 arg1Of antagonist,own
R6556 T10002 T10001 arg2Of of,is
R6557 T10003 T10002 arg2Of interest,of
R6558 T10003 T10004 arg1Of interest,in
R6559 T10005 T10004 arg2Of understanding,in
R6560 T10007 T10008 arg1Of regulation,and
R6561 T10008 T10005 arg2Of and,understanding
R6562 T10008 T10006 arg1Of and,the
R6563 T10008 T10010 arg1Of and,of
R6564 T10008 T10013 arg1Of and,in
R6565 T10009 T10008 arg2Of dysregulation,and
R6566 T10012 T10010 arg2Of signaling,of
R6567 T10012 T10011 arg1Of signaling,IL-1
R6568 T10014 T10015 arg1Of normal,and
R6569 T10016 T10015 arg2Of diseased,and
R6570 T10017 T10013 arg2Of tissue,in
R6571 T10017 T10014 arg1Of tissue,normal
R6572 T10017 T10016 arg1Of tissue,diseased
R6573 T10018 T10019 arg1Of Up-regulation,of
R6574 T10018 T10023 arg1Of Up-regulation,represents
R6575 T10022 T10019 arg2Of antagonist,of
R6576 T10022 T10020 arg1Of antagonist,the
R6577 T10022 T10021 arg1Of antagonist,receptor
R6578 T10025 T10023 arg2Of mechanism,represents
R6579 T10025 T10024 arg1Of mechanism,a
R6580 T10025 T10026 arg1Of mechanism,for
R6581 T10027 T10028 arg1Of turning,off
R6582 T10027 T10031 arg1Of turning,and
R6583 T10030 T10027 arg2Of signaling,turning
R6584 T10030 T10029 arg1Of signaling,IL-1
R6585 T10031 T10026 arg2Of and,for
R6586 T10032 T10031 arg2Of creating,and
R6587 T10035 T10032 arg2Of state,creating
R6588 T10035 T10033 arg1Of state,a
R6589 T10035 T10034 arg1Of state,temporary
R6590 T10035 T10036 arg1Of state,of
R6591 T10037 T10036 arg2Of refractoriness,of
R6592 T10040 T10038 arg1Of expression,The
R6593 T10040 T10039 arg2Of expression,elevated
R6594 T10040 T10041 arg1Of expression,of
R6595 T10040 T10043 arg1Of expression,","
R6596 T10040 T10044 arg1Of expression,without
R6597 T10040 T10052 arg1Of expression,suggests
R6598 T10042 T10041 arg2Of IL-1Ra,of
R6599 T10046 T10044 arg2Of change,without
R66 T291 T289 arg3Of ),(
R6600 T10046 T10045 arg1Of change,any
R6601 T10046 T10047 arg1Of change,of
R6602 T10046 T10049 arg1Of change,in
R6603 T10048 T10047 arg2Of IL-1,of
R6604 T10050 T10049 arg2Of tumors,in
R6605 T10052 T10051 arg1Of suggests,","
R6606 T10056 T10054 arg1Of system,the
R6607 T10056 T10055 arg1Of system,IL-1-signaling
R6608 T10056 T10057 arg1Of system,may
R6609 T10056 T10058 arg1Of system,be
R6610 T10056 T10059 arg2Of system,dysregulated
R6611 T10059 T10052 arg2Of dysregulated,suggests
R6612 T10059 T10053 arg1Of dysregulated,that
R6613 T10059 T10057 arg2Of dysregulated,may
R6614 T10059 T10058 arg2Of dysregulated,be
R6615 T10059 T10062 arg1Of dysregulated,in
R6616 T10061 T10059 arg1Of IL-1Ra,dysregulated
R6617 T10061 T10060 arg2Of IL-1Ra,by
R6618 T10063 T10062 arg2Of tumors,in
R6619 T10064 T10065 arg1Of IL-1Ra,has
R6620 T10064 T10066 arg1Of IL-1Ra,been
R6621 T10064 T10067 arg2Of IL-1Ra,shown
R6622 T10064 T10069 arg1Of IL-1Ra,inhibit
R6623 T10067 T10065 arg2Of shown,has
R6624 T10067 T10066 arg2Of shown,been
R6625 T10069 T10067 arg3Of inhibit,shown
R6626 T10069 T10068 arg1Of inhibit,to
R6627 T10069 T10080 arg1Of inhibit,[
R6628 T10069 T10083 arg1Of inhibit,","
R6629 T10069 T10084 arg1Of inhibit,[
R6630 T10069 T10087 arg1Of inhibit,","
R6631 T10069 T10088 arg1Of inhibit,[
R6632 T10071 T10069 arg2Of progression,inhibit
R6633 T10071 T10070 arg1Of progression,tumor
R6634 T10071 T10072 arg1Of progression,in
R6635 T10073 T10074 arg1Of prostate,","
R6636 T10074 T10077 arg1Of ",",and
R6637 T10075 T10074 arg2Of breast,","
R6638 T10077 T10072 arg2Of and,in
R6639 T10077 T10076 arg1Of and,","
R6640 T10079 T10077 arg2Of cancer,and
R6641 T10079 T10078 arg1Of cancer,skin
R6642 T10081 T10080 arg2Of 14,[
R6643 T10082 T10080 arg3Of ],[
R6644 T10085 T10084 arg2Of 15,[
R6645 T10086 T10084 arg3Of ],[
R6646 T10089 T10088 arg2Of 16,[
R6647 T10090 T10088 arg3Of ],[
R6648 T10092 T10091 arg1Of IL-1Ra,Intracellular
R6649 T10092 T10093 arg1Of IL-1Ra,(
R6650 T10092 T10096 arg1Of IL-1Ra,inhibits
R6651 T10092 T10105 arg1Of IL-1Ra,blocking
R6652 T10094 T10093 arg2Of icIL-1Ra,(
R6653 T10095 T10093 arg3Of ),(
R6654 T10096 T10104 arg1Of inhibits,by
R6655 T10097 T10098 arg1Of IL-6,and
R6656 T10099 T10098 arg2Of IL-8,and
R6657 T10100 T10096 arg2Of production,inhibits
R6658 T10100 T10097 arg1Of production,IL-6
R6659 T10100 T10099 arg1Of production,IL-8
R6660 T10100 T10101 arg1Of production,in
R6661 T10103 T10101 arg2Of cells,in
R6662 T10103 T10102 arg1Of cells,Caco-2
R6663 T10105 T10104 arg2Of blocking,by
R6664 T10107 T10105 arg2Of pathways,blocking
R6665 T10107 T10106 arg1Of pathways,NF-κB
R6666 T10107 T10108 arg1Of pathways,[
R6667 T10109 T10108 arg2Of 37,[
R6668 T10110 T10108 arg3Of ],[
R6669 T10111 T10112 arg1Of We,found
R6670 T10115 T10114 arg1Of levels,the
R6671 T10115 T10116 arg1Of levels,of
R6672 T10115 T10118 arg1Of levels,were
R6673 T10115 T10120 arg2Of levels,elevated
R6674 T10117 T10116 arg2Of IL-1Ra,of
R6675 T10120 T10112 arg2Of elevated,found
R6676 T10120 T10113 arg1Of elevated,that
R6677 T10120 T10118 arg2Of elevated,were
R6678 T10120 T10119 arg1Of elevated,significantly
R6679 T10120 T10121 arg1Of elevated,in
R6680 T10124 T10121 arg2Of tissues,in
R6681 T10124 T10122 arg1Of tissues,the
R6682 T10124 T10123 arg1Of tissues,tumor
R6683 T10124 T10125 arg1Of tissues,of
R6684 T10127 T10125 arg2Of mice,of
R6685 T10127 T10126 arg1Of mice,CCR5−/−
R6686 T10127 T10128 arg2Of mice,inoculated
R6687 T10128 T10129 arg1Of inoculated,with
R6688 T10132 T10129 arg2Of cells,with
R6689 T10132 T10130 arg1Of cells,B16
R6690 T10132 T10131 arg1Of cells,melanoma
R6691 T10133 T10134 arg1Of Taken,together
R6692 T10137 T10136 arg1Of data,these
R6693 T10137 T10138 arg1Of data,indicate
R6694 T10138 T10133 modOf indicate,Taken
R6695 T10138 T10135 arg1Of indicate,","
R6696 T10139 T10140 arg1Of IL-1Ra,could
R6697 T10139 T10141 arg1Of IL-1Ra,be
R6698 T10139 T10143 arg2Of IL-1Ra,involved
R6699 T10143 T10138 arg2Of involved,indicate
R67 T292 T284 arg1Of expression,C-C
R6700 T10143 T10140 arg2Of involved,could
R6701 T10143 T10141 arg2Of involved,be
R6702 T10143 T10142 arg1Of involved,critically
R6703 T10143 T10144 arg1Of involved,in
R6704 T10143 T10152 arg1Of involved,through
R6705 T10148 T10144 arg2Of inhibition,in
R6706 T10148 T10145 arg1Of inhibition,the
R6707 T10148 T10146 arg1Of inhibition,tumor
R6708 T10148 T10147 arg1Of inhibition,growth
R6709 T10148 T10149 arg1Of inhibition,of
R6710 T10151 T10149 arg2Of mice,of
R6711 T10151 T10150 arg1Of mice,CCR5−/−
R6712 T10154 T10152 arg2Of inactivation,through
R6713 T10154 T10153 arg1Of inactivation,the
R6714 T10154 T10155 arg1Of inactivation,of
R6715 T10154 T10157 arg1Of inactivation,in
R6716 T10156 T10155 arg2Of NF-κB,of
R6717 T10160 T10157 arg2Of study,in
R6718 T10160 T10158 arg1Of study,the
R6719 T10160 T10159 arg1Of study,present
R6720 T10161 T10162 arg1Of CCR5,increases
R6721 T10161 T10170 arg1Of CCR5,inhibits
R6722 T10162 T10165 arg1Of increases,in
R6723 T10162 T10169 arg1Of increases,and
R6724 T10164 T10162 arg2Of growth,increases
R6725 T10164 T10163 arg1Of growth,tumor
R6726 T10168 T10165 arg2Of model,in
R6727 T10168 T10166 arg1Of model,a
R6728 T10168 T10167 arg1Of model,local
R6729 T10170 T10169 arg2Of inhibits,and
R6730 T10172 T10170 arg2Of efficacy,inhibits
R6731 T10172 T10171 arg1Of efficacy,the
R6732 T10172 T10173 arg1Of efficacy,of
R6733 T10172 T10178 arg1Of efficacy,in
R6734 T10177 T10173 arg2Of vaccine,of
R6735 T10177 T10174 arg1Of vaccine,a
R6736 T10177 T10175 arg1Of vaccine,dendrite
R6737 T10177 T10176 arg1Of vaccine,cell
R6738 T10180 T10178 arg2Of mice,in
R6739 T10180 T10179 arg1Of mice,CCR5+/+
R6740 T10180 T10181 arg1Of mice,compared
R6741 T10182 T10181 arg2Of with,compared
R6742 T10184 T10182 arg2Of mice,with
R6743 T10184 T10183 arg1Of mice,CCR5−/−
R6744 T10184 T10185 arg1Of mice,[
R6745 T10186 T10185 arg2Of 10,[
R6746 T10187 T10185 arg3Of ],[
R6747 T10189 T10188 arg1Of J,Cheng
R6748 T10189 T10190 arg1Of J,and
R6749 T10190 T10193 arg1Of and,examined
R6750 T10192 T10190 arg2Of RS,and
R6751 T10192 T10191 arg1Of RS,Sung
R6752 T10193 T10208 arg1Of examined,in
R6753 T10195 T10193 arg2Of effect,examined
R6754 T10195 T10194 arg1Of effect,the
R6755 T10195 T10196 arg1Of effect,of
R6756 T10195 T10198 arg1Of effect,on
R6757 T10197 T10196 arg2Of CCR5,of
R6758 T10201 T10198 arg2Of response,on
R6759 T10201 T10199 arg1Of response,the
R6760 T10201 T10200 arg1Of response,immune
R6761 T10201 T10202 arg1Of response,to
R6762 T10204 T10203 arg1Of vectors,adenovirus
R6763 T10204 T10205 arg1Of vectors,and
R6764 T10205 T10202 arg2Of and,to
R6765 T10207 T10205 arg2Of function,and
R6766 T10207 T10206 arg1Of function,graft
R6767 T10212 T10208 arg2Of model,in
R6768 T10212 T10209 arg1Of model,an
R6769 T10212 T10210 arg1Of model,islet
R6770 T10212 T10211 arg1Of model,transplant
R6771 T10213 T10214 arg1Of They,found
R6772 T10217 T10216 arg1Of absence,CCR5
R6773 T10217 T10218 arg1Of absence,does
R6774 T10217 T10220 arg1Of absence,prevent
R6775 T10220 T10214 arg2Of prevent,found
R6776 T10220 T10215 arg1Of prevent,that
R6777 T10220 T10218 arg2Of prevent,does
R6778 T10220 T10219 arg1Of prevent,not
R6779 T10220 T10228 arg1Of prevent,[
R6780 T10224 T10220 arg2Of response,prevent
R6781 T10224 T10221 arg1Of response,the
R6782 T10224 T10222 arg1Of response,local
R6783 T10224 T10223 arg1Of response,immune
R6784 T10224 T10225 arg1Of response,to
R6785 T10227 T10225 arg2Of transduction,to
R6786 T10227 T10226 arg1Of transduction,adenovirus
R6787 T10229 T10228 arg2Of 48,[
R6788 T10230 T10228 arg3Of ],[
R6789 T10234 T10233 arg1Of MC,Tan
R6790 T10234 T10235 arg1Of MC,et
R6791 T10234 T10236 arg1Of MC,al.
R6792 T10234 T10237 arg1Of MC,suggested
R6793 T10237 T10231 arg1Of suggested,Additionally
R6794 T10237 T10232 arg1Of suggested,","
R6795 T10239 T10240 arg1Of disruption,of
R6796 T10239 T10243 arg1Of disruption,","
R6797 T10239 T10245 arg1Of disruption,by
R6798 T10239 T10253 arg1Of disruption,by
R6799 T10239 T10264 arg1Of disruption,reduced
R68 T292 T285 arg1Of expression,chemokine
R6800 T10242 T10240 arg2Of signaling,of
R6801 T10242 T10241 arg1Of signaling,CCR5/CCL5
R6802 T10245 T10244 arg1Of by,either
R6803 T10245 T10252 arg1Of by,or
R6804 T10246 T10245 arg2Of reducing,by
R6805 T10248 T10246 arg2Of production,reducing
R6806 T10248 T10247 arg1Of production,CCL5
R6807 T10248 T10249 arg1Of production,by
R6808 T10251 T10249 arg2Of cells,by
R6809 T10251 T10250 arg1Of cells,tumor
R6810 T10253 T10252 arg2Of by,or
R6811 T10255 T10253 arg2Of administration,by
R6812 T10255 T10254 arg1Of administration,systemic
R6813 T10255 T10256 arg1Of administration,of
R6814 T10259 T10256 arg2Of inhibitor,of
R6815 T10259 T10257 arg1Of inhibitor,a
R6816 T10259 T10258 arg1Of inhibitor,CCR5
R6817 T10259 T10260 arg1Of inhibitor,(
R6818 T10261 T10260 arg2Of TAK-779,(
R6819 T10262 T10260 arg3Of ),(
R6820 T10264 T10237 arg2Of reduced,suggested
R6821 T10264 T10238 arg1Of reduced,that
R6822 T10264 T10263 arg1Of reduced,","
R6823 T10264 T10274 arg1Of reduced,so
R6824 T10269 T10266 arg2Of cells,(
R6825 T10269 T10267 arg1Of cells,regulatory
R6826 T10269 T10268 arg1Of cells,T
R6827 T10270 T10266 arg3Of ),(
R6828 T10271 T10264 arg2Of migration,reduced
R6829 T10271 T10265 arg1Of migration,Treg
R6830 T10271 T10266 arg1Of migration,(
R6831 T10271 T10272 arg1Of migration,to
R6832 T10273 T10272 arg2Of tumors,to
R6833 T10274 T10275 arg1Of so,that
R6834 T10276 T10277 arg1Of tumors,are
R6835 T10276 T10278 arg1Of tumors,smaller
R6836 T10277 T10274 arg2Of are,so
R6837 T10278 T10277 arg2Of smaller,are
R6838 T10278 T10279 arg1Of smaller,in
R6839 T10281 T10279 arg2Of mice,in
R6840 T10281 T10280 arg1Of mice,control
R6841 T10281 T10282 arg1Of mice,[
R6842 T10283 T10282 arg2Of 9,[
R6843 T10284 T10282 arg3Of ],[
R6844 T10286 T10285 arg1Of data,These
R6845 T10286 T10287 arg1Of data,support
R6846 T10290 T10287 arg2Of premise,support
R6847 T10290 T10288 arg1Of premise,the
R6848 T10290 T10289 arg1Of premise,important
R6849 T10292 T10293 arg1Of inhibition,of
R6850 T10292 T10299 arg1Of inhibition,could
R6851 T10292 T10300 arg1Of inhibition,be
R6852 T10292 T10301 arg2Of inhibition,related
R6853 T10295 T10293 arg2Of growth,of
R6854 T10295 T10294 arg1Of growth,tumor
R6855 T10295 T10296 arg1Of growth,in
R6856 T10298 T10296 arg2Of mice,in
R6857 T10298 T10297 arg1Of mice,CCR5−/−
R6858 T10301 T10290 arg2Of related,premise
R6859 T10301 T10291 arg1Of related,that
R6860 T10301 T10299 arg2Of related,could
R6861 T10301 T10300 arg2Of related,be
R6862 T10301 T10302 arg1Of related,with
R6863 T10304 T10302 arg2Of inhibition,with
R6864 T10304 T10303 arg1Of inhibition,the
R6865 T10304 T10305 arg1Of inhibition,of
R6866 T10307 T10305 arg2Of escape,of
R6867 T10307 T10306 arg1Of escape,immune
R6868 T10308 T10309 arg1Of Similar,to
R6869 T10311 T10309 arg2Of finding,to
R6870 T10311 T10310 arg1Of finding,this
R6871 T10313 T10314 arg1Of we,found
R6872 T10314 T10308 arg1Of found,Similar
R6873 T10314 T10312 arg1Of found,","
R6874 T10318 T10316 arg1Of mice,the
R6875 T10318 T10317 arg1Of mice,CCR5+/+
R6876 T10318 T10319 arg2Of mice,injected
R6877 T10318 T10324 arg1Of mice,have
R6878 T10319 T10320 arg1Of injected,with
R6879 T10322 T10320 arg2Of cells,with
R6880 T10322 T10321 arg1Of cells,melanoma
R6881 T10324 T10314 arg2Of have,found
R6882 T10324 T10315 arg1Of have,that
R6883 T10324 T10323 arg1Of have,apparently
R6884 T10327 T10324 arg2Of number,have
R6885 T10327 T10325 arg1Of number,a
R6886 T10327 T10326 arg1Of number,lower
R6887 T10327 T10328 arg1Of number,of
R6888 T10331 T10329 arg1Of cells,cytotoxic
R6889 T10331 T10330 arg1Of cells,T
R6890 T10331 T10332 arg1Of cells,(
R6891 T10331 T10338 arg1Of cells,and
R6892 T10336 T10332 arg2Of cells,(
R6893 T10336 T10333 arg1Of cells,CD8+positive
R6894 T10336 T10334 arg1Of cells,T
R6895 T10336 T10335 arg1Of cells,Lymphocytes
R6896 T10337 T10332 arg3Of ),(
R6897 T10338 T10328 arg2Of and,of
R6898 T10338 T10354 arg1Of and,","
R6899 T10338 T10355 arg1Of and,in
R69 T292 T286 arg1Of expression,receptor
R6900 T10341 T10339 arg1Of cells,natural
R6901 T10341 T10340 arg1Of cells,killer
R6902 T10341 T10342 arg1Of cells,(
R6903 T10341 T10351 arg1Of cells,as
R6904 T10346 T10342 arg2Of cells,(
R6905 T10346 T10343 arg1Of cells,CD57
R6906 T10346 T10344 arg1Of cells,positive
R6907 T10346 T10345 arg1Of cells,NK
R6908 T10347 T10342 arg3Of ),(
R6909 T10351 T10338 arg2Of as,and
R6910 T10351 T10348 arg1Of as,","
R6911 T10351 T10349 arg1Of as,as
R6912 T10351 T10350 arg1Of as,well
R6913 T10353 T10351 arg2Of cells,as
R6914 T10353 T10352 arg1Of cells,dendrite
R6915 T10357 T10355 arg2Of tissues,in
R6916 T10357 T10356 arg1Of tissues,spleen
R6917 T10357 T10358 arg2Of tissues,compared
R6918 T10358 T10359 arg1Of compared,to
R6919 T10360 T10359 arg2Of those,to
R6920 T10360 T10361 arg1Of those,without
R6921 T10363 T10361 arg2Of cells,without
R6922 T10363 T10362 arg1Of cells,melanoma
R6923 T10366 T10365 arg1Of lymphocytes,the
R6924 T10366 T10367 arg1Of lymphocytes,of
R6925 T10366 T10371 arg1Of lymphocytes,did
R6926 T10366 T10373 arg1Of lymphocytes,decrease
R6927 T10370 T10367 arg2Of mice,of
R6928 T10370 T10368 arg1Of mice,the
R6929 T10370 T10369 arg1Of mice,CCR5−/−
R6930 T10373 T10364 arg1Of decrease,But
R6931 T10373 T10371 arg2Of decrease,did
R6932 T10373 T10372 arg1Of decrease,not
R6933 T10373 T10374 arg1Of decrease,when
R6934 T10375 T10374 arg2Of injected,when
R6935 T10375 T10376 arg1Of injected,with
R6936 T10378 T10376 arg2Of cells,with
R6937 T10378 T10377 arg1Of cells,melanoma
R6938 T10380 T10379 arg1Of differences,These
R6939 T10380 T10381 arg1Of differences,of
R6940 T10380 T10393 arg1Of differences,","
R6941 T10380 T10394 arg1Of differences,involving
R6942 T10380 T10399 arg1Of differences,may
R6943 T10380 T10400 arg1Of differences,be
R6944 T10380 T10401 arg2Of differences,connected
R6945 T10384 T10381 arg2Of response,of
R6946 T10384 T10382 arg1Of response,the
R6947 T10384 T10383 arg1Of response,immune
R6948 T10384 T10385 arg1Of response,between
R6949 T10388 T10386 arg1Of mice,the
R6950 T10388 T10387 arg1Of mice,CCR5+/+
R6951 T10388 T10389 arg1Of mice,and
R6952 T10389 T10385 arg2Of and,between
R6953 T10392 T10389 arg2Of mice,and
R6954 T10392 T10390 arg1Of mice,the
R6955 T10392 T10391 arg1Of mice,CCR5−/−
R6956 T10397 T10394 arg2Of tolerance,involving
R6957 T10397 T10395 arg1Of tolerance,tumor
R6958 T10397 T10396 arg1Of tolerance,immune
R6959 T10401 T10398 arg1Of connected,","
R6960 T10401 T10399 arg2Of connected,may
R6961 T10401 T10400 arg2Of connected,be
R6962 T10401 T10402 arg1Of connected,with
R6963 T10404 T10402 arg2Of inhibition,with
R6964 T10404 T10403 arg1Of inhibition,the
R6965 T10404 T10405 arg1Of inhibition,of
R6966 T10407 T10405 arg2Of progression,of
R6967 T10407 T10406 arg1Of progression,cancer
R6968 T10408 T10409 arg1Of Taken,together
R6969 T10415 T10411 arg2Of experiment,in
R6970 T10415 T10412 arg1Of experiment,the
R6971 T10415 T10413 arg1Of experiment,cytokine
R6972 T10415 T10414 arg1Of experiment,array
R6973 T10418 T10417 arg1Of level,the
R6974 T10418 T10419 arg1Of level,of
R6975 T10418 T10435 arg1Of level,was
R6976 T10418 T10436 arg2Of level,increased
R6977 T10420 T10419 arg2Of MIP-1α,of
R6978 T10420 T10421 arg1Of MIP-1α,(
R6979 T10422 T10421 arg2Of which,(
R6980 T10422 T10423 arg1Of which,has
R6981 T10426 T10423 arg2Of activity,has
R6982 T10426 T10424 arg1Of activity,a
R6983 T10426 T10425 arg1Of activity,potent
R6984 T10426 T10427 arg1Of activity,of
R6985 T10429 T10430 arg1Of cell,and
R6986 T10431 T10430 arg2Of B,and
R6987 T10433 T10427 arg2Of migration,of
R6988 T10433 T10428 arg1Of migration,T
R6989 T10433 T10429 arg1Of migration,cell
R6990 T10433 T10431 arg1Of migration,B
R6991 T10433 T10432 arg1Of migration,cell
R6992 T10434 T10421 arg3Of ),(
R6993 T10436 T10408 modOf increased,Taken
R6994 T10436 T10410 arg1Of increased,","
R6995 T10436 T10411 arg1Of increased,in
R6996 T10436 T10416 arg1Of increased,","
R6997 T10436 T10435 arg2Of increased,was
R6998 T10436 T10437 arg1Of increased,in
R6999 T10440 T10437 arg2Of mice,in
R70 T292 T287 arg1Of expression,type
R7000 T10440 T10438 arg1Of mice,the
R7001 T10440 T10439 arg1Of mice,CCR5−/−
R7002 T10440 T10441 arg2Of mice,compared
R7003 T10441 T10442 arg1Of compared,with
R7004 T10443 T10442 arg2Of those,with
R7005 T10443 T10444 arg1Of those,in
R7006 T10447 T10444 arg2Of mice,in
R7007 T10447 T10445 arg1Of mice,the
R7008 T10447 T10446 arg1Of mice,CCR5+/+
R7009 T10451 T10450 arg1Of increased,relatively
R7010 T10455 T10451 arg1Of lymphocytes,increased
R7011 T10455 T10452 arg1Of lymphocytes,tumor
R7012 T10455 T10453 arg2Of lymphocytes,associated
R7013 T10455 T10454 arg1Of lymphocytes,cytotoxic
R7014 T10455 T10456 arg1Of lymphocytes,could
R7015 T10455 T10457 arg1Of lymphocytes,play
R7016 T10457 T10448 arg1Of play,Thus
R7017 T10457 T10449 arg1Of play,","
R7018 T10457 T10456 arg2Of play,could
R7019 T10457 T10461 arg1Of play,in
R7020 T10460 T10457 arg2Of role,play
R7021 T10460 T10458 arg1Of role,an
R7022 T10460 T10459 arg1Of role,important
R7023 T10462 T10461 arg2Of inhibiting,in
R7024 T10465 T10462 arg2Of growth,inhibiting
R7025 T10465 T10463 arg1Of growth,the
R7026 T10465 T10464 arg1Of growth,tumor
R7027 T10465 T10466 arg1Of growth,in
R7028 T10468 T10466 arg2Of mice,in
R7029 T10468 T10467 arg1Of mice,CCR5−/−
R7030 T10469 T10470 arg1Of Activation,of
R7031 T10469 T10472 arg1Of Activation,could
R7032 T10469 T10473 arg1Of Activation,modulate
R7033 T10471 T10470 arg2Of NF-κB,of
R7034 T10473 T10472 arg2Of modulate,could
R7035 T10475 T10474 arg1Of localization,subcellular
R7036 T10475 T10476 arg1Of localization,of
R7037 T10475 T10479 arg1Of localization,and
R7038 T10478 T10476 arg2Of cells,of
R7039 T10478 T10477 arg1Of cells,NK
R7040 T10479 T10473 arg2Of and,modulate
R7041 T10480 T10479 arg2Of pathogenesis,and
R7042 T10480 T10481 arg1Of pathogenesis,[
R7043 T10482 T10481 arg2Of 49,[
R7044 T10483 T10481 arg3Of ],[
R7045 T10484 T10485 arg1Of Inhibition,of
R7046 T10484 T10488 arg1Of Inhibition,prevented
R7047 T10484 T10495 arg1Of Inhibition,increased
R7048 T10484 T10499 arg1Of Inhibition,decreasing
R7049 T10487 T10485 arg2Of activity,of
R7050 T10487 T10486 arg1Of activity,NF-κB
R7051 T10488 T10493 arg1Of prevented,and
R7052 T10491 T10488 arg2Of depletion,prevented
R7053 T10491 T10489 arg1Of depletion,NK
R7054 T10491 T10490 arg1Of depletion,cell
R7055 T10493 T10492 arg1Of and,","
R7056 T10495 T10493 arg2Of increased,and
R7057 T10495 T10494 arg1Of increased,thus
R7058 T10495 T10498 arg1Of increased,by
R7059 T10497 T10495 arg2Of activity,increased
R7060 T10497 T10496 arg1Of activity,anti-tumor
R7061 T10499 T10498 arg2Of decreasing,by
R7062 T10499 T10502 arg1Of decreasing,[
R7063 T10501 T10499 arg2Of production,decreasing
R7064 T10501 T10500 arg1Of production,IL-6
R7065 T10503 T10502 arg2Of 50,[
R7066 T10504 T10502 arg3Of ],[
R7067 T10509 T10508 arg2Of NF-κB,decreased
R7068 T10509 T10510 arg1Of NF-κB,and
R7069 T10510 T10507 arg1Of and,the
R7070 T10510 T10513 arg1Of and,could
R7071 T10510 T10515 arg1Of and,be
R7072 T10510 T10516 arg2Of and,associated
R7073 T10512 T10510 arg2Of IL-1Ra,and
R7074 T10512 T10511 arg1Of IL-1Ra,elevated
R7075 T10516 T10505 arg1Of associated,Thus
R7076 T10516 T10506 arg1Of associated,","
R7077 T10516 T10513 arg2Of associated,could
R7078 T10516 T10514 arg1Of associated,also
R7079 T10516 T10515 arg2Of associated,be
R7080 T10516 T10517 arg1Of associated,in
R7081 T10516 T10523 arg1Of associated,into
R7082 T10516 T10525 arg1Of associated,","
R7083 T10516 T10526 modOf associated,resulting
R7084 T10519 T10517 arg2Of infiltration,in
R7085 T10519 T10518 arg1Of infiltration,the
R7086 T10519 T10520 arg1Of infiltration,of
R7087 T10522 T10520 arg2Of lymphocytes,of
R7088 T10522 T10521 arg1Of lymphocytes,cytotoxic
R7089 T10524 T10523 arg2Of tumor,into
R7090 T10526 T10527 arg1Of resulting,in
R7091 T10530 T10527 arg2Of inhibition,in
R7092 T10530 T10528 arg1Of inhibition,tumor
R7093 T10530 T10529 arg1Of inhibition,growth
R7094 T10532 T10531 arg2Of contrast,In
R7095 T10534 T10535 arg1Of IL-23,","
R7096 T10534 T10542 arg1Of IL-23,increased
R7097 T10540 T10535 arg2Of cytokine,","
R7098 T10540 T10536 arg1Of cytokine,a
R7099 T10540 T10537 arg1Of cytokine,tumor
R71 T292 T288 arg1Of expression,5
R7100 T10540 T10538 arg1Of cytokine,growth
R7101 T10540 T10539 arg1Of cytokine,promoting
R7102 T10542 T10531 arg1Of increased,In
R7103 T10542 T10533 arg1Of increased,","
R7104 T10542 T10541 arg1Of increased,","
R7105 T10542 T10551 arg1Of increased,[
R7106 T10543 T10544 arg1Of NF-κB,and
R7107 T10544 T10542 arg2Of and,increased
R7108 T10544 T10548 arg1Of and,in
R7109 T10547 T10544 arg2Of infiltration,and
R7110 T10547 T10545 arg1Of infiltration,immune
R7111 T10547 T10546 arg1Of infiltration,cell
R7112 T10550 T10548 arg2Of tumor,in
R7113 T10550 T10549 arg1Of tumor,oral
R7114 T10552 T10551 arg2Of 51,[
R7115 T10553 T10551 arg3Of ],[
R7116 T10555 T10554 arg1Of data,These
R7117 T10555 T10556 arg1Of data,indicate
R7118 T10558 T10559 arg1Of NF-κB,could
R7119 T10558 T10560 arg1Of NF-κB,be
R7120 T10558 T10561 arg2Of NF-κB,involved
R7121 T10561 T10556 arg2Of involved,indicate
R7122 T10561 T10557 arg1Of involved,that
R7123 T10561 T10559 arg2Of involved,could
R7124 T10561 T10560 arg2Of involved,be
R7125 T10561 T10562 arg1Of involved,in
R7126 T10564 T10562 arg2Of cytokine,in
R7127 T10564 T10563 arg1Of cytokine,the
R7128 T10567 T10562 arg3Of activities,in
R7129 T10567 T10565 arg2Of activities,mediated
R7130 T10567 T10566 arg1Of activities,anti-tumor
R7131 T10567 T10568 arg1Of activities,of
R7132 T10570 T10568 arg2Of cells,of
R7133 T10570 T10569 arg1Of cells,immune
R7134 T10572 T10573 arg1Of is,also
R7135 T10574 T10572 arg2Of noteworthy,is
R7136 T10576 T10577 arg1Of IL-1Ra,inhibited
R7137 T10576 T10582 arg1Of IL-1Ra,increasing
R7138 T10577 T10571 arg1Of inhibited,It
R7139 T10577 T10572 arg1Of inhibited,is
R7140 T10577 T10574 arg1Of inhibited,noteworthy
R7141 T10577 T10575 arg1Of inhibited,that
R7142 T10577 T10581 arg1Of inhibited,by
R7143 T10580 T10577 arg2Of growth,inhibited
R7144 T10580 T10578 arg1Of growth,melanoma
R7145 T10580 T10579 arg1Of growth,tumor
R7146 T10582 T10581 arg2Of increasing,by
R7147 T10582 T10589 arg1Of increasing,in
R7148 T10584 T10582 arg2Of number,increasing
R7149 T10584 T10583 arg1Of number,the
R7150 T10584 T10585 arg1Of number,of
R7151 T10588 T10585 arg2Of cells,of
R7152 T10588 T10586 arg1Of cells,myeloid
R7153 T10588 T10587 arg1Of cells,suppressor
R7154 T10590 T10589 arg2Of tumor,in
R7155 T10590 T10591 arg1Of tumor,[
R7156 T10592 T10591 arg2Of 25,[
R7157 T10593 T10591 arg3Of ],[
R7158 T10597 T10594 arg1Of incidence,The
R7159 T10597 T10595 arg1Of incidence,3-methylcholatrene-induced
R7160 T10597 T10596 arg1Of incidence,tumor
R7161 T10597 T10598 arg1Of incidence,was
R7162 T10597 T10599 arg2Of incidence,reduced
R7163 T10597 T10606 arg1Of incidence,increased
R7164 T10599 T10598 arg2Of reduced,was
R7165 T10599 T10600 arg1Of reduced,in
R7166 T10599 T10605 arg1Of reduced,but
R7167 T10603 T10600 arg2Of mice,in
R7168 T10603 T10601 arg1Of mice,IL-1α
R7169 T10603 T10602 arg1Of mice,knockout
R7170 T10605 T10604 arg1Of but,","
R7171 T10606 T10605 arg2Of increased,but
R7172 T10606 T10607 arg1Of increased,in
R7173 T10606 T10610 arg1Of increased,with
R7174 T10609 T10607 arg2Of mice,in
R7175 T10609 T10608 arg1Of mice,IL-1Ra
R7176 T10612 T10611 arg1Of maturation,concomitant
R7177 T10612 T10613 arg1Of maturation,of
R7178 T10612 T10616 arg1Of maturation,and
R7179 T10615 T10613 arg2Of cells,of
R7180 T10615 T10614 arg1Of cells,NK
R7181 T10616 T10610 arg2Of and,with
R7182 T10618 T10616 arg2Of immunity,and
R7183 T10618 T10617 arg1Of immunity,anti-tumor
R7184 T10618 T10619 arg1Of immunity,[
R7185 T10620 T10619 arg2Of 52,[
R7186 T10621 T10619 arg3Of ],[
R7187 T10623 T10622 arg1Of data,These
R7188 T10623 T10624 arg1Of data,indicate
R7189 T10627 T10626 arg1Of decrease,the
R7190 T10627 T10628 arg1Of decrease,of
R7191 T10627 T10634 arg1Of decrease,of
R7192 T10627 T10636 arg1Of decrease,could
R7193 T10627 T10637 arg1Of decrease,be
R7194 T10627 T10638 arg1Of decrease,significant
R7195 T10629 T10631 arg1Of NF-κB,and
R7196 T10631 T10628 arg2Of and,of
R7197 T10631 T10630 arg1Of and,","
R7198 T10633 T10631 arg2Of increase,and
R7199 T10633 T10632 arg1Of increase,thus
R72 T292 T289 arg1Of expression,(
R7200 T10635 T10634 arg2Of IL-1Ra,of
R7201 T10637 T10624 arg2Of be,indicate
R7202 T10637 T10625 arg1Of be,that
R7203 T10637 T10636 arg2Of be,could
R7204 T10638 T10637 arg2Of significant,be
R7205 T10638 T10639 arg1Of significant,in
R7206 T10642 T10639 arg2Of inhibition,in
R7207 T10642 T10640 arg1Of inhibition,tumor
R7208 T10642 T10641 arg1Of inhibition,growth
R7209 T10642 T10643 arg1Of inhibition,of
R7210 T10645 T10643 arg2Of mice,of
R7211 T10645 T10644 arg1Of mice,CCR5−/−
R7212 T10647 T10646 arg1Of data,Our
R7213 T10647 T10649 arg1Of data,show
R7214 T10649 T10648 arg1Of show,thus
R7215 T10649 T10655 arg1Of show,","
R7216 T10649 T10656 arg1Of show,because
R7217 T10651 T10650 arg1Of clinical,significant
R7218 T10652 T10649 arg2Of implications,show
R7219 T10652 T10651 arg1Of implications,clinical
R7220 T10652 T10653 arg1Of implications,of
R7221 T10654 T10653 arg2Of CCR5,of
R7222 T10657 T10658 arg1Of CCR5,is
R7223 T10658 T10663 arg1Of is,and
R7224 T10661 T10660 arg1Of protein–coupled,G
R7225 T10662 T10658 arg2Of receptor,is
R7226 T10662 T10659 arg1Of receptor,a
R7227 T10662 T10661 arg1Of receptor,protein–coupled
R7228 T10663 T10656 arg2Of and,because
R7229 T10664 T10665 arg1Of it,is
R7230 T10664 T10666 arg1Of it,amenable
R7231 T10664 T10668 arg2Of it,use
R7232 T10665 T10663 arg2Of is,and
R7233 T10666 T10665 arg2Of amenable,is
R7234 T10668 T10666 arg2Of use,amenable
R7235 T10668 T10667 arg1Of use,to
R7236 T10668 T10669 arg1Of use,as
R7237 T10672 T10669 arg2Of molecule,as
R7238 T10672 T10670 arg1Of molecule,a
R7239 T10672 T10671 arg1Of molecule,small
R7240 T10672 T10673 arg1Of molecule,for
R7241 T10675 T10673 arg2Of inhibition,for
R7242 T10675 T10674 arg1Of inhibition,the
R7243 T10675 T10676 arg1Of inhibition,of
R7244 T10677 T10676 arg2Of CCR5,of
R7245 T10680 T10678 arg1Of compounds,Several
R7246 T10680 T10679 arg1Of compounds,such
R7247 T10680 T10681 arg1Of compounds,have
R7248 T10680 T10683 arg1Of compounds,been
R7249 T10680 T10684 arg2Of compounds,shown
R7250 T10680 T10686 arg1Of compounds,be
R7251 T10680 T10687 arg1Of compounds,safe
R7252 T10684 T10681 arg2Of shown,have
R7253 T10684 T10682 arg1Of shown,already
R7254 T10684 T10683 arg2Of shown,been
R7255 T10686 T10684 arg3Of be,shown
R7256 T10686 T10685 arg1Of be,to
R7257 T10687 T10686 arg2Of safe,be
R7258 T10687 T10688 arg1Of safe,in
R7259 T10690 T10688 arg2Of trials,in
R7260 T10690 T10689 arg1Of trials,clinical
R7261 T10690 T10691 arg1Of trials,for
R7262 T10692 T10691 arg2Of use,for
R7263 T10692 T10693 arg1Of use,in
R7264 T10695 T10693 arg2Of diseases,in
R7265 T10695 T10694 arg1Of diseases,certain
R7266 T10695 T10697 arg1Of diseases,as
R7267 T10697 T10696 arg1Of as,such
R7268 T10698 T10697 arg2Of HIV,as
R7269 T10698 T10699 arg1Of HIV,[
R7270 T10700 T10699 arg2Of 53,[
R7271 T10701 T10699 arg3Of ],[
R7272 T10704 T10705 arg1Of we,believe
R7273 T10705 T10702 arg1Of believe,Thus
R7274 T10705 T10703 arg1Of believe,","
R7275 T10706 T10707 arg1Of CCR5,is
R7276 T10707 T10705 arg2Of is,believe
R7277 T10710 T10707 arg2Of target,is
R7278 T10710 T10708 arg1Of target,a
R7279 T10710 T10709 arg1Of target,cancer
R7280 T10710 T10711 arg1Of target,that
R7281 T10710 T10712 arg1Of target,warrants
R7282 T10714 T10712 arg2Of investigation,warrants
R7283 T10714 T10713 arg1Of investigation,continued
R7284 T10716 T10715 arg2Of summary,In
R7285 T10719 T10718 arg1Of study,this
R7286 T10719 T10720 arg1Of study,showed
R7287 T10720 T10715 arg1Of showed,In
R7288 T10720 T10717 arg1Of showed,","
R7289 T10724 T10722 arg1Of growth,melanoma
R7290 T10724 T10723 arg1Of growth,cells
R7291 T10724 T10725 arg1Of growth,was
R7292 T10724 T10726 arg2Of growth,inhibited
R7293 T10726 T10720 arg2Of inhibited,showed
R7294 T10726 T10721 arg1Of inhibited,that
R7295 T10726 T10725 arg2Of inhibited,was
R7296 T10726 T10727 arg1Of inhibited,via
R7297 T10728 T10727 arg2Of modulation,via
R7298 T10728 T10729 arg1Of modulation,of
R7299 T10731 T10729 arg2Of pathways,of
R73 T292 T293 arg1Of expression,and
R7300 T10731 T10730 arg1Of pathways,NF-κB/IL-1Ra
R7301 T10731 T10732 arg1Of pathways,in
R7302 T10734 T10732 arg2Of mice,in
R7303 T10734 T10733 arg1Of mice,CCR5−/−
R74 T293 T283 arg2Of and,of
R75 T295 T293 arg2Of development,and
R76 T295 T294 arg1Of development,tumor
R77 T297 T280 arg1Of we,evaluate
R78 T297 T298 arg1Of we,compared
R79 T298 T279 modOf compared,To
R80 T298 T296 arg1Of compared,","
R81 T300 T298 arg2Of growth,compared
R82 T300 T299 arg1Of growth,melanoma
R83 T300 T301 arg1Of growth,in
R838 T1768 T1769 arg1Of Chemokines,are
R839 T1772 T1769 arg2Of molecules,are
R84 T303 T302 arg1Of knockout,CCR5
R840 T1772 T1770 arg1Of molecules,small
R841 T1772 T1771 arg1Of molecules,soluble
R842 T1772 T1773 arg1Of molecules,that
R843 T1772 T1774 arg1Of molecules,are
R844 T1772 T1776 arg2Of molecules,known
R845 T1776 T1774 arg2Of known,are
R846 T1776 T1775 arg1Of known,best
R847 T1776 T1777 arg1Of known,for
R848 T1780 T1777 arg2Of ability,for
R849 T1780 T1778 arg1Of ability,their
R85 T303 T304 arg1Of knockout,(
R850 T1780 T1779 arg1Of ability,potent
R851 T1780 T1781 modOf ability,to
R852 T1782 T1781 arg1Of induce,to
R853 T1782 T1786 arg1Of induce,by
R854 T1785 T1782 arg2Of growth,induce
R855 T1785 T1783 arg1Of growth,cancer
R856 T1785 T1784 arg1Of growth,cell
R857 T1787 T1786 arg2Of inflammation,by
R858 T1789 T1788 arg1Of types,Many
R859 T1789 T1790 arg1Of types,of
R86 T305 T304 arg2Of CCR5−/−,(
R860 T1789 T1793 arg1Of types,express
R861 T1792 T1790 arg2Of cells,of
R862 T1792 T1791 arg1Of cells,cancer
R863 T1793 T1798 arg1Of express,[
R864 T1794 T1795 arg1Of chemokines,and
R865 T1795 T1793 arg2Of and,express
R866 T1797 T1795 arg2Of receptors,and
R867 T1797 T1796 arg1Of receptors,chemokine
R868 T1799 T1798 arg2Of 1,[
R869 T1800 T1798 arg3Of ],[
R87 T306 T304 arg3Of ),(
R870 T1803 T1801 arg1Of evidence,The
R871 T1803 T1802 arg2Of evidence,accumulated
R872 T1803 T1804 arg1Of evidence,indicates
R873 T1810 T1808 arg2Of motif,(
R874 T1810 T1809 arg1Of motif,C-C
R875 T1811 T1808 arg3Of ),(
R876 T1812 T1806 arg1Of ligand,the
R877 T1812 T1807 arg1Of ligand,chemokine
R878 T1812 T1808 arg1Of ligand,(
R879 T1812 T1813 arg1Of ligand,5
R88 T307 T303 arg1Of mice,knockout
R880 T1812 T1814 arg1Of ligand,(
R881 T1812 T1817 arg1Of ligand,and
R882 T1815 T1814 arg2Of CCL5,(
R883 T1816 T1814 arg3Of ),(
R884 T1817 T1834 arg1Of and,may
R885 T1817 T1835 arg1Of and,be
R886 T1817 T1837 arg2Of and,involved
R887 T1820 T1817 arg2Of receptor,and
R888 T1820 T1818 arg1Of receptor,C-C
R889 T1820 T1819 arg1Of receptor,chemokine
R89 T307 T308 arg1Of mice,and
R890 T1820 T1821 arg1Of receptor,(
R891 T1820 T1824 arg1Of receptor,","
R892 T1820 T1825 arg1Of receptor,which
R893 T1820 T1826 arg1Of receptor,are
R894 T1822 T1821 arg2Of CCR5,(
R895 T1823 T1821 arg3Of ),(
R896 T1829 T1826 arg2Of factors,are
R897 T1829 T1827 arg1Of factors,potent
R898 T1829 T1828 arg1Of factors,chemotactic
R899 T1829 T1830 arg1Of factors,for
R90 T308 T301 arg2Of and,in
R900 T1832 T1830 arg2Of cells,for
R901 T1832 T1831 arg1Of cells,inflammatory
R902 T1837 T1804 arg2Of involved,indicates
R903 T1837 T1805 arg1Of involved,that
R9034 T13209 T13208 arg1Of Statement,Ethics
R9035 T13211 T13210 arg1Of experiments,All
R9036 T13211 T13212 arg1Of experiments,were
R9037 T13211 T13213 arg2Of experiments,approved
R9038 T13211 T13215 arg2Of experiments,carried
R9039 T13213 T13214 arg1Of approved,and
R904 T1837 T1833 arg1Of involved,","
R9040 T13214 T13212 arg2Of and,were
R9041 T13214 T13217 arg1Of and,according
R9042 T13214 T13221 arg1Of and,for
R9043 T13215 T13214 arg2Of carried,and
R9044 T13215 T13216 arg1Of carried,out
R9045 T13218 T13217 arg2Of to,according
R9046 T13220 T13218 arg2Of Guide,to
R9047 T13220 T13219 arg1Of Guide,the
R9048 T13223 T13224 arg1Of Care,and
R9049 T13224 T13221 arg2Of and,for
R905 T1837 T1834 arg2Of involved,may
R9050 T13224 T13222 arg1Of and,the
R9051 T13225 T13224 arg2Of Use,and
R9052 T13225 T13226 arg1Of Use,of
R9053 T13225 T13228 arg1Of Use,[
R9054 T13227 T13226 arg2Of Animals,of
R9055 T13231 T13228 arg2Of Committee,[
R9056 T13231 T13229 arg1Of Committee,Animal
R9057 T13231 T13230 arg1Of Committee,Care
R9058 T13231 T13232 arg1Of Committee,of
R9059 T13231 T13236 arg1Of Committee,","
R906 T1837 T1835 arg2Of involved,be
R9060 T13235 T13232 arg2Of University,of
R9061 T13235 T13233 arg1Of University,Chungbuk
R9062 T13235 T13234 arg1Of University,National
R9063 T13237 T13236 arg2Of Korea,","
R9064 T13237 T13238 arg1Of Korea,(
R9065 T13239 T13238 arg2Of CBNUA-045-0902-01,(
R9066 T13240 T13238 arg3Of ),(
R9067 T13241 T13228 arg3Of ],[
R907 T1837 T1836 arg1Of involved,significantly
R908 T1837 T1838 arg1Of involved,in
R909 T1840 T1841 arg1Of proliferation,and
R91 T310 T309 arg1Of type,wild
R910 T1841 T1838 arg2Of and,in
R9106 T13347 T13345 arg1Of type,CCR5
R9107 T13347 T13346 arg1Of type,wild
R9108 T13347 T13348 arg1Of type,(
R9109 T13347 T13351 arg1Of type,and
R911 T1841 T1839 arg1Of and,the
R9110 T13349 T13348 arg2Of CCR5+/+,(
R9111 T13350 T13348 arg3Of ),(
R9112 T13353 T13351 arg2Of knockout,and
R9113 T13353 T13352 arg1Of knockout,CCR5
R9114 T13353 T13354 arg1Of knockout,(
R9115 T13355 T13354 arg2Of CCR5−/−,(
R9116 T13356 T13354 arg3Of ),(
R9117 T13357 T13344 arg1Of mice,The
R9118 T13357 T13347 arg1Of mice,type
R9119 T13357 T13353 arg1Of mice,knockout
R912 T1841 T1843 arg1Of and,of
R9120 T13357 T13358 arg1Of mice,were
R9121 T13357 T13359 arg2Of mice,purchased
R9122 T13359 T13358 arg2Of purchased,were
R9123 T13359 T13360 arg1Of purchased,from
R9124 T13363 T13360 arg2Of Laboratory,from
R9125 T13363 T13361 arg1Of Laboratory,The
R9126 T13363 T13362 arg1Of Laboratory,Jackson
R9127 T13363 T13364 arg1Of Laboratory,(
R9128 T13366 T13364 arg2Of Harbor,(
R9129 T13366 T13365 arg1Of Harbor,Bar
R913 T1842 T1841 arg2Of metastasis,and
R9130 T13366 T13367 arg1Of Harbor,","
R9131 T13368 T13367 arg2Of Maine,","
R9132 T13368 T13369 arg1Of Maine,04609
R9133 T13368 T13370 arg1Of Maine,USA
R9134 T13371 T13364 arg3Of ),(
R9135 T13373 T13372 arg1Of mice,The
R9136 T13373 T13374 arg1Of mice,were
R9137 T13373 T13375 arg2Of mice,housed
R9138 T13373 T13377 arg2Of mice,bred
R9139 T13375 T13376 arg1Of housed,and
R914 T1845 T1843 arg2Of cancers,of
R9140 T13376 T13374 arg2Of and,were
R9141 T13376 T13378 arg1Of and,under
R9142 T13377 T13376 arg2Of bred,and
R9143 T13382 T13378 arg2Of conditions,under
R9144 T13382 T13379 arg1Of conditions,specific
R9145 T13382 T13380 arg1Of conditions,pathogen
R9146 T13382 T13381 arg1Of conditions,free
R9147 T13382 T13383 arg1Of conditions,at
R9148 T13388 T13383 arg2Of Center,at
R9149 T13388 T13384 arg1Of Center,the
R915 T1845 T1844 arg1Of cancers,several
R9150 T13388 T13385 arg1Of Center,Laboratory
R9151 T13388 T13386 arg1Of Center,Animal
R9152 T13388 T13387 arg1Of Center,Research
R9153 T13388 T13389 arg1Of Center,of
R9154 T13388 T13400 modOf Center,were
R9155 T13392 T13389 arg2Of University,of
R9156 T13392 T13390 arg1Of University,Chungbuk
R9157 T13392 T13391 arg1Of University,National
R9158 T13396 T13394 arg1Of mice,Korea.
R9159 T13396 T13395 arg1Of mice,The
R916 T1846 T1847 arg1Of Intermediate,and
R9160 T13396 T13397 arg1Of mice,(
R9161 T13396 T13400 arg1Of mice,were
R9162 T13396 T13401 arg2Of mice,maintained
R9163 T13398 T13397 arg2Of n = 4/cage,(
R9164 T13399 T13397 arg3Of ),(
R9165 T13401 T13393 arg1Of maintained,","
R9166 T13401 T13400 arg2Of maintained,were
R9167 T13401 T13402 arg1Of maintained,in
R9168 T13404 T13402 arg2Of room,in
R9169 T13404 T13403 arg1Of room,a
R917 T1848 T1847 arg2Of strong,and
R9170 T13404 T13405 arg1Of room,with
R9171 T13408 T13405 arg2Of temperature,with
R9172 T13408 T13406 arg1Of temperature,a
R9173 T13408 T13407 arg1Of temperature,constant
R9174 T13408 T13409 arg1Of temperature,of
R9175 T13410 T13411 arg1Of 22±1°C,","
R9176 T13411 T13418 arg1Of ",",and
R9177 T13413 T13411 arg2Of humidity,","
R9178 T13413 T13412 arg1Of humidity,relative
R9179 T13413 T13414 arg1Of humidity,of
R918 T1850 T1846 arg1Of expression,Intermediate
R9180 T13416 T13414 arg2Of %,of
R9181 T13416 T13415 arg1Of %,55±10
R9182 T13418 T13417 arg1Of and,","
R9183 T13418 T13423 arg1Of and,and
R9184 T13421 T13418 arg2Of cycle,and
R9185 T13421 T13419 arg1Of cycle,12-h
R9186 T13421 T13420 arg1Of cycle,light/dark
R9187 T13423 T13409 arg2Of and,of
R9188 T13423 T13422 arg1Of and,","
R9189 T13427 T13424 arg2Of chow,fed
R919 T1850 T1848 arg1Of expression,strong
R9190 T13427 T13425 arg1Of chow,standard
R9191 T13427 T13426 arg1Of chow,rodent
R9192 T13427 T13428 arg1Of chow,(
R9193 T13427 T13433 arg1Of chow,and
R9194 T13429 T13428 arg2Of Samyang,(
R9195 T13429 T13430 arg1Of Samyang,","
R9196 T13431 T13430 arg2Of Korea,","
R9197 T13432 T13428 arg3Of ),(
R9198 T13433 T13423 arg2Of and,and
R9199 T13438 T13433 arg2Of libitum,and
R92 T310 T311 arg1Of type,(
R920 T1850 T1849 arg1Of expression,CCR5
R9200 T13438 T13434 arg2Of libitum,purified
R9201 T13438 T13435 arg1Of libitum,tap
R9202 T13438 T13436 arg1Of libitum,water
R9203 T13438 T13437 arg1Of libitum,ad
R9204 T13441 T13440 arg1Of mice,CCR5+/+
R9205 T13441 T13442 arg1Of mice,(
R9206 T13441 T13445 arg1Of mice,and
R9207 T13443 T13442 arg2Of n = 20,(
R9208 T13444 T13442 arg3Of ),(
R9209 T13445 T13439 arg1Of and,The
R921 T1850 T1851 arg1Of expression,is
R9210 T13445 T13456 arg1Of and,had
R9211 T13445 T13457 arg1Of and,matched
R9212 T13447 T13445 arg2Of mice,and
R9213 T13447 T13446 arg1Of mice,CCR5−/−
R9214 T13447 T13448 arg1Of mice,(
R9215 T13447 T13451 arg1Of mice,","
R9216 T13447 T13452 arg1Of mice,that
R9217 T13447 T13453 arg1Of mice,were
R9218 T13447 T13454 arg2Of mice,used
R9219 T13449 T13448 arg2Of n = 20,(
R922 T1850 T1853 arg2Of expression,associated
R9220 T13450 T13448 arg3Of ),(
R9221 T13454 T13453 arg2Of used,were
R9222 T13457 T13455 arg1Of matched,","
R9223 T13457 T13456 arg2Of matched,had
R9224 T13458 T13459 arg1Of ages,(
R9225 T13458 T13464 arg1Of ages,and
R9226 T13461 T13459 arg2Of weeks,(
R9227 T13461 T13460 arg1Of weeks,10–11
R9228 T13461 T13462 arg1Of weeks,old
R9229 T13463 T13459 arg3Of ),(
R923 T1853 T1851 arg2Of associated,is
R9230 T13464 T13457 arg2Of and,matched
R9231 T13465 T13464 arg2Of weights,and
R9232 T13465 T13466 arg1Of weights,(
R9233 T13468 T13466 arg2Of g,(
R9234 T13468 T13467 arg1Of g,16–19
R9235 T13469 T13466 arg3Of ),(
R9236 T13471 T13470 arg1Of mice,Control
R9237 T13471 T13472 arg1Of mice,(
R9238 T13471 T13475 arg1Of mice,were
R9239 T13473 T13472 arg2Of B6129PF2/J,(
R924 T1853 T1852 arg1Of associated,significantly
R9240 T13474 T13472 arg3Of ),(
R9241 T13478 T13475 arg2Of mice,were
R9242 T13478 T13476 arg1Of mice,F2
R9243 T13478 T13477 arg1Of mice,hybrid
R9244 T13478 T13479 arg1Of mice,from
R9245 T13481 T13482 arg1Of C57BL/6J-AW-J,and
R9246 T13483 T13482 arg2Of 129P3/J,and
R9247 T13485 T13479 arg2Of strains,from
R9248 T13485 T13480 arg1Of strains,the
R9249 T13485 T13481 arg1Of strains,C57BL/6J-AW-J
R925 T1853 T1854 arg1Of associated,with
R9250 T13485 T13483 arg1Of strains,129P3/J
R9251 T13485 T13484 arg1Of strains,parental
R9252 T13487 T13486 arg1Of mice,CCR5
R9253 T13487 T13488 arg1Of mice,(
R9254 T13487 T13493 arg1Of mice,have
R9255 T13489 T13488 arg2Of B6,(
R9256 T13489 T13490 arg1Of B6,","
R9257 T13491 T13490 arg2Of 129P2-Ccr5tm1Kuz/J,","
R9258 T13492 T13488 arg3Of ),(
R9259 T13497 T13493 arg2Of region,have
R926 T1853 T1890 arg1Of associated,[
R9260 T13497 T13494 arg1Of region,the
R9261 T13497 T13495 arg1Of region,entire
R9262 T13497 T13496 arg1Of region,coding
R9263 T13497 T13498 arg1Of region,of
R9264 T13501 T13498 arg2Of gene,of
R9265 T13501 T13499 arg1Of gene,the
R9266 T13501 T13500 arg1Of gene,CCR5
R9267 T13501 T13502 arg2Of gene,deleted
R9268 T13501 T13507 arg1Of gene,","
R9269 T13502 T13503 arg1Of deleted,from
R927 T1856 T1855 arg1Of development,nonmetastatic
R9270 T13506 T13503 arg2Of strains,from
R9271 T13506 T13504 arg1Of strains,the
R9272 T13506 T13505 arg1Of strains,parental
R9273 T13508 T13507 arg2Of B6,","
R9274 T13508 T13509 arg1Of B6,;
R9275 T13510 T13511 arg1Of 129P2-Ccr5tm1kuz,and
R9276 T13511 T13509 arg2Of and,;
R9277 T13511 T13513 arg1Of and,;
R9278 T13512 T13511 arg2Of B6,and
R9279 T13514 T13513 arg2Of 129P2-Cmkbr5tm1Kuz,;
R928 T1856 T1857 arg1Of development,of
R929 T1856 T1884 arg1Of development,as
R93 T312 T311 arg2Of CCR5+/+,(
R930 T1859 T1858 arg1Of cancer,colorectal
R931 T1859 T1860 arg1Of cancer,[
R932 T1859 T1863 arg1Of cancer,","
R933 T1861 T1860 arg2Of 2,[
R934 T1862 T1860 arg3Of ],[
R935 T1863 T1868 arg1Of ",",","
R936 T1864 T1863 arg2Of melanoma,","
R937 T1864 T1865 arg1Of melanoma,[
R938 T1866 T1865 arg2Of 3,[
R939 T1867 T1865 arg3Of ],[
R94 T313 T311 arg3Of ),(
R940 T1868 T1873 arg1Of ",",","
R941 T1869 T1868 arg2Of hepatoma,","
R942 T1869 T1870 arg1Of hepatoma,[
R943 T1871 T1870 arg2Of 4,[
R944 T1872 T1870 arg3Of ],[
R945 T1873 T1875 arg1Of ",",","
R946 T1874 T1873 arg2Of glioblastoma,","
R947 T1875 T1857 arg2Of ",",of
R948 T1877 T1875 arg2Of lymphoma,","
R949 T1877 T1876 arg1Of lymphoma,Hodgkin
R9498 T13815 T13814 arg1Of Inoculation,Tumor
R9499 T13815 T13816 arg1Of Inoculation,and
R95 T314 T308 arg2Of mice,and
R950 T1877 T1878 arg1Of lymphoma,[
R9500 T13818 T13816 arg2Of Monitoring,and
R9501 T13818 T13817 arg1Of Monitoring,Tumor
R9502 T13821 T13819 arg1Of cells,B16
R9503 T13821 T13820 arg1Of cells,melanoma
R9504 T13821 T13822 arg1Of cells,were
R9505 T13821 T13823 arg2Of cells,injected
R9506 T13823 T13822 arg2Of injected,were
R9507 T13823 T13824 arg1Of injected,subcutaneously
R9508 T13823 T13825 arg1Of injected,[
R9509 T13823 T13840 modOf injected,using
R951 T1879 T1878 arg2Of 5,[
R9510 T13828 T13825 arg2Of cells,[
R9511 T13828 T13826 arg1Of cells,5×105
R9512 T13828 T13827 arg1Of cells,tumor
R9513 T13828 T13829 arg1Of cells,in
R9514 T13830 T13831 arg1Of 0.1,ml
R9515 T13832 T13829 arg2Of Phosphate,in
R9516 T13832 T13830 arg1Of Phosphate,0.1
R9517 T13832 T13833 arg2Of Phosphate,buffered
R9518 T13832 T13838 arg1Of Phosphate,/animal
R9519 T13834 T13833 arg3Of saline,buffered
R952 T1880 T1878 arg3Of ],[
R9520 T13834 T13835 arg1Of saline,(
R9521 T13836 T13835 arg2Of PBS,(
R9522 T13837 T13835 arg3Of ),(
R9523 T13839 T13825 arg3Of ],[
R9524 T13844 T13840 arg2Of needle,using
R9525 T13844 T13841 arg1Of needle,a
R9526 T13844 T13842 arg1Of needle,27
R9527 T13844 T13843 arg1Of needle,G
R9528 T13844 T13845 arg1Of needle,into
R9529 T13848 T13845 arg2Of flanks,into
R953 T1884 T1854 arg2Of as,with
R9530 T13848 T13846 arg1Of flanks,the
R9531 T13848 T13847 arg1Of flanks,right-lower
R9532 T13848 T13849 arg1Of flanks,of
R9533 T13848 T13853 arg1Of flanks,as
R9534 T13852 T13849 arg2Of mice,of
R9535 T13852 T13850 arg1Of mice,the
R9536 T13852 T13851 arg1Of mice,carrier
R9537 T13855 T13854 arg1Of described,previously
R9538 T13857 T13853 arg2Of 54,as
R9539 T13857 T13855 arg1Of 54,described
R954 T1884 T1881 arg1Of as,","
R9540 T13857 T13856 arg2Of 54,[
R9541 T13858 T13856 arg3Of ],[
R9542 T13861 T13860 arg1Of weights,body
R9543 T13861 T13862 arg1Of weights,and
R9544 T13862 T13859 arg1Of and,The
R9545 T13862 T13865 arg1Of and,of
R9546 T13862 T13868 arg1Of and,were
R9547 T13862 T13869 arg2Of and,monitored
R9548 T13864 T13862 arg2Of volumes,and
R9549 T13864 T13863 arg1Of volumes,tumor
R955 T1884 T1882 arg1Of as,as
R9550 T13867 T13865 arg2Of animals,of
R9551 T13867 T13866 arg1Of animals,the
R9552 T13869 T13868 arg2Of monitored,were
R9553 T13869 T13871 arg1Of monitored,weekly
R9554 T13871 T13870 arg1Of weekly,twice
R9555 T13874 T13872 arg1Of volumes,The
R9556 T13874 T13873 arg1Of volumes,tumor
R9557 T13874 T13875 arg1Of volumes,were
R9558 T13874 T13876 arg2Of volumes,measured
R9559 T13874 T13881 arg2Of volumes,calculated
R956 T1884 T1883 arg1Of as,well
R9560 T13876 T13875 arg2Of measured,were
R9561 T13876 T13877 arg1Of measured,with
R9562 T13876 T13880 arg1Of measured,and
R9563 T13879 T13877 arg2Of calipers,with
R9564 T13879 T13878 arg1Of calipers,Vernier
R9565 T13881 T13880 arg2Of calculated,and
R9566 T13881 T13882 modOf calculated,using
R9567 T13885 T13882 arg2Of formula,using
R9568 T13885 T13883 arg1Of formula,the
R9569 T13885 T13884 arg1Of formula,following
R957 T1889 T1884 arg2Of cells,as
R9570 T13885 T13886 arg1Of formula,:
R9571 T13888 T13887 arg2Of A×B2,(
R9572 T13889 T13887 arg3Of ),(
R9573 T13890 T13886 arg2Of /2,:
R9574 T13890 T13887 arg1Of /2,(
R9575 T13890 T13891 arg1Of /2,","
R9576 T13890 T13892 arg1Of /2,where
R9577 T13893 T13894 arg1Of A,is
R9578 T13893 T13896 arg1Of A,larger
R9579 T13894 T13897 arg1Of is,and
R958 T1889 T1885 arg1Of cells,oral
R9580 T13896 T13894 arg2Of larger,is
R9581 T13896 T13895 arg1Of larger,the
R9582 T13897 T13892 arg2Of and,where
R9583 T13898 T13899 arg1Of B,is
R9584 T13899 T13897 arg2Of is,and
R9585 T13901 T13899 arg2Of smaller,is
R9586 T13901 T13900 arg1Of smaller,the
R9587 T13901 T13902 arg1Of smaller,of
R9588 T13905 T13902 arg2Of dimensions,of
R9589 T13905 T13903 arg1Of dimensions,the
R959 T1889 T1886 arg1Of cells,and
R9590 T13905 T13904 arg1Of dimensions,two
R9591 T13908 T13906 arg2Of end,At
R9592 T13908 T13907 arg1Of end,the
R9593 T13908 T13909 arg1Of end,of
R9594 T13911 T13909 arg2Of experiment,of
R9595 T13911 T13910 arg1Of experiment,the
R9596 T13914 T13913 arg1Of animals,the
R9597 T13914 T13915 arg1Of animals,were
R9598 T13914 T13916 arg2Of animals,sacrificed
R9599 T13916 T13906 arg1Of sacrificed,At
R96 T314 T310 arg1Of mice,type
R960 T1889 T1887 arg1Of cells,prostate
R9600 T13916 T13912 arg1Of sacrificed,","
R9601 T13916 T13915 arg2Of sacrificed,were
R9602 T13918 T13917 arg1Of tumors,The
R9603 T13918 T13919 arg1Of tumors,were
R9604 T13918 T13920 arg2Of tumors,separated
R9605 T13920 T13919 arg2Of separated,were
R9606 T13920 T13921 arg1Of separated,from
R9607 T13924 T13925 arg1Of muscles,and
R9608 T13925 T13921 arg2Of and,from
R9609 T13925 T13922 arg1Of and,the
R961 T1889 T1888 arg1Of cells,cancer
R9610 T13925 T13923 arg1Of and,surrounding
R9611 T13926 T13925 arg2Of dermis,and
R962 T1891 T1890 arg2Of 6,[
R963 T1892 T1890 arg3Of ],[
R964 T1894 T1893 arg1Of production,Local
R965 T1894 T1895 arg1Of production,of
R966 T1894 T1898 arg1Of production,is
R967 T1894 T1900 arg1Of production,important
R968 T1894 T1913 arg1Of production,correlates
R969 T1897 T1895 arg2Of CCL5,of
R97 T316 T315 arg1Of mice,CCR5−/−
R970 T1897 T1896 arg1Of CCL5,the
R971 T1898 T1899 arg1Of is,also
R972 T1898 T1911 arg1Of is,and
R973 T1900 T1898 arg2Of important,is
R9736 T14103 T14102 arg1Of Blotting,Western
R9737 T14105 T14104 arg1Of tissues,Tumor
R9738 T14105 T14106 arg1Of tissues,were
R9739 T14105 T14107 arg2Of tissues,homogenized
R974 T1900 T1901 arg1Of important,in
R9740 T14105 T14124 arg2Of tissues,lysed
R9741 T14107 T14108 arg1Of homogenized,with
R9742 T14107 T14123 arg1Of homogenized,and
R9743 T14111 T14108 arg2Of solution,with
R9744 T14111 T14109 arg1Of solution,protein
R9745 T14111 T14110 arg1Of solution,extraction
R9746 T14111 T14112 arg1Of solution,(
R9747 T14113 T14114 arg1Of PRO-PREPTM,","
R9748 T14113 T14117 arg1Of PRO-PREPTM,","
R9749 T14116 T14114 arg2Of Biotechnology,","
R975 T1903 T1901 arg2Of progression,in
R9750 T14116 T14115 arg1Of Biotechnology,Intron
R9751 T14117 T14112 arg2Of ",",(
R9752 T14118 T14117 arg2Of Seoul,","
R9753 T14118 T14119 arg1Of Seoul,","
R9754 T14120 T14119 arg2Of Korea,","
R9755 T14121 T14112 arg3Of ),(
R9756 T14123 T14106 arg2Of and,were
R9757 T14123 T14122 arg1Of and,","
R9758 T14124 T14123 arg2Of lysed,and
R9759 T14128 T14124 arg1Of incubation,lysed
R976 T1903 T1902 arg1Of progression,the
R9760 T14128 T14125 arg2Of incubation,by
R9761 T14128 T14126 arg1Of incubation,60
R9762 T14128 T14127 arg1Of incubation,min
R9763 T14128 T14129 arg1Of incubation,on
R9764 T14130 T14129 arg2Of ice,on
R9765 T14133 T14131 arg1Of lysate,The
R9766 T14133 T14132 arg1Of lysate,tissue
R9767 T14133 T14134 arg2Of lysate,centrifuged
R9768 T14133 T14151 arg1Of lysate,were
R9769 T14133 T14152 arg2Of lysate,separated
R977 T1903 T1904 arg1Of progression,of
R9770 T14133 T14162 arg2Of lysate,transferred
R9771 T14134 T14135 arg1Of centrifuged,at
R9772 T14134 T14138 arg1Of centrifuged,for
R9773 T14137 T14135 arg2Of rpm,at
R9774 T14137 T14136 arg1Of rpm,"15,000"
R9775 T14140 T14138 arg2Of min,for
R9776 T14140 T14139 arg1Of min,15
R9777 T14140 T14141 arg1Of min,at
R9778 T14143 T14142 arg1Of Equal,4°C.
R9779 T14144 T14141 arg2Of amounts,at
R978 T1906 T1904 arg2Of cancer,of
R9780 T14144 T14143 arg1Of amounts,Equal
R9781 T14144 T14145 arg1Of amounts,of
R9782 T14146 T14145 arg2Of proteins,of
R9783 T14146 T14147 arg1Of proteins,(
R9784 T14149 T14147 arg2Of µg,(
R9785 T14149 T14148 arg1Of µg,40
R9786 T14150 T14147 arg3Of ),(
R9787 T14152 T14153 arg1Of separated,on
R9788 T14152 T14160 arg1Of separated,and
R9789 T14158 T14153 arg2Of gel,on
R979 T1906 T1905 arg1Of cancer,breast
R9790 T14158 T14154 arg1Of gel,a
R9791 T14158 T14155 arg1Of gel,SDS/12
R9792 T14158 T14156 arg1Of gel,%
R9793 T14158 T14157 arg1Of gel,-polyacrylamide
R9794 T14160 T14151 arg2Of and,were
R9795 T14160 T14159 arg1Of and,","
R9796 T14162 T14160 arg2Of transferred,and
R9797 T14162 T14161 arg1Of transferred,then
R9798 T14162 T14163 arg1Of transferred,to
R9799 T14168 T14167 arg2Of PVDF,(
R98 T316 T317 arg1Of mice,showed
R980 T1906 T1907 arg1Of cancer,[
R9800 T14169 T14167 arg3Of ),(
R9801 T14170 T14163 arg2Of membrane,to
R9802 T14170 T14164 arg1Of membrane,a
R9803 T14170 T14165 arg1Of membrane,polyvinylidene
R9804 T14170 T14166 arg1Of membrane,difluoride
R9805 T14170 T14167 arg1Of membrane,(
R9806 T14170 T14171 arg1Of membrane,(
R9807 T14173 T14172 arg1Of Water,GE
R9808 T14173 T14174 arg1Of Water,and
R9809 T14175 T14174 arg2Of Process,and
R981 T1908 T1907 arg2Of 7,[
R9810 T14176 T14171 arg2Of technologies,(
R9811 T14176 T14173 arg1Of technologies,Water
R9812 T14176 T14175 arg1Of technologies,Process
R9813 T14176 T14177 arg1Of technologies,","
R9814 T14176 T14181 arg1Of technologies,","
R9815 T14176 T14182 arg1Of technologies,USA
R9816 T14178 T14177 arg2Of Trevose,","
R9817 T14178 T14179 arg1Of Trevose,","
R9818 T14180 T14179 arg2Of PA,","
R9819 T14183 T14171 arg3Of ),(
R982 T1909 T1907 arg3Of ],[
R9820 T14184 T14185 arg1Of Blots,were
R9821 T14184 T14186 arg2Of Blots,blocked
R9822 T14186 T14185 arg2Of blocked,were
R9823 T14186 T14187 arg1Of blocked,for
R9824 T14186 T14190 arg1Of blocked,at
R9825 T14186 T14193 arg1Of blocked,with
R9826 T14189 T14187 arg2Of h,for
R9827 T14189 T14188 arg1Of h,1
R9828 T14192 T14190 arg2Of temperature,at
R9829 T14192 T14191 arg1Of temperature,room
R983 T1911 T1910 arg1Of and,","
R9830 T14195 T14194 arg1Of %,5
R9831 T14197 T14196 arg2Of w/v,(
R9832 T14198 T14196 arg3Of ),(
R9833 T14201 T14193 arg2Of milk,with
R9834 T14201 T14195 arg1Of milk,%
R9835 T14201 T14196 arg1Of milk,(
R9836 T14201 T14199 arg1Of milk,non-fat
R9837 T14201 T14200 arg2Of milk,dried
R9838 T14201 T14202 arg1Of milk,in
R9839 T14201 T14208 arg1Of milk,:
R984 T1913 T1911 arg2Of correlates,and
R9840 T14207 T14202 arg2Of TBST,in
R9841 T14207 T14203 arg1Of TBST,Tris-Buffered
R9842 T14207 T14204 arg1Of TBST,Saline
R9843 T14207 T14205 arg1Of TBST,Tween-20
R9844 T14207 T14206 arg1Of TBST,[
R9845 T14209 T14210 arg1Of 10,mM
R9846 T14211 T14209 arg1Of Tris,10
R9847 T14211 T14212 arg1Of Tris,(
R9848 T14211 T14216 arg1Of Tris,and
R9849 T14213 T14212 arg2Of pH,(
R985 T1913 T1912 arg1Of correlates,also
R9850 T14213 T14214 arg1Of pH,8.0
R9851 T14215 T14212 arg3Of ),(
R9852 T14216 T14224 arg1Of and,Tween-20
R9853 T14216 T14225 arg1Of and,]
R9854 T14217 T14218 arg1Of 150,mM
R9855 T14220 T14216 arg2Of solution,and
R9856 T14220 T14217 arg1Of solution,150
R9857 T14220 T14219 arg1Of solution,NaCl
R9858 T14220 T14221 arg1Of solution,containing
R9859 T14223 T14221 arg2Of %,containing
R986 T1913 T1914 arg1Of correlates,with
R9860 T14223 T14222 arg1Of %,0.05
R9861 T14229 T14226 arg2Of washing,After
R9862 T14229 T14227 arg1Of washing,a
R9863 T14229 T14228 arg1Of washing,short
R9864 T14229 T14230 arg1Of washing,in
R9865 T14231 T14230 arg2Of TBST,in
R9866 T14234 T14233 arg1Of membranes,the
R9867 T14234 T14235 arg1Of membranes,were
R9868 T14234 T14236 arg2Of membranes,immunoblotted
R9869 T14236 T14226 arg1Of immunoblotted,After
R987 T1913 T1917 arg1Of correlates,[
R9870 T14236 T14232 arg1Of immunoblotted,","
R9871 T14236 T14235 arg2Of immunoblotted,were
R9872 T14236 T14237 arg1Of immunoblotted,with
R9873 T14241 T14237 arg2Of antibodies,with
R9874 T14241 T14238 arg1Of antibodies,the
R9875 T14241 T14239 arg1Of antibodies,following
R9876 T14241 T14240 arg1Of antibodies,primary
R9877 T14241 T14242 arg1Of antibodies,:
R9878 T14245 T14243 arg1Of antibodies,mouse
R9879 T14245 T14244 arg1Of antibodies,monoclonal
R988 T1916 T1914 arg2Of prognosis,with
R9880 T14245 T14246 arg2Of antibodies,directed
R9881 T14245 T14251 arg1Of antibodies,(
R9882 T14245 T14264 arg1Of antibodies,","
R9883 T14246 T14247 arg1Of directed,against
R9884 T14248 T14249 arg1Of p65,and
R9885 T14249 T14247 arg2Of and,against
R9886 T14250 T14249 arg2Of p50,and
R9887 T14253 T14251 arg2Of dilutions,(
R9888 T14253 T14252 arg1Of dilutions,1∶500
R9889 T14253 T14254 arg1Of dilutions,;
R989 T1916 T1915 arg1Of prognosis,poor
R9890 T14253 T14261 arg1Of dilutions,","
R9891 T14253 T14262 arg1Of dilutions,CA
R9892 T14257 T14254 arg2Of Biotechnology,;
R9893 T14257 T14255 arg1Of Biotechnology,Santa
R9894 T14257 T14256 arg1Of Biotechnology,Cruz
R9895 T14257 T14258 arg1Of Biotechnology,","
R9896 T14260 T14258 arg2Of Cruz,","
R9897 T14260 T14259 arg1Of Cruz,Santa
R9898 T14263 T14251 arg3Of ),(
R9899 T14264 T14242 arg2Of ",",:
R99 T316 T330 arg1Of mice,compared
R990 T1918 T1917 arg2Of 8,[
R9900 T14264 T14268 arg2Of ",",directed
R9901 T14264 T14291 arg1Of ",",(
R9902 T14267 T14264 arg2Of antibodies,","
R9903 T14267 T14265 arg1Of antibodies,rabbit
R9904 T14267 T14266 arg1Of antibodies,polyclonal
R9905 T14268 T14269 arg1Of directed,against
R9906 T14268 T14283 arg1Of directed,against
R9907 T14269 T14282 arg1Of against,and
R9908 T14270 T14271 arg1Of Bax,and
R9909 T14271 T14269 arg2Of and,against
R991 T1919 T1917 arg3Of ],[
R9910 T14272 T14271 arg2Of PARP,and
R9911 T14272 T14273 arg1Of PARP,(
R9912 T14275 T14273 arg2Of dilutions,(
R9913 T14275 T14274 arg1Of dilutions,1∶500
R9914 T14275 T14276 arg1Of dilutions,;
R9915 T14279 T14276 arg2Of Biotechnology,;
R9916 T14279 T14277 arg1Of Biotechnology,Santa
R9917 T14279 T14278 arg1Of Biotechnology,Cruz
R9918 T14280 T14273 arg3Of ),(
R9919 T14282 T14281 arg1Of and,","
R992 T1923 T1922 arg1Of disruption,CCR5
R9920 T14283 T14282 arg2Of against,and
R9921 T14284 T14285 arg1Of caspase-3,","
R9922 T14285 T14287 arg1Of ",",","
R9923 T14286 T14285 arg2Of caspase-9,","
R9924 T14287 T14289 arg1Of ",",and
R9925 T14288 T14287 arg2Of Bcl-2,","
R9926 T14289 T14283 arg2Of and,against
R9927 T14290 T14289 arg2Of c-IAP-1,and
R9928 T14293 T14291 arg2Of dilutions,(
R9929 T14293 T14292 arg1Of dilutions,1∶1000
R993 T1923 T1924 arg1Of disruption,has
R9930 T14293 T14294 arg1Of dilutions,;
R9931 T14293 T14300 arg1Of dilutions,","
R9932 T14293 T14301 arg1Of dilutions,MA
R9933 T14297 T14295 arg1Of Technology,Cell
R9934 T14297 T14296 arg1Of Technology,Signaling
R9935 T14297 T14298 arg1Of Technology,","
R9936 T14298 T14294 arg2Of ",",;
R9937 T14299 T14298 arg2Of Beverly,","
R9938 T14302 T14291 arg3Of ),(
R9939 T14304 T14303 arg1Of blots,The
R994 T1923 T1925 arg1Of disruption,been
R9940 T14304 T14305 arg1Of blots,were
R9941 T14304 T14306 arg2Of blots,incubated
R9942 T14306 T14305 arg2Of incubated,were
R9943 T14306 T14307 arg1Of incubated,with
R9944 T14311 T14310 arg1Of peroxidase-conjugated,horseradish
R9945 T14312 T14313 arg1Of anti-rabbit,or
R9946 T14314 T14313 arg2Of anti-mouse,or
R9947 T14315 T14307 arg2Of IgG,with
R9948 T14315 T14308 arg1Of IgG,the
R9949 T14315 T14309 arg1Of IgG,respective
R995 T1923 T1926 arg2Of disruption,demonstrated
R9950 T14315 T14311 arg1Of IgG,peroxidase-conjugated
R9951 T14315 T14312 arg1Of IgG,anti-rabbit
R9952 T14315 T14314 arg1Of IgG,anti-mouse
R9953 T14315 T14316 arg1Of IgG,(
R9954 T14318 T14316 arg2Of dilutions,(
R9955 T14318 T14317 arg1Of dilutions,1∶4000
R9956 T14318 T14319 arg1Of dilutions,;
R9957 T14322 T14319 arg2Of Biotechnology,;
R9958 T14322 T14320 arg1Of Biotechnology,Santa
R9959 T14322 T14321 arg1Of Biotechnology,Cruz
R996 T1923 T1928 arg1Of disruption,inhibit
R9960 T14323 T14316 arg3Of ),(
R9961 T14325 T14324 arg1Of proteins,Immunoreactive
R9962 T14325 T14326 arg1Of proteins,were
R9963 T14325 T14327 arg2Of proteins,detected
R9964 T14327 T14326 arg2Of detected,were
R9965 T14327 T14328 arg1Of detected,with
R9966 T14332 T14328 arg2Of system,with
R9967 T14332 T14329 arg1Of system,the
R9968 T14332 T14330 arg1Of system,ECL
R9969 T14332 T14331 arg1Of system,detection
R997 T1926 T1920 arg1Of demonstrated,Meanwhile
R998 T1926 T1921 arg1Of demonstrated,","
R999 T1926 T1924 arg2Of demonstrated,has